Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23408.Triglycerides in VLDL,AGRP,Agouti-related protein,42754,0.283208897857775,0.00483222984427028,0.273737727363005,0.292680068352545,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCN1,CCN family member 1,42569,0.36567028283022,0.00701013695407446,0.351930414400234,0.379410151260206,0
NMR metabolomics,X23408.Triglycerides in VLDL,CES1,Liver carboxylesterase 1,42661,0.326513447003674,0.00798428439165732,0.310864249596026,0.342162644411322,0
NMR metabolomics,X23408.Triglycerides in VLDL,GCG,Pro-glucagon,42346,0.516194196819999,0.012435531369464,0.49182055533585,0.540567838304149,0
NMR metabolomics,X23408.Triglycerides in VLDL,LDLR,Low-density lipoprotein receptor,42644,0.400075147988502,0.00408508660934517,0.392068378234185,0.408081917742818,0
NMR metabolomics,X23408.Triglycerides in VLDL,LPL,Lipoprotein lipase,42636,-0.192332385745125,0.00458061483593451,-0.201310390823556,-0.183354380666693,0
NMR metabolomics,X23408.Triglycerides in VLDL,MFGE8,Lactadherin,42611,0.239810851550702,0.0040668536155838,0.231839818464158,0.247781884637247,0
NMR metabolomics,X23408.Triglycerides in VLDL,NPY,Pro-neuropeptide Y,42721,0.358584542571167,0.00598912161499478,0.346845864205777,0.370323220936557,0
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF9,Protein turtle homolog A,40511,0.323157554847001,0.00813235491803538,0.307218139207652,0.33909697048635,1.1125369292536e-308
NMR metabolomics,X23408.Triglycerides in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.290193067120924,0.00739355270744589,0.275701703814331,0.304684430427518,1.11253695772937e-308
NMR metabolomics,X23408.Triglycerides in VLDL,GHR,Growth hormone receptor,40283,0.108267398298364,0.00278226963602067,0.102814149811763,0.113720646784964,1.11912919728388e-308
NMR metabolomics,X23408.Triglycerides in VLDL,FURIN,Furin,42679,0.124224331812484,0.00323810336704232,0.117877649213081,0.130571014411887,1.05100377087358e-305
NMR metabolomics,X23408.Triglycerides in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0838764438367941,0.00218101992169768,0.0796016447902666,0.0881512428833215,2.98039155028191e-304
NMR metabolomics,X23408.Triglycerides in VLDL,ADIPOQ,Adiponectin,40539,-0.257664271068093,0.00682046773367455,-0.271032387826095,-0.244296154310091,2.7505107974865e-294
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.120982725771807,0.00326701626227039,0.114579373897757,0.127386077645857,5.22223802554896e-286
NMR metabolomics,X23408.Triglycerides in VLDL,PRAP1,Proline-rich acidic protein 1,40527,0.149586162028532,0.00411254120279976,0.141525581271045,0.15764674278602,4.42304039932036e-274
NMR metabolomics,X23408.Triglycerides in VLDL,F7,Coagulation factor VII,42671,0.109011033844208,0.00310375750077981,0.10292766914268,0.115094398545737,1.16604557518093e-258
NMR metabolomics,X23408.Triglycerides in VLDL,PTH,Parathyroid hormone,40182,0.286234812784491,0.00814403170048512,0.27027251065154,0.302197114917442,1.49974806566395e-256
NMR metabolomics,X23408.Triglycerides in VLDL,INHBC,Inhibin beta C chain,42611,0.142953112839341,0.00410962896489235,0.134898240068152,0.15100798561053,6.50297595532349e-254
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A5,Zinc transporter ZIP5,42594,0.187198482470756,0.00539683233846763,0.176620691087359,0.197776273854153,1.53636368546113e-252
NMR metabolomics,X23408.Triglycerides in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.146095435078916,0.00423429457882619,0.137796217704417,0.154394652453416,4.48600569732398e-250
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES2,Retinoic acid receptor responder protein 2,42705,0.161853493545014,0.0047148549880887,0.15261237776836,0.171094609321668,1.09531301439803e-247
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.274490931732898,0.00815714383360595,0.25850292981903,0.290478933646765,3.31525501486366e-238
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.291335173347769,0.00867659048848793,0.274329055990333,0.308341290705205,2.16842237163885e-237
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.111582461834558,0.00333401318573767,0.105047795990512,0.118117127678604,6.14190415792135e-236
NMR metabolomics,X23408.Triglycerides in VLDL,CCL27,C-C motif chemokine 27,42636,0.198034430583477,0.00591891216108193,0.186433362747757,0.209635498419198,8.04663612625698e-236
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS15,Enteropeptidase,42587,0.303609839418799,0.00917522681721102,0.285626394857065,0.321593283980532,7.10681205223117e-231
NMR metabolomics,X23408.Triglycerides in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.263113992186164,0.00797692387068652,0.247479221399619,0.27874876297271,1.80429703882139e-229
NMR metabolomics,X23408.Triglycerides in VLDL,NRP1,Neuropilin-1,42705,-0.0919954903254036,0.00279542293633165,-0.0974745192806136,-0.0865164613701936,1.4988457445647e-228
NMR metabolomics,X23408.Triglycerides in VLDL,C9,Complement component C9,40532,-0.174781857392866,0.00530442821099331,-0.185178536686413,-0.16438517809932,1.81628520100476e-227
NMR metabolomics,X23408.Triglycerides in VLDL,CCL23,C-C motif chemokine 23,42676,0.138546967835447,0.00422531011330727,0.130265360013365,0.14682857565753,5.95290162157817e-227
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.492173544207541,0.015097656001694,0.462582138444221,0.521764949970862,2.54535240639266e-224
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.112632949953645,0.00347126720813023,0.10582926622571,0.11943663368158,1.77748074756768e-222
NMR metabolomics,X23408.Triglycerides in VLDL,GPR37,Prosaposin receptor GPR37,42357,0.220265210252681,0.00687968081283215,0.20678103585953,0.233749384645832,1.15452999819885e-216
NMR metabolomics,X23408.Triglycerides in VLDL,DSG2,Desmoglein-2,42611,-0.0877022617463656,0.0027473957667089,-0.093087157449115,-0.0823173660436161,1.37404506808729e-215
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.335477316956059,0.0105215021951657,0.314855172653535,0.356099461258584,4.25649155751652e-215
NMR metabolomics,X23408.Triglycerides in VLDL,CD4,T-cell surface glycoprotein CD4,42570,0.097854326843137,0.0031337181857705,0.0917122391990268,0.103996414487247,1.11735972747975e-206
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.379040220234276,0.0121432935760141,-0.402841075643264,-0.355239364825289,1.25996333011564e-206
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN3,Contactin-3,42611,0.0980872823392044,0.00315339540905118,0.091906627337464,0.104267937340945,3.59052879720046e-205
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA5,Plasma serine protease inhibitor,40387,0.0976199669252201,0.00316911680625328,0.0914084979849637,0.103831435865477,4.54976570531674e-200
NMR metabolomics,X23408.Triglycerides in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.251713669319508,0.008208811390031,0.235624398995047,0.267802939643968,1.64201087195437e-199
NMR metabolomics,X23408.Triglycerides in VLDL,TTR,Transthyretin,40424,0.0776883103062065,0.00254077448624517,0.0727083923131659,0.082668228299247,2.66245875139942e-197
NMR metabolomics,X23408.Triglycerides in VLDL,CPM,Carboxypeptidase M,42655,0.103736395823781,0.00341205445868117,0.0970487690847655,0.110424022562796,2.0278738970838e-196
NMR metabolomics,X23408.Triglycerides in VLDL,PLTP,Phospholipid transfer protein,42752,-0.109418242939856,0.0036286168608506,-0.116530331987123,-0.102306153892589,2.12734246680945e-193
NMR metabolomics,X23408.Triglycerides in VLDL,PROC,Vitamin K-dependent protein C,42663,0.0765887128799181,0.00254255955072064,0.0716052961605057,0.0815721295993306,5.69665809473928e-193
NMR metabolomics,X23408.Triglycerides in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.21176061906981,0.00704967854900118,0.197943249113767,0.225577989025852,6.66011900268522e-192
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.18380793435491,0.00629123935280032,-0.196138763486399,-0.171477105223422,4.84179122607268e-182
NMR metabolomics,X23408.Triglycerides in VLDL,BCHE,Cholinesterase,40346,0.0822106666434099,0.00281269144223817,0.0766977914166231,0.0877235418701967,5.06171212845113e-181
NMR metabolomics,X23408.Triglycerides in VLDL,GUSB,Beta-glucuronidase,42711,0.1785283349296,0.0061551207448591,0.166464298269676,0.190592371589524,1.6971925128965e-179
NMR metabolomics,X23408.Triglycerides in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.173817175177372,0.00599310861839612,0.162070682285316,0.185563668069428,2.50750474210205e-179
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL6,C-X-C motif chemokine 6,42754,0.223957622889885,0.00776578002285635,0.208736694045087,0.239178551734683,1.5033418730863e-177
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA4,Kallistatin,40342,0.0696823179222729,0.00243657156694935,0.0649066376510521,0.0744579981934936,1.18548220959861e-173
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP6,Charged multivesicular body protein 6,40511,0.160205940991358,0.00565822947726775,0.149115811215913,0.171296070766803,1.87427795661943e-170
NMR metabolomics,X23408.Triglycerides in VLDL,APCS,Serum amyloid P-component,40419,0.0978383206821949,0.00345620613847736,0.0910641566507793,0.104612484713611,2.42937101475118e-170
NMR metabolomics,X23408.Triglycerides in VLDL,FGF21,Fibroblast growth factor 21,42689,0.335663097284317,0.0119077742446895,0.312323859764726,0.359002334803909,6.43171015220677e-170
NMR metabolomics,X23408.Triglycerides in VLDL,AFM,Afamin,40539,0.0569181039250369,0.00201670328413,0.0529653654881421,0.0608708423619317,1.98431710119424e-169
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR1,Asialoglycoprotein receptor 1,42495,0.086954630776327,0.00310308853121887,0.080872577255138,0.093036684297516,6.29648901823707e-168
NMR metabolomics,X23408.Triglycerides in VLDL,CRIP2,Cysteine-rich protein 2,42495,0.104101046902535,0.00372466088582262,0.0968007115663222,0.111401382238747,4.32609133800289e-167
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0557352204104678,0.00201091804856524,0.05179382103528,0.0596766197856557,2.43880252537497e-164
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.145732045824274,0.0052700276215322,0.135402791686071,0.156061299962478,8.88426524321658e-164
NMR metabolomics,X23408.Triglycerides in VLDL,AGR3,Anterior gradient protein 3,42326,0.167978565135956,0.00609109114121366,0.156040026499177,0.179917103772735,8.52748529139237e-163
NMR metabolomics,X23408.Triglycerides in VLDL,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0867828877706876,0.00315650696160181,-0.0929696414154272,-0.0805961341259481,4.90733808659777e-161
NMR metabolomics,X23408.Triglycerides in VLDL,PON3,Serum paraoxonase/lactonase 3,42676,-0.0786417721736668,0.00290043613942583,-0.0843266270069414,-0.0729569173403922,1.10358747599482e-157
NMR metabolomics,X23408.Triglycerides in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.200788852604561,0.00741477238501057,0.18625589872994,0.215321806479181,3.02049124227226e-157
NMR metabolomics,X23408.Triglycerides in VLDL,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0701826514281843,0.0025969048604303,0.0650927179017409,0.0752725849546277,1.14957428486713e-156
NMR metabolomics,X23408.Triglycerides in VLDL,ACY1,Aminoacylase-1,42636,0.16602675513984,0.00615346283873945,0.15396596797591,0.178087542303769,3.4335750726579e-156
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA3,Glutathione S-transferase A3,42346,0.209793221167069,0.0077747153645033,0.194554779052643,0.225031663281496,3.89416004387871e-156
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0515001220020514,0.00193453875383109,0.0477084260445425,0.0552918179595604,3.38125350453805e-152
NMR metabolomics,X23408.Triglycerides in VLDL,SHBG,Sex hormone-binding globulin,40532,-0.136719472838047,0.00512564622792987,-0.14676573944479,-0.126673206231304,4.42606147052099e-152
NMR metabolomics,X23408.Triglycerides in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.307771034170937,0.0115740052504913,0.285085983879974,0.3304560844619,7.06607243856687e-152
NMR metabolomics,X23408.Triglycerides in VLDL,SNCA,Alpha-synuclein,40283,0.311042918668002,0.0116662595389057,0.288177049971747,0.333908787364257,7.51216683368579e-152
NMR metabolomics,X23408.Triglycerides in VLDL,PLAT,Tissue-type plasminogen activator,42760,0.136792774339706,0.0051468533408764,0.126704941791588,0.146880606887824,9.07671052778477e-152
NMR metabolomics,X23408.Triglycerides in VLDL,NUMB,Protein numb homolog,40199,0.219860349602059,0.00833662346331327,0.203520567613965,0.236200131590153,1.10287770787853e-148
NMR metabolomics,X23408.Triglycerides in VLDL,ENO3,Beta-enolase,40223,0.15759015886151,0.00598928691405473,0.145851156509963,0.169329161213057,4.8810597797391e-148
NMR metabolomics,X23408.Triglycerides in VLDL,GLA,Alpha-galactosidase A,40267,0.0991657592198549,0.0037800544263354,0.0917568525442375,0.106574665895472,3.24167035325209e-147
NMR metabolomics,X23408.Triglycerides in VLDL,CCL16,C-C motif chemokine 16,42794,0.139261773277929,0.00532911812158384,0.128816701759625,0.149706844796234,6.4437195897262e-147
NMR metabolomics,X23408.Triglycerides in VLDL,SNAPIN,SNARE-associated protein Snapin,40482,0.152847042993217,0.00584563573764663,0.141389596947429,0.164304489039004,2.2927110377329e-146
NMR metabolomics,X23408.Triglycerides in VLDL,FLI1,Friend leukemia integration 1 transcription factor,42346,0.290727709646986,0.0112014959983827,0.268772777490156,0.312682641803816,6.98397221414825e-145
NMR metabolomics,X23408.Triglycerides in VLDL,PAMR1,Inactive serine protease PAMR1,42611,0.0708298283022238,0.00273217867502983,0.0654747580991653,0.0761848985052823,1.2519664655472e-144
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LG,CMRF35-like molecule 9,42611,-0.101708033548616,0.0039304141217474,-0.109411645227241,-0.0940044218699911,4.01023103884689e-144
NMR metabolomics,X23408.Triglycerides in VLDL,UPB1,Beta-ureidopropionase,40511,0.236951411758792,0.00913888855855099,0.219039190184032,0.254863633333552,4.9402930463185e-144
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF1,Pigment epithelium-derived factor,40351,0.0701289367048915,0.00271298898200275,0.0648114783001661,0.0754463951096168,3.84734084333031e-143
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.181307878248103,0.00703410675114875,0.167521029015852,0.195094727480355,2.14518417199728e-142
NMR metabolomics,X23408.Triglycerides in VLDL,LAT2,Linker for activation of T-cells family member 2,42587,0.323229650586705,0.012569326078362,0.298593771473116,0.347865529700295,2.16168461660733e-142
NMR metabolomics,X23408.Triglycerides in VLDL,CFH,Complement factor H,39956,0.0598478829830783,0.00232522171737992,0.0552904484170136,0.0644053175491429,8.00135812443608e-142
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0978348245766595,0.00383354181294324,-0.105348566530028,-0.0903210826232907,2.40856808645951e-140
NMR metabolomics,X23408.Triglycerides in VLDL,CFI,Complement factor I,40539,0.0508088107309885,0.00199091667591856,0.0469066140461881,0.0547110074157889,9.81629268896812e-140
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA1,Ephrin type-A receptor 1,42658,0.0855806393478402,0.00337422375131412,0.0789671607952645,0.0921941179004159,1.13254012195891e-138
NMR metabolomics,X23408.Triglycerides in VLDL,LATS1,Serine/threonine-protein kinase LATS1,40199,0.217822197681274,0.00857778898546793,0.201009731269756,0.234634664092791,2.7043557760249e-138
NMR metabolomics,X23408.Triglycerides in VLDL,F9,Coagulation factor IX,42663,0.0466150228427927,0.00184453845969757,0.0429997274617855,0.0502303182237999,1.02562497704373e-137
NMR metabolomics,X23408.Triglycerides in VLDL,CFP,Properdin,40539,0.0574548326077801,0.00227164179338979,0.0530024146927361,0.0619072505228241,2.38223827185659e-137
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.151295103470707,0.00602898939245657,-0.163111922679921,-0.139478284261492,8.01764825820634e-136
NMR metabolomics,X23408.Triglycerides in VLDL,CKB,Creatine kinase B-type,40527,-0.154532808122114,0.00615113222990375,-0.166589027292726,-0.142476588951503,1.38406154491851e-135
NMR metabolomics,X23408.Triglycerides in VLDL,P4HB,Protein disulfide-isomerase,42563,0.097977175818068,0.0039119737685204,0.090309707231768,0.105644644404368,2.51415271377813e-135
NMR metabolomics,X23408.Triglycerides in VLDL,GRP,Gastrin-releasing peptide,40223,0.143222376870974,0.0057151104004108,0.132020760486169,0.154423993255779,7.64005988721208e-135
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA1,Glutathione S-transferase A1,42611,0.210163167219038,0.00841288522190174,0.193673912184111,0.226652422253966,1.14445856269714e-134
NMR metabolomics,X23408.Triglycerides in VLDL,NOMO1,Nodal modulator 1,42611,0.0590858669957681,0.00236592246227855,0.0544486589697022,0.0637230750218341,1.36568106711437e-134
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.145642666695979,0.00582186728202241,0.134231806823215,0.157053526568742,2.16075673241984e-134
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.187860963563521,0.00753047206198218,0.173101238322036,0.202620688805007,2.78582552659994e-134
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS1,Protein MTSS 1,40449,0.283944236054174,0.0113658174901617,0.261667233773457,0.306221238334891,4.11749684233947e-134
NMR metabolomics,X23408.Triglycerides in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.349593718631584,0.0140778886278797,0.322001056920939,0.377186380342228,1.41098957570217e-132
NMR metabolomics,X23408.Triglycerides in VLDL,SERPIND1,Heparin cofactor 2,40516,0.0709233096216857,0.00286273291960921,0.0653123530992516,0.0765342661441197,5.29886647229192e-132
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0861690062329561,0.00349295649134085,-0.0930152009559841,-0.079322811509928,1.73414377659587e-131
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL2,Angiopoietin-related protein 2,42640,0.101273667227036,0.00410654297264771,0.0932248430006467,0.109322491453426,2.24608882591255e-131
NMR metabolomics,X23408.Triglycerides in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.139259583550874,0.00566614942946336,0.128153930669125,0.150365236432622,1.87454998848003e-130
NMR metabolomics,X23408.Triglycerides in VLDL,NOS3,"Nitric oxide synthase, endothelial",42311,0.137492505824398,0.0056043947284591,0.126507892156618,0.148477119492178,5.45951079129465e-130
NMR metabolomics,X23408.Triglycerides in VLDL,DTYMK,Thymidylate kinase,40511,0.169612041338344,0.00692328253515973,0.156042407569431,0.183181675107257,3.40399931038393e-129
NMR metabolomics,X23408.Triglycerides in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.169360164651184,0.00694610288269165,0.155745803001108,0.182974526301259,1.84358978578127e-128
NMR metabolomics,X23408.Triglycerides in VLDL,KYNU,Kynureninase,42754,0.110484294214272,0.00455095809829768,0.101564416341609,0.119404172086936,1.76313785333736e-127
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI,Tissue factor pathway inhibitor,42618,0.0765959225989659,0.00316850646880365,0.0703856499201108,0.0828061952778211,2.05648349239284e-126
NMR metabolomics,X23408.Triglycerides in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0777185245937633,0.00322398290411462,0.0713995181016986,0.0840375310858279,9.40234032313565e-126
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR2,Fibroblast growth factor receptor 2,42679,0.0552325915230059,0.00229210675954741,0.0507400622742929,0.0597251207717188,1.19963466123939e-125
NMR metabolomics,X23408.Triglycerides in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0977351489916625,0.00407610937055538,0.089745974625374,0.105724323357951,1.96234617838671e-124
NMR metabolomics,X23408.Triglycerides in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.118541703180123,0.00495949892745552,0.10882108528231,0.128262321077936,1.18901640340274e-123
NMR metabolomics,X23408.Triglycerides in VLDL,RBP5,Retinol-binding protein 5,42587,0.136309266093584,0.00571356874798339,0.125110671347536,0.147507860839631,3.12379048666016e-123
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP29,Synaptosomal-associated protein 29,42679,0.222457959667154,0.00933057575438786,0.204170031188554,0.240745888145754,4.26470992852174e-123
NMR metabolomics,X23408.Triglycerides in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.165161411481686,0.0069176538464299,0.151602809942683,0.178720013020689,7.50386510336366e-123
NMR metabolomics,X23408.Triglycerides in VLDL,SORT1,Sortilin,42613,0.0899986499213741,0.00378113224661263,0.0825876307180133,0.0974096691247348,1.09061822582215e-122
NMR metabolomics,X23408.Triglycerides in VLDL,YES1,Tyrosine-protein kinase Yes,42587,0.275590408235354,0.0115863154107488,0.252881230030287,0.298299586440422,1.59656967933483e-122
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.105946868665969,0.00446373601486148,0.0971979460768408,0.114695791255098,5.09807404598367e-122
NMR metabolomics,X23408.Triglycerides in VLDL,HJV,Hemojuvelin,40482,0.106714678300811,0.00450651555184287,0.0978819078191994,0.115547448782423,5.0186355940245e-121
NMR metabolomics,X23408.Triglycerides in VLDL,EEF1D,Elongation factor 1-delta,40511,0.220788446290922,0.00932710828082472,0.202507314060506,0.239069578521339,5.96582170584325e-121
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB1,BPI fold-containing family B member 1,42573,-0.15074931562067,0.00640854269269104,-0.163310059298345,-0.138188571942996,6.31669890909314e-120
NMR metabolomics,X23408.Triglycerides in VLDL,SYAP1,Synapse-associated protein 1,40283,0.137373493710348,0.00584028643089636,0.125926532305791,0.148820455114905,1.99574321661563e-119
NMR metabolomics,X23408.Triglycerides in VLDL,FYB1,FYN-binding protein 1,42590,0.220769856325557,0.00940647450194904,0.202333166301737,0.239206546349377,2.08808464363595e-119
NMR metabolomics,X23408.Triglycerides in VLDL,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0659324620990471,0.00282198862505281,0.0604013643939436,0.0714635598041506,2.2809468618199e-118
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.230644321259398,0.00987913542423738,0.211281215827893,0.250007426690903,3.35932725357923e-118
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC4,Apical endosomal glycoprotein,40451,0.131345448456525,0.00562069026859873,0.120328895530071,0.142362001382978,5.63485171269082e-118
NMR metabolomics,X23408.Triglycerides in VLDL,NAA80,N-alpha-acetyltransferase 80,40182,0.287739801503363,0.0123155693362718,0.26360128560427,0.311878317402456,7.22468842031434e-118
NMR metabolomics,X23408.Triglycerides in VLDL,IL16,Pro-interleukin-16,42754,0.0987301918660825,0.00423561150541804,0.0904283933154632,0.107031990416702,7.25880592504043e-118
NMR metabolomics,X23408.Triglycerides in VLDL,ABL1,Tyrosine-protein kinase ABL1,42587,0.159384803695097,0.0068395567683502,0.145979272429131,0.172790334961064,8.89246493412688e-118
NMR metabolomics,X23408.Triglycerides in VLDL,MYH9,Myosin-9,40527,0.272977158023599,0.0116991541014884,0.250046815984681,0.295907500062516,1.18388111758245e-117
NMR metabolomics,X23408.Triglycerides in VLDL,SARG,Specifically androgen-regulated gene protein,40456,0.258770215501991,0.0110918079707971,0.237030271879229,0.280510159124754,1.32234013101489e-117
NMR metabolomics,X23408.Triglycerides in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.20352688773118,0.00874428341987824,0.186388092228219,0.220665683234142,4.42966315388177e-117
NMR metabolomics,X23408.Triglycerides in VLDL,OXT,Oxytocin-neurophysin 1,42711,0.329370650441235,0.0141871522899391,0.301563831952955,0.357177468929516,5.98754642787214e-117
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0459541059498097,0.00198025887550611,0.0420727985538177,0.0498354133458017,7.35292016294627e-117
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF8,Immunoglobulin superfamily member 8,42636,0.072847471674735,0.00314309292128666,0.0666870095490131,0.0790079338004569,1.47664565526686e-116
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL13,C-X-C motif chemokine 13,42711,0.148912369110294,0.00642702151610291,0.136315406938733,0.161509331281856,1.68831654443548e-116
NMR metabolomics,X23408.Triglycerides in VLDL,GH1,Somatotropin,42613,-0.407716289034275,0.0175970420869369,-0.442206491524671,-0.373226086543879,1.75759975692496e-116
NMR metabolomics,X23408.Triglycerides in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.211107966393751,0.00911416169425661,0.193244209473008,0.228971723314494,2.16486545248973e-116
NMR metabolomics,X23408.Triglycerides in VLDL,TJAP1,Tight junction-associated protein 1,42679,0.194072265992681,0.00843302530314087,0.177543536398524,0.210600995586837,5.54651571113495e-115
NMR metabolomics,X23408.Triglycerides in VLDL,F11R,Junctional adhesion molecule A,42611,0.130499409309259,0.00569223393207859,0.119342630802385,0.141656187816133,3.9472128136601e-114
NMR metabolomics,X23408.Triglycerides in VLDL,ATRN,"Attractin, Isoform 2",40539,0.0392874466397503,0.00171459027630385,0.0359268496981947,0.0426480435813058,1.26106971798894e-113
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.127500486631811,0.00558529358286129,0.116553311209403,0.138447662054219,3.4595267511088e-113
NMR metabolomics,X23408.Triglycerides in VLDL,DPY30,Protein dpy-30 homolog,42651,0.140781181652849,0.00618190041462009,0.128664656840194,0.152897706465505,1.12688891276123e-112
NMR metabolomics,X23408.Triglycerides in VLDL,PYY,Peptide YY,40116,0.239383507022244,0.0104965741966117,0.218810221596885,0.259956792447603,1.6591218714412e-112
NMR metabolomics,X23408.Triglycerides in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.183645732297332,0.00807816102674828,0.167812536684906,0.199478927909759,6.74157919629487e-112
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4R,Reticulon-4 receptor,42721,0.0799162258886073,0.00353664630661003,0.0729843991276517,0.086848052649563,5.24377650075497e-111
NMR metabolomics,X23408.Triglycerides in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0777451144877229,0.00344366096200863,0.070995539002186,0.0844946899732598,8.55027521465496e-111
NMR metabolomics,X23408.Triglycerides in VLDL,MLN,Promotilin,42594,0.205723413689328,0.00911931430334834,0.187849557654765,0.22359726972389,1.24091575374161e-110
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK9,Mitogen-activated protein kinase 9,42594,0.0976325500259197,0.00432835917042284,0.0891489660518909,0.106116133999948,1.31340577679969e-110
NMR metabolomics,X23408.Triglycerides in VLDL,CD2AP,CD2-associated protein,42636,0.147025370810547,0.0065218486196781,0.134242547515978,0.159808194105116,1.71695001396078e-110
NMR metabolomics,X23408.Triglycerides in VLDL,F10,Coagulation factor X,40532,0.0655210944196443,0.00290413907161518,0.0598289818392785,0.07121320700001,2.72955103353597e-110
NMR metabolomics,X23408.Triglycerides in VLDL,PPY,Pancreatic prohormone,42600,0.239585727528644,0.0106438287214338,0.218723823234634,0.260447631822655,3.65347370798483e-110
NMR metabolomics,X23408.Triglycerides in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.22304216715679,0.00993575169699083,0.203568093830688,0.242516240482892,1.37654784213727e-109
NMR metabolomics,X23408.Triglycerides in VLDL,FAM20A,Pseudokinase FAM20A,40511,0.0650255671940336,0.00289449315232153,0.0593523606154834,0.0706987737725838,2.19134682239803e-109
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0543178327597987,0.00242251822795375,0.0495696970330094,0.0590659684865881,2.364524172309e-109
NMR metabolomics,X23408.Triglycerides in VLDL,CLUL1,Clusterin-like protein 1,42621,-0.103221911432616,0.00461024035484262,-0.112257982528108,-0.0941858403371246,4.85510300745597e-109
NMR metabolomics,X23408.Triglycerides in VLDL,BECN1,Beclin-1,40223,0.137295746611793,0.00613007793603399,0.125280793857166,0.14931069936642,1.09096470372654e-108
NMR metabolomics,X23408.Triglycerides in VLDL,CES3,Carboxylesterase 3,42587,0.161489900320065,0.00723266684988812,0.147313873294284,0.175665927345845,1.86758702809011e-108
NMR metabolomics,X23408.Triglycerides in VLDL,KDR,Vascular endothelial growth factor receptor 2,42679,0.0566204322381757,0.00253727909224188,0.0516473652173816,0.0615934992589698,2.36936354763705e-108
NMR metabolomics,X23408.Triglycerides in VLDL,HEG1,Protein HEG homolog 1,40283,0.0616136913603395,0.00275992573436397,0.0562042369209861,0.0670231457996928,5.03104273613617e-108
NMR metabolomics,X23408.Triglycerides in VLDL,TXLNA,Alpha-taxilin,42495,0.200351083059171,0.00899626988117828,0.182718394092062,0.21798377202628,6.62858580263688e-108
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR5,Cadherin-related family member 5,42636,0.0884766012442224,0.00397835038059666,0.0806790344982529,0.0962741679901919,1.23109071032934e-107
NMR metabolomics,X23408.Triglycerides in VLDL,KLKB1,Plasma kallikrein,40293,0.0561923606749798,0.00252436374642948,0.0512446077319781,0.0611401136179816,1.98368054608689e-107
NMR metabolomics,X23408.Triglycerides in VLDL,MASP1,Mannan-binding lectin serine protease 1,42476,0.0533499717484367,0.00241046560157811,0.0486254591693436,0.0580744843275298,1.28252243386884e-106
NMR metabolomics,X23408.Triglycerides in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.238702247332697,0.0108525404741041,0.217431268003453,0.259973226661941,2.32427080242823e-105
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0934201549456845,0.00424906611709694,-0.101748324535195,-0.0850919853561745,2.80052625130856e-105
NMR metabolomics,X23408.Triglycerides in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0486354680419202,0.0022148892340965,0.044294285143091,0.0529766509407493,1.19878080688145e-104
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.189032489552278,0.00861108110623385,0.172154770584059,0.205910208520496,1.40311624126554e-104
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.250853841996267,0.0114476563301129,0.228416435589246,0.273291248403288,3.08715002486926e-104
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS8,Prostasin,42568,0.0943856714009091,0.0043176307041395,0.0859231152207956,0.102848227581023,4.06523904511854e-104
NMR metabolomics,X23408.Triglycerides in VLDL,CREG1,Protein CREG1,42445,0.0865793470183615,0.0039625842747118,0.0788126818399263,0.0943460121967966,5.3631197885473e-104
NMR metabolomics,X23408.Triglycerides in VLDL,AXIN1,Axin-1,42594,0.212125134420272,0.00971530277708024,0.193083140977195,0.231167127863349,7.04711118302475e-104
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.181219002726501,0.00832410754539595,0.164903751937525,0.197534253515477,2.60449702335334e-103
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0891208032352716,0.00409423658020825,0.0810960995380635,0.0971455069324798,6.08576534539756e-103
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.179251694295137,0.00825014804512406,0.163081404126693,0.19542198446358,1.42423128428519e-102
NMR metabolomics,X23408.Triglycerides in VLDL,NPPC,C-type natriuretic peptide,42594,0.111922198634608,0.00516230245205255,0.101804085828585,0.122040311440631,1.78423769241305e-102
NMR metabolomics,X23408.Triglycerides in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0675434059855707,0.00311259975519507,0.0614427104653884,0.0736441015057531,2.52463245703456e-102
NMR metabolomics,X23408.Triglycerides in VLDL,STC1,Stanniocalcin-1,42711,0.10033822638516,0.00464788726148371,0.0912283673526515,0.109448085417668,1.20416364928636e-101
NMR metabolomics,X23408.Triglycerides in VLDL,STAB2,Stabilin-2,40527,0.0621611188463385,0.00287833975120204,0.0565195729339825,0.0678026647586945,2.1259820264444e-101
NMR metabolomics,X23408.Triglycerides in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.118126750577131,0.00548836255021708,0.107369559978705,0.128883941175556,4.95656287104192e-101
NMR metabolomics,X23408.Triglycerides in VLDL,CTSD,Cathepsin D,41747,0.0931606662482811,0.00433519031236484,0.0846636932360461,0.101657639260516,1.2579260234846e-100
NMR metabolomics,X23408.Triglycerides in VLDL,MVK,Mevalonate kinase,42370,0.176393814856734,0.00821866567623064,0.160285230131322,0.192502399582146,1.81263037896978e-100
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN1,Dynactin subunit 1,42721,0.142325012005126,0.00664028764068115,0.129310048229391,0.155339975780861,2.99768714971397e-100
NMR metabolomics,X23408.Triglycerides in VLDL,IL18R1,Interleukin-18 receptor 1,42754,0.072747576743625,0.00339492385437711,0.0660935259890458,0.0794016274982041,3.31091268832493e-100
NMR metabolomics,X23408.Triglycerides in VLDL,SCLY,Selenocysteine lyase,42674,0.102980031778548,0.00480589605319645,0.0935604755142831,0.112399588042813,3.41942374181021e-100
NMR metabolomics,X23408.Triglycerides in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.182948292430188,0.00852343025912414,0.166242369122305,0.199654215738072,3.61851091650221e-100
NMR metabolomics,X23408.Triglycerides in VLDL,PAXX,Protein PAXX,40283,0.0999013262012653,0.00465476315953198,0.0907779904085826,0.109024661993948,3.77038205252322e-100
NMR metabolomics,X23408.Triglycerides in VLDL,ARF6,ADP-ribosylation factor 6,40449,0.235376065426242,0.0109771083652774,0.213860933030298,0.256891197822186,5.29855147540197e-100
NMR metabolomics,X23408.Triglycerides in VLDL,S100A4,Protein S100-A4,42679,0.125211722081218,0.00585191343716845,0.113741971744368,0.136681472418068,6.51618171382516e-100
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS2,Protein MTSS 2,40451,0.216426468629869,0.0100998863855152,0.196630691314259,0.236222245945479,7.04521218900883e-100
NMR metabolomics,X23408.Triglycerides in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.212901466082993,0.00996834591744956,0.193363508084792,0.232439424081194,2.99626748240993e-99
NMR metabolomics,X23408.Triglycerides in VLDL,AP3S2,AP-3 complex subunit sigma-2,40483,0.104193901969791,0.00488013956301417,0.094628828426283,0.113758975513299,3.46991963654624e-99
NMR metabolomics,X23408.Triglycerides in VLDL,YTHDF3,YTH domain-containing family protein 3,42370,0.185758375745572,0.00871837346546719,0.168670363753256,0.202846387737887,4.59165517683678e-99
NMR metabolomics,X23408.Triglycerides in VLDL,KHK,Ketohexokinase,40223,0.137133187416275,0.00643480992258151,0.124520959968015,0.149745414864535,8.64832916383363e-99
NMR metabolomics,X23408.Triglycerides in VLDL,YOD1,Ubiquitin thioesterase OTU1,40116,0.138563138366682,0.00650735597216073,0.125808720661247,0.151317556072117,1.30216643248612e-98
NMR metabolomics,X23408.Triglycerides in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.140613169518685,0.00663145586867035,0.127615516016091,0.153610823021279,3.82275536798149e-98
NMR metabolomics,X23408.Triglycerides in VLDL,SORD,Sorbitol dehydrogenase,42658,0.14550183815984,0.00687334664251141,0.132030078740517,0.158973597579162,7.19964472752776e-98
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0803296404445644,0.00379893848657444,0.0728837210108785,0.0877755598782504,1.16466762699455e-97
NMR metabolomics,X23408.Triglycerides in VLDL,NCS1,Neuronal calcium sensor 1,42721,0.0629253558016916,0.00297723583206567,0.0570899735708429,0.0687607380325404,1.40798414919652e-97
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.156328090990851,0.00740528424011015,0.141813733880235,0.170842448101467,2.60715131903482e-97
NMR metabolomics,X23408.Triglycerides in VLDL,CEP85,Centrosomal protein of 85 kDa,42346,0.138820092159926,0.00657793945448241,0.125927330829141,0.151712853490712,2.97532588133161e-97
NMR metabolomics,X23408.Triglycerides in VLDL,PROS1,Vitamin K-dependent protein S,40539,0.0565619464225252,0.00268396219988895,0.0513013805107429,0.0618225123343075,9.70168521994279e-97
NMR metabolomics,X23408.Triglycerides in VLDL,HGF,Hepatocyte growth factor,42754,0.0752059713053891,0.00358490719141599,0.0681795532102138,0.0822323894005645,3.45332333908791e-96
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL17,C-X-C motif chemokine 17,42754,0.0875722082405429,0.00418067543905431,0.0793780843799965,0.0957663321010894,6.56864604841344e-96
NMR metabolomics,X23408.Triglycerides in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.14195762658247,0.00678678204700298,0.128655533770344,0.155259719394596,1.34619423954249e-95
NMR metabolomics,X23408.Triglycerides in VLDL,ISM1,Isthmin-1,42594,0.0827633915000797,0.0039636744633206,0.0749945895519713,0.0905321934481881,2.63535449165591e-95
NMR metabolomics,X23408.Triglycerides in VLDL,ADH1B,All-trans-retinol dehydrogenase,40283,0.159054736755662,0.00762906681938979,0.144101765789658,0.174007707721666,1.01791399714007e-94
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR2,Cadherin-related family member 2,42587,0.151154418198531,0.00726460974946905,0.136915783089572,0.16539305330749,1.16859024379944e-94
NMR metabolomics,X23408.Triglycerides in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.118236621662173,0.00568281840150437,0.107098297595225,0.129374945729122,1.29999196471209e-94
NMR metabolomics,X23408.Triglycerides in VLDL,IKBKG,NF-kappa-B essential modulator,42594,0.194239682460961,0.0093518595337383,0.175910037774834,0.212569327147088,2.45138193937668e-94
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.154470371368265,0.00742583997121167,0.13991572502469,0.16902501771184,2.6627925394402e-94
NMR metabolomics,X23408.Triglycerides in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.142840750838235,0.00688151403810548,0.129352983323548,0.156328518352922,5.8729100708143e-94
NMR metabolomics,X23408.Triglycerides in VLDL,FCN2,Ficolin-2,42597,0.0875123477247154,0.00422902417821287,0.0792234603354182,0.0958012351140126,1.15202720513651e-93
NMR metabolomics,X23408.Triglycerides in VLDL,KAZN,Kazrin,40449,0.221226454435933,0.0106899379781588,0.200274175998742,0.242178732873124,2.08917342500271e-93
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0675159525068458,0.00326859773510437,0.0611095009460412,0.0739224040676503,2.38444216026949e-93
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.219369615619502,0.0106533848128353,0.198488981386345,0.240250249852659,8.86630006879616e-93
NMR metabolomics,X23408.Triglycerides in VLDL,EHBP1,EH domain-binding protein 1,40511,0.156908339397894,0.00761729786758023,0.141978435577437,0.171838243218351,1.38412249291164e-92
NMR metabolomics,X23408.Triglycerides in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.118037178083698,0.00574068089555843,0.106785443528403,0.129288912638992,1.70632693544501e-92
NMR metabolomics,X23408.Triglycerides in VLDL,CD63,CD63 antigen,42475,0.107996947054865,0.00525626031755291,0.0976946768324614,0.118299217277269,2.25164869383822e-92
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFC,Platelet-derived growth factor C,42346,0.0602617935388991,0.00294165477356171,0.0544961501827182,0.0660274368950801,7.78571870172363e-92
NMR metabolomics,X23408.Triglycerides in VLDL,TARBP2,RISC-loading complex subunit TARBP2,42311,0.164406721219578,0.00802872883835938,0.148670412696394,0.180143029742763,9.27660734776843e-92
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0621155818595113,0.00303491539905792,0.0561671476773578,0.0680640160416648,1.89813852605736e-91
NMR metabolomics,X23408.Triglycerides in VLDL,NFX1,Transcriptional repressor NF-X1,40116,0.142966458713957,0.00698331304847111,0.129279165138954,0.15665375228896,1.94335623997262e-91
NMR metabolomics,X23408.Triglycerides in VLDL,NHLRC3,NHL repeat-containing protein 3,40013,0.0676643337100492,0.00331227129071349,0.0611722819802508,0.0741563854398477,4.82307315586754e-91
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3F,Semaphorin-3F,42636,0.0568409407192617,0.00279494128754229,0.0513628557956788,0.0623190256428446,1.38606178560761e-90
NMR metabolomics,X23408.Triglycerides in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0428448020742417,0.00211164652647339,0.0387059748823539,0.0469836292661295,3.57515883206719e-90
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.226989074116355,0.0111763367273348,0.205083454130778,0.248894694101931,4.35013255345312e-90
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.153066357779822,0.0075626306662447,0.138243601673982,0.167889113885661,1.8870151862575e-89
NMR metabolomics,X23408.Triglycerides in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.22273285954556,0.0110146679709954,0.201144110322409,0.24432160876871,2.39790352763278e-89
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0609362250076789,0.0030179103971847,0.0550211206291969,0.066851329386161,4.35230835659263e-89
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R9B,Neurabin-2,42754,0.194066367363111,0.00963327052882873,0.175185157126606,0.212947577599615,5.88119205778534e-89
NMR metabolomics,X23408.Triglycerides in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.102751887169462,0.00510559302049084,0.0927449248492997,0.112758849489624,9.54229117564678e-89
NMR metabolomics,X23408.Triglycerides in VLDL,ERBIN,Erbin,42587,0.210046036362113,0.0104814231464931,0.189502446994987,0.23058962572924,4.80817030873735e-88
NMR metabolomics,X23408.Triglycerides in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.102259406707154,0.00510200909682098,0.0922594688773848,0.112259344536923,8.26107077207336e-88
NMR metabolomics,X23408.Triglycerides in VLDL,ATG16L1,Autophagy-related protein 16-1,40449,0.173598320431095,0.00867046268482862,0.156604213568831,0.190592427293359,1.18279238264711e-87
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNA4,Plexin-A4,42594,0.168477462597748,0.00843813126077965,0.15193872532662,0.185016199868876,2.01367931770636e-87
NMR metabolomics,X23408.Triglycerides in VLDL,BCR,Breakpoint cluster region protein,42594,0.186763918728075,0.00937810022454877,0.168382842287959,0.20514499516819,5.45234416012236e-87
NMR metabolomics,X23408.Triglycerides in VLDL,EZR,Ezrin,42711,0.0488241510654662,0.00246051006753449,0.0440015513330986,0.0536467507978338,2.13637987808636e-86
NMR metabolomics,X23408.Triglycerides in VLDL,TNIP1,TNFAIP3-interacting protein 1,40483,0.180983424321355,0.00911615770824178,0.163115755213201,0.198851093429508,3.04488382346129e-86
NMR metabolomics,X23408.Triglycerides in VLDL,BTD,Biotinidase,40539,0.0420352841140504,0.00211867051312203,0.0378826899083312,0.0461878783197696,3.81923231825381e-86
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM7,PDZ and LIM domain protein 7,42676,0.251917978492938,0.0127212935431959,0.226984243148274,0.276851713837602,4.68055107079443e-86
NMR metabolomics,X23408.Triglycerides in VLDL,CCL22,C-C motif chemokine 22,42509,0.108326913490166,0.0054734343777862,0.0975989821097051,0.119054844870627,6.04351141607847e-86
NMR metabolomics,X23408.Triglycerides in VLDL,CEP20,Centrosomal protein 20,42346,0.152046543284691,0.0077071528936735,0.136940523613091,0.167152562956291,2.11917751775527e-85
NMR metabolomics,X23408.Triglycerides in VLDL,BACH1,Transcription regulator protein BACH1,42594,0.148258991736259,0.00752132089927238,0.133517202773685,0.163000780698833,2.74493971581835e-85
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.116709198884701,0.0059236846996676,0.105098776873352,0.128319620896049,3.37453032299219e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CTBS,Di-N-acetylchitobiase,40383,0.0541716078632089,0.0027570233916554,0.0487678420155643,0.0595753737108535,1.56804001103913e-84
NMR metabolomics,X23408.Triglycerides in VLDL,SLA2,Src-like-adapter 2,40482,0.209462911816759,0.0106657307194438,0.188558079606649,0.230367744026869,1.83444215352635e-84
NMR metabolomics,X23408.Triglycerides in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.139939075467255,0.00714656638784779,0.125931805347073,0.153946345587437,3.49499493166298e-84
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1B,C-type lectin domain family 1 member B,42711,0.191843692405355,0.00980779495670091,0.172620414290221,0.211066970520489,4.87153879720245e-84
NMR metabolomics,X23408.Triglycerides in VLDL,ELN,Elastin,40511,0.0739272226969691,0.00377808333184369,0.0665221793665554,0.0813322660273827,7.08094124691059e-84
NMR metabolomics,X23408.Triglycerides in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.149297132112095,0.00763759921532215,0.134327437650064,0.164266826574127,1.0295898857115e-83
NMR metabolomics,X23408.Triglycerides in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.2277684351633,0.0116740487710515,0.204887299572039,0.25064957075456,2.10897327983694e-83
NMR metabolomics,X23408.Triglycerides in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.138664734407449,0.00711112611355227,0.124726927224886,0.152602541590011,2.57302516093854e-83
NMR metabolomics,X23408.Triglycerides in VLDL,AMBP,Protein AMBP,42706,0.0420229845029898,0.00216179018089147,0.0377858757484425,0.0462600932575371,4.90084353779238e-83
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.136365539456205,0.00701709973346367,0.122612023978616,0.150119054933793,5.82288030018532e-83
NMR metabolomics,X23408.Triglycerides in VLDL,SOST,Sclerostin,42613,0.0780238375080134,0.00401730173700404,0.0701499261034854,0.0858977489125413,6.88758040617448e-83
NMR metabolomics,X23408.Triglycerides in VLDL,DKK1,Dickkopf-related protein 1,42711,0.117184850580613,0.00604840185754165,0.105329982939832,0.129039718221395,1.65887040397603e-82
NMR metabolomics,X23408.Triglycerides in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0927399537949525,0.00477985408030833,0.0833714397975482,0.102108467792357,1.71103358600159e-82
NMR metabolomics,X23408.Triglycerides in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.12126929225771,0.00625875636435284,0.109002129783578,0.133536454731841,1.74401777415925e-82
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP23,Synaptosomal-associated protein 23,42636,0.172465232460041,0.0089169740569423,0.154987963308434,0.189942501611648,3.15430348871192e-82
NMR metabolomics,X23408.Triglycerides in VLDL,STAT5B,Signal transducer and activator of transcription 5B,42587,0.272327649121434,0.0140928777921544,0.244705608648811,0.299949689594056,4.42407856226013e-82
NMR metabolomics,X23408.Triglycerides in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.100119288224245,0.00519217939016915,0.089942616619513,0.110295959828976,9.58176465450996e-82
NMR metabolomics,X23408.Triglycerides in VLDL,LSP1,Lymphocyte-specific protein 1,42594,0.0790069753073283,0.00410363767550107,0.0709638454633462,0.0870501051513104,1.67646171568273e-81
NMR metabolomics,X23408.Triglycerides in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.102864844800757,0.00534400169713509,0.0923906014743719,0.113339088127141,2.90877443243606e-81
NMR metabolomics,X23408.Triglycerides in VLDL,DAB2,Disabled homolog 2,42721,0.21579950403739,0.0112394982129032,0.1937700875401,0.23782892053468,4.41216566703023e-81
NMR metabolomics,X23408.Triglycerides in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.147217901620642,0.00765907322119596,0.132206118107098,0.162229685134186,5.14228533207007e-81
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO1,Forkhead box protein O1,42594,0.167690053874014,0.00874287244056092,0.150554023890515,0.184826083857514,6.55431845482338e-81
NMR metabolomics,X23408.Triglycerides in VLDL,TOP2B,DNA topoisomerase 2-beta,40199,0.157101217870549,0.00818569731708545,0.141057251129062,0.173145184612037,8.92027394034665e-81
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.193288030880823,0.0100999248545152,0.173492178165973,0.213083883595673,1.41342473045326e-80
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0750072468940722,0.00392708641623286,0.0673101575182558,0.0827043362698886,2.85558616843591e-80
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0786351112797881,0.00412241521915292,-0.0867150451093278,-0.0705551774502484,4.6364930217907e-80
NMR metabolomics,X23408.Triglycerides in VLDL,AGRN,Agrin,42676,0.0715908058455057,0.00375678559730257,0.0642275060747926,0.0789541056162187,6.50991756056196e-80
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1A,Meprin A subunit alpha,40449,0.14248572848873,0.00746895012374101,0.127846586246198,0.157124870731263,7.08762028022233e-80
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL10,C-X-C motif chemokine 10,42676,0.132962353869663,0.00698406989205452,0.119273576881236,0.14665113085809,9.17527608978221e-80
NMR metabolomics,X23408.Triglycerides in VLDL,SRPK2,SRSF protein kinase 2,42594,0.163439394919486,0.0085922330537544,0.146598618134127,0.180280171704844,1.25753303502478e-79
NMR metabolomics,X23408.Triglycerides in VLDL,CD6,T-cell differentiation antigen CD6,42746,0.103588480646292,0.00544837930193777,0.092909657214494,0.11426730407809,1.44855876799978e-79
NMR metabolomics,X23408.Triglycerides in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.208767659543245,0.0109778123411191,0.187251147354652,0.230284171731839,2.11195507511154e-79
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF2,Alpha-2-antiplasmin,40317,0.0265184819699213,0.00139441283172175,0.0237854328197466,0.0292515311200959,2.19944697332267e-79
NMR metabolomics,X23408.Triglycerides in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.142311304611929,0.00749763712908917,0.127615935838914,0.157006673384943,2.65058637997176e-79
NMR metabolomics,X23408.Triglycerides in VLDL,NCK2,Cytoplasmic protein NCK2,42676,0.204494017256422,0.0107770988767839,0.183370903457926,0.225617131054919,2.95880098126408e-79
NMR metabolomics,X23408.Triglycerides in VLDL,NUCB2,Nucleobindin-2,42683,0.0722509712392514,0.00381197572037821,0.0647794988273101,0.0797224436511927,4.37540824584095e-79
NMR metabolomics,X23408.Triglycerides in VLDL,MME,Neprilysin,42587,0.158638938440861,0.00838064885348259,0.142212866688036,0.175065010193687,6.99774915481775e-79
NMR metabolomics,X23408.Triglycerides in VLDL,MCAM,Cell surface glycoprotein MUC18,42689,-0.0656571379905493,0.0034724929742101,-0.0724632242200011,-0.0588510517610975,1.02138911380598e-78
NMR metabolomics,X23408.Triglycerides in VLDL,LEFTY2,Left-right determination factor 2,42689,0.0974430199118671,0.00516103036223953,0.0873274004018777,0.107558639421857,1.68888900844212e-78
NMR metabolomics,X23408.Triglycerides in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.204413943550498,0.0108308827182462,0.183185413422735,0.22564247367826,1.97146258252722e-78
NMR metabolomics,X23408.Triglycerides in VLDL,RLN2,Prorelaxin H2,40257,0.0971533726217258,0.00514307604276248,0.0870729435779113,0.10723380166554,2.33685407710923e-78
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.198941726694756,0.0105400744483203,0.178283180776048,0.219600272613464,3.12256500063788e-78
NMR metabolomics,X23408.Triglycerides in VLDL,PSIP1,PC4 and SFRS1-interacting protein,42594,0.125041117183648,0.00664067934555033,0.112025385666369,0.138056848700926,4.38891577807573e-78
NMR metabolomics,X23408.Triglycerides in VLDL,IDUA,Alpha-L-iduronidase,42721,0.0900510522860738,0.00478510731983721,0.0806722419391929,0.0994298626329547,5.21544722440274e-78
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0733814573516423,0.00389413103235442,0.0657489605282277,0.081013954175057,5.39671636607451e-78
NMR metabolomics,X23408.Triglycerides in VLDL,FN1,Fibronectin,40539,0.0517444588762525,0.00274641659711406,0.046361482345909,0.0571274354065961,5.39880994973097e-78
NMR metabolomics,X23408.Triglycerides in VLDL,FETUB,Fetuin-B,42663,0.0622673901990385,0.00331980528491353,0.055760571840608,0.068774208557469,1.66467248859323e-77
NMR metabolomics,X23408.Triglycerides in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0771172432299814,0.00411461157028605,0.0690526045522207,0.085181881907742,3.33143215143951e-77
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD7B,OTU domain-containing protein 7B,40482,0.119434465055898,0.00637489010349054,0.106939680453057,0.13192924965874,3.76578322079319e-77
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R2,Interleukin-1 receptor type 2,42600,0.038458233965259,0.00205756082122074,0.0344254147556663,0.0424910531748517,5.54253681399799e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.214021093045677,0.0114564162026308,0.191566517288521,0.236475668802833,6.6411549178245e-77
NMR metabolomics,X23408.Triglycerides in VLDL,LEP,Leptin,42636,0.12792208112364,0.006848435852165,0.114499146853397,0.141345015393883,6.87944444103527e-77
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH2,Neutral ceramidase,42495,0.103316541311172,0.00553338555502357,0.0924711056233258,0.114161976999018,8.07967295410065e-77
NMR metabolomics,X23408.Triglycerides in VLDL,DOK2,Docking protein 2,42636,0.230578324475538,0.0123895233484475,0.206294858712581,0.254861790238495,2.38768281387304e-76
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.197378950757388,0.0106144393066992,0.176574649716257,0.218183251798518,3.15032066199516e-76
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN1,Perilipin-1,42311,0.066956847013952,0.00360675182337743,0.0598876134401323,0.0740260805877718,5.85668549494824e-76
NMR metabolomics,X23408.Triglycerides in VLDL,CMIP,C-Maf-inducing protein,40451,0.158407137872392,0.00852532683093117,0.141697497283767,0.175116778461017,6.24917439682166e-76
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.208030626234789,0.0111964566466321,0.18608557120739,0.229975681262188,6.3349448567814e-76
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.18263558913919,0.00985553343084588,0.163318743614732,0.201952434663648,1.00412736830157e-75
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0518016461861597,0.00279710311451036,0.0463193240817194,0.0572839682906,1.25646776744877e-75
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.159570633452616,0.00861285578984868,0.142689436104512,0.176451830800719,1.63758710239212e-75
NMR metabolomics,X23408.Triglycerides in VLDL,CTSO,Cathepsin O,42754,0.0586853121509788,0.00317661310519369,0.0524591504647992,0.0649114738371585,2.78928082097034e-75
NMR metabolomics,X23408.Triglycerides in VLDL,ACE2,Angiotensin-converting enzyme 2,42357,0.102400370530489,0.00554536999965611,0.091531445331163,0.113269295729815,3.44810574665002e-75
NMR metabolomics,X23408.Triglycerides in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.130581047898354,0.00706780196201562,0.116728156052804,0.144433939743905,4.39334650241696e-75
NMR metabolomics,X23408.Triglycerides in VLDL,PCBP2,Poly(rC)-binding protein 2,40482,0.136746587359244,0.00741648662597644,0.122210273572331,0.151282901146158,8.09803350344937e-75
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.170612764244614,0.00926194179916691,0.152459358318247,0.188766170170982,1.10528302183162e-74
NMR metabolomics,X23408.Triglycerides in VLDL,TPD52L2,Tumor protein D54,40283,0.20305882988343,0.0110228213362186,0.181454100064442,0.224663559702419,1.13839804037351e-74
NMR metabolomics,X23408.Triglycerides in VLDL,PSME1,Proteasome activator complex subunit 1,42480,0.0704478451937021,0.00383615580556575,0.0629289798147932,0.077966710572611,2.1121802020935e-74
NMR metabolomics,X23408.Triglycerides in VLDL,KRT18,"Keratin, type I cytoskeletal 18",42587,0.15293905058726,0.00832893908199978,0.13661432998654,0.169263771187979,2.14593393565406e-74
NMR metabolomics,X23408.Triglycerides in VLDL,SELP,P-selectin,42689,0.105627281797712,0.00577638560789116,0.0943055660062453,0.116948997589179,8.30214644106209e-74
NMR metabolomics,X23408.Triglycerides in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.134599631630454,0.00735758712197833,0.120178760871377,0.149020502389532,1.07482958294244e-73
NMR metabolomics,X23408.Triglycerides in VLDL,CEP43,Centrosomal protein 43,42255,0.130088648352079,0.00712210290831711,0.116129326651778,0.144047970052381,1.28213428650531e-73
NMR metabolomics,X23408.Triglycerides in VLDL,RABEP1,Rab GTPase-binding effector protein 1,40283,0.146867166469908,0.00803839615517254,0.13111191000577,0.162622422934047,1.68724742667764e-73
NMR metabolomics,X23408.Triglycerides in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0457301412366008,0.00250864689586771,0.0408131933207,0.0506470891525015,2.29997451500446e-73
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM5,Tripartite motif-containing protein 5,42594,0.160390275271933,0.00880257360410116,0.143137231007894,0.177643319535971,2.69974343097956e-73
NMR metabolomics,X23408.Triglycerides in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.118227171968323,0.00648842366398732,0.105509861586908,0.130944482349738,2.78326081920633e-73
NMR metabolomics,X23408.Triglycerides in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.144004719888858,0.00790529578865104,0.128510340143102,0.159499099634614,2.93383121424441e-73
NMR metabolomics,X23408.Triglycerides in VLDL,LAT,Linker for activation of T-cells family member 1,42754,0.141527632391211,0.007771488962816,0.126295514024092,0.156759750758331,3.13487897651389e-73
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD2,Protein disulfide isomerase CRELD2,42654,0.097509484131522,0.00535462102338582,0.0870144269256858,0.108004541337358,3.22644951873957e-73
NMR metabolomics,X23408.Triglycerides in VLDL,MINK1,Misshapen-like kinase 1,40483,0.174122004084933,0.00955101725923783,0.155402010256827,0.192841997913039,3.28987426787258e-73
NMR metabolomics,X23408.Triglycerides in VLDL,LBR,Delta(14)-sterol reductase LBR,42711,0.125002083020047,0.00686675403531833,0.111543245110823,0.138460920929271,3.58532191835203e-73
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINH1,Serpin H1,40302,0.242024839945537,0.0132886395784805,0.215979106371716,0.268070573519359,4.69062902818625e-73
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD5,Programmed cell death protein 5,42711,0.107987994201484,0.0059413065107641,0.096343033440386,0.119632954962581,5.9195908888725e-73
NMR metabolomics,X23408.Triglycerides in VLDL,TCTN3,Tectonic-3,40511,0.056318283598893,0.00309501547564489,0.050252053266629,0.062384513931157,6.01001718182458e-73
NMR metabolomics,X23408.Triglycerides in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.158418923566282,0.00871608243888659,0.141335401986064,0.175502445146499,6.06339282433743e-73
NMR metabolomics,X23408.Triglycerides in VLDL,MUC13,Mucin-13,42311,0.0980052716549687,0.00540012922112297,0.0874210183815677,0.10858952492837,1.01750150884055e-72
NMR metabolomics,X23408.Triglycerides in VLDL,AAMDC,Mth938 domain-containing protein,40223,0.099524947591288,0.00548139965220654,0.0887814042729632,0.110268490909613,1.28781853932428e-72
NMR metabolomics,X23408.Triglycerides in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.14541180808534,0.00802056946296332,0.129691491937931,0.161132124232748,1.95332372292258e-72
NMR metabolomics,X23408.Triglycerides in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.207535741952129,0.0114709250889854,0.185052728777717,0.23001875512654,2.69669123192604e-72
NMR metabolomics,X23408.Triglycerides in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.176907795938433,0.00978143104556185,0.157736191089132,0.196079400787734,3.00348494606116e-72
NMR metabolomics,X23408.Triglycerides in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.124292959466231,0.00687455755293756,0.110818826662474,0.137767092269989,3.42968322125561e-72
NMR metabolomics,X23408.Triglycerides in VLDL,PLSCR3,Phospholipid scramblase 3,40457,0.10807147654465,0.0059774741613306,0.0963556271884421,0.119787325900858,4.77872366886987e-72
NMR metabolomics,X23408.Triglycerides in VLDL,NPL,N-acetylneuraminate lyase,40511,0.0849847666125366,0.00470081941919566,0.0757711605509131,0.0941983726741601,4.81716898834804e-72
NMR metabolomics,X23408.Triglycerides in VLDL,THOP1,Thimet oligopeptidase,42571,0.0575471599985251,0.00318722358286876,0.0513002017761024,0.0637941182209479,5.09600720398542e-72
NMR metabolomics,X23408.Triglycerides in VLDL,HEXIM1,Protein HEXIM1,42594,0.149905313513643,0.00832362254708815,0.13359101332135,0.166219613705936,1.14343371861852e-71
NMR metabolomics,X23408.Triglycerides in VLDL,SELE,E-selectin,42794,0.0942675487977591,0.00524687900662018,0.0839836659447836,0.104551431650735,2.38120388071635e-71
NMR metabolomics,X23408.Triglycerides in VLDL,METAP2,Methionine aminopeptidase 2,42689,0.105476953091677,0.00588303575467573,0.093946203012513,0.117007703170842,4.66372076064291e-71
NMR metabolomics,X23408.Triglycerides in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.117703286406877,0.00655738462381613,0.104850812544198,0.130555760269557,4.66826241166145e-71
NMR metabolomics,X23408.Triglycerides in VLDL,AMOT,Angiomotin,40283,0.0714799743382763,0.00399656386433278,0.0636467091641841,0.0793132395123685,1.49599274675183e-70
NMR metabolomics,X23408.Triglycerides in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.10149077509972,0.00568192947916114,0.0903541933205641,0.112627356878876,1.49600781663139e-70
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.153624748629449,0.00861697708159398,0.136735473549525,0.170514023709373,4.13290141132134e-70
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF3,Immunoglobulin superfamily member 3,42587,0.0666132825999631,0.00374293331606438,0.0592771333004769,0.0739494318994493,4.76017850403354e-70
NMR metabolomics,X23408.Triglycerides in VLDL,DCXR,L-xylulose reductase,42679,0.0966000621831251,0.00543110061170535,0.0859551049841827,0.107245019382068,5.65751162094483e-70
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFC,Vascular endothelial growth factor C,42679,0.101881870169848,0.00573712550786255,0.0906371041744374,0.113126636165259,9.23253212459056e-70
NMR metabolomics,X23408.Triglycerides in VLDL,SH2B3,SH2B adapter protein 3,42346,0.178527205707683,0.0100546327727735,0.158820125473047,0.198234285942319,1.01152920965781e-69
NMR metabolomics,X23408.Triglycerides in VLDL,PXN,Paxillin,42311,0.0938441266925752,0.00528735709597681,0.0834809067844607,0.10420734660069,1.14687189689812e-69
NMR metabolomics,X23408.Triglycerides in VLDL,USO1,General vesicular transport factor p115,42587,0.164523864976124,0.00927943890222153,0.146336164727769,0.182711565224478,1.53205535026095e-69
NMR metabolomics,X23408.Triglycerides in VLDL,CDH2,Cadherin-2,42636,0.0650727632365682,0.00367212490645545,0.0578753984199155,0.0722701280532208,1.78582569698115e-69
NMR metabolomics,X23408.Triglycerides in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0935619898168378,0.00529070613939778,0.0831922057836182,0.103931773850057,3.51716537208595e-69
NMR metabolomics,X23408.Triglycerides in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.172155226476525,0.00973777254514548,0.15306919228804,0.19124126066501,3.81765581010067e-69
NMR metabolomics,X23408.Triglycerides in VLDL,DNMBP,Dynamin-binding protein,42495,0.109405987738711,0.00619722687683932,0.0972594230601059,0.121552552417316,5.78577873138192e-69
NMR metabolomics,X23408.Triglycerides in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.168576359343176,0.00955266332490342,0.149853139226365,0.187299579459987,6.650154750745e-69
NMR metabolomics,X23408.Triglycerides in VLDL,GIT1,ARF GTPase-activating protein GIT1,40199,0.176295679700312,0.00998227798824371,0.156730414843354,0.19586094455727,7.44866434463396e-69
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0399403525293188,0.00226465986601053,0.0355016191919382,0.0443790858666994,7.90300081436269e-69
NMR metabolomics,X23408.Triglycerides in VLDL,AP3B1,AP-3 complex subunit beta-1,40449,0.139091259683769,0.00788357179487903,0.123639458965806,0.154543060401732,9.63320103713305e-69
NMR metabolomics,X23408.Triglycerides in VLDL,NIT2,Omega-amidase NIT2,40462,0.132937660892171,0.00753514574614753,0.118168775229721,0.14770654655462,9.74842061508898e-69
NMR metabolomics,X23408.Triglycerides in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.186756524940491,0.0105886441369725,0.166002782432025,0.207510267448957,1.06345448181971e-68
NMR metabolomics,X23408.Triglycerides in VLDL,STAMBP,STAM-binding protein,42476,0.114912103410764,0.00652919175510358,0.102114887570761,0.127709319250767,1.48180440421821e-68
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0424358397568763,0.00241204616426357,0.0377082292749197,0.0471634502388329,1.62709891758601e-68
NMR metabolomics,X23408.Triglycerides in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.209807588221325,0.0119448246973106,-0.233219444628054,-0.186395731814596,2.65393171496071e-68
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE1,Plasminogen activator inhibitor 1,42794,0.119797860676545,0.00682216871035769,0.106426410004244,0.133169311348846,2.81774932979355e-68
NMR metabolomics,X23408.Triglycerides in VLDL,EGLN1,Egl nine homolog 1,42594,0.100604573203427,0.0057339536340449,0.0893660240806992,0.111843122326155,3.72104226005651e-68
NMR metabolomics,X23408.Triglycerides in VLDL,SRP14,Signal recognition particle 14 kDa protein,42587,0.107398323971253,0.00612153575001023,0.0954001139012334,0.119396534041274,3.79346277197908e-68
NMR metabolomics,X23408.Triglycerides in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0707539597668464,0.00403908901005555,0.0628373453071375,0.0786705742265553,6.03288274057581e-68
NMR metabolomics,X23408.Triglycerides in VLDL,OGFR,Opioid growth factor receptor,42587,0.0588723589866734,0.00336162858446219,0.0522835669611275,0.0654611510122193,6.49669402302569e-68
NMR metabolomics,X23408.Triglycerides in VLDL,SYTL4,Synaptotagmin-like protein 4,40511,0.133326099614763,0.00760918130962681,0.118412104247894,0.148240094981631,7.66189687382286e-68
NMR metabolomics,X23408.Triglycerides in VLDL,CPB2,Carboxypeptidase B2,40516,0.0400919636791151,0.00229288757951067,0.0355979040232742,0.044586023334956,1.42590775798375e-67
NMR metabolomics,X23408.Triglycerides in VLDL,GAS6,Growth arrest-specific protein 6,42718,-0.0457665402674923,0.0026235586309705,-0.0509087151841945,-0.0406243653507901,2.07174137553796e-67
NMR metabolomics,X23408.Triglycerides in VLDL,PGF,Placenta growth factor,42754,0.0479557741376225,0.00275478693993216,0.0425563917353555,0.0533551565398896,3.83636223816076e-67
NMR metabolomics,X23408.Triglycerides in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.106934958093534,0.00613769911080556,0.094905067836355,0.118964848350713,4.20374306550017e-67
NMR metabolomics,X23408.Triglycerides in VLDL,PHACTR2,Phosphatase and actin regulator 2,40482,0.203603423454662,0.011690750886509,0.180689551717104,0.226517295192219,4.6982421292568e-67
NMR metabolomics,X23408.Triglycerides in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0741912036679331,0.00426491984000444,0.0658319607815244,0.0825504465543418,4.78518022089036e-67
NMR metabolomics,X23408.Triglycerides in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.113541212837075,0.00652233618525132,0.100757433913982,0.126324991760168,5.32971224886691e-67
NMR metabolomics,X23408.Triglycerides in VLDL,RGCC,Regulator of cell cycle RGCC,40482,0.135292005584604,0.00777728624174179,0.12004852455079,0.150535486618418,6.59980699346663e-67
NMR metabolomics,X23408.Triglycerides in VLDL,STK11,Serine/threonine-protein kinase STK11,42357,0.129823191936942,0.00747609323325699,0.115170049199759,0.144476334674126,8.40224195994404e-67
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR,GMP reductase 1,42754,0.0885197081728704,0.00510565208092616,0.0785126300942551,0.0985267862514857,1.27786614317772e-66
NMR metabolomics,X23408.Triglycerides in VLDL,AZI2,5-azacytidine-induced protein 2,40482,0.098530021327123,0.00568156641698946,0.0873941511498237,0.109665891504422,1.6428775559404e-66
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL5,C-X-C motif chemokine 5,42605,0.202489119015054,0.0116997229598722,0.179557662013704,0.225420576016403,2.18231695925264e-66
NMR metabolomics,X23408.Triglycerides in VLDL,SNX15,Sorting nexin-15,40283,0.0968218099462973,0.00559425986342207,0.0858570606139901,0.107786559278605,3.06083834823922e-66
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0629558084137044,0.0036458312609738,-0.070101637685213,-0.0558099791421957,4.25559523367255e-66
NMR metabolomics,X23408.Triglycerides in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.126446607956335,0.00731420926123805,0.112110757804308,0.140782458108362,4.25887677503636e-66
NMR metabolomics,X23408.Triglycerides in VLDL,OPHN1,Oligophrenin-1,40483,0.190325671495533,0.0110273558659785,0.168712053998215,0.211939288992851,6.64401084318107e-66
NMR metabolomics,X23408.Triglycerides in VLDL,BRAP,BRCA1-associated protein,40342,0.193717806222619,0.0112445335942399,0.171678520377909,0.215757092067329,1.16085006023202e-65
NMR metabolomics,X23408.Triglycerides in VLDL,NSFL1C,NSFL1 cofactor p47,42711,0.115269450731656,0.00670068037479135,0.102136117197064,0.128402784266247,1.26559046901859e-65
NMR metabolomics,X23408.Triglycerides in VLDL,AMN,Protein amnionless,42370,0.0838390444336936,0.00487597768689928,0.0742821281673711,0.0933959607000162,1.51794276029694e-65
NMR metabolomics,X23408.Triglycerides in VLDL,CNST,Consortin,42636,0.191907233306104,0.0111996346299736,0.169955949431356,0.213858517180852,3.98480691449339e-65
NMR metabolomics,X23408.Triglycerides in VLDL,FABP5,Fatty acid-binding protein 5,42678,0.11981347094008,0.00699498859773185,0.106103293288526,0.133523648591635,4.4355900886997e-65
NMR metabolomics,X23408.Triglycerides in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.140444680165541,0.00820878069268176,0.124355470007885,0.156533890323197,8.30826176415858e-65
NMR metabolomics,X23408.Triglycerides in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0776831686988717,0.00455062513185766,0.0687639434404307,0.0866023939573127,1.17910547237308e-64
NMR metabolomics,X23408.Triglycerides in VLDL,SH2D1A,SH2 domain-containing protein 1A,42594,0.102001371972487,0.00597537546684004,0.090289636057481,0.113713107887494,1.1898983862123e-64
NMR metabolomics,X23408.Triglycerides in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.159196076985057,0.00932078983863849,0.140927328901325,0.177464825068788,1.36566931718903e-64
NMR metabolomics,X23408.Triglycerides in VLDL,PON2,Serum paraoxonase/arylesterase 2,42357,0.0617985793935919,0.0036224137302876,0.0546986484822282,0.0688985103049556,1.45232614108986e-64
NMR metabolomics,X23408.Triglycerides in VLDL,GLB1,Beta-galactosidase,42495,0.0730220713250639,0.00428343015945296,0.0646265482125361,0.0814175944375917,1.76109889296587e-64
NMR metabolomics,X23408.Triglycerides in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.110336440189616,0.00647982847700883,0.0976359763746783,0.123036904004553,2.49982846869297e-64
NMR metabolomics,X23408.Triglycerides in VLDL,CDC27,Cell division cycle protein 27 homolog,42346,0.105853983437558,0.00622882482507381,0.0936454867804135,0.118062480094703,4.37168292836217e-64
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH1A1,Retinal dehydrogenase 1,42611,0.0940068676183558,0.00554863988038787,0.0831315334527956,0.104882201783916,1.00686962952714e-63
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.182380969422812,0.0107662788664311,0.161279062844607,0.203482876001017,1.03873649114509e-63
NMR metabolomics,X23408.Triglycerides in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.133891081330156,0.0079085778284929,0.118390268786309,0.149391893874002,1.24489498977618e-63
NMR metabolomics,X23408.Triglycerides in VLDL,LYN,Tyrosine-protein kinase Lyn,42587,0.146705201112122,0.00866734833037462,0.129717198384587,0.163693203839656,1.32043706289267e-63
NMR metabolomics,X23408.Triglycerides in VLDL,FAM13A,Protein FAM13A,40449,0.117706581633981,0.00694875947025151,0.104087013072288,0.131326150195674,1.41372832762033e-63
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RB,Interleukin-17 receptor B,42416,-0.0935602742674606,0.00553828476174635,-0.104415312400483,-0.0827052361344378,2.32231587548501e-63
NMR metabolomics,X23408.Triglycerides in VLDL,BID,BH3-interacting domain death agonist,42594,0.117350201631143,0.00694863901576632,0.103730869160241,0.130969534102045,2.47890158407143e-63
NMR metabolomics,X23408.Triglycerides in VLDL,TAX1BP1,Tax1-binding protein 1,40483,0.110320769415559,0.00652875842014662,0.0975244029120718,0.123117135919047,2.79813517859437e-63
NMR metabolomics,X23408.Triglycerides in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0824403737533955,0.00488676937080343,-0.0920184417201702,-0.0728623057866208,3.3048069090993e-63
NMR metabolomics,X23408.Triglycerides in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.13476730495132,0.00799338279787317,0.119100274667489,0.150434335235152,5.22619684559e-63
NMR metabolomics,X23408.Triglycerides in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0502201974583861,0.00298149209560196,0.0443764729510062,0.0560639219657659,5.32731111964094e-63
NMR metabolomics,X23408.Triglycerides in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.058119890272613,0.00345015962101891,0.0513575774154159,0.06488220312981,7.11283764140163e-63
NMR metabolomics,X23408.Triglycerides in VLDL,MITD1,MIT domain-containing protein 1,42495,0.166421873356197,0.00989772749352801,0.147022327468882,0.185821419243512,8.5451510301276e-63
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0348936005825038,0.00207608944413284,0.0308244652720034,0.0389627358930041,9.46207689560385e-63
NMR metabolomics,X23408.Triglycerides in VLDL,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0967861975703755,0.00575561783508916,0.0855051866136008,0.10806720852715,1.12473512713212e-62
NMR metabolomics,X23408.Triglycerides in VLDL,MTDH,Protein LYRIC,40199,0.162921317748817,0.00968868905632082,0.143931487198428,0.181911148299206,1.132718324765e-62
NMR metabolomics,X23408.Triglycerides in VLDL,NIT1,Deaminated glutathione amidase,40223,0.082497492242339,0.00490660591967027,0.0728805446397853,0.0921144398448928,1.16735429168153e-62
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0480642071259278,0.00286231743319568,0.0424540649568642,0.0536743492949913,1.21186446534943e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CES2,Cocaine esterase,42587,0.0952628780878951,0.00567929400881002,0.0841314618306275,0.106394294345163,1.64874428358845e-62
NMR metabolomics,X23408.Triglycerides in VLDL,FUOM,Fucose mutarotase,40283,0.109701469115047,0.00653471113698056,0.0968934352865652,0.122509502943529,1.77458557111466e-62
NMR metabolomics,X23408.Triglycerides in VLDL,DAG1,Dystroglycan,42676,0.0794783932911392,0.00474381200785055,0.0701805217557521,0.0887762648265263,2.25565205497005e-62
NMR metabolomics,X23408.Triglycerides in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.154028366121858,0.00918714073691099,0.136021570277512,0.172035161966204,2.57439604853332e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.047519613732379,0.00283905350909565,0.0419550688545515,0.0530841586102064,2.96733265891652e-62
NMR metabolomics,X23408.Triglycerides in VLDL,APOF,Apolipoprotein F,40532,-0.0411829456143597,0.00246490865421215,-0.0460141665766155,-0.0363517246521038,6.32264083467973e-62
NMR metabolomics,X23408.Triglycerides in VLDL,ST13,Hsc70-interacting protein,40283,0.0971981885075247,0.00582046728994297,0.0857900726192364,0.108606304395813,7.52136216706438e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CRKL,Crk-like protein,42636,0.180372157700857,0.0108149146681132,0.159174924951355,0.201569390450359,7.90188613792414e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CCN2,CCN family member 2,42624,0.0951082415106384,0.0057063084974264,0.0839238768556827,0.106292606165594,9.45718465026799e-62
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT5,ADP-sugar pyrophosphatase,42611,0.0870688469764871,0.00522771725780668,0.076822521151186,0.0973151728017882,1.15230487653361e-61
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF2,TNF receptor-associated factor 2,42594,0.119529307722973,0.00718386496620883,0.105448932389203,0.133609683056742,1.51607886530219e-61
NMR metabolomics,X23408.Triglycerides in VLDL,DLK1,Protein delta homolog 1,42794,0.0948308300106062,0.00570133965497489,0.0836562042868554,0.106005455734357,1.6250230329886e-61
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD1,COMM domain-containing protein 1,40223,0.103823927717044,0.00624108380838532,0.0915914034526087,0.116056451981479,2.15053773851976e-61
NMR metabolomics,X23408.Triglycerides in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0906483817367711,0.00545197617028321,0.079962508443016,0.101334255030526,2.45457451725628e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CMC1,COX assembly mitochondrial protein homolog,40511,0.155059607699494,0.00934463246341676,0.136744128071197,0.173375087327791,4.08873944632283e-61
NMR metabolomics,X23408.Triglycerides in VLDL,GOLGA3,Golgin subfamily A member 3,40482,0.134252043465657,0.00809312333739616,0.11838952172436,0.150114565206953,4.45585693929655e-61
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP4,Secreted frizzled-related protein 4,40283,0.0690201929783001,0.004165067608491,0.0608566604656578,0.0771837254909425,6.06724175268166e-61
NMR metabolomics,X23408.Triglycerides in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.171697350051131,0.0103849633859724,0.151342821814625,0.192051878287636,8.44778925814198e-61
NMR metabolomics,X23408.Triglycerides in VLDL,GASK1A,Golgi-associated kinase 1A,40116,0.0741359939287589,0.00447957255380244,0.0653560317233061,0.0829159561342117,8.80599397760434e-61
NMR metabolomics,X23408.Triglycerides in VLDL,QDPR,Dihydropteridine reductase,42581,0.0726033815636775,0.0043932009228814,0.0639927077548299,0.081214055372525,9.472317271731e-61
NMR metabolomics,X23408.Triglycerides in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.105817498502848,0.00639918372955739,0.0932750983929159,0.118359898612781,1.0993600132909e-60
NMR metabolomics,X23408.Triglycerides in VLDL,TBCC,Tubulin-specific chaperone C,42495,0.136907955578457,0.00829296341370004,0.120653747287605,0.153162163869309,1.26728094521204e-60
NMR metabolomics,X23408.Triglycerides in VLDL,MYDGF,Myeloid-derived growth factor,40511,0.167530608905941,0.0101417640907798,0.147652751288013,0.187408466523869,1.37057270949499e-60
NMR metabolomics,X23408.Triglycerides in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.179462491827087,0.0108703911623191,0.158156525148942,0.200768458505232,1.64958103089775e-60
NMR metabolomics,X23408.Triglycerides in VLDL,SEC31A,Protein transport protein Sec31A,40223,0.130795354921351,0.00792321066446913,0.115265862018991,0.14632484782371,1.70777248975205e-60
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.134235457695537,0.00815016554033507,0.11826113323648,0.150209782154594,2.34854203735629e-60
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP45,Rho GTPase-activating protein 45,40283,0.140023065423398,0.00849569268371713,0.123371507763312,0.156674623083483,2.58563107905127e-60
NMR metabolomics,X23408.Triglycerides in VLDL,FKBPL,FK506-binding protein-like,40449,0.0995661266376506,0.00605100264423973,0.0877061614549408,0.111426091820361,3.9139043743422e-60
NMR metabolomics,X23408.Triglycerides in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0992247008251929,0.00603938034680435,0.0873875153454564,0.111061886304929,4.50923516559182e-60
NMR metabolomics,X23408.Triglycerides in VLDL,DBNL,Drebrin-like protein,42676,0.155637888806619,0.00947432961761671,0.13706820275609,0.174207574857148,4.66788871240337e-60
NMR metabolomics,X23408.Triglycerides in VLDL,EREG,Proepiregulin,42476,0.13665646210933,0.00833223761949217,0.120325276375125,0.152987647843534,7.29229801470426e-60
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.150574089119992,0.00917935528426573,0.132582552762831,0.168565625477153,8.88715377556928e-60
NMR metabolomics,X23408.Triglycerides in VLDL,ARSB,Arylsulfatase B,42587,0.0932001923367467,0.00568712772564607,0.0820534219944804,0.104346962679013,8.89642883633534e-60
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL7,Angiopoietin-related protein 7,42721,0.0617300655077397,0.00377168399295922,0.0543375648815396,0.0691225661339397,1.23591350913833e-59
NMR metabolomics,X23408.Triglycerides in VLDL,BAG4,BAG family molecular chaperone regulator 4,40199,0.0827565093833411,0.00506262891837017,0.0728337567033355,0.0926792620633466,2.29878067622237e-59
NMR metabolomics,X23408.Triglycerides in VLDL,RAB27B,Ras-related protein Rab-27B,40511,0.13900110209869,0.0085104495559438,0.12232062096904,0.155681583228339,2.7344758070056e-59
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GLB2,Endophilin-B2,40483,0.112557519352515,0.00689541151582417,0.0990425127815,0.126072525923531,3.19342274544929e-59
NMR metabolomics,X23408.Triglycerides in VLDL,CCL5,C-C motif chemokine 5,42689,0.167628756202017,0.0103036891623627,0.147433525443786,0.187823986960248,5.97374057973881e-59
NMR metabolomics,X23408.Triglycerides in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0746649349769036,0.00459374214468921,0.0656612003733128,0.0836686695804945,7.6922818506639e-59
NMR metabolomics,X23408.Triglycerides in VLDL,DDHD2,Phospholipase DDHD2,40482,0.110199104475903,0.00677524806127013,0.0969196182758131,0.123478590675992,8.14466565625346e-59
NMR metabolomics,X23408.Triglycerides in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0806068865392136,0.00495727608385449,0.0708906254148588,0.0903231476635684,8.80644868239685e-59
NMR metabolomics,X23408.Triglycerides in VLDL,CCL17,C-C motif chemokine 17,42604,0.154169534300365,0.00949176777339103,0.135565669464519,0.172773399136211,9.18237865494867e-59
NMR metabolomics,X23408.Triglycerides in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0870618505334024,0.00535956936233502,0.0765570945832257,0.097566606483579,1.13914418388682e-58
NMR metabolomics,X23408.Triglycerides in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0826299709556833,0.00508943229797301,0.0726546836516562,0.0926052582597104,1.35738954034932e-58
NMR metabolomics,X23408.Triglycerides in VLDL,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0788431768633241,0.00485838589983183,0.0693207404996538,0.0883656132269945,1.46788969025234e-58
NMR metabolomics,X23408.Triglycerides in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.1124391864708,0.00693524285924619,0.0988461104666774,0.126032262474922,1.87139961552465e-58
NMR metabolomics,X23408.Triglycerides in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.073127886104206,0.00451924447454684,0.0642701669340942,0.0819856052743178,2.49178310401224e-58
NMR metabolomics,X23408.Triglycerides in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.141663957016594,0.00876023726747826,0.124493891972337,0.158834022060852,3.72207121014879e-58
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0855337184425427,0.00529441741552402,0.0751566603081156,0.0959107765769698,3.7679559961832e-58
NMR metabolomics,X23408.Triglycerides in VLDL,IST1,IST1 homolog,40375,0.16483392824555,0.0102012746829678,0.144839429866933,0.184828426624167,4.51339915125715e-58
NMR metabolomics,X23408.Triglycerides in VLDL,SIAE,Sialate O-acetylesterase,42646,0.0766265671098019,0.00474750331789084,0.0673214606067358,0.0859316736128679,4.65376543920944e-58
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.110053957133761,0.00681257428698954,0.0967013115312611,0.12340660273626,4.71418617378769e-58
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR2,GMP reductase 2,40283,0.112125584863104,0.00695174245297693,0.0985001696552694,0.125751000070939,7.23644569288586e-58
NMR metabolomics,X23408.Triglycerides in VLDL,APOA2,Apolipoprotein A-II,40532,-0.0820741122116,0.00509331430368767,-0.0920570082468278,-0.0720912161763721,8.88551687280383e-58
NMR metabolomics,X23408.Triglycerides in VLDL,STIP1,Stress-induced-phosphoprotein 1,42586,0.107592648309645,0.00669181552980214,0.0944766898712328,0.120708606748057,1.25423143111055e-57
NMR metabolomics,X23408.Triglycerides in VLDL,F13B,Coagulation factor XIII B chain,40479,0.0431592140630759,0.00268210633995154,0.0379022856367709,0.0484161424893809,1.27760627080583e-57
NMR metabolomics,X23408.Triglycerides in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.178820798250029,0.0111192047978526,0.157027156846238,0.20061443965382,1.48094901463079e-57
NMR metabolomics,X23408.Triglycerides in VLDL,DGKA,Diacylglycerol kinase alpha,40199,0.0908398028916327,0.00565317381310706,0.0797595822179429,0.101920023565323,1.89702521896477e-57
NMR metabolomics,X23408.Triglycerides in VLDL,IGBP1,Immunoglobulin-binding protein 1,40482,0.101259511534944,0.00630631001085563,0.0888991439136673,0.113619879156221,2.20713195355051e-57
NMR metabolomics,X23408.Triglycerides in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.135575716285838,0.0084536171222054,0.119006626726316,0.152144805845361,2.4387647485555e-57
NMR metabolomics,X23408.Triglycerides in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0633765510352636,0.00394914674542465,0.0556362234142313,0.0711168786562959,2.54111583507494e-57
NMR metabolomics,X23408.Triglycerides in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.191154933898946,0.0119353346452094,0.167761677994336,0.214548189803556,3.36035460388534e-57
NMR metabolomics,X23408.Triglycerides in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0954708074419421,0.00596498907690943,0.0837794288511996,0.107162186032685,5.1042942370493e-57
NMR metabolomics,X23408.Triglycerides in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.100689101593781,0.00630242847167797,0.0883363417892922,0.11304186139827,6.26262839535082e-57
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM5,PDZ and LIM domain protein 5,40482,0.19264591919951,0.0120664736421836,0.168995630860831,0.21629620753819,9.29278396890444e-57
NMR metabolomics,X23408.Triglycerides in VLDL,GIGYF2,GRB10-interacting GYF protein 2,40482,0.12401955422812,0.00777701542341747,0.108776603998222,0.139262504458018,1.24074450563334e-56
NMR metabolomics,X23408.Triglycerides in VLDL,OGA,Protein O-GlcNAcase,40449,0.115363880825229,0.00724034347706482,0.101172807610182,0.129554954040276,1.53778226947528e-56
NMR metabolomics,X23408.Triglycerides in VLDL,STAT2,Signal transducer and activator of transcription 2,40199,0.125191215951595,0.00785796043393869,0.109789613501075,0.140592818402115,1.63054868727037e-56
NMR metabolomics,X23408.Triglycerides in VLDL,GOLM2,Protein GOLM2,42711,0.0380383186216313,0.00239131541103707,0.0333513404159986,0.042725296827264,1.84600669935305e-56
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE4,Ribonuclease 4,40169,0.048156186931531,0.00303070672048573,0.042216001759379,0.054096372103683,3.1706904630116e-56
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2L,Ataxin-2-like protein,40482,0.079300220028705,0.00499281230422616,0.0695143079124217,0.0890861321449882,3.37610177778902e-56
NMR metabolomics,X23408.Triglycerides in VLDL,ADD1,Alpha-adducin,40283,0.116678046117626,0.00734937351845607,0.102273274021452,0.131082818213799,3.85719907402161e-56
NMR metabolomics,X23408.Triglycerides in VLDL,AHSG,Alpha-2-HS-glycoprotein,40532,0.0445917789923621,0.00281030836428944,0.0390835745983548,0.0500999833863694,4.28339799709991e-56
NMR metabolomics,X23408.Triglycerides in VLDL,CCL13,C-C motif chemokine 13,42734,0.113393785403686,0.0071576644814661,0.0993647630200121,0.127422807787359,5.05976196953164e-56
NMR metabolomics,X23408.Triglycerides in VLDL,GHRL,Appetite-regulating hormone,42636,0.139411858372051,0.0088053317938701,0.122153408056066,0.156670308688036,5.92919219967777e-56
NMR metabolomics,X23408.Triglycerides in VLDL,HS1BP3,HCLS1-binding protein 3,40223,0.14485133940786,0.00915480335963986,0.126907924822966,0.162794753992754,8.93083864098162e-56
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS8,Galectin-8,42711,0.0978696058298169,0.0061932662989475,0.0857308038838798,0.110008407775754,9.41703523722275e-56
NMR metabolomics,X23408.Triglycerides in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.126294487971798,0.00800705838658354,0.110600653534094,0.141988322409502,1.54224793145461e-55
NMR metabolomics,X23408.Triglycerides in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.116266983859039,0.00737895601616109,0.101804230067363,0.130729737650715,1.94568749729338e-55
NMR metabolomics,X23408.Triglycerides in VLDL,ELOA,Elongin-A,42587,0.0873211863071935,0.00554855180271975,0.0764460247738628,0.0981963478405242,2.61098682373508e-55
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFB,Platelet-derived growth factor subunit B,42676,0.139123207078594,0.00884829830411577,0.121780542402527,0.156465871754661,3.24487024053605e-55
NMR metabolomics,X23408.Triglycerides in VLDL,GZMA,Granzyme A,42754,0.0578939093535741,0.00368669325965449,0.0506679905646513,0.0651198281424969,4.37366994568342e-55
NMR metabolomics,X23408.Triglycerides in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0735641325175737,0.00469038866300473,0.0643709707380844,0.0827572942970629,5.98048544212043e-55
NMR metabolomics,X23408.Triglycerides in VLDL,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0836288490225514,0.00533216624011341,0.0731778031919291,0.0940798948531737,6.15076061842372e-55
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0728049509521444,0.0046469417349078,-0.0819129567525637,-0.0636969451517251,9.53566635776248e-55
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D23,TBC1 domain family member 23,42587,0.144846938289327,0.00925561430473368,0.126705934252049,0.162987942326605,1.01925694666696e-54
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0747671354660944,0.00478947877738458,0.0653797570624206,0.0841545138697682,1.89077144180241e-54
NMR metabolomics,X23408.Triglycerides in VLDL,TWF2,Twinfilin-2,40527,0.134008587149596,0.0085812869354214,0.117189264756171,0.150827909543022,2.07487655985037e-54
NMR metabolomics,X23408.Triglycerides in VLDL,CD36,Platelet glycoprotein 4,40199,0.0723814854745333,0.00463697965033207,0.0632930053598825,0.0814699655891842,2.39123041879082e-54
NMR metabolomics,X23408.Triglycerides in VLDL,WASHC3,WASH complex subunit 3,40483,0.120717301435806,0.00774358288915118,0.105539878973069,0.135894723898542,3.15689459218519e-54
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP3,Metalloproteinase inhibitor 3,42676,0.209975934265402,0.0134893477502216,0.183536812674968,0.236415055855836,3.66300013377994e-54
NMR metabolomics,X23408.Triglycerides in VLDL,UBXN1,UBX domain-containing protein 1,40283,0.109981451788504,0.00706582259854063,0.0961324394953645,0.123830464081644,4.66923855653702e-54
NMR metabolomics,X23408.Triglycerides in VLDL,SPART,Spartin,40283,0.123151810867677,0.0079132689574631,0.107641803711049,0.138661818024305,4.85676310348944e-54
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB3,Plexin-B3,42597,0.0751890551818298,0.00484723660635001,0.0656884714333838,0.0846896389302758,8.47508070385642e-54
NMR metabolomics,X23408.Triglycerides in VLDL,FUS,RNA-binding protein FUS,42336,0.0640098338224662,0.00412653557306248,0.0559218240992638,0.0720978435456687,8.65261896525266e-54
NMR metabolomics,X23408.Triglycerides in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0963550340972977,0.00622619849830771,0.0841516850406146,0.108558383153981,1.49607798816383e-53
NMR metabolomics,X23408.Triglycerides in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.23311480412968,0.0150653354975618,0.203586746554458,0.262642861704901,1.855375378144e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CIRBP,Cold-inducible RNA-binding protein,40449,0.151998668200785,0.00982319287139671,0.132745210172848,0.171252126228723,1.85933756243144e-53
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.131246062288013,0.00848966053951006,0.114606327630574,0.147885796945453,2.29754284504855e-53
NMR metabolomics,X23408.Triglycerides in VLDL,GTPBP2,GTP-binding protein 2,40182,0.129119248466798,0.00835794517851902,0.112737675916901,0.145500821016695,2.7922369960556e-53
NMR metabolomics,X23408.Triglycerides in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.135838564488253,0.00880662993724151,0.11857756981126,0.153099559165247,3.19036868167121e-53
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP8,Vesicle-associated membrane protein 8,40199,0.140457557301088,0.00910472117447155,0.122612303799123,0.158302810803052,3.878772872202e-53
NMR metabolomics,X23408.Triglycerides in VLDL,GIP,Gastric inhibitory polypeptide,40223,0.0937323041793262,0.00608314433851995,0.0818093412758271,0.105655267082825,5.10943675595712e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CASC3,Protein CASC3,40182,0.0669120399773439,0.0043448352790432,0.0583961628304193,0.0754279171242686,5.80899547464828e-53
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.111363310199294,0.00724909662670611,0.0971550808109499,0.125571539587638,8.20558225836277e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CCL3,C-C motif chemokine 3,42594,0.0915703496730984,0.00596730718833034,0.079874427583971,0.103266271762226,1.06733527749051e-52
NMR metabolomics,X23408.Triglycerides in VLDL,DOK1,Docking protein 1,40483,0.215324373108218,0.0140550167450242,0.18777654028797,0.242872205928465,1.88879182720809e-52
NMR metabolomics,X23408.Triglycerides in VLDL,SNCG,Gamma-synuclein,42495,0.109289851530192,0.0071491061984202,0.0952776033812884,0.123302099679096,2.5893584476701e-52
NMR metabolomics,X23408.Triglycerides in VLDL,COCH,Cochlin,40511,0.0743406317714746,0.00485982110532584,0.0648153824050359,0.0838658811379132,2.66758529684464e-52
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.138850596396933,0.00908908303277362,0.121035993652697,0.156665199141169,3.01592938168636e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0404725562720336,0.00265020363796348,0.0352781571416252,0.0456669554024421,3.21925223679538e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.146133436853183,0.00956858229693055,0.127379015551199,0.164887858155167,3.28062619676506e-52
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP5,Microfibrillar-associated protein 5,42794,0.0651932872565639,0.00426943140516211,0.0568252017024462,0.0735613728106816,3.29359408026351e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM24,Transcription intermediary factor 1-alpha,40287,0.102623546433594,0.00671514611926157,0.0894618600398412,0.115785232827347,3.40257828239886e-52
NMR metabolomics,X23408.Triglycerides in VLDL,RWDD1,RWD domain-containing protein 1,42711,0.0993685498049596,0.00651091105704141,0.0866071641331584,0.112129935476761,3.73433358866985e-52
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.164110159288544,0.010752753887691,0.14303476166867,0.185185556908418,3.74967004152603e-52
NMR metabolomics,X23408.Triglycerides in VLDL,IL32,Interleukin-32,42594,-0.0701886835347876,0.00459927705675804,-0.0792032665660333,-0.0611741005035418,3.82634320267902e-52
NMR metabolomics,X23408.Triglycerides in VLDL,TP53,Cellular tumor antigen p53,42346,0.0680575684097376,0.00446602095298318,0.0593041673418906,0.0768109694775847,5.41578063082649e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.125961897287482,0.00826032756929106,0.109771655251671,0.142152139323292,5.66442963026539e-52
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0520411537525908,0.00342024609922882,0.0453374713981023,0.0587448361070792,7.557286579307e-52
NMR metabolomics,X23408.Triglycerides in VLDL,C1S,Complement C1s subcomponent,40539,0.0328175921026426,0.00215661041109402,0.0285906356968983,0.0370445485083869,8.81154148668457e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA5,Integrin alpha-5,42611,0.0395042425462612,0.00259843898230142,0.0344113021409504,0.044597182951572,9.10561961559929e-52
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0608489658447038,0.00400817732907421,0.0529929382797184,0.0687049934096893,1.28666977538868e-51
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.137733062633269,0.00906695300614006,0.119961834741235,0.155504290525304,1.3226954925168e-51
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS9,Galectin-9,42620,0.0507608200631242,0.00334694404037101,0.044200809743997,0.0573208303822514,1.57869864130641e-51
NMR metabolomics,X23408.Triglycerides in VLDL,FOXJ3,Forkhead box protein J3,40199,0.0686904630751421,0.00452742714458165,0.0598167058717621,0.0775642202785222,1.79302088291104e-51
NMR metabolomics,X23408.Triglycerides in VLDL,CD207,C-type lectin domain family 4 member K,42365,0.0625315829285314,0.00412971701168352,0.0544373375856317,0.0706258282714311,2.31944169704319e-51
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN3,Ataxin-3,40483,0.0975003036576203,0.00644768717386587,0.0848628367968432,0.110137770518397,3.68587955905506e-51
NMR metabolomics,X23408.Triglycerides in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0770821596282678,0.0051089124809179,0.0670686911656688,0.0870956280908669,5.10272994445954e-51
NMR metabolomics,X23408.Triglycerides in VLDL,TDRKH,Tudor and KH domain-containing protein,42311,0.132201493777465,0.0087631995013426,0.115025622754834,0.149377364800097,5.3600156106745e-51
NMR metabolomics,X23408.Triglycerides in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0910146651360284,0.00603700798733168,0.0791821294808583,0.102847200791198,6.08186303031127e-51
NMR metabolomics,X23408.Triglycerides in VLDL,TALDO1,Transaldolase,40499,0.0688412899047407,0.00456434732594016,0.059895169145898,0.0777874106635834,6.60611292125428e-51
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.170973839699587,0.0113544538609324,0.14871911013216,0.193228569267015,7.93445429215846e-51
NMR metabolomics,X23408.Triglycerides in VLDL,MPHOSPH8,M-phase phosphoprotein 8,42357,0.117494920780603,0.00780452415355466,0.102198053439635,0.13279178812157,8.50602934591429e-51
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0616896302338534,0.00409963432085039,0.0536543469649866,0.0697249135027202,9.16881989600364e-51
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD1,Sushi domain-containing protein 1,42357,0.0768509503994415,0.00510880758946348,0.0668376875240931,0.0868642132747899,1.01488711880481e-50
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS2,Trypsin-2,42689,0.0871670580419414,0.00579864407748428,0.0758017156500722,0.0985324004338106,1.1588322962686e-50
NMR metabolomics,X23408.Triglycerides in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.111844297089171,0.00744037359767306,0.0972611648377315,0.12642742934061,1.1637154591004e-50
NMR metabolomics,X23408.Triglycerides in VLDL,LPP,Lipoma-preferred partner,40116,0.102516073067823,0.00681635970643561,0.0891560080432088,0.115876138092436,1.29352077579788e-50
NMR metabolomics,X23408.Triglycerides in VLDL,IFNLR1,Interferon lambda receptor 1,42594,0.0567344147732489,0.0037804544767881,0.0493247239987442,0.0641441055477536,1.69077526786277e-50
NMR metabolomics,X23408.Triglycerides in VLDL,DLG4,Disks large homolog 4,40483,0.108743265948976,0.00725320805201574,0.0945269781670254,0.122959553730927,2.50675233012832e-50
NMR metabolomics,X23408.Triglycerides in VLDL,FMNL1,Formin-like protein 1,42311,0.0960821749938407,0.00642008807901105,0.0834988023589791,0.108665547628702,3.18525127322318e-50
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0676783437476919,0.00452341919124734,0.0588124421328471,0.0765442453625367,3.34031288356095e-50
NMR metabolomics,X23408.Triglycerides in VLDL,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0512098599011454,0.00342507452305182,0.0444967138359638,0.057923005966327,3.8409340095313e-50
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH9,Protocadherin-9,40449,0.0535061867498487,0.00357714808510059,0.0464949765030516,0.0605173969966459,4.19311753200972e-50
NMR metabolomics,X23408.Triglycerides in VLDL,AP2B1,AP-2 complex subunit beta,40182,0.0748746037880324,0.00501002540059465,0.0650549540028669,0.0846942535731979,5.20033067207926e-50
NMR metabolomics,X23408.Triglycerides in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.186654334880483,0.0125064254290346,0.162141741039575,0.21116692872139,5.9014563683461e-50
NMR metabolomics,X23408.Triglycerides in VLDL,MAVS,Mitochondrial antiviral-signaling protein,42346,0.140332515415653,0.00940328814692713,0.121902070647675,0.15876296018363,5.91423500327363e-50
NMR metabolomics,X23408.Triglycerides in VLDL,IMPACT,Protein IMPACT,40483,0.0866977589115416,0.0058054960552352,0.0753189866432806,0.0980765311798026,5.95383416899936e-50
NMR metabolomics,X23408.Triglycerides in VLDL,MMP10,Stromelysin-2,42608,-0.0910334089514523,0.00610713650744832,-0.103003396506051,-0.0790634213968536,7.53855046461897e-50
NMR metabolomics,X23408.Triglycerides in VLDL,DFFA,DNA fragmentation factor subunit alpha,42754,0.102764206669912,0.00692167793291158,0.0891977179214055,0.116330695418419,1.78660548550109e-49
NMR metabolomics,X23408.Triglycerides in VLDL,NUDC,Nuclear migration protein nudC,42754,0.0953494904749973,0.00642436929462015,0.0827577266575418,0.107941254292453,1.91906267721576e-49
NMR metabolomics,X23408.Triglycerides in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.117494243347409,0.00791835968952676,0.101974258355936,0.133014228338881,2.04343602550878e-49
NMR metabolomics,X23408.Triglycerides in VLDL,RTBDN,Retbindin,42587,0.0459859402846839,0.00310289263153901,0.0399042707268674,0.0520676098425003,2.65905564345671e-49
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R2,Protein phosphatase inhibitor 2,42636,0.120668251954325,0.00814610097686132,0.104701894039677,0.136634609868973,2.95114268732094e-49
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0426542648666102,0.00288122962544342,0.0370070548007411,0.0483014749324793,3.36862456082814e-49
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFA,Vascular endothelial growth factor A,42716,0.0898650929858447,0.0060728764909558,0.0779622550635713,0.101767930908118,3.66857773587845e-49
NMR metabolomics,X23408.Triglycerides in VLDL,APOD,Apolipoprotein D,40033,-0.0670126732784341,0.00452405309760679,-0.0758798173497434,-0.0581455292071247,3.67289223159244e-49
NMR metabolomics,X23408.Triglycerides in VLDL,ICA1,Islet cell autoantigen 1,42370,0.120665564567776,0.00815398232541403,0.104683759209965,0.136647369925588,3.72222122317794e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY4,Protein canopy homolog 4,42587,0.113245785088479,0.00766188702974847,0.098228486510172,0.128263083666786,4.7694778241557e-49
NMR metabolomics,X23408.Triglycerides in VLDL,CPB1,Carboxypeptidase B,42794,0.0930788688317786,0.00630077315795611,0.0807293534421846,0.105428384221373,5.27350198034007e-49
NMR metabolomics,X23408.Triglycerides in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.106466189032337,0.00720171541856788,0.092350826811944,0.12058155125273,5.52915202753908e-49
NMR metabolomics,X23408.Triglycerides in VLDL,YJU2,Splicing factor YJU2,40451,0.0496274702516639,0.00336236529608997,0.0430372342713276,0.0562177062320002,7.61664293321792e-49
NMR metabolomics,X23408.Triglycerides in VLDL,RBM17,Splicing factor 45,40482,0.116684215451333,0.00790876665994183,0.101183032797847,0.132185398104819,8.27650310481769e-49
NMR metabolomics,X23408.Triglycerides in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0579681224310382,0.00393317371176252,0.0502591019559837,0.0656771429060928,8.82099763002976e-49
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6AP2,Renin receptor,42346,0.0616701686879224,0.00419449307916665,0.0534489622527558,0.069891375123089,1.50452165039597e-48
NMR metabolomics,X23408.Triglycerides in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.100217303489774,0.00681612099928707,0.0868577063311717,0.113576900648377,1.7590591145559e-48
NMR metabolomics,X23408.Triglycerides in VLDL,FGF19,Fibroblast growth factor 19,42676,0.118208421877251,0.00805398734700432,0.102422606677122,0.133994237077379,2.13717973002771e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.128506945128085,0.00875676916558903,0.11134367756353,0.145670212692639,2.24267453421121e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TADA3,Transcriptional adapter 3,40451,0.0599445538511228,0.00409807635701245,0.0519123241913784,0.0679767835108672,5.16806296665787e-48
NMR metabolomics,X23408.Triglycerides in VLDL,SULT2A1,Bile salt sulfotransferase,42594,0.0851340559071539,0.00582569997825072,0.0737156839497824,0.0965524278645253,5.38630956032866e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL3,C-X-C motif chemokine 3,42620,0.141156534401704,0.00966237178670895,0.122218285699755,0.160094783103654,5.75058032760147e-48
NMR metabolomics,X23408.Triglycerides in VLDL,APPL2,DCC-interacting protein 13-beta,40283,0.167770456973384,0.0114763751660946,0.145276761647838,0.190264152298929,5.94956516615122e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CCL11,Eotaxin,42754,0.055610872579353,0.00381112038699423,0.0481410766208443,0.0630806685378617,7.30612634996702e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.108723431240597,0.00744537537244046,0.0941304955106135,0.12331636697058,7.55597768385552e-48
NMR metabolomics,X23408.Triglycerides in VLDL,NT5E,5'-nucleotidase,42679,0.0857479311482288,0.0058783468502741,0.0742263713216915,0.097269490974766,7.84983893033472e-48
NMR metabolomics,X23408.Triglycerides in VLDL,YWHAQ,14-3-3 protein theta,40283,0.110942924119483,0.0076012220552881,0.0960445288911179,0.125841319347847,8.32835415993994e-48
NMR metabolomics,X23408.Triglycerides in VLDL,HAO1,Hydroxyacid oxidase 1,42721,0.188742294028843,0.0129738430271528,0.163313561695624,0.214171026362063,1.3768447449663e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP1A,Charged multivesicular body protein 1a,42495,0.118957244560963,0.00818217397174593,0.102920183576341,0.134994305545585,1.59645966676769e-47
NMR metabolomics,X23408.Triglycerides in VLDL,UROD,Uroporphyrinogen decarboxylase,40283,0.103488854303055,0.00713115446571629,0.0895117915502507,0.117465917055859,2.74746481768578e-47
NMR metabolomics,X23408.Triglycerides in VLDL,VNN1,Pantetheinase,40532,0.109468560535589,0.00754783031941673,0.0946748131095319,0.124262307961645,3.05393253336839e-47
NMR metabolomics,X23408.Triglycerides in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0854699863939571,0.00589572364758118,0.073914368044698,0.0970256047432162,3.44370785199978e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CETN3,Centrin-3,40449,0.113639303912135,0.00784556811009424,0.09826199041635,0.129016617407919,4.02357391587411e-47
NMR metabolomics,X23408.Triglycerides in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0991003841212753,0.00684600333377273,0.0856822175870808,0.11251855065547,4.63292497075346e-47
NMR metabolomics,X23408.Triglycerides in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0797825042385764,0.00552883622758318,0.0689459852325134,0.0906190232446395,7.49571192196868e-47
NMR metabolomics,X23408.Triglycerides in VLDL,RFC4,Replication factor C subunit 4,40451,0.0316412815472478,0.00219195865546099,0.0273450425825442,0.0359375205119513,8.13373587282496e-47
NMR metabolomics,X23408.Triglycerides in VLDL,TP53I3,Quinone oxidoreductase PIG3,40058,0.0794974028647797,0.00550718389229793,0.0687033224358758,0.0902914832936837,8.41141152825211e-47
NMR metabolomics,X23408.Triglycerides in VLDL,NFASC,Neurofascin,42754,0.0433642595493746,0.00301728449998757,0.037450381929399,0.0492781371693503,1.70373398235939e-46
NMR metabolomics,X23408.Triglycerides in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0836804797432776,0.00582416956009486,0.0722651074054917,0.0950958520810636,1.82500755609372e-46
NMR metabolomics,X23408.Triglycerides in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0857101356399778,0.00596535314900128,0.0740180434679353,0.0974022278120203,1.85217257167955e-46
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0865972128101281,0.00603343534636963,0.0747716795312437,0.0984227460890126,2.28831010875536e-46
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0800138628607426,0.0055740098857608,0.0690888034846514,0.0909389222368338,2.58234150039384e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.14603153680888,0.0101831352040051,0.12607259180903,0.16599048180873,2.72705891129754e-46
NMR metabolomics,X23408.Triglycerides in VLDL,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0519281715545611,0.00362328632844667,0.0448265303508056,0.0590298127583165,3.04056122959902e-46
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0474705988151837,0.0033125626140489,0.0409779760916478,0.0539632215387195,3.66242777113656e-46
NMR metabolomics,X23408.Triglycerides in VLDL,NEXN,Nexilin,40532,0.102328308605493,0.00714208260475837,0.0883298267001668,0.11632679051082,3.72213351684756e-46
NMR metabolomics,X23408.Triglycerides in VLDL,A1BG,Alpha-1B-glycoprotein,40539,0.0252520737935637,0.00176404268937579,0.0217945501223871,0.0287095974647402,4.44702657311727e-46
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0991369576991058,0.00693236482521226,0.0855495226416898,0.112724392756522,4.7008953138496e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CD226,CD226 antigen,40199,0.0629065733409092,0.00439751627555271,0.0542874414408259,0.0715257052409925,5.25755889985625e-46
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.124855944225048,0.00872899110863615,0.107747121652122,0.141964766797975,5.32674802881755e-46
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.119409216607588,0.00834906933984926,0.103045040701483,0.135773392513692,5.35186273338412e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MGLL,Monoglyceride lipase,42654,0.127140583450719,0.00889698230002456,0.109702498142671,0.144578668758767,5.45559356848418e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CD99L2,CD99 antigen-like protein 2,42611,0.0360005920403003,0.00252075016389931,0.0310599217190576,0.0409412623615429,6.17676568865665e-46
NMR metabolomics,X23408.Triglycerides in VLDL,HYOU1,Hypoxia up-regulated protein 1,42794,0.0342762721268617,0.00240119271784267,0.0295699343998901,0.0389826098538334,6.75029273579939e-46
NMR metabolomics,X23408.Triglycerides in VLDL,RRAS,Ras-related protein R-Ras,40182,0.191789708785214,0.0134385755811734,0.165450100646114,0.218129316924314,8.43612739797516e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CTSZ,Cathepsin Z,42648,0.0477430608909021,0.00334825296617077,0.0411804850772074,0.0543056367045969,8.48207715560671e-46
NMR metabolomics,X23408.Triglycerides in VLDL,ERMAP,Erythroid membrane-associated protein,40199,0.0662343666045054,0.0046452209324777,0.0571297335768491,0.0753389996321617,1.01119113270712e-45
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0878701640299746,0.00616866763044617,0.0757795754743001,0.0999607525856491,1.05903858564225e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CD5,T-cell surface glycoprotein CD5,42706,0.053364924066016,0.00374846699906906,0.0460179287478406,0.0607119193841913,1.16335538674076e-45
NMR metabolomics,X23408.Triglycerides in VLDL,GRAP2,GRB2-related adapter protein 2,42636,0.186920738125215,0.0131554880122249,0.161135981621254,0.212705494629175,1.72969160058038e-45
NMR metabolomics,X23408.Triglycerides in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.111422426569657,0.00784131378067968,0.0960534515595247,0.126791401579789,1.73184339961093e-45
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA11,Annexin A11,42570,0.0982823053686332,0.0069170659625548,0.0847248560820258,0.111839754655241,1.73379785214446e-45
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.122137938912882,0.00859808766946539,0.10528568708073,0.138990190745034,1.81264269954122e-45
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.137146844308864,0.00965305863027549,0.118226849393524,0.156066839224204,2.02280746361004e-45
NMR metabolomics,X23408.Triglycerides in VLDL,NUB1,NEDD8 ultimate buster 1,42594,0.122239877832951,0.00861459357708331,0.105355274421867,0.139124481244034,2.25551580554283e-45
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0713716515698457,0.00502636702888028,0.0615199721932403,0.081223330946451,2.26784346740088e-45
NMR metabolomics,X23408.Triglycerides in VLDL,DNM3,Dynamin-3,40482,0.0807936277428257,0.00569399806549787,0.0696333915344499,0.0919538639512016,2.61593641090154e-45
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.142829712846599,0.0100692462379791,0.123093990220161,0.162565435473038,2.78647022000397e-45
NMR metabolomics,X23408.Triglycerides in VLDL,RILPL2,RILP-like protein 2,40511,0.142353741230523,0.0100366432709061,0.122681920419547,0.162025562041499,2.83327844624703e-45
NMR metabolomics,X23408.Triglycerides in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0889447517786753,0.0062867102376561,0.0766227997128693,0.101266703844481,4.03544452837069e-45
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0758338839306801,0.00535723024096663,0.0653337126583855,0.0863340552029747,4.21009768618147e-45
NMR metabolomics,X23408.Triglycerides in VLDL,KIFBP,KIF-binding protein,42587,0.119430454431939,0.00846026491165941,0.102848335205087,0.136012573658792,6.29620263968823e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CPA1,Carboxypeptidase A1,42794,0.0915363808881084,0.00649058887206496,0.0788148266988611,0.104257935077356,7.53941759596788e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CACYBP,Calcyclin-binding protein,40267,0.148900249968147,0.0105522049067561,0.128217928350905,0.169582571585389,7.96024443798476e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0951763340060131,0.0067512598417232,0.0819438647162356,0.108408803295791,8.16291219724755e-45
NMR metabolomics,X23408.Triglycerides in VLDL,PRKG1,cGMP-dependent protein kinase 1,40283,0.181625432336572,0.0128751243818888,0.15639018854807,0.206860676125074,8.42030415144004e-45
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.113977553773401,0.00808790754952979,0.0981252549763226,0.129829852570479,8.97820274133082e-45
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.114050276511437,0.00809715190237296,0.0981798587827863,0.129920694240088,9.81031450280509e-45
NMR metabolomics,X23408.Triglycerides in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0826427549190026,0.00587262322003218,0.0711324134077395,0.0941530964302656,1.16293725490751e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.123402996939472,0.0087687596691928,0.106216227987854,0.14058976589109,1.1726816290274e-44
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.127271098644607,0.00904685152695313,-0.145002927637435,-0.109539269651779,1.2367332157894e-44
NMR metabolomics,X23408.Triglycerides in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0748943388277455,0.00532562153846055,0.0644561206123628,0.0853325570431282,1.31572055979261e-44
NMR metabolomics,X23408.Triglycerides in VLDL,RBKS,Ribokinase,42317,0.0725275555371569,0.00516149971171084,0.0624110161022037,0.0826440949721102,1.58193627227632e-44
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0481280988902082,0.00342626673265955,-0.054843581686221,-0.0414126160941955,1.64904856302921e-44
NMR metabolomics,X23408.Triglycerides in VLDL,MAX,Protein max,42311,0.152676777333789,0.010869075734353,0.131373388894457,0.173980165773121,1.69050793362233e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CRADD,Death domain-containing protein CRADD,42476,0.108876461895242,0.00776470331102417,0.0936576434056351,0.12409528038485,2.368599802234e-44
NMR metabolomics,X23408.Triglycerides in VLDL,TMED8,Protein TMED8,40449,0.148387791382435,0.010576836570564,0.12765719170413,0.16911839106074,2.42910875361386e-44
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO3,Forkhead box protein O3,42346,0.138224023778256,0.00985975126282537,0.118898911303118,0.157549136253393,2.48546875155499e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.150224955537246,0.0107251036402125,0.129203752402429,0.171246158672062,3.3663399860102e-44
NMR metabolomics,X23408.Triglycerides in VLDL,GYS1,"Glycogen [starch] synthase, muscle",42357,0.13393505302217,0.00957657603594269,0.115164963991722,0.152705142052617,3.94301115497741e-44
NMR metabolomics,X23408.Triglycerides in VLDL,GPC5,Glypican-5,42495,0.0817761707469868,0.00585352924277958,0.0703032534311388,0.0932490880628348,4.83632324718377e-44
NMR metabolomics,X23408.Triglycerides in VLDL,SPRY2,Protein sprouty homolog 2,42370,0.13333229386176,0.00954603347201353,0.114622068256614,0.152042519466907,5.08279516002078e-44
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0704447765188785,0.0050414948761184,0.0605634465616864,0.0803261064760705,5.28338002825202e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CASP10,Caspase-10,42311,0.103615565829625,0.00742268658398724,0.0890671001250098,0.11816403153424,5.69491499545063e-44
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD6B,Deubiquitinase OTUD6B,40449,0.0847190334795183,0.00606739528182369,0.0728269387271439,0.0966111282318927,6.09258619811709e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CST3,Cystatin-C,42659,0.0437527761216071,0.00314027174182612,0.0375978435076279,0.0499077087355863,8.0632600738569e-44
NMR metabolomics,X23408.Triglycerides in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.137959520463855,0.00990631346547784,0.118543146071519,0.157375894856192,8.83453728519267e-44
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.124140386509518,0.00891455589971959,0.106667856946067,0.141612916072968,9.131900924407e-44
NMR metabolomics,X23408.Triglycerides in VLDL,ESM1,Endothelial cell-specific molecule 1,42618,-0.0497012493748259,0.00357515681694216,-0.0567085567360325,-0.0426939420136193,1.23837204855996e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CCT5,T-complex protein 1 subunit epsilon,42346,0.0663015780944446,0.004772893166052,0.0569467074889827,0.0756564486999065,1.45271872498696e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL2,ADAMTS-like protein 2,40527,0.0492865744309453,0.00355070836407453,0.0423271860373592,0.0562459628245313,1.87760411533569e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ATG4A,Cysteine protease ATG4A,42346,0.0848200808511901,0.00611465804347909,0.0728353510859711,0.0968048106164091,1.90414588865303e-43
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0845150233474863,0.00609814480473136,0.0725626595302128,0.0964673871647598,2.24211283265746e-43
NMR metabolomics,X23408.Triglycerides in VLDL,SCG2,Secretogranin-2,42636,0.0493282784420579,0.00355973065065706,0.0423512063667701,0.0563053505173458,2.2826690601064e-43
NMR metabolomics,X23408.Triglycerides in VLDL,KLK10,Kallikrein-10,42636,0.0585233916791296,0.00422501937675028,0.050242353700699,0.0668044296575601,2.46779665154162e-43
NMR metabolomics,X23408.Triglycerides in VLDL,GPI,Glucose-6-phosphate isomerase,40532,0.0673765970909657,0.00486553627468631,0.0578401459925806,0.0769130481893509,2.95213715797718e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0705121700306403,0.00509671817242627,0.0605226024126848,0.0805017376485958,3.58086926063864e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CD244,Natural killer cell receptor 2B4,42754,0.0392705312807321,0.00284832104262552,0.0336878220371861,0.0448532405242782,5.92498433093266e-43
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE2,Glia-derived nexin,40511,0.0919135659041863,0.00666333627154364,0.0788534268119607,0.104973704996412,6.16557048967804e-43
NMR metabolomics,X23408.Triglycerides in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0813809408510253,0.00590082726132777,0.0698153194188229,0.0929465622832277,6.40450609729871e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ANG,Angiogenin,42618,0.0480265950251027,0.00348656539558659,0.041192926849753,0.0548602632004524,7.07513995012259e-43
NMR metabolomics,X23408.Triglycerides in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0465103025187301,0.00337891318362789,-0.0531329723586407,-0.0398876326788194,8.07551012096443e-43
NMR metabolomics,X23408.Triglycerides in VLDL,RASSF2,Ras association domain-containing protein 2,42346,0.0812437620638176,0.00590470320129694,0.0696705437892756,0.0928169803383596,8.8739273045522e-43
NMR metabolomics,X23408.Triglycerides in VLDL,TSC22D1,TSC22 domain family protein 1,40482,0.0930647552388505,0.00676226809322094,0.0798107097761374,0.106318800701564,9.49714019428281e-43
NMR metabolomics,X23408.Triglycerides in VLDL,ESYT2,Extended synaptotagmin-2,40483,0.117392393376387,0.00853307766449718,0.100667561153973,0.134117225598802,1.01683211446878e-42
NMR metabolomics,X23408.Triglycerides in VLDL,TBCB,Tubulin-folding cofactor B,42495,0.14193339979436,0.0103267918080882,0.121692887850507,0.162173911738213,1.08004506693284e-42
NMR metabolomics,X23408.Triglycerides in VLDL,THPO,Thrombopoietin,42357,0.0556547737419943,0.00404936520866957,0.047718017933002,0.0635915295509867,1.08934327985961e-42
NMR metabolomics,X23408.Triglycerides in VLDL,ATOX1,Copper transport protein ATOX1,42679,0.0988929163188423,0.00722264100969066,0.0847365399398486,0.113049292697836,2.1744529315168e-42
NMR metabolomics,X23408.Triglycerides in VLDL,ERP29,Endoplasmic reticulum resident protein 29,40283,0.167789238787577,0.0122539643731635,0.143771468616176,0.191807008958977,2.48028055085579e-42
NMR metabolomics,X23408.Triglycerides in VLDL,GET3,ATPase GET3,40511,0.0768054185653278,0.00561257422280009,0.0658047730886396,0.087806064042016,2.72522714971422e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CALCA,Calcitonin,42476,0.0898153673000257,0.00658031738630203,0.0769179452228738,0.102712789377178,3.93183014219501e-42
NMR metabolomics,X23408.Triglycerides in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0615698823102146,0.00451232180730496,0.0527257315678969,0.0704140330525324,4.68936469132922e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CCL7,C-C motif chemokine 7,42594,0.0838112616491012,0.00614923909824314,0.0717587530165447,0.0958637702816578,5.09329769570702e-42
NMR metabolomics,X23408.Triglycerides in VLDL,IL18,Interleukin-18,42566,0.0657837632668505,0.00482750203976971,0.0563218592689018,0.0752456672647991,5.28673558856892e-42
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.10785305975894,0.00791257635117389,0.0923444101106396,0.123361709407241,5.75930925554558e-42
NMR metabolomics,X23408.Triglycerides in VLDL,PENK,Proenkephalin-A,40283,0.0463294934133563,0.00340282410589429,0.0396599581658035,0.0529990286609091,7.07393542429767e-42
NMR metabolomics,X23408.Triglycerides in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.119969110992753,0.00881338459979171,0.102694877177161,0.137243344808344,7.25333708662991e-42
NMR metabolomics,X23408.Triglycerides in VLDL,C19orf12,Protein C19orf12,42311,0.0899402244163725,0.0066120074960703,0.0769806897240747,0.10289975910867,7.43207724125986e-42
NMR metabolomics,X23408.Triglycerides in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0917834583316443,0.00675498410966017,0.0785436894767104,0.105023227186578,9.08691590617507e-42
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.089291407090029,0.00657008907562316,0.0764140325018076,0.10216878167825,9.71497309713139e-42
NMR metabolomics,X23408.Triglycerides in VLDL,EHD3,EH domain-containing protein 3,40223,0.164569120618663,0.0121735761812042,0.140708911303503,0.188429329933823,2.59114201768852e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CETN2,Centrin-2,42311,0.0938903709760054,0.00698251534807693,0.0802046408937746,0.107576101058236,6.02622215087979e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0408664967174446,0.00304200234688087,0.0349041721175581,0.0468288213173311,6.95716764086e-41
NMR metabolomics,X23408.Triglycerides in VLDL,FIS1,Mitochondrial fission 1 protein,42624,0.105011106231635,0.00781771080478537,0.0896883930542557,0.120333819409014,7.16231634381667e-41
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2,Microtubule-associated protein 2,40483,0.0647032411863912,0.00482611580652578,0.0552440542056007,0.0741624281671818,1.12721908434999e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PARK7,Parkinson disease protein 7,42611,0.0720834948089444,0.00538043949717003,0.0615378333944911,0.0826291562233976,1.14398495038714e-40
NMR metabolomics,X23408.Triglycerides in VLDL,THTPA,Thiamine-triphosphatase,40436,0.122257963655883,0.00911997062194865,0.104382821236863,0.140133106074902,1.15139354028601e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.064140691984996,0.00479037394030333,0.0547515590620015,0.0735298249079906,1.26384376445688e-40
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL3,Angiopoietin-related protein 3,42652,0.0497065811392185,0.00371515293070281,0.042424881395041,0.056988280883396,1.44861300463051e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PF4,Platelet factor 4,40463,0.136315460254016,0.0101834530834107,0.116355892210531,0.156275028297501,1.4894580906242e-40
NMR metabolomics,X23408.Triglycerides in VLDL,MIF,Macrophage migration inhibitory factor,42586,0.0939319508574332,0.00702886637324766,0.0801553727658677,0.107708528948999,1.78875047201943e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0547141866431334,0.00409720758168988,0.0466836597830213,0.0627447135032456,2.02680996572487e-40
NMR metabolomics,X23408.Triglycerides in VLDL,FEN1,Flap endonuclease 1,42346,0.0883906799069501,0.00662602085252673,0.0754036790359977,0.101377680777902,2.47854052868306e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB9,Serpin B9,42495,0.045545868271779,0.00341550877891555,0.0388514710651046,0.0522402654784535,2.62752292457068e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CD69,Early activation antigen CD69,42585,0.120953882210091,0.00907427147043649,0.103168310128035,0.138739454292146,2.82195601101308e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SPARC,SPARC,42679,0.0968313279340443,0.00726968604175889,0.0825827432921969,0.111079912575892,3.18433019944317e-40
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0441195301289431,0.00331278882807297,0.03762646402592,0.0506125962319661,3.27262871986457e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0923221293847213,0.00693300593962242,0.0787334377430613,0.105910821026381,3.34381896272228e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CTF1,Cardiotrophin-1,42357,0.116088881730888,0.00872000304704572,0.0989976757586786,0.133180087703098,3.53984560289712e-40
NMR metabolomics,X23408.Triglycerides in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0370042332405553,0.00277853626367576,-0.0424501643173598,-0.0315583021637508,3.64626573854607e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PQBP1,Polyglutamine-binding protein 1,42346,0.0787945082320822,0.00592489028925038,0.0671817232651514,0.0904072931990129,4.26304029430334e-40
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.124339246655749,0.00935413418635274,0.106005143650497,0.142673349661,5.20711200037891e-40
NMR metabolomics,X23408.Triglycerides in VLDL,COMT,Catechol O-methyltransferase,42214,0.114439542379267,0.00862624939939291,0.0975320935564567,0.131346991202077,6.57865697224449e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0781361670866336,0.00589324514550092,0.0665854066014518,0.0896869275718154,7.16682695047619e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CASP2,Caspase-2,42594,0.0925631734229948,0.00699028898530999,0.0788622070117872,0.106264139834202,8.95930505211036e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4D,Semaphorin-4D,42711,0.041114816430697,0.00310536525423629,0.0350283005323939,0.0472013323290001,9.12279814216023e-40
NMR metabolomics,X23408.Triglycerides in VLDL,EGF,Pro-epidermal growth factor,42597,0.141108679064319,0.0106618144568367,0.120211522728919,0.162005835399719,9.78539849124527e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB1,Leukocyte elastase inhibitor,42569,0.121858700618061,0.0092081573741309,0.103810712164764,0.139906689071357,9.95040752435598e-40
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0857581953975049,0.0064764056843086,0.0730644402562601,0.0984519505387498,1.00937244459216e-39
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0577927959781263,0.00437092664743134,0.0492257797491609,0.0663598122070918,1.29063514435518e-39
NMR metabolomics,X23408.Triglycerides in VLDL,FAM172A,Cotranscriptional regulator FAM172A,40223,0.083606824831376,0.00632673310189713,0.0712064279516576,0.0960072217110944,1.43881175820802e-39
NMR metabolomics,X23408.Triglycerides in VLDL,NACC1,Nucleus accumbens-associated protein 1,40451,0.0756805130783255,0.00573231191178176,0.0644451817312333,0.0869158444254178,1.66904189093798e-39
NMR metabolomics,X23408.Triglycerides in VLDL,GGCT,Gamma-glutamylcyclotransferase,40500,0.0653152581524656,0.00494740726491753,0.0556183399132272,0.0750121763917039,1.67567456158244e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CASP7,Caspase-7,40483,0.114406616104581,0.00867373838533704,0.0974060888693205,0.131407143339842,1.96001008280981e-39
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.127766175716109,0.00969235307425718,0.108769163690565,0.146763187741653,1.96384730705076e-39
NMR metabolomics,X23408.Triglycerides in VLDL,FGL1,Fibrinogen-like protein 1,40532,-0.0900757452374717,0.00683237374957068,-0.10346719778663,-0.0766842926883132,2.12293101734462e-39
NMR metabolomics,X23408.Triglycerides in VLDL,JAM3,Junctional adhesion molecule C,40283,0.0693568253645896,0.00526361709899358,0.0590401358505622,0.079673514878617,2.3613733690629e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.125211341103443,0.00950599923477118,0.106579582603291,0.143843099603594,2.5239637302978e-39
NMR metabolomics,X23408.Triglycerides in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0999617668126331,0.00759545948261367,0.0850746662267103,0.114848867398556,2.61971339185146e-39
NMR metabolomics,X23408.Triglycerides in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.135212092902647,0.0102754555388077,0.115072200046584,0.15535198575871,3.00919545884701e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CIAPIN1,Anamorsin,42679,0.0845877586159817,0.00643739636478963,0.071970461740994,0.0972050554909694,3.3785683249435e-39
NMR metabolomics,X23408.Triglycerides in VLDL,LEPR,Leptin receptor,42636,-0.0425776195683044,0.00324119967898224,-0.0489303709391095,-0.0362248681974992,3.5510092933429e-39
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT1,Dynein light chain Tctex-type 1,40182,0.110000241891752,0.00837115886335584,0.0935927705195746,0.126407713263929,3.81096189745684e-39
NMR metabolomics,X23408.Triglycerides in VLDL,RILP,Rab-interacting lysosomal protein,42674,0.0811535886793569,0.00618375232152868,0.0690334341291607,0.0932737432295531,4.1838009264392e-39
NMR metabolomics,X23408.Triglycerides in VLDL,MENT,Protein MENT,40283,-0.0315900942809448,0.00240801173784164,-0.0363097972871144,-0.0268703912747751,5.01840734838482e-39
NMR metabolomics,X23408.Triglycerides in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0540782141001943,0.00412253518663504,0.0459980451343897,0.062158383065999,5.02781722100964e-39
NMR metabolomics,X23408.Triglycerides in VLDL,RAB33A,Ras-related protein Rab-33A,40116,0.089231929609667,0.00681726955085986,0.0758700812899816,0.102593777929352,7.44754507347622e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0406806879093982,0.00311254572655415,0.034580098285352,0.0467812775334443,9.45457985141352e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0516878976386579,0.00395738851339074,0.043931416152412,0.0594443791249038,9.56095575739407e-39
NMR metabolomics,X23408.Triglycerides in VLDL,F12,Coagulation factor XII,40539,0.0563543748960973,0.00431267757232437,0.0479015268543415,0.064807222937853,9.65610611224831e-39
NMR metabolomics,X23408.Triglycerides in VLDL,FGF23,Fibroblast growth factor 23,42711,0.0739999180879366,0.00566723916529669,0.0628921293239551,0.0851077068519181,9.8777248379072e-39
NMR metabolomics,X23408.Triglycerides in VLDL,WDR46,WD repeat-containing protein 46,40451,0.0487970646981867,0.00373571374367213,0.0414750657605893,0.056119063635784,1.03303246478971e-38
NMR metabolomics,X23408.Triglycerides in VLDL,POSTN,Periostin,40527,-0.0523838378464803,0.00401481111027241,-0.0602528676226142,-0.0445148080703464,1.24349999537947e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.150009162074721,0.0115032645725641,0.127462763512496,0.172555560636947,1.25005842237936e-38
NMR metabolomics,X23408.Triglycerides in VLDL,LARP1,La-related protein 1,40451,0.082857136016306,0.00635977120775363,0.0703919844491089,0.0953222875835031,1.60301553616714e-38
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0984779457581575,0.00756131916875765,0.0836577601873925,0.113298131328922,1.69120646708164e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0480402794702006,0.00369668584002176,0.0407947752237579,0.0552857837166432,2.20305800718547e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0454880050796222,0.0035018722068332,0.0386243355542291,0.0523516746050152,2.38817802607756e-38
NMR metabolomics,X23408.Triglycerides in VLDL,BIN2,Bridging integrator 2,42611,0.121839712016296,0.00938066916603612,0.103453600450865,0.140225823581727,2.42448775754033e-38
NMR metabolomics,X23408.Triglycerides in VLDL,STX4,Syntaxin-4,42587,0.0801263380911756,0.0061721571528188,0.0680289100716508,0.0922237661107005,2.63833895333215e-38
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0562159212809335,0.0043329423853442,0.0477233542056589,0.0647084883562082,2.93329386378636e-38
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.067450927464564,0.0051965289867681,0.0572657306504986,0.0776361242786295,3.03112137038823e-38
NMR metabolomics,X23408.Triglycerides in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0597842778326273,0.00460810386648187,0.0507523942543228,0.0688161614109317,3.26842976421788e-38
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0405940608924223,0.00313427972934717,0.0344508726229018,0.0467372491619427,3.8826446819987e-38
NMR metabolomics,X23408.Triglycerides in VLDL,JPT2,Jupiter microtubule associated homolog 2,40449,0.116870312968016,0.00902184594897874,0.0991874949080173,0.134553131028014,4.16590151965322e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.071576648210054,0.00552953361434298,0.0607387623259418,0.0824145340941662,4.31166291770026e-38
NMR metabolomics,X23408.Triglycerides in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0660019216662404,0.00509596635650153,0.0560138276074975,0.0759900157249834,4.34836217026548e-38
NMR metabolomics,X23408.Triglycerides in VLDL,KLK13,Kallikrein-13,42381,0.062077179516022,0.00480029557951028,0.0526686001801818,0.0714857588518621,5.05938987910782e-38
NMR metabolomics,X23408.Triglycerides in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0503467313701947,0.0038969592543023,0.0427086912317622,0.0579847715086272,5.87806912544272e-38
NMR metabolomics,X23408.Triglycerides in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.089438040571663,0.00691881020065031,0.0758771725783884,0.102998908564938,6.0285203157049e-38
NMR metabolomics,X23408.Triglycerides in VLDL,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0835373585244265,0.00646395260089452,0.0708680114266733,0.0962067056221798,6.15479914575706e-38
NMR metabolomics,X23408.Triglycerides in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.034545308180291,0.00267292330719214,0.0293063784981944,0.0397842378623876,6.19662734585288e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG3,Proteasome assembly chaperone 3,42594,0.0686587626130913,0.00532404198643211,0.0582236403196844,0.0790938849064983,7.95911082104755e-38
NMR metabolomics,X23408.Triglycerides in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0635850885475434,0.0049312544240381,0.0539198298764288,0.0732503472186581,8.95112176906407e-38
NMR metabolomics,X23408.Triglycerides in VLDL,BAG6,Large proline-rich protein BAG6,42357,0.0476566979043806,0.00369817408865993,0.0404082766906071,0.0549051191181541,9.0649046032447e-38
NMR metabolomics,X23408.Triglycerides in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0802037632789281,0.00622180779010602,0.0680090200103203,0.0923985065475359,9.46964381359949e-38
NMR metabolomics,X23408.Triglycerides in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.119220739434282,0.00927739369265392,0.10103704779668,0.137404431071883,1.55967458641822e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PMVK,Phosphomevalonate kinase,42303,0.14401986248799,0.0112213540461458,0.122026008557544,0.166013716418435,1.76762144362718e-37
NMR metabolomics,X23408.Triglycerides in VLDL,HPSE,Heparanase,40408,0.125003943309541,0.00974184570888179,0.105909925720133,0.144097960898949,1.99799961789131e-37
NMR metabolomics,X23408.Triglycerides in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.100841231907617,0.00787091840677867,0.0854142318303309,0.116268231984903,2.32528171809977e-37
NMR metabolomics,X23408.Triglycerides in VLDL,MICALL2,MICAL-like protein 2,40182,0.0917165972284859,0.00715508636001514,0.0776926279628563,0.105740566494116,2.3945313850292e-37
NMR metabolomics,X23408.Triglycerides in VLDL,TREH,Trehalase,40527,0.0989694763790144,0.00772626700958766,0.0838259930402225,0.114112959717806,2.6317835088118e-37
NMR metabolomics,X23408.Triglycerides in VLDL,LACTB2,Endoribonuclease LACTB2,42636,0.0864020265863693,0.00675421388844577,0.0731637673650156,0.099640285807723,2.98445423144121e-37
NMR metabolomics,X23408.Triglycerides in VLDL,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0957101118060218,0.00748099978236814,0.0810473522325803,0.110372871379463,3.21234405287647e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0420661846079411,0.00329009503381266,0.0356175983416683,0.0485147708742139,3.23711881585043e-37
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0699750912352703,0.00547114637437603,0.0592516443414933,0.0806985381290473,3.38466810456835e-37
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB1,Heat shock protein beta-1,42448,0.0897059424968754,0.00702540362920613,0.0759361513836314,0.103475733610119,4.05184137873651e-37
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0491585968468014,0.00384803664396044,0.0416164450246389,0.0567007486689639,4.08620375213376e-37
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0848019244608284,0.00664481630304181,0.0717780845068665,0.0978257644147904,4.81761781028839e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.050747779083537,0.00397997418437198,0.0429470296821679,0.0585485284849061,5.60927740910003e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0266231626240976,0.00208905786473812,0.0225286092092109,0.0307177160389843,6.03999532426555e-37
NMR metabolomics,X23408.Triglycerides in VLDL,STK24,Serine/threonine-protein kinase 24,42311,0.0813250008688406,0.00638749575881472,0.0688055091815637,0.0938444925561174,6.49995727001102e-37
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.080484699298618,0.00632037702394737,0.0680967603316812,0.0928726382655549,6.83838894440015e-37
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB6,Serpin B6,42679,0.076382796535124,0.00600877738191926,0.0646055928665623,0.0881600002036858,8.26147387033183e-37
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0482483115314699,0.0037999767652383,0.0408003570716028,0.0556962659913369,1.10559824865347e-36
NMR metabolomics,X23408.Triglycerides in VLDL,XCL1,Lymphotactin,42721,0.0741554606348274,0.00584473941365895,0.0626997713840559,0.085611149885599,1.12134238144635e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRD2,Protein ZNRD2,40449,0.0918027506750373,0.00724554670683472,0.0776014791296412,0.106004022220433,1.53514149877807e-36
NMR metabolomics,X23408.Triglycerides in VLDL,IL7,Interleukin-7,42594,0.0835337776008524,0.00659897613114012,0.0705997843838177,0.096467770817887,1.6224557358551e-36
NMR metabolomics,X23408.Triglycerides in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0971753624578593,0.00767364199978962,0.0821350241382716,0.112215700777447,1.68268390119784e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FCN1,Ficolin-1,40515,0.0732852017202821,0.00579242603274058,0.0619320466961105,0.0846383567444536,1.92620530686695e-36
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.129974738147088,0.0102870434004025,0.109812133082299,0.150137343211876,2.18840961558142e-36
NMR metabolomics,X23408.Triglycerides in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.119409756232094,0.00945807046233268,0.100871938125922,0.137947574338266,2.73669134345377e-36
NMR metabolomics,X23408.Triglycerides in VLDL,F2,Prothrombin,40539,0.0195075217278696,0.00154722129903991,0.0164749679817514,0.0225400754739878,3.33099623805115e-36
NMR metabolomics,X23408.Triglycerides in VLDL,MESD,LRP chaperone MESD,42611,0.157423310062834,0.0124955090062592,0.132932112410566,0.181914507715102,3.45341636747376e-36
NMR metabolomics,X23408.Triglycerides in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.11258261835639,0.0089329055025328,0.0950741235714262,0.130091113141355,3.58993357405742e-36
NMR metabolomics,X23408.Triglycerides in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0794976885207395,0.00631066856886287,-0.0918665989157107,-0.0671287781257683,3.87111770417159e-36
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L1,Bcl-2-like protein 1,40483,0.12958335719894,0.0102913803933569,0.109412251627961,0.14975446276992,4.11336696124561e-36
NMR metabolomics,X23408.Triglycerides in VLDL,SUGT1,Protein SGT1 homolog,42346,0.104757695324979,0.00832732169516697,0.0884361448024516,0.121079245847506,4.38858425193303e-36
NMR metabolomics,X23408.Triglycerides in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.117881991021793,0.00937058453032187,0.099515645342362,0.136248336701224,4.73874468404884e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0449573832988984,0.00357453450393023,0.0379512956711951,0.0519634709266016,4.92627158244525e-36
NMR metabolomics,X23408.Triglycerides in VLDL,REEP4,Receptor expression-enhancing protein 4,40482,0.0808942112934084,0.00643569107636442,0.0682802567837342,0.0935081658030827,5.40175430208233e-36
NMR metabolomics,X23408.Triglycerides in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0956929115561522,0.00761249550560652,0.0807724203651634,0.110613402747141,5.412071881027e-36
NMR metabolomics,X23408.Triglycerides in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.140374890524787,0.0111772574481834,0.118467465926348,0.162282315123227,6.17806724335512e-36
NMR metabolomics,X23408.Triglycerides in VLDL,PPBP,Platelet basic protein,40471,0.109653936289046,0.00873669633500432,0.0925300114724378,0.126777861105655,6.82008974694635e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ACYP1,Acylphosphatase-1,40250,0.0852001908322338,0.0068000744176508,0.0718720449736382,0.0985283366908293,9.02749576444683e-36
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0819064634555073,0.00656000249192355,0.0690488585713372,0.0947640683396775,1.40670865317297e-35
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.143968388330141,0.0115325709231601,0.121364549320747,0.166572227339535,1.44244122704836e-35
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0683179686153689,0.00547385927707083,0.0575892044323101,0.0790467327984278,1.6327811766848e-35
NMR metabolomics,X23408.Triglycerides in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.135211109784142,0.0108619649525394,0.113921658477165,0.15650056109112,2.44528174107401e-35
NMR metabolomics,X23408.Triglycerides in VLDL,GMFG,Glia maturation factor gamma,40511,0.0923242712391419,0.0074227591499476,0.0777756633052446,0.106872879173039,2.76311298721852e-35
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0744492961625183,0.00599246673639526,0.0627040613591836,0.0861945309658531,3.0441357107888e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CERT,Ceramide transfer protein,42311,0.0789175567610688,0.00635365517956969,0.0664643926091122,0.0913707209130254,3.17905454269323e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CCL2,C-C motif chemokine 2,42475,0.0686560275265563,0.00553976699233881,0.0577980842215722,0.0795139708315404,4.43940009722049e-35
NMR metabolomics,X23408.Triglycerides in VLDL,TTF2,Transcription termination factor 2,40182,0.0630365887946251,0.00509486883772326,0.0530506458726875,0.0730225317165627,6.28251109049198e-35
NMR metabolomics,X23408.Triglycerides in VLDL,DCTD,Deoxycytidylate deaminase,40283,0.120507097260667,0.0097528817025554,0.101391449123658,0.139622745397676,7.65714196606511e-35
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0696217827633388,0.00563545389421146,0.0585762931306844,0.0806672723959933,7.8507998757565e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.102102653308522,0.00829350472565176,0.0858473840462445,0.118357922570799,1.33204261205227e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CEMIP2,Cell surface hyaluronidase,40199,0.0441148052098999,0.00358370935449984,0.0370907348750802,0.0511388755447196,1.35407261001098e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CTRB1,Chymotrypsinogen B,42611,0.0743084415660508,0.00604454165623811,0.0624611399198241,0.0861557432122775,1.50638717804724e-34
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3BP,Galectin-3-binding protein,40539,0.0391868775798088,0.0031871558149803,0.0329400521824474,0.0454337029771702,1.59290708779284e-34
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA3,Annexin A3,42681,0.0886394757201328,0.00721917624301167,0.0744898902838299,0.102789061156436,1.80883464705468e-34
NMR metabolomics,X23408.Triglycerides in VLDL,NRGN,Neurogranin,40532,0.115772234729335,0.00942736164083239,0.0972946059133038,0.134249863545367,1.90889536646941e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFA,Platelet-derived growth factor subunit A,42794,0.0914246912841592,0.00745296843180936,0.0768168731578129,0.106032509410506,2.07326634372571e-34
NMR metabolomics,X23408.Triglycerides in VLDL,SLMAP,Sarcolemmal membrane-associated protein,40449,0.105291101266957,0.0085793885856075,0.0884754996391664,0.122106702894748,2.10927862759215e-34
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D5,TBC1 domain family member 5,42594,0.0998942090849427,0.00815160987259421,0.0839170537346581,0.115871364435227,2.42539654837623e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA4,Protein disulfide-isomerase A4,40527,0.0762475274827495,0.00622200140451888,0.0640524047298925,0.0884426502356065,2.61938993197872e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DBI,Acyl-CoA-binding protein,42562,0.0972231884652768,0.00793788085677123,0.0816649419860052,0.112781434944548,2.629223690703e-34
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP1,Syntaxin-binding protein 1,40482,0.0976898725420159,0.00797863593470151,0.0820517461100009,0.113327998974031,2.98480685493342e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DDT,D-dopachrome decarboxylase,40527,0.0529385225711607,0.0043248558920624,0.0444618050227184,0.061415240119603,3.10481254784246e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DIABLO,"Diablo homolog, mitochondrial",42603,0.138000018567838,0.0112986942839288,0.115854577771337,0.160145459364338,3.98215353947936e-34
NMR metabolomics,X23408.Triglycerides in VLDL,MYO9B,Unconventional myosin-IXb,42370,0.0838849988411498,0.00686801087955879,0.0704236975172145,0.097346300165085,4.0080851655359e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.097262586961272,0.00797539277201195,0.0816308171281286,0.112894356794415,5.39200942066952e-34
NMR metabolomics,X23408.Triglycerides in VLDL,TSNAX,Translin-associated protein X,40116,0.0501029250726266,0.00410981742294839,0.0420476829236477,0.0581581672216054,5.76561297759765e-34
NMR metabolomics,X23408.Triglycerides in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.119075251147666,0.00977550040573015,0.0999152703524354,0.138235231942898,6.41453613944107e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CCL4,C-C motif chemokine 4,42642,0.0866910365262584,0.00712127677431542,0.0727333340486002,0.100648739003917,6.48576703271363e-34
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINC1,Antithrombin-III,40516,0.0186502401276769,0.00153125270630084,0.0156489848233273,0.0216514954320266,6.49497338647979e-34
NMR metabolomics,X23408.Triglycerides in VLDL,MPI,Mannose-6-phosphate isomerase,42587,0.106727959132381,0.00877050067329811,0.0895377778127169,0.123918140452045,6.86527896112545e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CASP3,Caspase-3,42794,0.109546995765424,0.00901170066648053,0.0918840624591224,0.127209929071726,7.97506380550736e-34
NMR metabolomics,X23408.Triglycerides in VLDL,NBN,Nibrin,42370,0.0677648661075765,0.00557612331242559,0.0568356644152223,0.0786940677999306,8.4179369053303e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DXO,Decapping and exoribonuclease protein,40483,0.0576738856068074,0.00474881971348246,0.0483661989683818,0.066981572245233,9.9092829483563e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CD22,B-cell receptor CD22,42754,0.0550894303136991,0.00454053230833523,0.0461899869893621,0.0639888736380362,1.0579843023227e-33
NMR metabolomics,X23408.Triglycerides in VLDL,STX8,Syntaxin-8,42594,0.0603547584975857,0.00497480359956345,0.0506041434424413,0.0701053735527301,1.07238359765224e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.117477485063941,0.00968444740257297,0.0984959681548976,0.136459001972984,1.09073039107456e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.117250702514203,0.00967249211084864,0.09829261797694,0.136208787051467,1.21044014227549e-33
NMR metabolomics,X23408.Triglycerides in VLDL,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0604918148544641,0.00498824528638865,0.0507148540931423,0.0702687756157858,1.23145687883432e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PKD2,Polycystin-2,40116,0.0734844234302783,0.00606702541685534,0.0615930536132419,0.0853757932473148,1.49484293890871e-33
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0428671307961155,0.00354168150829004,0.035925435039867,0.049808826552364,1.51247821810339e-33
NMR metabolomics,X23408.Triglycerides in VLDL,IL12A_IL12B,Interleukin-12,42587,0.103220047253622,0.00853441197773386,0.0864925997772635,0.11994749472998,1.68651265055091e-33
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK3,NT-3 growth factor receptor,42711,-0.0274116696548039,0.00226932363503452,-0.0318595439794715,-0.0229637953301362,2.02130470019841e-33
NMR metabolomics,X23408.Triglycerides in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.086733596603287,0.00717798736448164,0.0726647413689029,0.100802451837671,2.11372783075219e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.133395726215206,0.0110468940823284,0.111743813813842,0.15504763861657,2.34159346716264e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CDC37,Hsp90 co-chaperone Cdc37,42679,0.104530206632663,0.00867226965017589,0.0875325581183179,0.121527855147007,2.75997487240488e-33
NMR metabolomics,X23408.Triglycerides in VLDL,TBCA,Tubulin-specific chaperone A,40283,0.1059912498531,0.00879327284383851,0.0887564350791763,0.123226064627023,2.9925451392245e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0324617615143636,0.00269938962156214,0.0271709578561018,0.0377525651726254,3.85626604735849e-33
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0535211243884346,0.00445122153660646,0.044796730176686,0.0622455186001833,3.92863666898729e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PLG,Plasminogen,40285,0.0268105577588285,0.00223017094166173,0.0224394227131715,0.0311816928044855,4.38400758103948e-33
NMR metabolomics,X23408.Triglycerides in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0665573657376411,0.00553714496735357,0.0557045616016281,0.0774101698736541,4.48451708039093e-33
NMR metabolomics,X23408.Triglycerides in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.050139986180912,0.00417396354151745,0.0419590176395378,0.0583209547222862,4.49260275247447e-33
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0862872287216004,0.00718608817005458,0.0722024959082934,0.100371961534907,5.23253648113584e-33
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT1,Angiopoietin-1,42554,0.104509563100405,0.00871920551469903,0.087419920291595,0.121599205909215,6.1968397078814e-33
NMR metabolomics,X23408.Triglycerides in VLDL,KLF4,Krueppel-like factor 4,40136,0.0501053282779917,0.00417823783444758,0.0419159821224745,0.058294674433509,6.29407591976403e-33
NMR metabolomics,X23408.Triglycerides in VLDL,SWAP70,Switch-associated protein 70,40449,0.0444899172087623,0.00371312856498918,0.0372121852213835,0.0517676491961411,7.01416168962268e-33
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0500340658992874,0.00418036013964941,0.0418405600255745,0.0582275717730002,8.16275019169416e-33
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS1,Galectin-1,42636,0.0436574951662969,0.0036500374653086,0.036503421734292,0.0508115685983017,8.3600605452939e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL2,Chordin-like protein 2,42636,0.0585461135607092,0.00491910654525762,0.0489046647320043,0.0681875623894141,1.6870023925899e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.120275409150057,0.0101070171770137,0.10046565548311,0.140085162817003,1.84365510660567e-32
NMR metabolomics,X23408.Triglycerides in VLDL,GNAS,Neuroendocrine secretory protein 55,40482,0.106434689681448,0.0089482742197928,0.0888960722106544,0.123973307152242,1.97571047169529e-32
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB2,BPI fold-containing family B member 2,40473,0.0850432232238701,0.00717113233355928,0.0709878038500939,0.0990986425976463,3.00000253539889e-32
NMR metabolomics,X23408.Triglycerides in VLDL,DTNB,Dystrobrevin beta,40430,0.05276647931868,0.00445116924713462,0.0440421875942961,0.0614907710430638,3.17200198267648e-32
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.10554287916066,0.0089099622145144,0.0880793532202114,0.123006405101108,3.52096622276188e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CD274,Programmed cell death 1 ligand 1,42495,0.0432157217870401,0.0036505792342543,0.0360605864879017,0.0503708570861786,3.59923405030816e-32
NMR metabolomics,X23408.Triglycerides in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0845510659271999,0.00713991587789398,0.0705568308065277,0.0985453010478721,3.72162267142526e-32
NMR metabolomics,X23408.Triglycerides in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.111274985657748,0.00941779361895148,0.0928161101646027,0.129733861150893,4.6876404097885e-32
NMR metabolomics,X23408.Triglycerides in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0782233287592039,0.00662823261473165,0.0652319928343299,0.0912146646840779,5.56162633107412e-32
NMR metabolomics,X23408.Triglycerides in VLDL,C3,Complement C3,39989,0.0577924805305324,0.0048979536843113,0.0481924913092823,0.0673924697517826,6.1805984959777e-32
NMR metabolomics,X23408.Triglycerides in VLDL,OCLN,Occludin,40482,0.0553000516675039,0.00468800819228005,0.046111555610635,0.0644885477243728,6.29624227993394e-32
NMR metabolomics,X23408.Triglycerides in VLDL,BMPER,BMP-binding endothelial regulator protein,40283,0.0284717268146914,0.00241424452511531,0.0237398075454654,0.0332036460839174,6.55982242171097e-32
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM106A,Transmembrane protein 106A,40451,0.0857616907739889,0.00728591736568754,0.0714812927372413,0.100042088810736,8.46820490307313e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0749573683269897,0.00637916779116131,0.0624541994563135,0.0874605371976658,1.00651013100692e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4G,C-type lectin domain family 4 member G,42594,0.0405466861950694,0.00345142398269649,0.0337818951889843,0.0473114772011545,1.03669359375841e-31
NMR metabolomics,X23408.Triglycerides in VLDL,F2R,Proteinase-activated receptor 1,42654,0.0683676985637355,0.00582103406528251,0.0569584717957817,0.0797769253316892,1.07047053906972e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CD72,B-cell differentiation antigen CD72,40283,0.0541858817526766,0.00461254357700652,0.0451452963417438,0.0632264671636093,1.12035284917806e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CCL8,C-C motif chemokine 8,42706,0.0738903292905882,0.00629456413175127,0.0615529835923557,0.0862276749888206,1.14932841387222e-31
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX2,Heme oxygenase 2,42311,0.0557944343549968,0.00475720648472379,0.0464703096449382,0.0651185590650554,1.3110119417511e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.04412760934663,0.00376478934341248,0.0367486222335415,0.0515065964597185,1.53411711747545e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.133214663478027,0.0113809239479296,0.110908052540085,0.155521274415969,1.71925157375613e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0287635464976809,0.00245940919742426,0.0239431044707293,0.0335839885246324,1.90499529372343e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB1,Beta-crystallin B1,40511,0.0775709687171167,0.00663538809213594,0.0645656080565303,0.0905763293777032,2.15944250334195e-31
NMR metabolomics,X23408.Triglycerides in VLDL,HNMT,Histamine N-methyltransferase,42439,0.0584228077601619,0.00500298101291405,0.0486169649748503,0.0682286505454734,2.3632001761871e-31
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA1,GDNF family receptor alpha-1,42689,0.0361548456408544,0.00309678887507364,0.0300851394457101,0.0422245518359987,2.42150770844017e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA1,Paraneoplastic antigen Ma1,40223,0.0678276388430791,0.00580777102590074,0.0564444076323136,0.0792108700538446,2.50145434256322e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0732882878406438,0.00628508228133285,0.0609695265692314,0.0856070491120561,2.88466912514437e-31
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0806543522126903,0.00692370060532314,0.0670838990262569,0.0942248053991236,3.30278473699971e-31
NMR metabolomics,X23408.Triglycerides in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.142751072776648,0.0122575705328879,0.118726234532188,0.166775911021108,3.39353416876516e-31
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0583320596240339,0.0050094050208766,0.0485136257831158,0.0681504934649521,3.47485364370178e-31
NMR metabolomics,X23408.Triglycerides in VLDL,BMP6,Bone morphogenetic protein 6,42342,0.0491511365702428,0.00422473660941258,0.0408706528157942,0.0574316203246915,3.92643905112975e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.123305587926105,0.0105937670808699,0.1025418044476,0.14406937140461,3.94749683039433e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0918335035121043,0.00789143956234386,0.0763662819699103,0.107300725054298,4.02239069649985e-31
NMR metabolomics,X23408.Triglycerides in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.151920033701388,0.0130662980553879,0.126310089512828,0.177529977889949,4.52346624412128e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G4A,Cytosolic phospholipase A2,42676,0.104648961954628,0.00900784578878073,0.0869935842086176,0.122304339700638,4.71858150686344e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0811783662105797,0.00699218072794848,0.0674736919838006,0.0948830404373587,5.5797900784727e-31
NMR metabolomics,X23408.Triglycerides in VLDL,KLRD1,Natural killer cells antigen CD94,42754,0.0568654772560865,0.00490576537724812,0.0472501771166802,0.0664807773954928,6.36109205501365e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0735676639558821,0.00634332779173421,0.0611347414840831,0.0860005864276811,6.4103601017311e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PKN3,Serine/threonine-protein kinase N3,40302,0.0902091374984741,0.00778815369852008,0.0749443562493747,0.105473918747573,7.56828796968879e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0364315592580996,0.00314700631784438,0.0302634268751246,0.0425996916410745,8.10250744801049e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0250220397371517,0.00216270790947097,-0.0292609472397148,-0.0207831322345886,8.19721871525828e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CCN4,CCN family member 4,42721,0.04814201199876,0.00417425315650729,0.0399604758120057,0.0563235481855142,1.24966318613165e-30
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0796655632060474,0.00690919143322906,0.0661235479969184,0.0932075784151764,1.28969971526787e-30
NMR metabolomics,X23408.Triglycerides in VLDL,KLB,Beta-klotho,42311,-0.0896501735365769,0.00778172229997192,-0.104902349244522,-0.0743979978286319,1.45722121639425e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0722143513079998,0.00628184573770619,0.0599019336620956,0.0845267689539039,1.92539613430088e-30
NMR metabolomics,X23408.Triglycerides in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0522339029097583,0.00454579158015331,0.0433241514126578,0.0611436544068588,2.18964882485959e-30
NMR metabolomics,X23408.Triglycerides in VLDL,GLO1,Lactoylglutathione lyase,42357,0.0692005341845062,0.0060338151146549,0.0573742565597826,0.0810268118092299,2.63666401592658e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0625425901896124,0.00545528844024544,0.0518502248467314,0.0732349555324935,2.74898882571318e-30
NMR metabolomics,X23408.Triglycerides in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.082149342492079,0.00716249590593232,0.0681108505164516,0.0961878344677063,2.79513233040524e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SMTN,Smoothelin,40460,0.109942360231723,0.00959876112725175,0.0911287884223099,0.128755932041137,3.30637439001042e-30
NMR metabolomics,X23408.Triglycerides in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0646140722153766,0.00564560153301117,0.0535486932106747,0.0756794512200785,3.68760546679822e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0571159676596917,0.00499984292116167,0.0473162755342148,0.0669156597851686,4.4185912346977e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0728849231106749,0.00638460985612246,0.0603710877926749,0.085398758428675,4.79007026076958e-30
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1,Allograft inflammatory factor 1,42346,0.0619294712125719,0.00542737201102014,0.0512918220709725,0.0725671203541714,5.12449660228387e-30
NMR metabolomics,X23408.Triglycerides in VLDL,APOC1,Apolipoprotein C-I,40516,0.0438581350610575,0.00384246702736185,0.0363268996874282,0.0513893704346867,5.18967466458099e-30
NMR metabolomics,X23408.Triglycerides in VLDL,APP,Amyloid-beta precursor protein,42592,0.0787332758520258,0.00691740902683855,0.0651751541594223,0.0922913975446294,7.05864099604424e-30
NMR metabolomics,X23408.Triglycerides in VLDL,BLNK,B-cell linker protein,40199,0.0484040328441426,0.00425176707626664,0.04007056937466,0.0567374963136252,7.34144323319112e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SPON2,Spondin-2,42562,-0.0424610152177485,0.00373732023415428,-0.0497861628766909,-0.0351358675588061,8.91879857948939e-30
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0874000213395623,0.00769592548920074,0.0723160073807288,0.102484035298396,9.45428938192266e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CEP170,Centrosomal protein of 170 kDa,40223,0.0911538611102859,0.00803450204063082,0.0754062371106495,0.106901485109922,1.14251436771274e-29
NMR metabolomics,X23408.Triglycerides in VLDL,FGR,Tyrosine-protein kinase Fgr,42311,0.0675942104972696,0.00596494193349331,0.0559029243076228,0.0792854966869165,1.25215990166096e-29
NMR metabolomics,X23408.Triglycerides in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0827922751912319,0.00730575248767904,0.068473000315381,0.0971115500670828,1.30809239552496e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BP1,SH3 domain-binding protein 1,40449,0.0563960182704336,0.00498107372889397,0.0466331137618014,0.0661589227790658,1.4742334489154e-29
NMR metabolomics,X23408.Triglycerides in VLDL,RP2,Protein XRP2,42587,0.0494277779695496,0.00436900518775404,0.0408645278015517,0.0579910281375475,1.53567851821622e-29
NMR metabolomics,X23408.Triglycerides in VLDL,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0506578619958909,0.00447631753233012,0.0418842796325238,0.0594314443592579,1.57717788166746e-29
NMR metabolomics,X23408.Triglycerides in VLDL,TMSB10,Thymosin beta-10,42611,0.0870890766710849,0.00771078505985575,0.0719759379537676,0.102202215388402,1.89816828947971e-29
NMR metabolomics,X23408.Triglycerides in VLDL,DBN1,Drebrin,40199,0.0587853213361304,0.00520278381113357,0.0485878650663086,0.0689827776059522,1.93143708729155e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0474990206687224,0.0042068855600978,0.0392535249709307,0.0557445163665141,1.97544313960008e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0537545557894479,0.00475994096644661,0.0444250714952125,0.0630840400836832,2.05787928283057e-29
NMR metabolomics,X23408.Triglycerides in VLDL,C2,Complement C2,42663,0.0269418974435895,0.00238756471393015,0.0222622706042864,0.0316215242828926,2.12670384435095e-29
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.116312825981166,0.0103234033145605,0.0960789554846274,0.136546696477705,2.73955144477435e-29
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0287973099393643,0.00255754564624696,0.0237845204727203,0.0338100994060084,2.80755830418939e-29
NMR metabolomics,X23408.Triglycerides in VLDL,GDNF,Glial cell line-derived neurotrophic factor,42311,0.044797083413289,0.00398436379425398,0.0369877303765512,0.0526064364500268,3.40087045624817e-29
NMR metabolomics,X23408.Triglycerides in VLDL,RAB10,Ras-related protein Rab-10,40511,0.0625295256869063,0.00556541880645924,0.0516213048262462,0.0734377465475665,3.89829471880681e-29
NMR metabolomics,X23408.Triglycerides in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0390243338228391,0.00347890394159247,0.0322056820973179,0.0458429855483604,4.49616460570421e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CCS,Copper chaperone for superoxide dismutase,42495,0.0555097769213174,0.00495352148418398,0.0458008748123168,0.0652186790303179,5.13214373952081e-29
NMR metabolomics,X23408.Triglycerides in VLDL,BAP18,Chromatin complexes subunit BAP18,40483,0.0790488699000932,0.00705480287816593,0.065221456258888,0.0928762835412984,5.48123544009047e-29
NMR metabolomics,X23408.Triglycerides in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0947688845907656,0.00847441260181341,0.0781590358912113,0.11137873329032,6.63546799626105e-29
NMR metabolomics,X23408.Triglycerides in VLDL,OPLAH,5-oxoprolinase,40223,0.0788184220024675,0.00704500558150501,0.0650102110627177,0.0926266329422173,6.69042316741869e-29
NMR metabolomics,X23408.Triglycerides in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.112909804615603,0.0100988139074597,0.0931161293569816,0.132703479874224,7.26096076038149e-29
NMR metabolomics,X23408.Triglycerides in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0659093528793543,0.00590555977139127,0.0543344557274274,0.0774842500312812,8.57399873247949e-29
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3B,Protein FAM3B,42587,0.0410400751528176,0.00367944059885978,0.0338283715790524,0.0482517787265828,9.17624619424748e-29
NMR metabolomics,X23408.Triglycerides in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0857119628761503,0.0076869410819594,0.0706455583555099,0.100778367396791,1.00671700237617e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0516980190669249,0.00463657679215174,0.0426103285543075,0.0607857095795423,1.01984635388823e-28
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT16,U8 snoRNA-decapping enzyme,40429,0.100303406630897,0.00900038469586911,0.0826626526269939,0.117944160634801,1.07867119748158e-28
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB2,Lysosome membrane protein 2,42302,0.0406840751905377,0.00365452874234351,0.0335211988555444,0.047846951525531,1.17142353220768e-28
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN9,Septin-9,42587,0.0329884100920187,0.00296579136985441,0.027175459007104,0.0388013611769333,1.29430246889832e-28
NMR metabolomics,X23408.Triglycerides in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0774688566004633,0.006963844950932,0.0638197204966366,0.0911179927042901,1.34329666412675e-28
NMR metabolomics,X23408.Triglycerides in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0228207315632497,0.00205249004226548,-0.0268436120460901,-0.0187978510804094,1.35930048935222e-28
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0374070636031782,0.00336441119045291,0.0308128176698905,0.0440013095364658,1.43533900859269e-28
NMR metabolomics,X23408.Triglycerides in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0546116218335499,0.00491717917072671,0.0449739506589256,0.0642492930081743,1.64248033605909e-28
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0603183436049051,0.00544316493670082,0.0496497403289715,0.0709869468808387,2.06099786881192e-28
NMR metabolomics,X23408.Triglycerides in VLDL,MET,Hepatocyte growth factor receptor,42654,-0.022925969847192,0.00207043012068725,-0.026984012883739,-0.018867926810645,2.2478200409427e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ARSA,Arylsulfatase A,42611,0.0512739850299066,0.004640967762415,0.0421776882155732,0.06037028184424,2.9630927450275e-28
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA4,Ephrin-A4,42475,0.0391220077686098,0.00354578580102851,0.0321722675985939,0.0460717479386257,3.49618248208403e-28
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN6,Dynactin subunit 6,42311,0.0823839399349644,0.00747385710769679,0.0677351800038787,0.0970326998660501,3.93574344762815e-28
NMR metabolomics,X23408.Triglycerides in VLDL,IL12B,Interleukin-12 subunit beta,42754,0.065173114540544,0.00591719274718662,0.0535754167560583,0.0767708123250298,4.29407297123363e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0480723423455038,0.00436315660775712,0.0395205553942998,0.0566241292967077,4.38590958129357e-28
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0319487324153113,0.00290295848908058,0.0262589337767134,0.0376385310539093,5.0302145997664e-28
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0604655929261023,0.00549488950332385,0.0496956094995876,0.0712355763526171,5.1138641273567e-28
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP1,Metalloproteinase inhibitor 1,42501,0.0335538354620167,0.00305399054144445,0.0275680140007856,0.0395396569232479,5.82745929247664e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PPP3R1,Calcineurin subunit B type 1,42495,0.0458446460971583,0.00417346167889622,0.0376646612065217,0.0540246309877949,5.96287004842529e-28
NMR metabolomics,X23408.Triglycerides in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.135477296589308,0.0123557735718389,0.111259980388504,0.159694612790112,7.40818526330826e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ING1,Inhibitor of growth protein 1,42292,0.0538422401701283,0.00491271423345112,0.0442133202725641,0.0634711600676925,7.8784602068898e-28
NMR metabolomics,X23408.Triglycerides in VLDL,AK2,"Adenylate kinase 2, mitochondrial",40483,0.120336164743345,0.0109768928845575,0.098821454689612,0.141850874797077,7.97760838850989e-28
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF6,SLAM family member 6,42346,0.0443342593919198,0.00405132702285515,0.0363936584271237,0.0522748603567159,9.43992385193549e-28
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0323938998922346,0.00296243480204486,0.0265875276802267,0.0382002721042425,1.07983149031818e-27
NMR metabolomics,X23408.Triglycerides in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0654805885945301,0.00599501395625639,0.0537303612402676,0.0772308159487927,1.17404068348639e-27
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0320676239830568,0.00293787754691424,0.0263093839911049,0.0378258639750087,1.26995769117686e-27
NMR metabolomics,X23408.Triglycerides in VLDL,F11,Coagulation factor XI,40383,0.034266809086291,0.00313842155707377,0.0281155028344264,0.0404181153381556,1.29595947631832e-27
NMR metabolomics,X23408.Triglycerides in VLDL,LONP1,"Lon protease homolog, mitochondrial",40223,0.098593603748616,0.0090322534504905,0.0808903869856546,0.116296820511577,1.34166940480846e-27
NMR metabolomics,X23408.Triglycerides in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0684617016325934,0.00627235125160273,0.056167893179452,0.0807555100857348,1.34362159642277e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CTSE,Cathepsin E,40283,0.0582545199488797,0.0053378322027047,0.0477923688315785,0.0687166710661809,1.37193955106126e-27
NMR metabolomics,X23408.Triglycerides in VLDL,LAMB1,Laminin subunit beta-1,40223,0.0345397124931534,0.00317127720608514,0.0283240091692266,0.0407554158170803,1.74766063788718e-27
NMR metabolomics,X23408.Triglycerides in VLDL,ADM,Pro-adrenomedullin,42721,0.0304127976051239,0.00279923367300189,0.0249262996060402,0.0358992956042076,2.20303087541209e-27
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0433736527917699,0.00399211445533432,0.0355491084593147,0.0511981971242252,2.31525829434431e-27
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC3,PDZ domain-containing protein GIPC3,40449,0.109891807995952,0.0101164434676068,0.0900635787994422,0.129720037192461,2.37181736905133e-27
NMR metabolomics,X23408.Triglycerides in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.04892106605166,0.00450512107194529,0.0400910287506473,0.0577511033526728,2.46659877109559e-27
NMR metabolomics,X23408.Triglycerides in VLDL,UMOD,Uromodulin,42764,-0.0624905582580786,0.0057604194474193,-0.0737809803750204,-0.0512001361411367,2.63066149047906e-27
NMR metabolomics,X23408.Triglycerides in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.134914018707411,0.0124460987826555,0.110519665093406,0.159308372321416,2.89086463610597e-27
NMR metabolomics,X23408.Triglycerides in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0576847183776069,0.0053409019427327,0.0472165505698509,0.068152886185363,4.41719833312078e-27
NMR metabolomics,X23408.Triglycerides in VLDL,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0973110864317703,0.00900962955086086,0.0796522125120831,0.114969960351458,4.66333371936139e-27
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.039561009326101,0.00366301559075441,0.0323814987682224,0.0467405198839796,4.69826331452115e-27
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.065289496491321,0.00605322160754051,0.0534251821405416,0.0771538108421004,5.20475421434199e-27
NMR metabolomics,X23408.Triglycerides in VLDL,SDC4,Syndecan-4,42636,0.0528481970426515,0.00490968356340896,0.0432252172583699,0.062471176826933,6.54841962474909e-27
NMR metabolomics,X23408.Triglycerides in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0523506878101752,0.00486865770309911,0.042808118712101,0.0618932569082495,7.45029543158224e-27
NMR metabolomics,X23408.Triglycerides in VLDL,LPA,Apolipoprotein(a),40324,-0.203912546975087,0.0189609207760136,-0.241075951696073,-0.1667491422541,7.6572309372519e-27
NMR metabolomics,X23408.Triglycerides in VLDL,PVR,Poliovirus receptor,42711,0.0411766936231862,0.00383109033407935,0.0336677565683906,0.0486856306779817,7.77049990711961e-27
NMR metabolomics,X23408.Triglycerides in VLDL,S100P,Protein S100-P,42357,0.0609793137313247,0.00568066298206915,0.0498452142864691,0.0721134131761802,9.04228563234914e-27
NMR metabolomics,X23408.Triglycerides in VLDL,TCOF1,Treacle protein,40511,0.0360648295804213,0.00335932859202035,0.0294805455400614,0.0426491136207811,9.30499274558724e-27
NMR metabolomics,X23408.Triglycerides in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0803140955583428,0.00748533533346986,0.0656428383047419,0.0949853528119438,9.51728372577535e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL11,C-X-C motif chemokine 11,42711,0.0891789161049222,0.00831679552108852,0.0728779968835887,0.105479835326256,1.01938639350904e-26
NMR metabolomics,X23408.Triglycerides in VLDL,LBP,Lipopolysaccharide-binding protein,42689,-0.0657166474229516,0.00612954454446064,-0.0777305547300945,-0.0537027401158088,1.03583998095858e-26
NMR metabolomics,X23408.Triglycerides in VLDL,VSNL1,Visinin-like protein 1,40483,0.0429048166996694,0.00400302548275721,0.0350588867534652,0.0507507466458735,1.12466331095062e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0770653200724313,0.00720195193032512,0.0629494942889941,0.0911811458558686,1.35775559979504e-26
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR2,Interferon gamma receptor 2,42495,0.0580692551279125,0.00543590907178217,0.0474148733472195,0.0687236369086056,1.57404922772776e-26
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF1,Scavenger receptor class F member 1,42794,0.0465439833796382,0.00435820780956222,0.0380018960728963,0.0550860706863802,1.61504383757509e-26
NMR metabolomics,X23408.Triglycerides in VLDL,EGFL7,Epidermal growth factor-like protein 7,42346,0.04434153472449,0.00415496004638446,0.0361978130335764,0.0524852564154035,1.76714488630433e-26
NMR metabolomics,X23408.Triglycerides in VLDL,LAP3,Cytosol aminopeptidase,42370,0.0537427615139791,0.00505215815193921,0.0438405315361782,0.06364499149178,2.54747660716058e-26
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA9,Serpin A9,42538,0.0794300072481814,0.0074811050699041,0.0647670413111694,0.0940929731851934,3.14690085448176e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL1,Growth-regulated alpha protein,42607,0.105561962330943,0.00995695841145884,0.0860463238444835,0.125077600817402,3.70849312257822e-26
NMR metabolomics,X23408.Triglycerides in VLDL,TPP1,Tripeptidyl-peptidase 1,42545,0.0498130076627409,0.00470048046321291,0.0406000659548436,0.0590259493706382,3.88985547401739e-26
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0508896298045975,0.00480468646264963,0.0414724443378043,0.0603068152713908,4.32142390277754e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0905008963618365,0.0085610858400014,0.0737211681154338,0.107280624608239,5.36078973206552e-26
NMR metabolomics,X23408.Triglycerides in VLDL,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0871194663072146,0.00825093696783164,-0.103291302764165,-0.0709476298502646,5.84884597764719e-26
NMR metabolomics,X23408.Triglycerides in VLDL,KITLG,Kit ligand,42636,-0.0413123383065279,0.00391349507618618,-0.0489827886558528,-0.033641887957203,5.99628441196833e-26
NMR metabolomics,X23408.Triglycerides in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0581474270301135,0.00550948976674001,0.0473488270873031,0.068946026972924,6.15088215184126e-26
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM2,Neural cell adhesion molecule 2,42611,-0.0299440967172542,0.00283907447699192,-0.0355086826921584,-0.0243795107423501,6.61398562662337e-26
NMR metabolomics,X23408.Triglycerides in VLDL,POMC,Pro-opiomelanocortin,40223,0.0770095033585336,0.00729993995071702,0.0627016210551283,0.091317385661939,6.79514553066669e-26
NMR metabolomics,X23408.Triglycerides in VLDL,MMP7,Matrilysin,42333,0.0554157274563024,0.0052629474044408,0.0451003505435984,0.0657311043690064,8.0120787635493e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0329858141766418,0.00313505960347094,0.0268410973538387,0.0391305309994448,8.65740929030091e-26
NMR metabolomics,X23408.Triglycerides in VLDL,RPL14,60S ribosomal protein L14,40223,0.0439735000761085,0.00417918515689655,0.0357822971685913,0.0521647029836257,9.05716736441633e-26
NMR metabolomics,X23408.Triglycerides in VLDL,MZT1,Mitotic-spindle organizing protein 1,42346,0.0566160412400702,0.00538293326305469,0.046065492044483,0.0671665904356574,9.0617900849603e-26
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD4B,FERM domain-containing protein 4B,40116,0.0768465178539492,0.00731256681311822,0.0625138869002375,0.0911791488076609,1.04322338398545e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CRLF1,Cytokine receptor-like factor 1,42676,0.0275531801621341,0.00262380603167553,0.0224105203400501,0.0326958399842182,1.07136337623136e-25
NMR metabolomics,X23408.Triglycerides in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.131045872210082,0.0124988174093134,-0.155543554332336,-0.106548190087828,1.27882527239741e-25
NMR metabolomics,X23408.Triglycerides in VLDL,NPPB,Natriuretic peptides B,42357,-0.154918483060914,0.0147774988502466,-0.183882380807397,-0.125954585314431,1.29892702100628e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CPA2,Carboxypeptidase A2,42670,0.0721074849021643,0.00688812646064036,0.0586067570393092,0.0856082127650195,1.51247106633752e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0310915965691302,0.00297075279988441,0.0252689210813567,0.0369142720569036,1.63565558772178e-25
NMR metabolomics,X23408.Triglycerides in VLDL,SNX9,Sorting nexin-9,42636,0.0727481743738138,0.00696971174039952,0.0590875393626307,0.0864088093849968,2.08465543799847e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CD164,Sialomucin core protein 24,42611,0.0297573913996891,0.0028542379035856,0.0241630851086613,0.0353516976907168,2.36568371814485e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ABHD14B,Protein ABHD14B,42460,0.0619366872952749,0.00594098459257733,0.0502923574938233,0.0735810170967264,2.3806746534455e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CSTB,Cystatin-B,42437,0.0462166945376707,0.00444005227896483,0.0375141920708996,0.0549191970044417,2.82220238389946e-25
NMR metabolomics,X23408.Triglycerides in VLDL,GP6,Platelet glycoprotein VI,42590,0.094151975910463,0.00906159115475102,0.076391257247151,0.111912694573775,3.42416101448449e-25
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN2,Dynactin subunit 2,42587,0.101210909047718,0.00975738900889949,0.0820864265902753,0.120335391505161,4.10649703518134e-25
NMR metabolomics,X23408.Triglycerides in VLDL,HEPH,Hephaestin,40511,0.0286826306708345,0.00276429616349521,0.0232646101903839,0.0341006511512851,4.12729405394263e-25
NMR metabolomics,X23408.Triglycerides in VLDL,PRG2,Bone marrow proteoglycan,40527,-0.0571338375712597,0.00551923142409683,-0.0679515311624895,-0.04631614398003,5.30871755508366e-25
NMR metabolomics,X23408.Triglycerides in VLDL,GP5,Platelet glycoprotein V,40283,0.0388545523298677,0.0037635036413211,0.0314780851928784,0.0462310194668571,7.11047715325749e-25
NMR metabolomics,X23408.Triglycerides in VLDL,MMP3,Stromelysin-1,42611,-0.0544102241124356,0.00527318389500553,-0.0647456645466464,-0.0440747836782248,7.2156253474439e-25
NMR metabolomics,X23408.Triglycerides in VLDL,FADD,FAS-associated death domain protein,42636,0.0810167862170306,0.00785660765687754,0.0656178352095506,0.0964157372245106,7.70225079883228e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0350432934949327,0.00339791416411958,0.0283833817332583,0.0417032052566071,7.91718521300219e-25
NMR metabolomics,X23408.Triglycerides in VLDL,PSPN,Persephin,42594,0.10017189201925,0.00972207722414028,0.0811166206599346,0.119227163378565,8.40379659637509e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0476272746371018,0.00463244204279864,-0.0567068610409871,-0.0385476882332165,1.05598775725088e-24
NMR metabolomics,X23408.Triglycerides in VLDL,MSTN,Growth/differentiation factor 8,42357,0.0570248014103908,0.00556151641410125,0.0461242292387523,0.0679253735820292,1.4125069503655e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SCRG1,Scrapie-responsive protein 1,40511,0.0304774349716277,0.00298030714694761,0.0246360329636104,0.0363188369796451,1.93151683989959e-24
NMR metabolomics,X23408.Triglycerides in VLDL,BAG3,BAG family molecular chaperone regulator 3,42475,0.0432703168388364,0.00423673932862248,0.0349663077547364,0.0515743259229365,2.13178439902514e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CA4,Carbonic anhydrase 4,42794,-0.0257111446967298,0.00251763674749695,-0.0306457127218239,-0.0207765766716358,2.13683984087906e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CTSS,Cathepsin S,39872,0.0260661126219939,0.00255149814733048,0.0210651762532261,0.0310670489907616,2.17664965331016e-24
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G15,Phospholipase A2 group XV,42679,0.0283178971124611,0.00277448124318092,0.0228799138758265,0.0337558803490957,2.27264147431826e-24
NMR metabolomics,X23408.Triglycerides in VLDL,STX16,Syntaxin-16,42346,0.0615568102238882,0.00603788085144052,0.0497225637550648,0.0733910566927116,2.5679165891581e-24
NMR metabolomics,X23408.Triglycerides in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0772133420376227,0.00759481466714733,0.0623275052900139,0.0920991787852314,3.42758233772521e-24
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0698810200981299,0.00688186347754271,0.0563925676821462,0.0833694725141136,3.86518464894083e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA12,Serpin A12,42249,0.109366628267288,0.0107879983080903,0.0882221515834316,0.130511104951145,4.60916484937212e-24
NMR metabolomics,X23408.Triglycerides in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0457171678764417,0.0045119790961416,0.0368736888480041,0.0545606469048792,4.84588931545931e-24
NMR metabolomics,X23408.Triglycerides in VLDL,RBP2,Retinol-binding protein 2,42587,-0.0817000917351326,0.00806356381475368,-0.0975046768120499,-0.0658955066582154,4.86353032993503e-24
NMR metabolomics,X23408.Triglycerides in VLDL,AMOTL2,Angiomotin-like protein 2,40404,0.0509948149917555,0.0050335603784222,0.041129036650048,0.060860593333463,5.10883715030063e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SCRN1,Secernin-1,42594,0.0583569709953142,0.00576285623435802,0.0470617727759725,0.0696521692146559,5.14795783492531e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SCRIB,Protein scribble homolog,40223,0.0958463741861761,0.00947251859484577,0.0772802377402784,0.114412510632074,5.82681392245319e-24
NMR metabolomics,X23408.Triglycerides in VLDL,BDNF,Brain-derived neurotrophic factor,40527,0.0884051283821198,0.00874207976300875,0.0712706520466226,0.105539604717617,6.13740973578114e-24
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0457975070030399,0.00452915887066386,0.0369203556165387,0.054674658389541,6.20292172011339e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0549690714535423,0.00543933012611673,0.0443079844063535,0.065630158500731,6.36659731383109e-24
NMR metabolomics,X23408.Triglycerides in VLDL,EPPK1,Epiplakin,40223,0.0765464000619329,0.00757310738753423,0.0617031095823658,0.0913896905415,6.4930282595176e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA2,Integrin alpha-2,40283,0.036709289128251,0.00363731087901842,0.0295801598053749,0.0438384184511271,7.56384580315383e-24
NMR metabolomics,X23408.Triglycerides in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0692563458045575,0.0068696579896444,0.0557918161448545,0.0827208754642606,8.13850151498646e-24
NMR metabolomics,X23408.Triglycerides in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.125647589425691,0.012476403388474,0.101193838784282,0.1501013400671,9.03395846954225e-24
NMR metabolomics,X23408.Triglycerides in VLDL,APOL1,Apolipoprotein L1,40532,0.060994745272619,0.00606615426962618,0.0491050829041517,0.0728844076410863,1.09814769130446e-23
NMR metabolomics,X23408.Triglycerides in VLDL,APOA1,Apolipoprotein A-I,40539,-0.0289528459142192,0.00288087437980877,-0.0345993596986444,-0.023306332129794,1.15356837467498e-23
NMR metabolomics,X23408.Triglycerides in VLDL,NRP2,Neuropilin-2,42611,-0.0301180202518247,0.00300049645235111,-0.0359989932984329,-0.0242370472052166,1.26120379050144e-23
NMR metabolomics,X23408.Triglycerides in VLDL,NCF2,Neutrophil cytosol factor 2,42578,0.0868059624396934,0.00865057627561543,0.0698508329394872,0.1037610919399,1.30014058279406e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA2,Annexin A2,40054,0.0760107863337435,0.00757735481238001,0.0611591709014787,0.0908624017660083,1.40625964666689e-23
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3C,Protein FAM3C,42613,0.0325245034081044,0.00324565067814503,0.0261630280789402,0.0388859787372687,1.49211351445488e-23
NMR metabolomics,X23408.Triglycerides in VLDL,MSR1,Macrophage scavenger receptor types I and II,42711,0.048133336151689,0.00480903747728054,0.0387076226962192,0.0575590496071589,1.68109534153513e-23
NMR metabolomics,X23408.Triglycerides in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.039241755171908,0.00392223347353778,0.0315541775637739,0.0469293327800421,1.75871260994661e-23
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0316847869004534,0.00316667492890363,0.0254781040398023,0.0378914697611045,1.80088833041448e-23
NMR metabolomics,X23408.Triglycerides in VLDL,TLR3,Toll-like receptor 3,42754,0.0636635555528566,0.00637082848625491,0.0511767317197969,0.0761503793859162,1.97150165449348e-23
NMR metabolomics,X23408.Triglycerides in VLDL,FGF2,Fibroblast growth factor 2,42594,0.0712902387212631,0.00713665725818847,0.0573023904952137,0.0852780869473125,2.04995401025027e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH1,Acid ceramidase,40418,0.0475535893312851,0.00476766603515227,0.0382089639023867,0.0568982147601836,2.47243069100175e-23
NMR metabolomics,X23408.Triglycerides in VLDL,PARD3,Partitioning defective 3 homolog,40302,0.0773086810713146,0.00775152655444231,0.0621156890246077,0.0925016731180215,2.49897145573626e-23
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX,Glutaredoxin-1,42546,0.0580511826530848,0.0058420414211362,0.0466007814676578,0.0695015838385117,3.46560104131046e-23
NMR metabolomics,X23408.Triglycerides in VLDL,RAB2B,Ras-related protein Rab-2B,40451,0.0626263341407631,0.00630916818573463,0.0502603644967232,0.074992303784803,3.98335636905176e-23
NMR metabolomics,X23408.Triglycerides in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0318744817794923,0.00322069084084267,0.0255619277314406,0.0381870358275439,5.14936560206542e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0377118093826342,0.00381188163266946,0.0302405213826021,0.0451830973826664,5.34790654122801e-23
NMR metabolomics,X23408.Triglycerides in VLDL,NID1,Nidogen-1,42652,0.0395575860302972,0.0039994306612985,0.0317187019341521,0.0473964701264422,5.46634866558668e-23
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0452196725847803,0.00457091362093078,0.036260681887756,0.0541786632818047,5.57161788647104e-23
NMR metabolomics,X23408.Triglycerides in VLDL,TST,Thiosulfate sulfurtransferase,42277,0.0768292845146551,0.00777005391324913,0.0615999788446868,0.0920585901846234,5.65675133677774e-23
NMR metabolomics,X23408.Triglycerides in VLDL,MAGED1,Melanoma-associated antigen D1,42346,0.0498361874749316,0.00504450281661958,0.0399489619543572,0.059723412995506,6.15179957696393e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CDA,Cytidine deaminase,40494,0.0482986493405461,0.00489519761506017,0.0387040620150282,0.057893236666064,7.19187754138403e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0601347186477471,0.00609816484350137,0.0481823155544844,0.0720871217410098,7.62686385840208e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CA13,Carbonic anhydrase 13,42483,0.105306050465376,0.0106918219120007,0.0843500795178548,0.126262021412897,8.26887128239272e-23
NMR metabolomics,X23408.Triglycerides in VLDL,NADK,NAD kinase,42636,0.0561455144859949,0.00570284519025565,0.0449679379130939,0.067323091058896,8.58783362265721e-23
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1F,Protein phosphatase 1F,40511,0.0533727880783674,0.0054255954113816,0.0427386210720594,0.0640069550846753,9.60109848875507e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ERI1,3'-5' exoribonuclease 1,40302,0.0352697303497782,0.00359258845058282,0.0282282569866359,0.0423112037129205,1.17199104811303e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0681637704250971,0.00695210189085401,0.0545376507190233,0.081789890131171,1.28429697893162e-22
NMR metabolomics,X23408.Triglycerides in VLDL,DENR,Density-regulated protein,40199,0.0582910613845572,0.0059450146772608,0.046638832617126,0.0699432901519883,1.32549854617804e-22
NMR metabolomics,X23408.Triglycerides in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0991582355036114,0.0101280574487097,0.0793072429041405,0.119009228103082,1.4725215260092e-22
NMR metabolomics,X23408.Triglycerides in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0333906656195792,0.00341311919341448,0.0267009520004868,0.0400803792386715,1.63518977561136e-22
NMR metabolomics,X23408.Triglycerides in VLDL,DHPS,Deoxyhypusine synthase,40451,0.0412182158435602,0.00422045917993616,0.0329461158508854,0.0494903158362351,1.92869442683956e-22
NMR metabolomics,X23408.Triglycerides in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0698357613659657,0.00715488407132985,0.0558121885861592,0.0838593341457722,2.04514986041851e-22
NMR metabolomics,X23408.Triglycerides in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0655814100442842,0.00672334972757187,0.0524036445782434,0.0787591755103251,2.17815973671719e-22
NMR metabolomics,X23408.Triglycerides in VLDL,MIA,Melanoma-derived growth regulatory protein,42679,0.0383690581068798,0.00393660072039325,0.0306533206949091,0.0460847955188506,2.25771296256187e-22
NMR metabolomics,X23408.Triglycerides in VLDL,PALM2,Paralemmin-2,40483,0.0383720572642338,0.00394007691596458,0.0306495065089432,0.0460946080195244,2.51872414436396e-22
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0588277296444863,0.00604266514663873,0.0469841059570744,0.0706713533318983,2.53307890825995e-22
NMR metabolomics,X23408.Triglycerides in VLDL,APOE,Apolipoprotein E,40539,0.0738731495759099,0.00758812632962342,0.059000421969848,0.0887458771819718,2.60489071092224e-22
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAL,Integrin alpha-L,40199,0.045234582421274,0.00465707795560281,0.0361067096282924,0.0543624552142555,3.25628327233983e-22
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL4,ADAMTS-like protein 4,40223,0.0241040830634138,0.00248273180502969,0.0192379287255556,0.028970237401272,3.39681228562998e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TPMT,Thiopurine S-methyltransferase,42346,0.0737331395312173,0.00759917219065035,0.0588387620375427,0.088627517024892,3.48166972731501e-22
NMR metabolomics,X23408.Triglycerides in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0572949718028259,0.00590819667488386,0.0457149063200536,0.0688750372855983,3.66403121824641e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CD84,SLAM family member 5,42594,0.031665543651322,0.00327307698600443,0.0252503127587533,0.0380807745438907,4.56704395118886e-22
NMR metabolomics,X23408.Triglycerides in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.038403642842391,0.00397229245147611,0.0306179496374979,0.0461893360472842,5.02501831606983e-22
NMR metabolomics,X23408.Triglycerides in VLDL,IMMT,MICOS complex subunit MIC60,40451,0.0455601849061642,0.00471379528843159,0.0363211461408383,0.0547992236714901,5.15556286469084e-22
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0873675429127874,0.00904436043287851,0.0696405964643456,0.105094489361229,5.26641137129811e-22
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFA2,BPI fold-containing family A member 2,39838,-0.114168339061704,0.0118159779399925,-0.13732765582409,-0.0910090222993192,5.37218266550228e-22
NMR metabolomics,X23408.Triglycerides in VLDL,APLP1,Amyloid-like protein 1,42636,-0.0519953254991498,0.00538477662409575,-0.0625494876823775,-0.0414411633159222,5.46519399390221e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB8,Serpin B8,42754,0.05805658883451,0.00602175942444691,0.0462539403625941,0.069859237306426,6.30153674445361e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0523442889141496,0.00543171409011932,0.0416981292975158,0.0629904485307835,6.57535081747436e-22
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH7,Protocadherin-7,40449,0.0365249605057784,0.00378885388709352,0.0290988068870751,0.0439511141244817,6.57777354714118e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CORO1A,Coronin-1A,42353,0.0895921777809717,0.0093024651955162,0.07135934599776,0.107825009564183,6.9835319292662e-22
NMR metabolomics,X23408.Triglycerides in VLDL,C1R,Complement C1r subcomponent,40539,0.0195209138610117,0.00202832484923517,0.0155453971565108,0.0234964305655126,7.66126275329147e-22
NMR metabolomics,X23408.Triglycerides in VLDL,APRT,Adenine phosphoribosyltransferase,42480,0.0474944217764505,0.0049380658884716,0.0378158126350461,0.0571730309178548,7.90485203560361e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TNF,Tumor necrosis factor,42339,0.0386109574113702,0.00401454546891953,0.0307424482922879,0.0464794665304525,7.93823061943837e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CD40LG,CD40 ligand,42754,0.0776807922539601,0.00808228805262016,0.0618395076708246,0.0935220768370957,8.41189454532403e-22
NMR metabolomics,X23408.Triglycerides in VLDL,NGRN,Neugrin,40483,0.0232424808660242,0.0024193498660169,0.018500555128631,0.0279844066034173,9.05508942757703e-22
NMR metabolomics,X23408.Triglycerides in VLDL,CCL18,C-C motif chemokine 18,42477,0.0697412935221635,0.00726803977492381,0.0554959355633128,0.0839866514810142,9.81165922791939e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SCARA5,Scavenger receptor class A member 5,42711,0.0308901986996731,0.00322116866912499,0.0245767081081881,0.037203689291158,1.03525930988746e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TREML2,Trem-like transcript 2 protein,42611,0.034785635631778,0.00363274257788046,0.0276654601791323,0.0419058110844237,1.1877660517091e-21
NMR metabolomics,X23408.Triglycerides in VLDL,UNC79,Protein unc-79 homolog,40080,0.0555222246316993,0.00580548337309517,0.0441434772204327,0.0669009720429658,1.38039975214816e-21
NMR metabolomics,X23408.Triglycerides in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0873956356586652,0.00914207779842531,0.0694771631737516,0.105314108143579,1.38758116110494e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.037620607198568,0.0039350627439931,0.0299078842203415,0.0453333301767945,1.42104200436644e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM1,Probable carboxypeptidase X1,42679,0.069301085604852,0.00725207845966786,0.055087011823903,0.083515159385801,1.43197348291341e-21
NMR metabolomics,X23408.Triglycerides in VLDL,BLMH,Bleomycin hydrolase,42794,0.0311591538897083,0.00326512325893136,0.0247595123022029,0.0375587954772138,1.61999630868675e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CDCP1,CUB domain-containing protein 1,42495,0.0541524047235945,0.00567490897772826,0.0430295831272471,0.0652752263199419,1.63497282151495e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ARFIP1,Arfaptin-1,40482,0.0680251987881382,0.00712683026935694,0.0540566114601986,0.0819937861160778,1.64157756480027e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0339492230342722,0.00355985576973642,0.0269719057255889,0.0409265403429556,1.72739711314043e-21
NMR metabolomics,X23408.Triglycerides in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0352212641191458,0.00369285189967296,-0.0424592538425048,-0.0279832743957868,1.76728119649071e-21
NMR metabolomics,X23408.Triglycerides in VLDL,RGS10,Regulator of G-protein signaling 10,40482,0.0590160050597544,0.00618868210774033,0.0468861881285834,0.0711458219909255,1.78619535066922e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SF3B4,Splicing factor 3B subunit 4,42587,0.072295024782765,0.00758468639600306,0.057429039446599,0.087161010118931,1.80970212655606e-21
NMR metabolomics,X23408.Triglycerides in VLDL,C1RL,Complement C1r subcomponent-like protein,40519,0.0197147757225114,0.00206923523613875,0.0156590746596795,0.0237704767853434,1.93716024067123e-21
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP3,Syntaxin-binding protein 3,42346,0.0430428545913263,0.00452281566649151,0.034178135885003,0.0519075732976497,2.09239778482548e-21
NMR metabolomics,X23408.Triglycerides in VLDL,BTC,Probetacellulin,42346,0.0741331065997318,0.00780714066637974,0.0588311108936275,0.0894351023058361,2.56345394575617e-21
NMR metabolomics,X23408.Triglycerides in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0343222338471404,0.00361835701375655,0.0272302541001775,0.0414142135941032,2.80935754566942e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0295331478712318,0.00311473876048272,0.0234282599006857,0.035638035841778,2.92002443025783e-21
NMR metabolomics,X23408.Triglycerides in VLDL,DKK4,Dickkopf-related protein 4,42477,0.0458974806626638,0.0048464453384788,0.0363984477992454,0.0553965135260823,3.25397489393812e-21
NMR metabolomics,X23408.Triglycerides in VLDL,HDGF,Hepatoma-derived growth factor,42700,0.0918216057403885,0.00970494875011977,0.0727999061901537,0.110843305290623,3.53637064700614e-21
NMR metabolomics,X23408.Triglycerides in VLDL,HPCAL1,Hippocalcin-like protein 1,42754,0.0713734734879859,0.00754839546483816,0.0565786183769031,0.0861683285990687,3.73686156406309e-21
NMR metabolomics,X23408.Triglycerides in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0864933021853931,0.00915210531417204,0.0685551757696159,0.10443142860117,4.03237065601681e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PSME2,Proteasome activator complex subunit 2,42441,0.0356386468565754,0.00377748028201731,0.0282347855038214,0.0430425082093293,4.57429786124721e-21
NMR metabolomics,X23408.Triglycerides in VLDL,RPE,Ribulose-phosphate 3-epimerase,40302,0.0687972086839037,0.00729000307058717,0.0545088026655528,0.0830856147022546,4.59094281115856e-21
NMR metabolomics,X23408.Triglycerides in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0246877844368597,0.00261704230056682,0.0195583815277488,0.0298171873459707,4.61173273177907e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CD302,CD302 antigen,42587,0.0315511866978216,0.00334818537401147,0.0249887433647592,0.0381136300308841,5.07452077517053e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0236222336519985,0.00250864851147033,-0.0285391847344804,-0.0187052825695167,5.41906123388869e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CNDP1,Beta-Ala-His dipeptidase,42689,0.0453329476724726,0.00481612449374454,0.0358933436647333,0.0547725516802119,5.60474973843894e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TPK1,Thiamin pyrophosphokinase 1,40511,0.0268956062367867,0.00285774456116533,0.0212944268969026,0.0324967855766707,5.83511496574019e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SLIT2,Slit homolog 2 protein,42311,0.0515621427297499,0.00548978296965028,0.0408021681092354,0.0623221173502644,6.82187373865469e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SPAG1,Sperm-associated antigen 1,40482,0.0562246461806773,0.00598471400206953,0.044494606736621,0.0679546856247335,6.83838551532997e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TPR,Nucleoprotein TPR,40116,0.0475748587758101,0.00506969127491704,0.0376382638769727,0.0575114536746475,7.59604266908387e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0568750534066343,0.00606170714529069,0.0449941074018645,0.068755999411404,7.65886801538743e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0406851976628873,0.00433764407409016,0.0321834152776705,0.049186980048104,7.66080255689761e-21
NMR metabolomics,X23408.Triglycerides in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0394211765019195,0.0042066448206336,0.0311761526534777,0.0476662003503614,8.57287963883959e-21
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA1,BolA-like protein 1,40136,0.0529621331780117,0.0056576408154191,0.0418731571797902,0.0640511091762331,9.42690879552777e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PPME1,Protein phosphatase methylesterase 1,42587,0.0582142903885955,0.0062215262504569,0.0460200989377,0.070408481839491,9.49766421264116e-21
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.026760436693079,0.00286397245595432,0.0211470506794085,0.0323738227067494,1.10869338950062e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA11,Integrin alpha-11,42594,-0.0330897724406408,0.00354799389696737,-0.0400438404786969,-0.0261357044025848,1.26541616662696e-20
NMR metabolomics,X23408.Triglycerides in VLDL,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0332494175365287,0.00357579943930196,0.0262408506354969,0.0402579844375606,1.68945388239322e-20
NMR metabolomics,X23408.Triglycerides in VLDL,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0292208272314718,0.00314516419886209,-0.0353853490612415,-0.0230563054017021,1.76439601385097e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0259132607343268,0.00279428725149252,0.0204364577214015,0.0313900637472522,2.1242053826522e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL16,C-X-C motif chemokine 16,42778,0.0230772855663962,0.00249315273644816,0.0181907062029578,0.0279638649298346,2.42951022534974e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0225220254122185,0.00243313611198571,0.0177530786327266,0.0272909721917105,2.49394644984608e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0920410181957259,0.00995502580729804,0.0725291676134217,0.11155286877803,2.68905974782563e-20
NMR metabolomics,X23408.Triglycerides in VLDL,C7orf50,Uncharacterized protein C7orf50,40483,0.0219720047135647,0.00237719277806755,0.0173127068685523,0.0266313025585771,2.82986068899391e-20
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0411780355485171,0.00445688716112755,0.0324425367127071,0.0499135343843271,2.94243917637975e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0537898367667324,0.00582952762262132,0.0423639626263946,0.0652157109070701,3.28066813265351e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ITGBL1,Integrin beta-like protein 1,40527,0.0375076992072999,0.0040677145531142,0.0295349786831961,0.0454804197314038,3.46794644373747e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MATN2,Matrilin-2,42638,0.0284660055765871,0.00309172515236578,0.0224062242779502,0.034525786875224,3.83731115049592e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PTGR1,Prostaglandin reductase 1,40511,0.0806011958180706,0.00875225171956457,0.0634467824477241,0.0977556091884172,3.8629043956004e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MMP1,Interstitial collagenase,42136,0.0876406041844743,0.00953196761080409,0.0689579476672983,0.10632326070165,4.34108967486909e-20
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.049387612617639,0.00537174792604659,0.0388589866825877,0.0599162385526903,4.44592330650868e-20
NMR metabolomics,X23408.Triglycerides in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0295982820169509,0.00322116168173522,0.0232848051207499,0.035911758913152,4.55276465143942e-20
NMR metabolomics,X23408.Triglycerides in VLDL,GBP1,Guanylate-binding protein 1,40466,0.0627983340884019,0.0068499923394748,0.0493723491030313,0.0762243190737725,5.67088147006036e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SBSN,Suprabasin,40511,-0.0335569634961483,0.00366054642187678,-0.0407316344830268,-0.0263822925092698,5.69080794081525e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.111791669629186,0.012207223678451,0.0878655112194222,0.13571782803895,6.20866347978657e-20
NMR metabolomics,X23408.Triglycerides in VLDL,GRK5,G protein-coupled receptor kinase 5,42357,0.0484875613217625,0.00530085472631861,0.0380978860581781,0.058877236585347,6.69588778649756e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SMS,Spermine synthase,40136,0.0608992497861528,0.00666188966392314,0.0478419460448635,0.0739565535274422,7.25034926816282e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ACRBP,Acrosin-binding protein,40451,0.0373418023687025,0.00409018411768518,0.0293250414980395,0.0453585632393654,8.04459466550355e-20
NMR metabolomics,X23408.Triglycerides in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0302731252417058,0.00331914417314336,-0.0367786478210668,-0.0237676026623448,8.66355826590567e-20
NMR metabolomics,X23408.Triglycerides in VLDL,LTA,Lymphotoxin-alpha,42594,0.038817875037578,0.00426661869254047,0.0304553024001987,0.0471804476749573,1.04782275580581e-19
NMR metabolomics,X23408.Triglycerides in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0427528200209752,0.00470149645459791,0.0335378869699633,0.0519677530719871,1.1240006405613e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0598884121709698,0.00660054780564919,0.0469513384718973,0.0728254858700422,1.34535162795551e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0461530782697144,0.00508807110309077,0.0361804589076565,0.0561256976317723,1.37662048125395e-19
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP25,Synaptosomal-associated protein 25,40136,0.0447710255484391,0.00495008043678272,0.035068867892345,0.0544731832045332,1.75698792085153e-19
NMR metabolomics,X23408.Triglycerides in VLDL,DGKZ,Diacylglycerol kinase zeta,42370,0.0328341673427233,0.00364535788378511,0.0256892658905045,0.0399790687949421,2.40291392462083e-19
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0338817013814634,0.00376211526041833,0.0265079554710435,0.0412554472918833,2.42070404000095e-19
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0827241788062759,0.00918822760130594,0.0647152527077163,0.100733104904836,2.54791713654759e-19
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0391787970466046,0.00435183885494068,0.0306491928909209,0.0477084012022884,2.56074787472976e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CHI3L1,Chitinase-3-like protein 1,42416,0.0775319507998199,0.00861752885163594,0.0606415942506134,0.0944223073490263,2.63217497488859e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0329685839270925,0.00367306789454326,0.0257693708537877,0.0401677970003973,3.27053181033473e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB2,Plexin-B2,42743,0.022597769676231,0.00252143307364537,0.0176557608518861,0.0275397785005759,3.59149665606983e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0405746240257696,0.00452787092529157,0.0316999970121982,0.0494492510393411,3.633738279728e-19
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0761858029768807,0.00850807243164217,0.0595099810108621,0.0928616249428994,3.85621065697219e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ENO2,Gamma-enolase,42711,0.0601268009619671,0.00671951174331253,0.0469565579450745,0.0732970439788597,4.0822217772726e-19
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0308185434607996,0.00344836474512025,0.0240597485603639,0.0375773383612353,4.51970589388351e-19
NMR metabolomics,X23408.Triglycerides in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0639434498086583,0.00715682320303899,0.0499160763307019,0.0779708232866147,4.61360519342781e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PTX3,Pentraxin-related protein PTX3,42594,-0.0456024301565829,0.00511352352838935,-0.055624936272226,-0.0355799240409398,5.35551011347916e-19
NMR metabolomics,X23408.Triglycerides in VLDL,HRG,Histidine-rich glycoprotein,40479,0.0287056122782671,0.00322544112631823,0.0223837476706833,0.0350274768858508,6.45017468604747e-19
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1B,Meprin A subunit beta,42636,0.109560219309341,0.0123278430877634,0.0853976468573247,0.133722791761357,7.05400066699109e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS27,Serine protease 27,42603,0.0374098402376908,0.00420960899245387,0.0291590066124812,0.0456606738629004,7.08412953384308e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CPQ,Carboxypeptidase Q,40516,0.0331866660025969,0.00373370184781788,0.0258686103808738,0.0405047216243199,7.13517423712444e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN4,Cerebellin-4,42721,0.0301454432678662,0.00339997049479249,0.0234815010980729,0.0368093854376595,8.49088891072583e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0510788085917203,0.00576213610493088,0.0397850218260557,0.0623725953573848,8.83440608337257e-19
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP1,Ran-specific GTPase-activating protein,40223,0.0485338269787137,0.00547601476885578,0.0378008380317563,0.059266815925671,8.9853437132586e-19
NMR metabolomics,X23408.Triglycerides in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0383292210822429,0.00432790335146546,0.0298465305133706,0.0468119116511152,9.5115919955294e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0603135513592586,0.00681317980861755,0.0469597189343682,0.073667383784149,9.82813725650136e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CCL24,C-C motif chemokine 24,42654,0.0765120682069646,0.00864566783562207,0.0595665592491454,0.0934575771647839,9.85335340980323e-19
NMR metabolomics,X23408.Triglycerides in VLDL,KLK7,Kallikrein-7,40009,0.036164706067812,0.00408613545799167,0.0281558805701483,0.0441735315654756,1.00617657253943e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NAA10,N-alpha-acetyltransferase 10,40116,0.0475106375160886,0.00537112479348438,0.0369832329208592,0.058038042111318,1.05066908378926e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0373491985221263,0.00422778180400311,0.0290627461862802,0.0456356508579724,1.16202133751905e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA6,Integrin alpha-6,42594,0.046883071354413,0.00531133686922139,0.0364728510907391,0.057293291618087,1.20730164498763e-18
NMR metabolomics,X23408.Triglycerides in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0407860027812915,0.00461969887244875,0.031731392991292,0.0498406125712911,1.21867327772273e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP1,Secreted frizzled-related protein 1,42457,0.0406708606623745,0.0046197147885786,0.0316162196767604,0.0497255016479885,1.4853416862062e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PTGES2,Prostaglandin E synthase 2,40102,0.0499877885742599,0.00567965701400561,0.0388556608268089,0.0611199163217109,1.55764708931059e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0523153340490548,0.00595074987098653,0.0406518643019212,0.0639788037961884,1.69400691559603e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD2,Sushi domain-containing protein 2,42611,-0.0265112612829069,0.00301912378095442,-0.0324287438935776,-0.0205937786722362,1.81270392629677e-18
NMR metabolomics,X23408.Triglycerides in VLDL,GSR,"Glutathione reductase, mitochondrial",40490,0.0206274364310528,0.00234853985386887,0.0160242983174698,0.0252305745446358,1.81939388181879e-18
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0319984171345774,0.0036464186364609,0.024851436607114,0.0391453976620408,1.90784206305443e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0545490988582372,0.00621601342536325,0.0423657125445253,0.0667324851719492,1.94668273410106e-18
NMR metabolomics,X23408.Triglycerides in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0485207944692851,0.0055334259109504,0.0376752796838223,0.0593663092547479,2.06651821724905e-18
NMR metabolomics,X23408.Triglycerides in VLDL,DSCAM,Down syndrome cell adhesion molecule,40482,0.0331263698517759,0.0037827477909899,0.0257121841814357,0.0405405555221161,2.28591665884455e-18
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.0301738416635493,0.00344806266725606,0.0234156388357274,0.0369320444913711,2.36419493515834e-18
NMR metabolomics,X23408.Triglycerides in VLDL,STK4,Serine/threonine-protein kinase 4,42636,0.0779547447208263,0.00892708539115836,0.0604576573541559,0.0954518320874967,2.78506110632696e-18
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM3,Myomesin-3,40283,-0.084307810263664,0.00967331700020465,-0.103267511584065,-0.0653481089432629,3.30613290246664e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CALB2,Calretinin,42311,0.0291701564207354,0.00335017860754538,0.0226038063499465,0.0357365064915244,3.48858721610702e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ADA,Adenosine deaminase,42754,0.0314972256802826,0.00362003098267316,0.0244019649542432,0.038592486406322,3.670975024306e-18
NMR metabolomics,X23408.Triglycerides in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0612774861479178,0.00704370239846412,0.0474718294469281,0.0750831428489075,3.79238957458849e-18
NMR metabolomics,X23408.Triglycerides in VLDL,INSL5,Insulin-like peptide INSL5,40449,0.0896363742296199,0.010305440529802,0.0694377107912079,0.109835037668032,3.84753598540279e-18
NMR metabolomics,X23408.Triglycerides in VLDL,IMPA1,Inositol monophosphatase 1,42495,0.0548887505174786,0.00631252508416717,0.042516201352511,0.0672612996824463,3.86376394915172e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0691772409422476,0.00795680252539095,0.0535819079924813,0.0847725738920139,3.98670171927477e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CA14,Carbonic anhydrase 14,42721,-0.0326363484554286,0.00376159025720237,-0.0400090653595452,-0.0252636315513119,4.55429481639128e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PTN,Pleiotrophin,42357,0.0448222950445675,0.005166532136301,0.0346958920574175,0.0549486980317174,4.59584087062929e-18
NMR metabolomics,X23408.Triglycerides in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0347765517958859,0.00401125016687013,0.0269145014688204,0.0426386021229513,4.83322022562771e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CBLIF,Cobalamin binding intrinsic factor,42613,0.0732395724762926,0.00845599833583816,0.0566658157380498,0.0898133292145353,5.19402614265108e-18
NMR metabolomics,X23408.Triglycerides in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0494597473233568,0.00572865675649327,0.03823158008063,0.0606879145660836,6.60223932077465e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD6,MICOS complex subunit MIC25,40451,0.0260478671076678,0.00301865427150492,0.0201313047355181,0.0319644294798174,7.02123304518032e-18
NMR metabolomics,X23408.Triglycerides in VLDL,TF,Serotransferrin,40539,0.0192011838317149,0.00222646962193292,0.0148373033727264,0.0235650642907034,7.32037727644101e-18
NMR metabolomics,X23408.Triglycerides in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0422243163011153,0.00490907058496915,0.0326025379545758,0.0518460946476549,8.92285528871169e-18
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0349127789976618,0.00406373488235898,0.0269478586282382,0.0428776993670854,9.54862328680515e-18
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0534047066134911,0.0062253521693805,0.0412030163615053,0.0656063968654769,1.06697222740307e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CFB,Complement factor B,40344,0.0289893402057599,0.00337992713058082,0.0223646830298215,0.0356139973816983,1.10326865110888e-17
NMR metabolomics,X23408.Triglycerides in VLDL,BGLAP,Osteocalcin,40527,0.0810950144745315,0.00946042340275684,0.0625525846051281,0.0996374443439349,1.14849012160922e-17
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO2,Amphoterin-induced protein 2,42587,0.0210108660464774,0.00245290945307162,0.016203163518457,0.0258185685744978,1.19064703508978e-17
NMR metabolomics,X23408.Triglycerides in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.052971656715649,0.00618753272853923,0.0408440925677121,0.0650992208635859,1.23951692784919e-17
NMR metabolomics,X23408.Triglycerides in VLDL,AK1,Adenylate kinase isoenzyme 1,42636,0.0562507468580481,0.00657336871515053,0.043366944176353,0.0691345495397431,1.27880592904361e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SDHB,Succinate dehydrogenase,40449,0.0593337828239485,0.00693738343080354,0.0457365112995736,0.0729310543483234,1.35712757599392e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0649045211492333,0.00759489999581241,0.050018517157441,0.0797905251410256,1.41640312462145e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TXN,Thioredoxin,40384,0.0396866409758014,0.00464907312178381,0.0305744576571051,0.0487988242944977,1.56248392973913e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0627664413053336,0.00735441404185691,0.0483517897832941,0.0771810928273732,1.59045280567985e-17
NMR metabolomics,X23408.Triglycerides in VLDL,STX6,Syntaxin-6,42346,0.0589577262247581,0.00691205299922039,0.0454101023462861,0.07250535010323,1.62647498587261e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CCL15,C-C motif chemokine 15,42794,0.0398524973869489,0.00467438016068611,0.0306907122720042,0.0490142825018937,1.67725046347654e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0399156898416912,0.00468470245574563,-0.0490977066549526,-0.0307336730284297,1.75714219818431e-17
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0816081376166548,0.00958111014999418,0.0628291617226662,0.100387113510643,1.8351369957353e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CCL26,C-C motif chemokine 26,42594,0.0828051570629116,0.00974962204698249,0.063695897850826,0.101914416274997,2.22097134304198e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.028987289749841,0.00341514638553431,0.0222936028341937,0.0356809766654882,2.32479840276919e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CDH5,Cadherin-5,42794,-0.0266935628132704,0.00314963584015737,-0.0328668490599788,-0.020520276566562,2.5877499482198e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0804419559738309,0.00949311716849608,0.0618354463235786,0.0990484656240832,2.67659262634493e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CASP8,Caspase-8,42674,0.0541841756313198,0.00639656252788605,0.0416469130766631,0.0667214381859764,2.68687474585493e-17
NMR metabolomics,X23408.Triglycerides in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0344349956937292,0.00406642295688635,0.026464806698232,0.0424051846892265,2.75074603244857e-17
NMR metabolomics,X23408.Triglycerides in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.060548256248303,0.0071512359421459,0.0465318338016971,0.074564678694909,2.84174007003903e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0699279711043743,0.00827738607176734,0.0537042944037103,0.0861516478050383,3.32508046290187e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CA6,Carbonic anhydrase 6,42581,-0.0551812390691636,0.00653853567096526,-0.0679967689842556,-0.0423657091540717,3.51509636427408e-17
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN2,Nectin-2,42613,0.0277150086412306,0.00329367512069382,0.0212594054046707,0.0341706118777905,4.33770000028077e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0397039793663618,0.00472172764344677,0.0304493931852062,0.0489585655475175,4.56653166659133e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CLTA,Clathrin light chain A,42357,0.0418188691701292,0.00497605091830194,0.0320658093702574,0.051571928970001,4.75395221888215e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CFC1,Cryptic protein,42346,0.0415810716261033,0.00495720971177797,0.0318649405910184,0.0512972026611881,5.44534744426315e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD83,CD83 antigen,42594,0.0309708353088466,0.00369367033116265,0.0237312414597679,0.0382104291579254,5.58287407261861e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CTSL,Cathepsin L1,42636,0.0217137985314616,0.00259062437030698,0.0166361747656599,0.0267914222972633,5.73210692266583e-17
NMR metabolomics,X23408.Triglycerides in VLDL,GRSF1,G-rich sequence factor 1,40014,0.0706774240168141,0.00843178291861892,0.054151129496321,0.0872037185373072,5.83515657257316e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD1C,T-cell surface glycoprotein CD1c,42679,0.0220535406447035,0.0026338730802506,0.0168911494074123,0.0272159318819947,6.1643521041344e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CCL20,C-C motif chemokine 20,42754,0.0802032910263479,0.00957994125140884,0.0614266061735866,0.0989799758791093,6.215724611199e-17
NMR metabolomics,X23408.Triglycerides in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0430469899095987,0.00514099570141373,0.0329706383348278,0.0531233414843696,6.29689025634596e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CIT,Citron Rho-interacting kinase,40182,0.0396996283418912,0.00474408104922137,0.0304012294854173,0.0489980271983651,6.55619560293725e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CA2,Carbonic anhydrase 2,42573,0.0606830069774185,0.00725926222534996,0.0464548530157326,0.0749111609391044,6.92232844677211e-17
NMR metabolomics,X23408.Triglycerides in VLDL,LY75,Lymphocyte antigen 75,42594,0.0340278966496295,0.00407336980479628,0.0260440918322288,0.0420117014670302,7.25857428697069e-17
NMR metabolomics,X23408.Triglycerides in VLDL,FRZB,Secreted frizzled-related protein 3,42454,0.0217559035280306,0.00260469232885558,0.0166507065634736,0.0268611004925875,7.33735927291078e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD93,Complement component C1q receptor,42141,-0.0281338955717181,0.00337349930992593,-0.0347459542191729,-0.0215218369242633,8.19775460380676e-17
NMR metabolomics,X23408.Triglycerides in VLDL,DMD,Dystrophin,40223,0.0449020249292833,0.00538707504369096,0.034343357843649,0.0554606920149175,8.65863956127445e-17
NMR metabolomics,X23408.Triglycerides in VLDL,LIPF,Gastric triacylglycerol lipase,40223,0.0542382851490785,0.00651773352044291,0.0414635274490104,0.0670130428491466,9.69671649185588e-17
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB2,Dynein regulatory complex protein 8,40302,0.030337503343896,0.00364611182559366,0.0231911241657324,0.0374838825220596,9.78213692079154e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1F,V-type proton ATPase subunit F,42292,0.057702084123565,0.00693706160821859,0.0441054433714566,0.0712987248756735,9.82914297158806e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0261949088933245,0.00315068895330426,-0.0323702592418009,-0.0200195585448481,1.013559095608e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0427145723653715,0.0051385812257831,0.0326429531628366,0.0527861915679063,1.04442952162166e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PSAP,Prosaposin,40440,0.0251899109860295,0.00303036926702935,0.0192503872226519,0.031129434749407,1.04481432058156e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC3B,Tetranectin,40269,0.0182456873467589,0.00219657739680796,0.0139403956490153,0.0225509790445025,1.10115698623314e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX6,Peroxiredoxin-6,42721,-0.052523593751477,0.00633946822285412,-0.0649489514682711,-0.0400982360346829,1.28954220443948e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0619068557020049,0.00747444480801779,0.04725694387829,0.0765567675257197,1.32215503309627e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CAT,Catalase,40361,0.0468677336788293,0.0056652552721382,0.0357638333454385,0.0579716340122202,1.45649806435766e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0330359403923282,0.00400315763028618,0.0251897514369673,0.0408821293476891,1.69553685054192e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0971302004649598,0.0118126800740938,0.0739773475197359,0.120283053410184,2.2110298059912e-16
NMR metabolomics,X23408.Triglycerides in VLDL,GGH,Gamma-glutamyl hydrolase,42437,0.0293718980965551,0.00357478513475356,0.0223653192324381,0.0363784769606721,2.29037452867359e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0278334559926481,0.00339212341719849,0.021184894094939,0.0344820178903571,2.5050827648011e-16
NMR metabolomics,X23408.Triglycerides in VLDL,NID2,Nidogen-2,42611,0.0632872461662784,0.00772543726813117,0.0481453891207413,0.0784291032118155,2.7988691685871e-16
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0370744775992934,0.0045276522665807,0.0282002791567953,0.0459486760417916,2.88806447038734e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CSDE1,Cold shock domain-containing protein E1,40116,0.0997764581547872,0.0121866064018062,0.0758907096072471,0.123662206702327,2.96655211663477e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PDZD2,PDZ domain-containing protein 2,40116,0.0515798060315389,0.0063134743677012,0.0392053962708445,0.0639542157922332,3.42964901338237e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0242863215944608,0.0029737568244382,0.0184577582185619,0.0301148849703596,3.44325345512235e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SNX5,Sorting nexin-5,40223,0.0248262631045503,0.00303940708943012,0.0188690252092672,0.0307835009998333,3.47365609545656e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CD276,CD276 antigen,42618,-0.0313256757531006,0.00384070110120227,-0.038853449911457,-0.0237979015947441,3.76130620128223e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0338427958320124,0.00414945895728469,0.0257098562757344,0.0419757353882904,3.76772520102089e-16
NMR metabolomics,X23408.Triglycerides in VLDL,FST,Follistatin,42654,0.0417889642551299,0.00513562029791687,0.0317231484712128,0.0518547800390469,4.4022357126256e-16
NMR metabolomics,X23408.Triglycerides in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0563112312161326,0.00691961457329948,0.0427487866524656,0.0698736757797996,4.44288599527557e-16
NMR metabolomics,X23408.Triglycerides in VLDL,WAS,Wiskott-Aldrich syndrome protein,42370,0.0563084197008043,0.0069343806319828,0.042717033662118,0.0698998057394906,5.06636530028489e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DNM1,Dynamin-1,40449,0.0966016632433673,0.0118955388329013,0.0732864071308807,0.119916919355854,5.11250799293824e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PMM2,Phosphomannomutase 2,40116,0.0509728439574387,0.00627858264402348,0.0386668219751526,0.0632788659397247,5.22560310218013e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS22,Brain-specific serine protease 4,40199,0.0310118250893596,0.00382506698155222,0.0235146938055172,0.0385089563732019,5.71358223852431e-16
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0323568467062061,0.00399158425614801,0.024533341564156,0.0401803518482563,5.76729987497995e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0572331932295165,0.00706260673119161,0.0433904840363809,0.071075902422652,5.79194077903197e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DAPK2,Death-associated protein kinase 2,40199,0.0458375284480947,0.00565734435607167,0.0347491335101942,0.0569259233859951,5.9627030655009e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN3,Calsyntenin-3,40483,0.025983555524934,0.00320927731866569,0.0196933719803493,0.0322737390695188,6.24233487334649e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0460699821694958,0.00570057162937879,0.0348968617759134,0.0572431025630782,6.93459048172428e-16
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0476438997196136,0.00589968839791194,0.0360805104597062,0.059207288979521,7.40874581037734e-16
NMR metabolomics,X23408.Triglycerides in VLDL,AFP,Alpha-fetoprotein,42459,0.0565074463725806,0.00700474796019835,0.0427781403705918,0.0702367523745694,7.81889782743003e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CASP9,Caspase-9,40199,0.0526675367528386,0.00653612753114908,0.0398567267917864,0.0654783467138908,8.56271134959071e-16
NMR metabolomics,X23408.Triglycerides in VLDL,AGXT,Serine--pyruvate aminotransferase,42636,0.0632612873000297,0.00786348862706926,0.047848849590974,0.0786737250090855,9.34788631572038e-16
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF2,Scavenger receptor class F member 2,42711,-0.025474260026455,0.00316811235939954,-0.0316837602508781,-0.0192647598020319,9.6607843896489e-16
NMR metabolomics,X23408.Triglycerides in VLDL,FXN,"Frataxin, mitochondrial",42721,0.0613904814296432,0.00763590366535474,0.0464241102455479,0.0763568526137385,9.74836093914599e-16
NMR metabolomics,X23408.Triglycerides in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0438658149217727,0.00545591207051114,0.0331722272635709,0.0545594025799745,9.89727441863985e-16
NMR metabolomics,X23408.Triglycerides in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.028851029282374,0.00359006873747368,0.0218144945569256,0.0358875640078224,1.00266762382914e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK1D,Casein kinase I isoform delta,40199,0.0527553648278029,0.00657132161412109,0.0398755744641255,0.0656351551914802,1.09047401405378e-15
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_E,,42594,0.0258398016683914,0.00322399505598034,0.0195207713586699,0.0321588319781129,1.19360714923673e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA4,Annexin A4,42584,0.0596658654898636,0.00744476732512384,0.0450741215326209,0.0742576094471063,1.19724886384585e-15
NMR metabolomics,X23408.Triglycerides in VLDL,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0285312174513322,0.00355996398556905,0.0215536880396168,0.0355087468630475,1.19728378381326e-15
NMR metabolomics,X23408.Triglycerides in VLDL,STX7,Syntaxin-7,40199,0.041884002759938,0.00522583765302047,0.0316413609600179,0.0521266445598581,1.21471711383935e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM1,Intercellular adhesion molecule 1,42595,0.0244108930439889,0.00304762425841603,0.0184375494974935,0.0303842365904843,1.24318741341895e-15
NMR metabolomics,X23408.Triglycerides in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0489322376337995,0.00615121072028831,0.0368758646220344,0.0609886106455646,1.93707454735176e-15
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.043641692154397,0.00548819354927964,0.0328848327978089,0.0543985515109851,1.98108001048259e-15
NMR metabolomics,X23408.Triglycerides in VLDL,FAP,Prolyl endopeptidase FAP,42794,0.0226679488033469,0.00285561306118429,0.0170709472034257,0.0282649504032681,2.2142523308932e-15
NMR metabolomics,X23408.Triglycerides in VLDL,OMD,Osteomodulin,42676,-0.0350762159453412,0.00441883684468811,-0.0437371361609299,-0.0264152957297525,2.21833457205837e-15
NMR metabolomics,X23408.Triglycerides in VLDL,COL6A3,Collagen alpha-3(VI) chain,42794,0.0314722176163397,0.00396973982633286,0.0236915275567273,0.0392529076759521,2.39914771682715e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI2,Serpin I2,40449,0.0460838024223649,0.00585827907548495,0.0346015754344144,0.0575660294103154,3.98227000645403e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GAS2,Growth arrest-specific protein 2,40302,0.0433032661376363,0.00551081571018976,0.0325020673456644,0.0541044649296082,4.267699964263e-15
NMR metabolomics,X23408.Triglycerides in VLDL,BGN,Biglycan,42328,-0.0987616388268658,0.0125732529235006,-0.123405214556927,-0.0741180630968046,4.3106448714127e-15
NMR metabolomics,X23408.Triglycerides in VLDL,COL2A1,Collagen alpha-1(II) chain,40223,0.066375958290732,0.00845434923506642,0.0498054337900019,0.0829464827914622,4.50590424451409e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0271944477338723,0.00346896514321639,-0.0339936194145764,-0.0203952760531681,4.93389640433412e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SEL1L,Protein sel-1 homolog 1,40223,0.0266286418109409,0.00341684586955182,0.0199316239066194,0.0333256597152625,7.11241884310865e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP8,GTPase IMAP family member 8,40080,0.0428839242713561,0.00551326348523744,0.0320779278402907,0.0536899207024215,8.01350972508437e-15
NMR metabolomics,X23408.Triglycerides in VLDL,TGFA,Protransforming growth factor alpha,42594,0.0385200259009545,0.00495956119234241,0.0287992859639633,0.0482407658379456,8.63084954305887e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GDF2,Growth/differentiation factor 2,42636,0.0290642353736922,0.00374582423548856,0.0217224198721346,0.0364060508752498,9.16815355772983e-15
NMR metabolomics,X23408.Triglycerides in VLDL,C7,Complement component C7,40251,-0.0267522310697158,0.00344772750646808,-0.0335097769823932,-0.0199946851570383,9.28571161667483e-15
NMR metabolomics,X23408.Triglycerides in VLDL,MDK,Midkine,42638,0.0413299662681803,0.00533496260264351,0.0308734395669991,0.0517864929693616,1.00807893644135e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ZBP1,Z-DNA-binding protein 1,40199,0.0324058478377449,0.00418552577497586,0.0242022173187922,0.0406094783566976,1.06142799009937e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0246846861251285,0.00318987426648163,-0.0309368396874325,-0.0184325325628245,1.07774720137987e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CTSC,Dipeptidyl peptidase 1,42616,0.0356302313279531,0.00460494962258669,0.0266045300676832,0.0446559325882231,1.08713541115039e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0260966846940786,0.00338736196120886,0.0194574552501092,0.0327359141380479,1.40965410655561e-14
NMR metabolomics,X23408.Triglycerides in VLDL,COLEC12,Collectin-12,42618,0.022499914504654,0.00292838941412008,0.0167602712529786,0.0282395577563293,1.65670321658953e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA3,Protein disulfide-isomerase A3,40283,0.0198359237628432,0.00258417694588775,0.0147709369489032,0.0249009105767832,1.78030745578543e-14
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS7_LGALS7B,Galectin-7,42524,0.0347509698012516,0.00453118421075,0.0258698487481816,0.0436320908543216,1.84911810678872e-14
NMR metabolomics,X23408.Triglycerides in VLDL,S100A12,Protein S100-A12,42434,0.0601572192202553,0.00785969227421515,0.0447522223627936,0.075562216077717,2.08459681882955e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0173166987409329,0.00227205664407895,0.0128634677185382,0.0217699297633277,2.67371841538514e-14
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.035601246900478,0.00467090048038978,0.026446281958914,0.044756211842042,2.69997822903568e-14
NMR metabolomics,X23408.Triglycerides in VLDL,EDF1,Endothelial differentiation-related factor 1,40482,0.0532786575798881,0.00700207288061236,0.0395545947338879,0.0670027204258884,2.98230323434583e-14
NMR metabolomics,X23408.Triglycerides in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0329643968289847,0.00433596283487941,-0.0414628839853483,-0.024465909672621,3.09627496240529e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CD46,Membrane cofactor protein,42580,0.0229431585832711,0.00302339168250469,0.0170173108855619,0.0288690062809803,3.44847460785696e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.0196926452918007,0.00259697552005813,-0.0247827173111146,-0.0146025732724868,3.59738795225662e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0203609182944718,0.00268712375304387,0.0150941557385058,0.0256276808504378,3.80733569729e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CCL19,C-C motif chemokine 19,42711,0.103450453837129,0.0137000235766975,0.0765984076268023,0.130302500047457,4.59174037806417e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IL17D,Interleukin-17D,42370,0.0272313790183505,0.003607152333623,0.0201613604444494,0.0343013975922516,4.66431251652974e-14
NMR metabolomics,X23408.Triglycerides in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0361229297339685,0.00478688566589569,0.0267406338288129,0.045505225639124,4.83690551487376e-14
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0167249704608246,0.00222034094753591,0.0123731022036542,0.021076838717995,5.29170376664041e-14
NMR metabolomics,X23408.Triglycerides in VLDL,KIF22,Kinesin-like protein KIF22,40116,0.0983644628917466,0.0130630920993662,0.0727608023769889,0.123968123406504,5.47615308299575e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0309412330662586,0.00411068950646011,0.0228842816335967,0.0389981844989204,5.59783153873914e-14
NMR metabolomics,X23408.Triglycerides in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0412161877709163,0.0054775158692475,0.0304802566671912,0.0519521188746414,5.6309116073853e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0329630717598036,0.00438011500902159,0.0243780463421213,0.0415480971774859,5.64609874999462e-14
NMR metabolomics,X23408.Triglycerides in VLDL,RNASET2,Ribonuclease T2,42749,0.0216774687363431,0.00289281929836231,0.016007542911553,0.0273473945611332,7.11870403521941e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CDH15,Cadherin-15,42692,0.0487879380123774,0.00652289029914603,0.0360030730260512,0.0615728029987037,7.92097520547451e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0297161799652907,0.00397488677387281,0.0219254018885,0.0375069580420814,8.14751950981793e-14
NMR metabolomics,X23408.Triglycerides in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0431332738936981,0.00577173692967775,0.0318206695115297,0.0544458782758665,8.42230923047275e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0405171426503721,0.00542554739728782,0.0298830697516879,0.0511512155490562,8.65536547457332e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CST5,Cystatin-D,42357,0.0446215075337573,0.00597621516854893,0.0329081258034014,0.0563348892641132,8.75216360457117e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CD248,Endosialin,40527,-0.0317672476626977,0.00426838711203425,-0.0401332864022848,-0.0234012089231106,1.05990210445522e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.032797758003458,0.00440891792523557,0.0241562788699963,0.0414392371369197,1.07766005008168e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CCN5,CCN family member 5,42611,0.0299933291680131,0.00404137580744071,0.0220722325854294,0.0379144257505969,1.22706878319324e-13
NMR metabolomics,X23408.Triglycerides in VLDL,DPT,Dermatopontin,42794,0.0196192598728279,0.0026449031341905,0.0144352497298145,0.0248032700158413,1.26167392834162e-13
NMR metabolomics,X23408.Triglycerides in VLDL,AZU1,Azurocidin,42216,0.0592075135365467,0.00799411162524299,0.0435390547510704,0.0748759723220229,1.3776600845394e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LGMN,Legumain,42676,0.0275904341916997,0.00372859418194499,0.0202823895950876,0.0348984787883119,1.44577358145123e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LACRT,Extracellular glycoprotein lacritin,40419,0.039957258591555,0.00540103355455487,0.0293712328246275,0.0505432843584826,1.48028873017551e-13
NMR metabolomics,X23408.Triglycerides in VLDL,C5,Complement C5,40539,0.0116278566870692,0.00157430786669863,0.00854221326833985,0.0147135001057985,1.61903962167659e-13
NMR metabolomics,X23408.Triglycerides in VLDL,AGR2,Anterior gradient protein 2 homolog,42215,0.0781467218251717,0.0106060449350089,0.0573588737525543,0.098934569897789,1.83461234306329e-13
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0411797223209778,0.00558985866080772,0.0302235993457947,0.052135845296161,1.84802459426014e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0421976857842967,0.00574538539368078,0.0309367304126824,0.053458641155911,2.21043847355511e-13
NMR metabolomics,X23408.Triglycerides in VLDL,SLC16A1,Monocarboxylate transporter 1,42311,0.0440881845052959,0.00601457072081702,0.0322996258924946,0.0558767431180973,2.43212193017069e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CCL14,C-C motif chemokine 14,42618,0.0308119730420334,0.0042161551370975,0.0225483089733223,0.0390756371107445,2.86307032472865e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CD300A,CMRF35-like molecule 8,40283,0.0238079284423561,0.00325809158742846,0.0174220689309963,0.0301937879537159,2.91242499463558e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0288023778365193,0.00394226086732299,0.0210755465365662,0.0365292091364723,2.93697850959002e-13
NMR metabolomics,X23408.Triglycerides in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0404395996448343,0.00554546320954448,0.0295704917541271,0.0513087075355415,3.21952904173087e-13
NMR metabolomics,X23408.Triglycerides in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0430573839115209,0.00590926681151028,0.0314752209609607,0.054639546862081,3.39887951626812e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.026767846486952,0.00368274511075862,0.0195496660698651,0.033986026904039,3.83825598497479e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.052061132231057,0.00716459501206694,0.0380185260074058,0.0661037384547082,3.89336432440955e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CR1,Complement receptor type 1,40509,0.027459778576101,0.00378142632674953,0.020048182975672,0.0348713741765301,4.07182970531069e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0295421627496434,0.00407159442224761,0.0215618376820381,0.0375224878172487,4.22019856874361e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ASS1,Argininosuccinate synthase,40116,0.0589496629228286,0.00813040110858222,0.0430140767500074,0.0748852490956497,4.43239910763037e-13
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL1,Fc receptor-like protein 1,42636,0.0356078237553298,0.00491319434496537,0.0259779628391976,0.0452376846714619,4.48062760443254e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL8,Interleukin-8,42494,0.0526760260111626,0.00728821990932752,0.0383911149888806,0.0669609370334445,5.1857852635413e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0370995283356312,0.00513445363944216,0.0270359992023245,0.0471630574689378,5.25763949993866e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.016204986290707,0.00224447755932862,0.011805810274423,0.0206041623069911,5.48029699297838e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0360719254398825,0.00499661193176168,0.0262785660536297,0.0458652848261354,5.51346766292906e-13
NMR metabolomics,X23408.Triglycerides in VLDL,GPR15L,Protein GPR15L,40449,0.0458440547772653,0.00636610437566743,0.0333664902009571,0.0583216193535734,6.34578992512261e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA4,Laminin subunit alpha-4,42676,0.0249153099555694,0.00346253317888706,0.0181287449249507,0.031701874986188,6.54299411724589e-13
NMR metabolomics,X23408.Triglycerides in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0687977775786016,0.00956349568861596,0.0500533260289143,0.0875422291282889,6.71041487863984e-13
NMR metabolomics,X23408.Triglycerides in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0290236839929628,0.00406291816568421,0.0210603643882217,0.0369870035977038,9.66931666570357e-13
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC1,MANSC domain-containing protein 1,42679,-0.0209721626458086,0.00293983768244878,-0.0267342445034083,-0.015210080788209,1.02629548892129e-12
NMR metabolomics,X23408.Triglycerides in VLDL,XRCC4,DNA repair protein XRCC4,42311,0.0274906625578828,0.00385429322660818,0.0199362478337308,0.0350450772820349,1.03747655842479e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RALY,RNA-binding protein Raly,40451,0.0353042422896472,0.00495920871491152,0.0255841932084207,0.0450242913708738,1.15392510014112e-12
NMR metabolomics,X23408.Triglycerides in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0339355678831523,0.00476856845398402,0.0245891737133436,0.043281962052961,1.16325792817503e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CD300C,CMRF35-like molecule 6,42711,0.0267412962319186,0.0037597054495841,0.0193722735507338,0.0341103189131035,1.19600549074833e-12
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0315773421398926,0.00444878405033372,0.0228577254012385,0.0402969588785467,1.32972278111974e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ELOB,Elongin-B,40116,0.0297836266214207,0.00419828357230806,0.0215549908196969,0.0380122624231445,1.38119007419767e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RCOR1,REST corepressor 1,42357,0.03283988522366,0.00463349417483679,0.0237582366409799,0.0419215338063401,1.43514398435035e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CENPF,Centromere protein F,40302,0.040360576786978,0.00570750024938963,0.0291738762981743,0.0515472772757816,1.62477331722846e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TNC,Tenascin,42689,-0.0356780650008833,0.00505513070701227,-0.0455861211866273,-0.0257700088151392,1.77429404210116e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.038582166337224,0.0054670253915736,0.0278667965697398,0.0492975361047083,1.78341702149046e-12
NMR metabolomics,X23408.Triglycerides in VLDL,C2orf69,UPF0565 protein C2orf69,40182,0.0450623391415087,0.00638662905359991,0.0325445461964528,0.0575801320865645,1.82031561817837e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0424399045388636,0.00601705735979718,0.0306464721136612,0.0542333369640661,1.83506317497403e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.0598675237243003,0.00849218632278129,0.043222838531649,0.0765122089169516,1.88062832440394e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CRYM,Ketimine reductase mu-crystallin,40136,0.0559343742047949,0.00793448909378796,0.0403827755809705,0.0714859728286193,1.90346624573807e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TREML1,Trem-like transcript 1 protein,40532,0.038469185462015,0.00547842080158951,0.0277314806908995,0.0492068902331304,2.31306749254333e-12
NMR metabolomics,X23408.Triglycerides in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0460874607812799,0.00656932623800927,0.0332115813547817,0.058963340207778,2.40280640152324e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4D,C-type lectin domain family 4 member D,42594,0.0456747281030287,0.00651362867456088,0.0329080159008894,0.058441440305168,2.45880324101435e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0536668931402142,0.00765448760062527,0.0386640974429887,0.0686696888374397,2.50053398209426e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0740235019002668,0.0105759747274305,0.053294591434503,0.0947524123660306,2.69746747057229e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0206157059595286,0.00294875700514367,0.014836142229447,0.0263952696896102,2.85123152187844e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CRYGD,Gamma-crystallin D,40483,0.0707193756911157,0.0101865147709021,0.0507538067401476,0.0906849446420837,4.06496839550856e-12
NMR metabolomics,X23408.Triglycerides in VLDL,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0382240683163684,0.00550972229987409,-0.0490231240241216,-0.0274250126086152,4.17201770610066e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ALPP,"Alkaline phosphatase, placental type",42587,0.073142790968277,0.0105458768790004,0.0524728722854362,0.0938127096511178,4.22833581150152e-12
NMR metabolomics,X23408.Triglycerides in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0198506908060315,0.00286267655031486,0.0142398447674144,0.0254615368446486,4.30562633502298e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM4,Intercellular adhesion molecule 4,42594,-0.0382826772729014,0.00552341196386621,-0.0491085647220792,-0.0274567898237236,4.37040640845786e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CD209,CD209 antigen,42668,-0.0281387456209672,0.00406487757070461,-0.0361059056595482,-0.0201715855823862,4.64122772270906e-12
NMR metabolomics,X23408.Triglycerides in VLDL,AHCY,Adenosylhomocysteinase,42636,0.0484815253031571,0.00700610238697885,0.0347495646246785,0.0622134859816356,4.72439063796553e-12
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0420784305786726,0.00608548706022902,0.0301508759406237,0.0540059852167214,4.90991753566933e-12
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0484193519185503,0.00701015903854245,0.0346794402030071,0.0621592636340935,5.22433461324408e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0270301424330658,0.00391604969192858,0.0193546850368858,0.0347055998292458,5.39660832855925e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.037853184562933,0.0054935665768398,0.027085794072327,0.048620575053539,5.85661404645108e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SDK2,Protein sidekick-2,40283,0.0290977766126349,0.00422832160430791,0.0208102662681914,0.0373852869570784,6.23595459227836e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA7A,Semaphorin-7A,42760,0.0204757431581674,0.00297787119770644,0.0146391156106627,0.026312370705672,6.42646978375797e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN1,Tetraspanin-1,42357,0.0487737677805944,0.00710324274765562,0.0348514119951894,0.0626961235659994,6.87922414222647e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GNLY,Granulysin,42611,0.0384751700639543,0.00560596291570696,0.0274874827491687,0.04946285737874,7.02636571857253e-12
NMR metabolomics,X23408.Triglycerides in VLDL,STAM,Signal transducing adapter molecule 1,40451,0.0268063986494629,0.00391406843187778,0.0191348245229824,0.0344779727759433,7.8390024992429e-12
NMR metabolomics,X23408.Triglycerides in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0697296173194192,0.0101959803742816,0.0497454957858273,0.0897137388530111,8.32227606383275e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0254085073358169,0.00371889498885249,-0.0326975415139678,-0.018119473157666,8.72552856250168e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PER3,Period circadian protein homolog 3,40199,0.0879019816569969,0.012881592162112,0.0626540610192573,0.113149902294736,9.32931151947047e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SPP1,Osteopontin,42771,-0.0336781070321844,0.0049460894343833,-0.0433724423235757,-0.0239837717407932,1.02384550217659e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0246488969438703,0.0036253708102873,0.0175431701557072,0.0317546237320334,1.09755948470559e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPD,Pulmonary surfactant-associated protein D,42636,0.048207614435748,0.00710365543557564,0.0342844497820197,0.0621307790894762,1.19857777875413e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0444449429624189,0.00655386567825827,0.0315993662330327,0.0572905196918051,1.25052029312731e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GAST,Gastrin,40483,0.102933329294239,0.0152343599896492,0.0730739837145268,0.132792674873952,1.48160832191812e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0306849668975309,0.00454380052890359,0.0217791178608799,0.0395908159341819,1.51794209999232e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0263960629649527,0.00393240242288442,0.0186885542160993,0.0341035717138062,1.99057701542628e-11
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFB,Vascular endothelial growth factor B,40199,0.0207686008417153,0.00309809144383865,0.0146963416117915,0.026840860071639,2.13185603656252e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CABP2,Calcium-binding protein 2,40182,0.0453814639693158,0.0067704287284034,0.0321114236616452,0.0586515042769865,2.14341431378249e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CA1,Carbonic anhydrase 1,42362,0.0421059232163486,0.00629183981898153,0.0297739171711448,0.0544379292615524,2.28818745096219e-11
NMR metabolomics,X23408.Triglycerides in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0392489629434133,0.00587281583616132,0.0277382439045371,0.0507596819822895,2.45182782467454e-11
NMR metabolomics,X23408.Triglycerides in VLDL,BRDT,Bromodomain testis-specific protein,40116,0.0260300548163275,0.00389533978233701,0.0183951888429469,0.033664920789708,2.46575214729222e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TSHB,Thyrotropin subunit beta,42636,0.0553444658852047,0.00829251901236458,0.0390911286209702,0.0715978031494393,2.58641693379311e-11
NMR metabolomics,X23408.Triglycerides in VLDL,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0800911823123981,0.0120141442264336,0.0565434596285883,0.103638904996208,2.72523064998188e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0413824704852445,0.00621584595522063,0.0291994124130121,0.0535655285574769,2.8906944958703e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0333918322277523,0.00501866747904837,0.0235552439688174,0.0432284204866871,2.99393826039547e-11
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2,Brorin,42456,0.0286713992928151,0.00431242676684324,0.0202190428298023,0.0371237557558278,3.07574548945537e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0148855616114865,0.0022391408907256,-0.0192742777573087,-0.0104968454656643,3.09048539088051e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0330759316152523,0.00497619757001663,0.0233225843780197,0.0428292788524849,3.11286558638718e-11
NMR metabolomics,X23408.Triglycerides in VLDL,VCAM1,Vascular cell adhesion protein 1,42663,-0.0194091903070717,0.00292552554344071,-0.0251432203722155,-0.0136751602419279,3.38209139263776e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CD101,Immunoglobulin superfamily member 2,40449,0.0301977136455687,0.00456281004120905,0.021254605964799,0.0391408213263385,3.80047068993516e-11
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX1,Heme oxygenase 1,42500,-0.0333823217461022,0.00505507057069091,-0.0432902600646564,-0.023474383427548,4.16165644992348e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CX3CL1,Fractalkine,42495,-0.0238131052842196,0.00360604008460331,-0.0308809438500421,-0.0167452667183971,4.16334687496166e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0334494429984487,0.005067521488436,0.0235171008811141,0.0433817851157833,4.24840858233866e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CDH3,Cadherin-3,42711,0.0258956828750613,0.0039247411893036,0.0182031901440262,0.0335881756060963,4.3208503436439e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ECE1,Endothelin-converting enzyme 1,42311,0.0245526851348765,0.00372479657268564,0.0172520838524126,0.0318532864173404,4.51498281663003e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0250815576878391,0.00382705498166659,0.0175805299237725,0.0325825854519056,5.8138335462748e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FABP6,Gastrotropin,42334,0.0401645233936272,0.00614585372601839,0.0281186500906311,0.0522103966966232,6.58586536822935e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0340440797517127,0.00521107269514336,0.0238303772692317,0.0442577822341937,6.68264125843118e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0294261925636559,0.00451245748796121,0.0205817758872519,0.0382706092400599,7.23392534861991e-11
NMR metabolomics,X23408.Triglycerides in VLDL,BCAM,Basal cell adhesion molecule,42611,-0.0167755243901633,0.00258192430292151,-0.0218360960238895,-0.0117149527564372,8.46636436556955e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0247722710645897,0.00381540434410242,0.017294078550149,0.0322504635790305,8.7942680863872e-11
NMR metabolomics,X23408.Triglycerides in VLDL,IFNG,Interferon gamma,42370,0.0768003107138096,0.0118340324385408,0.0536056071342696,0.0999950142933496,8.90362835358778e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.018085566049112,0.00278787775899561,0.0126213256414806,0.0235498064567434,9.0478996325277e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LYZL2,Lysozyme-like protein 2,40080,0.0244162308574903,0.00377271047603538,0.0170217183244609,0.0318107433905196,1.01004313728576e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0335114133866944,0.00517997911005526,-0.0436641724424027,-0.0233586543309861,1.02447325038215e-10
NMR metabolomics,X23408.Triglycerides in VLDL,BSG,Basigin,42746,0.0146978133309001,0.00227483922105439,0.0102391284576335,0.0191564982041667,1.07543851849552e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL3,Fc receptor-like protein 3,42370,0.0382114087833493,0.00591523456338934,0.0266175490391062,0.0498052685275924,1.08504056900427e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SCT,Secretin,40182,0.033846525412828,0.00523914087906812,0.0235778092898545,0.0441152415358015,1.08899132989741e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TAFA5,Chemokine-like protein TAFA-5,42587,0.0260716869432731,0.00403771186896501,0.0181577716801017,0.0339856022064446,1.1045087384511e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CBS,Cystathionine beta-synthase,40223,0.0347271630695015,0.00537814538043001,0.0241859981238587,0.0452683280151443,1.11222609783234e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CD80,T-lymphocyte activation antigen CD80,40511,0.0235669980508855,0.00365162596885317,0.0164098111519333,0.0307241849498377,1.13509409270587e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PRELP,Prolargin,42618,0.016432894964749,0.00255034524354774,0.0114342182873954,0.0214315716421025,1.20813750617416e-10
NMR metabolomics,X23408.Triglycerides in VLDL,EPCAM,Epithelial cell adhesion molecule,42616,-0.066627613397368,0.0103506608680687,-0.0869149086987827,-0.0463403180959532,1.25968834925773e-10
NMR metabolomics,X23408.Triglycerides in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0440344764842666,0.00684286238573312,0.0306224662082297,0.0574464867603035,1.28580359695523e-10
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0230075838321152,0.00357910142100717,-0.0300226226172893,-0.0159925450469412,1.33384649875309e-10
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0394001309463085,0.0061281573767549,0.0273889424878689,0.0514113194047481,1.33448539652932e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PRKD2,Serine/threonine-protein kinase D2,40116,0.0307567480470868,0.00478606604279019,0.021376058603218,0.0401374374909556,1.36183372919507e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ENAH,Protein enabled homolog,42370,0.0317336775525772,0.00494188698906848,0.022047579054003,0.0414197760511514,1.39689042965234e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO1,Roundabout homolog 1,42638,0.0164823420529896,0.00256713505733378,0.0114507573406154,0.0215139267653638,1.403732676314e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0274832235963186,0.00428082800002867,0.0190928007162624,0.0358736464763748,1.41691311120321e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR2,Folate receptor beta,42711,-0.01987617245585,0.00309825975276268,-0.0259487615712649,-0.0138035833404352,1.452562565465e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0233824468568621,0.00364712474830867,0.0162340823501771,0.0305308113635471,1.49172157467518e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SNX2,Sorting nexin-2,40451,0.0550109346742044,0.00859199616035733,0.038170622199904,0.0718512471485047,1.58854344945546e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MARCO,Macrophage receptor MARCO,42636,0.0175540465286677,0.00274231254122899,0.0121791139478589,0.0229289791094765,1.5929685449375e-10
NMR metabolomics,X23408.Triglycerides in VLDL,APOBR,Apolipoprotein B receptor,40223,-0.028597628026443,0.00446744852606973,-0.0373538271375396,-0.0198414289153463,1.60279986806949e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0412566586831126,0.00644620317350961,0.0286221004630337,0.0538912169031914,1.61586904260287e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SPARCL1,SPARC-like protein 1,42644,-0.0185225303994975,0.00289815876637659,-0.0242029215815956,-0.0128421392173993,1.70087266821839e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TPM3,Tropomyosin alpha-3 chain,40116,-0.0293515187192285,0.00459654228496616,-0.0383607415977622,-0.0203422958406949,1.77700720463655e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0390654192539332,0.00612174659227141,0.0270667959330812,0.0510640425747851,1.81219511426937e-10
NMR metabolomics,X23408.Triglycerides in VLDL,APOM,Apolipoprotein M,42663,0.0187898399603868,0.00295070574803756,0.0130064566942332,0.0245732232265404,1.97836922849228e-10
NMR metabolomics,X23408.Triglycerides in VLDL,AOC3,Membrane primary amine oxidase,42689,-0.0201380143462311,0.00316384016483217,-0.0263391410693022,-0.0139368876231601,2.01534483151338e-10
NMR metabolomics,X23408.Triglycerides in VLDL,COPB2,Coatomer subunit beta',40116,0.0289015407533921,0.00454068952237722,0.0200017892895327,0.0378012922172514,2.03104104054116e-10
NMR metabolomics,X23408.Triglycerides in VLDL,DKK3,Dickkopf-related protein 3,42794,-0.0200940632912785,0.00315933575013773,-0.0262863613615485,-0.0139017652210086,2.07913317310093e-10
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0359011424206752,0.00565067048209928,0.0248258282757606,0.0469764565655898,2.1749911088607e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0262931449063254,0.00414310619089819,0.018172656772165,0.0344136330404859,2.27748514512077e-10
NMR metabolomics,X23408.Triglycerides in VLDL,THBD,Thrombomodulin,42636,0.0200361386437357,0.00315836129170908,0.0138457505119859,0.0262265267754855,2.31288915673105e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX1,Peroxiredoxin-1,42261,-0.0595202765919574,0.00938281675051737,-0.0779105974229715,-0.0411299557609434,2.31947480777684e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LTB,Lymphotoxin-beta,40451,0.0237421549979249,0.00375188778211649,0.0163884549449765,0.0310958550508732,2.57700918878166e-10
NMR metabolomics,X23408.Triglycerides in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.021464874232307,0.00339645048743639,0.0148078312769317,0.0281219171876824,2.7201489504144e-10
NMR metabolomics,X23408.Triglycerides in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.055657722008246,0.00882949785444445,0.0383519062135349,0.0729635378029571,3.00103592014634e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL3,Follistatin-related protein 3,42574,0.0223393535271331,0.00354521909095936,0.0153907241088527,0.0292879829454134,3.04486799468505e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN2,Alpha-actinin-2,40116,-0.0392243236566549,0.00623797920041283,-0.051450762889464,-0.0269978844238457,3.33896140337887e-10
NMR metabolomics,X23408.Triglycerides in VLDL,EPO,Erythropoietin,42594,0.0486567558657228,0.00774125249917437,0.033483900967341,0.0638296107641045,3.37175530558903e-10
NMR metabolomics,X23408.Triglycerides in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0550481140355998,0.00876553046342924,0.0378676743272785,0.0722285537439211,3.51290545676322e-10
NMR metabolomics,X23408.Triglycerides in VLDL,VGF,Neurosecretory protein VGF,40482,0.0207474019637616,0.00330463205756057,0.0142703231309429,0.0272244807965803,3.54909472260011e-10
NMR metabolomics,X23408.Triglycerides in VLDL,S100A14,Protein S100-A14,40482,0.0360647511710914,0.00574647726190813,0.0248016557377514,0.0473278466044313,3.60185788700969e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0168975491073273,0.0026949331096433,0.0116154802124264,0.0221796180022281,3.71826547025344e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TEK,Angiopoietin-1 receptor,42679,0.0143668072575447,0.00229758094068483,0.00986354861380246,0.018870065901287,4.14749653736085e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0256071042392205,0.00409657164807048,0.0175778238090024,0.0336363846694386,4.23422425952766e-10
NMR metabolomics,X23408.Triglycerides in VLDL,HMBS,Porphobilinogen deaminase,42721,0.0282378732393226,0.00451892179696592,0.0193807865172694,0.0370949599613758,4.26002377705326e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NFIC,Nuclear factor 1 C-type,40482,0.0309404964558642,0.00497640236832179,0.0211867478139535,0.040694245097775,5.2317104102885e-10
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.031613715956685,0.00509068221699761,0.0216359788113697,0.0415914531020004,5.48519979143563e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL2,Fc receptor-like protein 2,42681,0.0341222278231906,0.00551444585516743,0.0233139139470624,0.0449305416993187,6.27794128800068e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MPO,Myeloperoxidase,42611,0.030079268097555,0.00486719804463311,0.0205395599300741,0.0396189762650359,6.59583577597004e-10
NMR metabolomics,X23408.Triglycerides in VLDL,PI3,Elafin,42446,0.0367719522742055,0.00595234489879477,0.0251053562725677,0.0484385482758432,6.69349767381012e-10
NMR metabolomics,X23408.Triglycerides in VLDL,BOC,Brother of CDO,42357,-0.0151234420220874,0.002453186254784,-0.0199316870814641,-0.0103151969627108,7.26273560259282e-10
NMR metabolomics,X23408.Triglycerides in VLDL,COL1A1,Collagen alpha-1(I) chain,42794,-0.016170799843742,0.00262571184166142,-0.0213171950533984,-0.0110244046340856,7.54411974179737e-10
NMR metabolomics,X23408.Triglycerides in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0277458900432902,0.00450575483988139,0.0189146105571226,0.0365771695294577,7.58817838475585e-10
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE3,Eosinophil cationic protein,42578,0.0707185624415345,0.0114889619736278,0.048200196973224,0.0932369279098451,7.70523342578395e-10
NMR metabolomics,X23408.Triglycerides in VLDL,COL15A1,Collagen alpha-1(XV) chain,40527,0.0180473456019591,0.00293451981482686,0.0122956867648984,0.0237990044390197,8.00849688055294e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.0171010894511855,0.0027820766989615,-0.02255395978115,-0.0116482191212209,8.12655112820097e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0228681153714486,0.00372091972059139,-0.0301611180238077,-0.0155751127190894,8.22413687112549e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MYL3,Myosin light chain 3,40223,-0.0472409177003583,0.00769346594664724,-0.0623201109557869,-0.0321617244449297,8.51498715779122e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GRN,Progranulin,42552,0.0157674806118796,0.00257111729368156,0.0107280907162637,0.0208068705074955,8.89258016598712e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MDM1,Nuclear protein MDM1,40182,0.0201337403095818,0.00328324880124912,0.0136985726591335,0.0265689079600301,8.96160794653249e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CRH,Corticoliberin,42322,0.0551429476829854,0.00900270288624192,0.0374976500259513,0.0727882453400196,9.31834375878911e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB6,Integrin beta-6,42370,0.0199949059980944,0.00327206005223766,0.0135816682957086,0.0264081437004803,1.01927936477948e-09
NMR metabolomics,X23408.Triglycerides in VLDL,DPP7,Dipeptidyl peptidase 2,42551,0.0384198137794774,0.00629550402391498,0.0260806258926041,0.0507590016663508,1.07151093670204e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0188429818120609,0.00308820227932837,0.0127901053445773,0.0248958582795445,1.0787985292254e-09
NMR metabolomics,X23408.Triglycerides in VLDL,S100A11,Protein S100-A11,42531,0.0290558438564686,0.00476202132562701,0.0197222820582397,0.0383894056546976,1.07934344981536e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CTSF,Cathepsin F,42679,0.025264291461809,0.00414494023382006,0.0171402086035217,0.0333883743200963,1.12272260573504e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL1,Angiopoietin-related protein 1,42439,0.0185295283648906,0.00304189460721245,0.0125674149347542,0.024491641795027,1.14996729547466e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ENSA,Alpha-endosulfine,40451,0.033750591823272,0.00556081771526727,0.0228513891013481,0.0446497945451959,1.32557170031642e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAM,Integrin alpha-M,42611,-0.020105215663872,0.0033137851117487,-0.0266002344828995,-0.0136101968448446,1.3370782561689e-09
NMR metabolomics,X23408.Triglycerides in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0235328584711094,0.00387871296662403,0.0159305810565263,0.0311351358856925,1.34446312764778e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD6,Programmed cell death protein 6,42636,-0.0446753652482612,0.00737174692480243,-0.059123989220874,-0.0302267412756484,1.3945817336757e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA7,Thyroxine-binding globulin,40539,0.0117131055624444,0.00193349650305364,0.0079234524164593,0.0155027587084296,1.42201431815463e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0265356831195396,0.00438768474511515,0.0179358210191139,0.0351355452199653,1.5086287741416e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PALM,Paralemmin-1,40384,0.0198959102094367,0.00330262549096579,0.0134227642471437,0.0263690561717296,1.75215855247943e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0233399279460298,0.0038776905454517,0.0157396544769445,0.0309402014151152,1.81060250340493e-09
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR2,TGF-beta receptor type-2,42679,0.0225870582617599,0.00375682233910435,0.0152236864771154,0.0299504300464044,1.87660461466082e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RAB44,Ras-related protein Rab-44,40451,0.0264157328124363,0.00439485703891111,0.0178018130161705,0.0350296526087021,1.90562546607187e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB1A1,Uteroglobin,42646,0.0350750395133159,0.00583774460919933,0.0236330600792852,0.0465170189473466,1.922970018933e-09
NMR metabolomics,X23408.Triglycerides in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0295159553448323,0.00491412500506645,0.0198842703349021,0.0391476403547626,1.94774616015975e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L2,Seizure 6-like protein 2,42587,-0.0148867099269438,0.00248636367479341,-0.0197599827295389,-0.0100134371243487,2.18755855193303e-09
NMR metabolomics,X23408.Triglycerides in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0297293258699043,0.00496974653167051,-0.0394700290719785,-0.0199886226678301,2.25939436893857e-09
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0414217332702977,0.00692984775561346,0.0278392316692954,0.0550042348713001,2.33750932977239e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0188210480442556,0.00315726689778186,0.0126328049246032,0.0250092911639081,2.58099938372666e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LYAR,Cell growth-regulating nucleolar protein,42346,0.0337815658033084,0.00569391102140297,0.0226215002013586,0.0449416314052582,3.05060468094135e-09
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB6,Heat shock protein beta-6,42721,0.0244290502681101,0.00412923837753467,0.0163357430481421,0.0325223574880781,3.37600113999779e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CAPG,Macrophage-capping protein,42461,0.0362056949356177,0.00612440226590549,0.0242018664944429,0.0482095233767924,3.46892126911608e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LF,CMRF35-like molecule 1,42721,0.037624525571142,0.00637990890435121,0.0251199041186137,0.0501291470236704,3.78212208534382e-09
NMR metabolomics,X23408.Triglycerides in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0173049382399102,0.00293581159205864,0.0115507475194753,0.0230591289603451,3.84960708865704e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CDH1,Cadherin-1,42188,0.0245658793943986,0.00416919976059596,0.0163942478636305,0.0327375109251667,3.90458687009393e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PIGR,Polymeric immunoglobulin receptor,42464,0.0220971313329615,0.00375088822273196,0.0147453904164069,0.0294488722495161,3.92756123655738e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CR2,Complement receptor type 2,42689,0.0295450127460078,0.0050184719474684,0.0197088077289697,0.0393812177630458,4.0199851963872e-09
NMR metabolomics,X23408.Triglycerides in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0332270483255058,0.00565839526015432,0.0221365936156034,0.0443175030354083,4.40309670659346e-09
NMR metabolomics,X23408.Triglycerides in VLDL,BAX,Apoptosis regulator BAX,42292,0.0545292140654061,0.00929220383425589,0.0363164945502646,0.0727419335805476,4.50998385591181e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RGMB,RGM domain family member B,42711,0.0174901685870779,0.00298161660952502,0.0116462000324088,0.0233341371417469,4.56869704987963e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CTSB,Cathepsin B,42659,-0.03299214737072,0.00562477188051835,-0.044016700256536,-0.0219675944849041,4.58267666240819e-09
NMR metabolomics,X23408.Triglycerides in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0510469169725316,0.00871135602863938,0.0339726591563984,0.0681211747886648,4.74279920366947e-09
NMR metabolomics,X23408.Triglycerides in VLDL,KLRK1,NKG2-D type II integral membrane protein,40483,0.0299916498599892,0.00511850762150917,0.0199593749218312,0.0400239247981472,4.77369943997254e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0334681823502485,0.00572322701745572,0.0222506573960352,0.0446857073044617,5.12361944695334e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0265254014760099,0.00454076771394965,0.0176254967566686,0.0354253061953512,5.31624201368521e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP7,GTPase IMAP family member 7,40283,-0.0194586309998238,0.00333205787863721,-0.0259894644419528,-0.0129277975576949,5.37229356230422e-09
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0340818361918548,0.00584050353695485,0.0226344492594233,0.0455292231242863,5.48935320065559e-09
NMR metabolomics,X23408.Triglycerides in VLDL,MMP12,Macrophage metalloelastase,42592,0.0342368081425318,0.00587049615406682,0.0227306356805608,0.0457429806045028,5.60258078308944e-09
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFD,Vascular endothelial growth factor D,42734,-0.0219385216600659,0.00377749748555186,-0.0293424167317476,-0.0145346265883843,6.47638307896096e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN4,Contactin-4,42611,-0.0145831352147709,0.00252016033524208,-0.0195226494718454,-0.00964362095769643,7.34337534011907e-09
NMR metabolomics,X23408.Triglycerides in VLDL,AMPD3,AMP deaminase 3,40483,0.0428299339902785,0.00741877919607456,0.0282891267659723,0.0573707412145846,7.98398533398797e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR2,Asialoglycoprotein receptor 2,40532,0.0162734452099077,0.00281994870202668,0.0107463457539354,0.02180054466588,8.09480301773336e-09
NMR metabolomics,X23408.Triglycerides in VLDL,REG4,Regenerating islet-derived protein 4,42638,0.0317796598227601,0.00551431219640096,0.0209716079178142,0.042587711727706,8.43828152901851e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0247942805375862,0.00430904131760146,0.0163485595550873,0.0332400015200851,8.9416055523619e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SERPING1,Plasma protease C1 inhibitor,40516,0.0110074795529633,0.00191553708514447,0.00725302686608011,0.0147619322398464,9.35044115608801e-09
NMR metabolomics,X23408.Triglycerides in VLDL,F3,Tissue factor,42636,-0.0163808615126277,0.00285861557337947,-0.0219837480364514,-0.0107779749888039,1.02375060572514e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0171489883407111,0.00299563738373619,0.0112775390685882,0.023020437612834,1.05836083929842e-08
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE6,Ribonuclease K6,40468,0.020365763619348,0.00356405412887333,0.0133802175267563,0.0273513097119397,1.13005899648702e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CCL21,C-C motif chemokine 21,42676,0.0252114963047121,0.0044198902523598,0.0165485114100869,0.0338744811993373,1.19416326657583e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0164950559023077,0.00289565412400347,0.0108195738192609,0.0221705379853545,1.24857018299825e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM2,Myomesin-2,40116,-0.0301132607206389,0.00528775333919242,-0.040477257265456,-0.0197492641758218,1.26626819858268e-08
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0267222765175098,0.00469915939699142,-0.035932628935613,-0.0175119240994066,1.32290386177574e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3,Galectin-3,42669,0.0177418889546514,0.00312993013066066,0.0116072258985565,0.0238765520107463,1.47040147930244e-08
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L15,Bcl-2-like protein 15,40199,0.0333054030963776,0.00589542548704877,0.021750369141762,0.0448604370509932,1.65041056019492e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SAA4,Serum amyloid A-4 protein,40539,0.0191105620462109,0.00339201766071117,0.012462207431217,0.0257589166612048,1.80291286911504e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SCN4B,Sodium channel subunit beta-4,40223,0.0259571701469344,0.00461446947793634,0.0169128099701792,0.0350015303236896,1.8984091054667e-08
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0197199485173401,0.00350905316950417,0.012842204305112,0.0265976927295683,1.95796775517461e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPB1,Signal-regulatory protein beta-1,42600,0.0283303599751801,0.00504622250386628,0.0184397638676022,0.038220956082758,2.01426602718333e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1A,Protein phosphatase 1A,42346,0.0186784732642038,0.00333720689953076,0.0121375477411235,0.0252193987872841,2.22405295195332e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ULBP2,UL16-binding protein 2,42495,0.0234215370124667,0.00418846778831467,0.01521214014737,0.0316309338775635,2.29008865435776e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR3,Small proline-rich protein 3,40483,0.0408628151974319,0.0073461813163608,0.0264642998173648,0.0552613305774991,2.72059567429797e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN1,Contactin-1,42794,-0.0162043753327277,0.00291514694287946,-0.0219180633407715,-0.010490687324684,2.76934506104581e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GZMH,Granzyme H,42357,0.0451243194372598,0.00812596349175408,0.0291974309934218,0.0610512078810978,2.86077889251358e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.018044633910368,0.00325209847103925,-0.024418746913605,-0.0116705209071311,2.93506316742942e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CCL25,C-C motif chemokine 25,42754,0.027711571218873,0.00501630185023775,0.017879619592407,0.037543522845339,3.36890196051568e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA1,Alpha-1-antitrypsin,40327,-0.00473119262903613,0.000857878899323757,-0.00641263527171069,-0.00304974998636156,3.56589827456132e-08
NMR metabolomics,X23408.Triglycerides in VLDL,INSR,Insulin receptor,40199,0.0100316507285292,0.00182046604323518,0.00646353728378827,0.0135997641732702,3.65904221101607e-08
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0200402764489331,0.00364750625740873,0.012891164184412,0.0271893887134542,4.01129686508483e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0261908036442632,0.00478931287395657,0.0168037504113083,0.0355778568772181,4.63311316794108e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GC,Vitamin D-binding protein,40539,0.0147750465541695,0.00270902632660769,0.00946535495401841,0.0200847381543205,5.02803427707644e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0195226528813464,0.00358494085468643,0.012496168806161,0.0265491369565317,5.2491544873031e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0175664175467019,0.00322741873824458,-0.0238921582736612,-0.0112406768197425,5.3566445005672e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D17,TBC1 domain family member 17,42311,0.0257112217769655,0.00474953359960826,0.0164021359217334,0.0350203076321977,6.29201991548969e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CTSH,Pro-cathepsin H,42332,0.0422086656034922,0.00779935751516692,0.026921924873765,0.0574954063332193,6.348463428609e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR2,Complement factor H-related protein 2,40451,0.0327680654474084,0.00605714712574824,0.0208960570809418,0.0446400738138749,6.43805502581498e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0247534816485313,0.00458395646149478,0.0157689269840015,0.0337380363130611,6.77895777778474e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA5,Protein disulfide-isomerase A5,40080,0.0346887364070531,0.00643052786395949,0.0220849017936925,0.0472925710204137,7.01991970632403e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH1,Protocadherin-1,42721,0.0122557436565242,0.00227483352480588,0.00779706994790463,0.0167144173651437,7.26268848449522e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL,Podocalyxin,42587,0.00860121679652939,0.00159940314225687,0.00546638663770593,0.0117360469553529,7.66819726678013e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PPL,Periplakin,40199,0.0187700890866327,0.00349072604272178,0.011928266042898,0.0256119121303674,7.72307246799901e-08
NMR metabolomics,X23408.Triglycerides in VLDL,MTPN,Myotrophin,42357,0.0186730351492339,0.0034767656026804,0.0118585745679803,0.0254874957304874,7.97180627398367e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GBP4,Guanylate-binding protein 4,42311,0.0277862815455309,0.00517406238663929,0.0176451192677178,0.0379274438233439,7.9945278998595e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SIL1,Nucleotide exchange factor SIL1,40223,0.0174334651898027,0.00324733655439402,0.0110686855431905,0.023798244836415,8.0985624584959e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0208022119653105,0.00387757695639582,-0.0284022627998463,-0.0132021611307747,8.26615066741322e-08
NMR metabolomics,X23408.Triglycerides in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0132671966656936,0.00247507865886181,-0.0181183508370628,-0.00841604249432447,8.47531101173485e-08
NMR metabolomics,X23408.Triglycerides in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.056976167271059,0.0106659955217692,0.0360708160483914,0.0778815184937266,9.37952201438765e-08
NMR metabolomics,X23408.Triglycerides in VLDL,FGF16,Fibroblast growth factor 16,40199,0.0264212470786634,0.0049649125721803,0.0166900184371901,0.0361524757201368,1.04882908330325e-07
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00887693810720951,0.00167047824057921,0.00560280075567426,0.0121510754587448,1.08931415298013e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0210234537923333,0.00395939992169164,0.0132630299458177,0.0287838776388489,1.11854754897327e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ICOSLG,ICOS ligand,42587,0.0107581357418933,0.00202712669034895,0.00678496742880933,0.0147313040549772,1.13168160090869e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PVALB,Parvalbumin alpha,42654,0.0609656297581756,0.0114948738301186,0.0384356770511431,0.0834955824652081,1.15260374962573e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0166860917669938,0.00314685841897321,0.0105182492658063,0.0228539342681813,1.16055582965475e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CILP,Cartilage intermediate layer protein 1,40527,0.0306685978708087,0.00578523245496315,0.0193295422590809,0.0420076534825364,1.17213941492078e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0320513854849177,0.00605047223572047,-0.0439103110669299,-0.0201924599029056,1.19363915993159e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SNU13,NHP2-like protein 1,40116,0.0351161183463038,0.00664580120413634,0.0220903479861966,0.048141888706411,1.28858178851195e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GLYR1,Putative oxidoreductase GLYR1,40451,0.0325430981057922,0.00616690300282578,0.0204559682202537,0.0446302279913308,1.33714532984732e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LUZP2,Leucine zipper protein 2,40451,0.0253375201535384,0.00481786736530415,0.0158945001175423,0.0347805401895345,1.47437580921722e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DSG3,Desmoglein-3,42651,0.0193361527612918,0.00368347180548222,0.0121165480225467,0.0265557575000369,1.54885528118574e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.0159189526490049,0.00303292951066422,-0.0218634944899068,-0.00997441080810307,1.55476032803868e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0183889007970448,0.00350942654929247,0.0115104247604316,0.0252673768336581,1.6367114212522e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0217319085201152,0.00415268223634119,-0.029871165703344,-0.0135926513368865,1.69556505498634e-07
NMR metabolomics,X23408.Triglycerides in VLDL,KEL,Kell blood group glycoprotein,42311,0.0198706460367973,0.0038004457261596,0.0124217724135245,0.0273195196600701,1.73513045349098e-07
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0423371290405003,0.00810273513235537,0.0264557681810838,0.0582184898999169,1.76777427555806e-07
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0234975446785254,0.0044975031244935,0.0146824385545181,0.0323126508025326,1.77666109957588e-07
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE1,Ribonuclease pancreatic,40532,0.0144566060396274,0.00276806416665037,0.00903120027299271,0.0198820118062622,1.79514165056269e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SPTLC1,Serine palmitoyltransferase 1,40483,0.0211975586473771,0.00405918875917962,0.0132415486793851,0.0291535686153692,1.80035701895705e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PON1,Serum paraoxonase/arylesterase 1,40532,-0.0149019463279717,0.00286227428036818,-0.0205120039174933,-0.00929188873845009,1.95982617239324e-07
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0181581519346512,0.0034888965901719,0.0113199146179143,0.0249963892513881,1.97868249612158e-07
NMR metabolomics,X23408.Triglycerides in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0214656783176264,0.00412725951332188,-0.0295551069637373,-0.0133762496715155,2.01191736097009e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA1,Annexin A1,40235,0.0226045745372291,0.00435153016158429,0.0140755754205239,0.0311335736539343,2.08786624865502e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0223368696286228,0.00430078412467327,-0.0307664065129824,-0.0139073327442631,2.09207364385632e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0234776044352337,0.00452934659122397,0.0146000851164348,0.0323551237540327,2.20973477512069e-07
NMR metabolomics,X23408.Triglycerides in VLDL,EGFLAM,Pikachurin,40449,0.0168232560088833,0.00324854782799596,0.0104561022660112,0.0231904097517554,2.27296016362248e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LIF,Leukemia inhibitory factor,42311,0.0279108793827661,0.00539019441684087,0.017346098325758,0.0384756604397742,2.27493697369277e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CLGN,Calmegin,40182,0.0252485992981661,0.00487579150018873,0.0156920479577962,0.0348051506385361,2.2780578196465e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0190836088283548,0.00369208907123121,0.0118471142487416,0.026320103407968,2.39013438541903e-07
NMR metabolomics,X23408.Triglycerides in VLDL,AGER,Advanced glycosylation end product-specific receptor,42587,0.0227389250093334,0.00439963480034443,0.0141156408006583,0.0313622092180085,2.39546112591121e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0214327112148319,0.00415691947020386,0.0132851490532324,0.0295802733764315,2.56056006145723e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1,Macrophage colony-stimulating factor 1,42676,0.015024460765817,0.00291565088550936,0.00930978503021867,0.0207391365014154,2.59920104688647e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0209278103907997,0.00406092258259514,0.0129684021289133,0.0288872186526862,2.60160338090267e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PADI4,Protein-arginine deiminase type-4,42292,0.0387830418151229,0.00753053714867349,0.0240231890037228,0.0535428946265229,2.64121225921269e-07
NMR metabolomics,X23408.Triglycerides in VLDL,RAB37,Ras-related protein Rab-37,42370,0.043573502283978,0.00847374008628744,0.0269649717148546,0.0601820328531014,2.75461588825318e-07
NMR metabolomics,X23408.Triglycerides in VLDL,AFAP1,Actin filament-associated protein 1,40283,0.044690977431733,0.00869335299089186,0.027652005569585,0.0617299492938811,2.78200094127409e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO2,Roundabout homolog 2,42711,0.0125928107584991,0.00245164949638611,0.00778757774558232,0.0173980437714159,2.8385044018062e-07
NMR metabolomics,X23408.Triglycerides in VLDL,AREG,Amphiregulin,42587,0.0228986170693458,0.00445947244132501,0.0141580510843488,0.0316391830543429,2.86365577920714e-07
NMR metabolomics,X23408.Triglycerides in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0151649877465095,0.00296073889373767,0.00936193951478366,0.0209680359782353,3.0643775318058e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL9,C-X-C motif chemokine 9,42676,0.0362278955008427,0.00709658373219416,0.0223185913857421,0.0501371996159432,3.35341384241076e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PRUNE2,Protein prune homolog 2,40302,0.0160792236408647,0.00315373416381122,0.00989790467979472,0.0222605426019347,3.4804649786378e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.0125981900268888,0.00247261402189446,0.00775186654397569,0.017444513509802,3.53353174361217e-07
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A2,Collagen alpha-2(IX) chain,40302,0.0239033420738319,0.00469236598875199,0.014706304735878,0.0331003794117858,3.56169392062183e-07
NMR metabolomics,X23408.Triglycerides in VLDL,APOB,Apolipoprotein B-100,40532,0.01190236949585,0.00233708025917105,0.0073216921878747,0.0164830468038252,3.58410986984715e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0161212914655403,0.00318322819712861,0.00988216419916823,0.0223604187319124,4.15069888139377e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0229027202760474,0.00452501473182387,0.0140336914016727,0.0317717491504222,4.21892779972514e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM26,Tripartite motif-containing protein 26,40080,0.0298516944066346,0.0059007203581562,0.0182862825046484,0.0414171063086207,4.28352815736482e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0188998065278642,0.00373958225014822,0.0115702253175737,0.0262293877381547,4.38312627901837e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0465737961102854,0.00924757894203873,0.0284485413838895,0.0646990508366813,4.80702180205711e-07
NMR metabolomics,X23408.Triglycerides in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0143874754957819,0.00285883022286702,0.00878416825896254,0.0199907827326012,4.89992235166585e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DDI2,Protein DDI1 homolog 2,40283,0.0412104057309075,0.00820291024872467,0.0251327016434071,0.0572881098184079,5.14278180433172e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CLIC5,Chloride intracellular channel protein 5,40182,-0.0166877060756928,0.00332230571275601,-0.0231994252726946,-0.0101759868786911,5.16889188486567e-07
NMR metabolomics,X23408.Triglycerides in VLDL,THBS2,Thrombospondin-2,42611,0.0204319838942116,0.00406864119821924,0.0124574471457019,0.0284065206427213,5.18414398234999e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAP,Cartilage-associated protein,40182,0.0252302680263714,0.00503027800452829,0.015370923137496,0.0350896129152469,5.36717324682672e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MUC16,Mucin-16,42587,0.100732499038889,0.0201086159537354,0.0613196117695673,0.14014538630821,5.529003342483e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.021087457119966,0.00420949437850184,0.0128368481381024,0.0293380661018296,5.54001407246781e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GZMB,Granzyme B,42594,0.0348366237643216,0.00695582196248218,0.0212032127178565,0.0484700348107867,5.56207400707262e-07
NMR metabolomics,X23408.Triglycerides in VLDL,B2M,Beta-2-microglobulin,40539,0.0164211823136985,0.00328817646388347,0.00997635644448689,0.0228660081829101,6.00185303290648e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0204488155591207,0.00409748767679284,-0.0284798914056347,-0.0124177397126068,6.1097905769148e-07
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN1,Nectin-1,40199,0.0171135031855196,0.00343022876809019,0.0103902548000628,0.0238367515709764,6.16115338775799e-07
NMR metabolomics,X23408.Triglycerides in VLDL,STX3,Syntaxin-3,40483,0.020262890649349,0.0040706539982743,0.0122844088127314,0.0282413724859667,6.52614642290297e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0147342296558949,0.00296453693483004,0.00892373726362797,0.0205447220481617,6.79019964644878e-07
NMR metabolomics,X23408.Triglycerides in VLDL,OLFM4,Olfactomedin-4,39870,0.0642160754146291,0.0129303269902615,0.0388726345137164,0.0895595163155417,6.9293303089648e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SATB1,DNA-binding protein SATB1,40482,0.015245611779567,0.00307208399437108,0.00922432715059966,0.0212668964085343,7.05603023367091e-07
NMR metabolomics,X23408.Triglycerides in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.039556033328799,0.00798616688193754,0.0239031462402015,0.0552089204173966,7.41392484485723e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0556617417610814,0.011240598165846,0.0336301693560232,0.0776933141661396,7.4413640480385e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IL18BP,Interleukin-18-binding protein,42689,0.0167484402095079,0.00338598611657655,0.0101119074210179,0.0233849729979979,7.65089268446802e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ECM1,Extracellular matrix protein 1,40269,0.0193327197660392,0.00391401841326821,0.0116612436760335,0.0270041958560449,7.95268917863414e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0413380524157044,0.00837359470842228,0.0249258067871968,0.0577502980442121,8.06275703373232e-07
NMR metabolomics,X23408.Triglycerides in VLDL,C4BPB,C4b-binding protein beta chain,42679,0.0208181734560898,0.00421790415194052,0.0125510813182864,0.0290852655938933,8.08313764690425e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CD300E,CMRF35-like molecule 2,42677,0.0223303395309985,0.0045290853254435,0.0134533322931292,0.0312073467688677,8.30251402133733e-07
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP3,Dual specificity protein phosphatase 3,42311,0.0441736492683138,0.00896847739268665,0.0265954335786479,0.0617518649579796,8.51988287864422e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0148540793534682,0.00302795824178246,-0.0207888775073619,-0.00891928119957462,9.42123583964186e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0296228376390498,0.00604875998033407,0.017767268077595,0.0414784072005046,9.82972090316811e-07
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0515390102918306,0.0105363175387574,0.0308878279158662,0.0721901926677951,1.01467736651145e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KIF1C,Kinesin-like protein KIF1C,40116,0.0184141781282789,0.00376871801395486,0.0110274908209274,0.0258008654356304,1.04335406897577e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CHGA,Chromogranin-A,40527,-0.0501207288285572,0.0102670324807369,-0.0702441124908015,-0.0299973451663129,1.06601170588619e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PROCR,Endothelial protein C receptor,40116,-0.0178953652496682,0.00366693722760121,-0.0250825622157665,-0.0107081682835698,1.07479610140273e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0361806179597614,0.00741665619470543,-0.050717264101384,-0.0216439718181388,1.08469149223358e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GBA,Lysosomal acid glucosylceramidase,40182,0.028351142289002,0.00582021293535276,0.0169435249357106,0.0397587596422934,1.12497100659575e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1,Programmed cell death protein 1,42689,0.022943138523856,0.00472015809766413,0.0136916286524343,0.0321946483952777,1.18304564737637e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KLK6,Kallikrein-6,42656,0.0161115235836954,0.00332292102744656,0.00959859836990012,0.0226244487974907,1.25723290327118e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BLVRB,Flavin reductase,42611,0.0333508730483455,0.00688682972046447,0.0198526867962352,0.0468490593004559,1.29513529705203e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0129685787572682,0.00267899306349245,0.00771775235282296,0.0182194051617134,1.30995770452944e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SHISA5,Protein shisa-5,40527,0.0141163091709048,0.00291836749869106,0.00839630887347033,0.0198363094683393,1.33509991039759e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FUCA1,Tissue alpha-L-fucosidase,42721,0.042578363273268,0.00881111766240041,0.0253085726549632,0.0598481538915728,1.3641481082245e-06
NMR metabolomics,X23408.Triglycerides in VLDL,UROS,Uroporphyrinogen-III synthase,40182,0.0344181336589966,0.00712401039170395,0.0204550732912569,0.0483811940267363,1.37486851189614e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RPA2,Replication protein A 32 kDa subunit,40199,0.016029169138071,0.0033227756521026,0.0095165288599499,0.0225418094161921,1.42573416732757e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0178165454271727,0.00369811285757715,0.0105682442263215,0.025064846628024,1.46783486851729e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PROK1,Prokineticin-1,42594,0.0278904474385287,0.00579227853882116,0.0165375815024392,0.0392433133746182,1.48727840877292e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0134562096002893,0.00279693333621377,0.00797422026131028,0.0189381989392682,1.51783088264425e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CA7,Carbonic anhydrase 7,40302,-0.0177593694858964,0.00369546768203528,-0.0250024861426855,-0.0105162528291072,1.56217536973555e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GSTT2B,Glutathione S-transferase theta-2B,40483,0.120745708104816,0.0251430382352688,0.0714653531636888,0.170026063045943,1.58827924244773e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL6,Fc receptor-like protein 6,42594,0.0351106548664275,0.00734561315344197,0.0207132530856813,0.0495080566471738,1.77322172412074e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN8,Tetraspanin-8,40449,0.051322117425253,0.0107409029948421,0.0302699475553625,0.0723742872951435,1.79112274163171e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KLK8,Kallikrein-8,42154,0.0187174971739399,0.00392122214068895,0.0110319017781895,0.0264030925696902,1.83135717105909e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PZP,Pregnancy zone protein,40539,0.0252755626835741,0.00533842343566358,0.0148122527496735,0.0357388726174748,2.22089907846514e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PRTG,Protogenin,42721,0.0123456576824173,0.00260787535261715,0.00723422199128765,0.0174570933735469,2.22379465164981e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CD59,CD59 glycoprotein,42130,0.0123617595448685,0.00262056874882565,0.00722544479717022,0.0174980742925668,2.41607478135195e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0200687473113803,0.00425729211095868,0.0117244547739013,0.0284130398488593,2.45829101086425e-06
NMR metabolomics,X23408.Triglycerides in VLDL,STX5,Syntaxin-5,40199,0.0202909911448947,0.00430532998601493,0.0118525443723054,0.0287294379174839,2.47096832935514e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD1,Leiomodin-1,40482,-0.0176580741540436,0.00374982527533909,-0.0250077316937082,-0.010308416614379,2.51851932515428e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CKAP4,Cytoskeleton-associated protein 4,42713,0.0142722563761099,0.00303204519606551,0.00832944779182147,0.0202150649603983,2.5371119414526e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0181193991385132,0.00385109427845744,0.0105712543527366,0.0256675439242898,2.5698127011639e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GSN,Gelsolin,40488,-0.00953880907543985,0.00203260399188728,-0.0135227128995389,-0.00555490525134079,2.72522648366006e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0216389038931174,0.00461872170252428,0.0125862093561698,0.030691598430065,2.83225204973421e-06
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0214368858261254,0.00459150952564687,0.0124375271558575,0.0304362444963933,3.06037634366666e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ARG1,Arginase-1,42488,0.0252835979975015,0.00542651872182292,0.0146476213027286,0.0359195746922744,3.2041655743739e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TK1,"Thymidine kinase, cytosolic",40302,0.022181281331722,0.00476256517580372,0.0128466535871467,0.0315159090762973,3.23906710951302e-06
NMR metabolomics,X23408.Triglycerides in VLDL,OSM,Oncostatin-M,42534,0.0341155651291674,0.00733027401969355,0.019748228050568,0.0484829022077667,3.28588606732764e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.0157495484714056,0.0033859569400494,0.00911307286890877,0.0223860240739024,3.32786131621878e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CLU,Clusterin,40539,0.0153558261439796,0.00330428806332129,0.00887942153986988,0.0218322307480893,3.4019141440178e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH1,Neurexophilin-1,42311,0.0189449017951835,0.00407902875301869,0.0109500054392669,0.0269397981511002,3.44272534320571e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2,Ataxin-2,40136,0.0537693308924949,0.0115854247653845,0.0310618983523413,0.0764767634326486,3.50554920139381e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0235145858743549,0.00507801035800695,0.0135616855726613,0.0334674861760485,3.68667127699163e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0136208761228936,0.00294219746137763,0.00785416909859346,0.0193875831471938,3.70082576988532e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SPOCK1,Testican-1,42495,0.0124467500984546,0.00269941968961975,0.00715588750679986,0.0177376126901093,4.04666924896402e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CPE,Carboxypeptidase E,42588,-0.0185592914872195,0.00404504439952622,-0.0264875785102909,-0.0106310044641481,4.51238543306092e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF7,SLAM family member 7,42594,-0.0285502361644898,0.00623604198677096,-0.0407728784585608,-0.0163275938704187,4.73072483702313e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP1,Dipeptidase 1,42476,-0.0239778355697353,0.00523788481348283,-0.0342440898041616,-0.0137115813353089,4.74221330481923e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM1,Neural cell adhesion molecule 1,42689,-0.0144918500258187,0.00316774320237857,-0.0207006267024807,-0.00828307334915666,4.80878545706933e-06
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0164344261595998,0.00359901737425112,0.00938035210606764,0.023488500213132,5.01519875069371e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LEO1,RNA polymerase-associated protein LEO1,40482,0.0155519175664248,0.00341199483920114,0.00886440768159059,0.0222394274512591,5.21823107526666e-06
NMR metabolomics,X23408.Triglycerides in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0266080450660907,0.00584039896781583,0.0151608630891717,0.0380552270430097,5.2720187414596e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0161855662397033,0.00355858921030505,0.00921073138750538,0.0231604010919012,5.45484050075526e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0513028593582117,0.0112847735795222,0.0291847031423483,0.0734210155740751,5.52063713130466e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB2,Lamin-B2,40483,0.0136517917434494,0.00300642902967227,0.00775919084529176,0.019544392641607,5.66036534571009e-06
NMR metabolomics,X23408.Triglycerides in VLDL,HGFAC,Hepatocyte growth factor activator,40428,0.0131895850196209,0.00290634291530149,0.00749315290562999,0.0188860171336119,5.7323599931432e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CA12,Carbonic anhydrase 12,42587,-0.0157274718524612,0.00346863410496781,-0.0225259946981981,-0.00892894900672433,5.83244035901945e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CLASP1,CLIP-associating protein 1,40080,0.0345162578179383,0.00762583637471988,0.0195696185234873,0.0494628971123893,6.06832625341198e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN2,Prefoldin subunit 2,42311,0.026255784300198,0.00580417151370445,0.0148796081333373,0.0376319604670587,6.13284592332022e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0194953809143094,0.00431490544007606,0.0110381662517603,0.0279525955768584,6.29264265185923e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BST2,Bone marrow stromal antigen 2,42711,0.0241442665530772,0.00535515413882886,0.0136481644409726,0.0346403686651818,6.58044139789574e-06
NMR metabolomics,X23408.Triglycerides in VLDL,GPC1,Glypican-1,42721,0.0140832028316623,0.00313231905161768,0.00794385749049166,0.020222548172833,6.97882897780473e-06
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0303608081141855,0.00675295779204567,0.017125010841776,0.043596605386595,6.99766252367766e-06
NMR metabolomics,X23408.Triglycerides in VLDL,C1QA,Complement C1q subcomponent subunit A,42701,-0.010357068354552,0.00230821760101762,-0.0148811748525465,-0.00583296185655746,7.28155736660644e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DCC,Netrin receptor DCC,40182,0.0109212036271441,0.00243424217486559,0.00615008896440752,0.0156923182898806,7.31414914708653e-06
NMR metabolomics,X23408.Triglycerides in VLDL,VIM,Vimentin,42357,0.0544217012718914,0.0121401141108775,0.0306270776145715,0.0782163249292114,7.42923020703678e-06
NMR metabolomics,X23408.Triglycerides in VLDL,VCAN,Versican core protein,42711,-0.014349231438258,0.00320228487446964,-0.0206257097922185,-0.0080727530842975,7.49268931917019e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0192975678435606,0.00430872318436813,-0.0277426652849222,-0.0108524704021991,7.58539514996077e-06
NMR metabolomics,X23408.Triglycerides in VLDL,S100A13,Protein S100-A13,40199,0.0167092417302001,0.00373119203053091,0.00939610535035951,0.0240223781100407,7.6012329486528e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.0140381330437992,0.00314163484979252,0.00788052873820583,0.0201957373493925,7.94587561211759e-06
NMR metabolomics,X23408.Triglycerides in VLDL,STC2,Stanniocalcin-2,42591,0.0116383894296052,0.00260749164037734,0.00652770581446559,0.0167490730447448,8.13114831831588e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RAB39B,Ras-related protein Rab-39B,40116,0.0432432285369787,0.00969043290727091,0.0242499800387277,0.0622364770352296,8.18327888629112e-06
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP5,Vesicle-associated membrane protein 5,42357,0.0258790629850965,0.00581068290938721,0.0144901244826975,0.0372680014874954,8.50966754571171e-06
NMR metabolomics,X23408.Triglycerides in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0110798270341075,0.00248847022376351,0.00620242539553105,0.015957228672684,8.55753438246075e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0339859501398444,0.00764396214775264,0.0190037843302492,0.0489681159494396,8.8137066456749e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FOSB,Protein fosB,42311,0.0178711105548088,0.00402077599314743,0.00999038960823985,0.0257518315013778,8.87399423702476e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0184182704622708,0.00414963327378073,0.0102849892456605,0.026551551678881,9.13125953996523e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LCP1,Plastin-2,40527,0.022326323861749,0.00502986723992744,0.0124677840714913,0.0321848636520068,9.13379068138903e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM5,Intercellular adhesion molecule 5,42636,0.0211587417654717,0.00480251230901238,0.0117458176398075,0.030571665891136,1.06226852968807e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ALPI,Intestinal-type alkaline phosphatase,40199,0.0579284734098661,0.0131530612828975,0.0321484732953869,0.0837084735243452,1.07186849136113e-05
NMR metabolomics,X23408.Triglycerides in VLDL,VIT,Vitrin,40511,0.0177591006491776,0.00404043440150396,0.00983984922222984,0.0256783520761254,1.11605258797595e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FMR1,Synaptic functional regulator FMR1,42346,0.0163377939851409,0.00371750834861242,0.00905147762186061,0.0236241103484213,1.11731285930926e-05
NMR metabolomics,X23408.Triglycerides in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0318770691202341,0.00725483329776884,0.0176575958566072,0.046096542383861,1.12370971700692e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BRD1,Bromodomain-containing protein 1,40302,-0.0140789440070782,0.00321037506942263,-0.0203712791431465,-0.00778660887100985,1.16811054457637e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN10,Ataxin-10,42311,0.033129998677876,0.0075682825975859,0.0182961647866076,0.0479638325691443,1.20988907522363e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0165034831741407,0.00377163042572641,-0.0238958788085645,-0.00911108753971693,1.21958238681882e-05
NMR metabolomics,X23408.Triglycerides in VLDL,XG,Glycoprotein Xg,42734,0.0158063461123998,0.00361323962907282,0.00872439643941704,0.0228882957853825,1.2258541979765e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PMS1,PMS1 protein homolog 1,40182,0.0238324577025967,0.00546046388770018,0.0131299484827043,0.034534966922489,1.28549865840163e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0204250408926621,0.00468035868715405,0.0112515378658402,0.029598543919484,1.28875805040221e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.0123856193655572,0.0028477784190704,-0.0179672650669352,-0.00680397366417926,1.37815776759579e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IL1B,Interleukin-1 beta,42293,0.0258986525425464,0.00596029279631314,0.0142164786617727,0.0375808264233202,1.40198175466876e-05
NMR metabolomics,X23408.Triglycerides in VLDL,JAM2,Junctional adhesion molecule B,42711,0.0129151870637686,0.00297851271303602,0.00707730214621799,0.0187530719813192,1.46070135440105e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AGT,Angiotensinogen,40532,0.0108522170210218,0.00250265878278046,0.00594700580677206,0.0157574282352715,1.46169286926691e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB2A2,Mammaglobin-A,40116,-0.0144439880505165,0.00333747046764831,-0.0209854301671071,-0.00790254593392578,1.51929456226289e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS1,Nephrin,40199,0.015227008864342,0.00352496775362537,0.00831807206723632,0.0221359456614478,1.57570160137466e-05
NMR metabolomics,X23408.Triglycerides in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00907281871448515,0.00211723188031702,-0.0132225931999065,-0.0049230442290638,1.83816887289636e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0229296543690613,0.00535532234297674,0.0124332225768269,0.0334260861612957,1.87044415688641e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL14,C-X-C motif chemokine 14,42370,0.0253393825535877,0.00592254056531764,0.0137312030455651,0.0369475620616103,1.89514751534335e-05
NMR metabolomics,X23408.Triglycerides in VLDL,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0363613898768769,0.00850976948945969,0.0196822416775359,0.0530405380762179,1.94579975653852e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DLL4,Delta-like protein 4,40223,0.0384287672771817,0.00899966144225131,0.0207894308503692,0.0560681037039943,1.9708867358466e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0245518723512306,0.00576314831821211,0.0132561016475349,0.0358476430549263,2.05710843192164e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.017847021324431,0.00420077279365941,0.00961350664885854,0.0260805360000034,2.16649160048555e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0118546130186554,0.00279957038753597,-0.0173417709782259,-0.00636745505908494,2.30969781074078e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD14,Monocyte differentiation antigen CD14,42416,0.0184949451888043,0.00437364203775873,0.00992260679479716,0.0270672835828114,2.36596376187703e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RPS10,40S ribosomal protein S10,40116,-0.0180526976093584,0.00427477755966339,-0.0264312616262986,-0.00967413359241816,2.42947049031186e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD9,Enhancer of filamentation 1,40199,0.0146648413291485,0.00349253618397417,0.0078194704085591,0.0215102122497378,2.70314844416518e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.014743717247916,0.00351639309238559,0.00785158678684028,0.0216358477089918,2.77619913110339e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LY9,T-lymphocyte surface antigen Ly-9,42443,0.013451647409388,0.00321655651142067,0.00714719664700352,0.0197560981717725,2.90811860694936e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLC,Galectin-10,42611,-0.0287025623324743,0.00689739707216697,-0.0422214605939216,-0.0151836640710271,3.18328207522927e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0158699599524164,0.00381885312344773,-0.0233549120743739,-0.00838500783045885,3.26339945038173e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS4,Galectin-4,42618,0.0246058767185041,0.00592373392332709,0.0129953582287831,0.0362163952082252,3.29053893407919e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0293814505430976,0.00708496921489451,0.0154949108819043,0.0432679902042908,3.3934736496745e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IL34,Interleukin-34,42292,0.0159003079882349,0.00383470225995353,0.00838429155872597,0.0234163244177438,3.39833176335197e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SOD3,Extracellular superoxide dismutase,40532,-0.0253706741961731,0.00612184823108739,-0.0373694967291043,-0.0133718516632418,3.4335473618945e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK2,Protein AHNAK2,40223,0.0131361849827898,0.0031717766569456,0.00691950273517641,0.0193528672304031,3.4748303245347e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB6,Ephrin type-B receptor 6,42476,0.0145899045586574,0.0035231156365592,0.00768459791100139,0.0214952112063135,3.47638988765277e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0146960369701318,0.0035532231587059,-0.0216603543611953,-0.0077317195790682,3.55609615621082e-05
NMR metabolomics,X23408.Triglycerides in VLDL,HSBP1,Heat shock factor-binding protein 1,40223,0.0409963834467368,0.00991526533991977,0.021562463380494,0.0604303035129795,3.58091783422861e-05
NMR metabolomics,X23408.Triglycerides in VLDL,KLK11,Kallikrein-11,42543,0.0141788974102121,0.00343227588282989,0.00745163667986553,0.0209061581405587,3.63313419045783e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ERC2,ERC protein 2,40182,0.0329294632937124,0.00797111032651451,0.017306087053744,0.0485528395336809,3.63703978304056e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PREB,Prolactin regulatory element-binding protein,42370,0.012767887583866,0.00309208292619411,0.00670740504852556,0.0188283701192065,3.66241256830422e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SAFB2,Scaffold attachment factor B2,40482,0.0118972515108475,0.00288227253320948,0.00624799734575693,0.0175465056759381,3.68990429883554e-05
NMR metabolomics,X23408.Triglycerides in VLDL,WIF1,Wnt inhibitory factor 1,42721,-0.0148873206956531,0.00361380622715882,-0.0219703809008844,-0.00780426049042179,3.81842018662311e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MST1,Hepatocyte growth factor-like protein,40370,0.0282017975761161,0.00685947158685018,0.0147572332658898,0.0416463618863425,3.96137996665049e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN8,Septin-8,40470,0.0139779804128253,0.00340449523045409,0.00730516976113533,0.0206507910645154,4.0585996289679e-05
NMR metabolomics,X23408.Triglycerides in VLDL,THBS4,Thrombospondin-4,42652,0.0196748567949131,0.00479347456855829,0.0102796466405389,0.0290700669492874,4.07565351519972e-05
NMR metabolomics,X23408.Triglycerides in VLDL,KLK14,Kallikrein-14,42721,-0.0202678798259815,0.00494232493608609,-0.0299548367007102,-0.0105809229512527,4.13989691433439e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD109,CD109 antigen,42611,-0.0144556459913623,0.00352737770492569,-0.0213693062930167,-0.00754198568970797,4.18954287508717e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0162772885404078,0.00398192061815952,-0.0240818529520005,-0.00847272412881517,4.38585501000731e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PGA4,Pepsin A-4,40532,0.0345413119468976,0.00845613342261538,0.0179672904385715,0.0511153334552238,4.44249895045706e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PRL,Prolactin,42711,-0.0320246370080525,0.00784175501394239,-0.0473944768353796,-0.0166547971807254,4.45487176544603e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD48,CD48 antigen,42654,0.0131765641580653,0.0032513160419049,0.00680398471593171,0.0195491436001989,5.09173887807982e-05
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0208372051654103,0.00515393337315275,0.010735495754031,0.0309389145767897,5.31404119829074e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DGCR6,Protein DGCR6,40136,0.0187258774217731,0.0046511958552453,0.00960953354549233,0.0278422212980539,5.7107827894607e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RCC1,Regulator of chromosome condensation,40451,0.0220814604581777,0.00550598931923245,0.0112897213924821,0.0328731995238733,6.09962130607208e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD7,T-cell antigen CD7,40166,0.0187934744097369,0.00468760613655355,0.0096057663820919,0.0279811824373818,6.13323246739574e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EBI3_IL27,Interleukin-27,42689,-0.0129502068477873,0.00323342893239948,-0.0192877275552902,-0.00661268614028428,6.23234117948508e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.016103525734991,0.00402067520074999,0.00822300234152099,0.023984049128461,6.2379877027588e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0215291765110242,0.00538218979538458,0.0109800845120704,0.0320782685099779,6.37366988057028e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0136397618235291,0.00340995237348078,-0.0203232684755514,-0.00695625517150677,6.37638302951991e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0275233657759571,0.00691537340055754,0.0139692339108643,0.0410774976410499,6.93401715460979e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0234148465365681,0.00589023148525131,0.0118699928254756,0.0349597002476607,7.07595692757358e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.0120362510783374,0.00303794995436594,0.00608186916778014,0.0179906329888946,7.4809652063362e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH17,Protocadherin-17,42636,0.0154274174633664,0.00390047502271685,0.00778248641884138,0.0230723485078914,7.68416878712468e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CASP1,Caspase-1,42311,0.0285665846642618,0.00724630981800501,0.0143638174209719,0.0427693519075516,8.11483515578248e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LXN,Latexin,42461,-0.0280044481565031,0.00710397899752231,-0.0419282469916468,-0.0140806493213593,8.11929293090953e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MMP13,Collagenase 3,42311,-0.0137747695470199,0.00349807545992498,-0.0206309974484729,-0.00691854164556694,8.26525677854536e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH12,Protocadherin-12,40482,0.0106588222679215,0.0027069577001686,0.00535318517559103,0.015964459360252,8.28072028839051e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0107876107461965,0.00274613140524947,-0.0161700283004855,-0.00540519319190759,8.60790415168029e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.0116619575695906,0.0029786371012559,0.00582382885112903,0.0175000862880522,9.08594382774438e-05
NMR metabolomics,X23408.Triglycerides in VLDL,QSOX1,Sulfhydryl oxidase 1,40342,0.01779604283043,0.00454680651370218,0.00888430206357377,0.0267077835972863,9.13326947394283e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CALB1,Calbindin,42587,0.018704734225625,0.00478024139623097,0.00933546108901233,0.0280740073622377,9.16350264181048e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD99,CD99 antigen,42611,-0.00828814888307006,0.00211868662232742,-0.0124407746628318,-0.00413552310330833,9.20137578863699e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.0165514850570346,0.0042315575024421,0.00825763235224805,0.0248453377618211,9.21949094261958e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NDRG1,Protein NDRG1,42311,0.0266094758334964,0.00682971080046001,0.0132232426645948,0.0399957090023981,9.82253336802857e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MILR1,Allergin-1,42370,-0.0210301848241026,0.00540333488138359,-0.0316207211916145,-0.0104396484565908,9.98799841159119e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF21,Immunoglobulin superfamily member 21,40223,0.0161351603915665,0.00415576900196274,0.00798985314771951,0.0242804676354134,0.000103951076767927
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0103965633493506,0.00267900283173518,0.00514571779914967,0.0156474088995516,0.000104628317753416
NMR metabolomics,X23408.Triglycerides in VLDL,NRTN,Neurturin,42370,0.0199822412926017,0.00516341691865827,0.00986194413203147,0.0301025384531719,0.000109375767912154
NMR metabolomics,X23408.Triglycerides in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0265232237845644,0.00685508254039991,-0.0399591855637482,-0.0130872620053805,0.000109732804449908
NMR metabolomics,X23408.Triglycerides in VLDL,PKD1,Polycystin-1,40511,0.0108123547507989,0.00281460207382435,0.0052957346861032,0.0163289748154947,0.000122941447938539
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0178495891053875,0.0046571806588037,0.00872151501413227,0.0269776631966428,0.000127432634943241
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR5,Complement factor H-related protein 5,40382,0.0169725416013359,0.00443038787840894,0.00828898135965434,0.0256561018430174,0.000128353245667788
NMR metabolomics,X23408.Triglycerides in VLDL,CD200,OX-2 membrane glycoprotein,42594,-0.0109925241545738,0.00287837403590157,-0.0166341372649409,-0.00535091104420674,0.000134595192056739
NMR metabolomics,X23408.Triglycerides in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0164165213207235,0.00430047896106515,0.00798758255703579,0.0248454600844112,0.000135604394054672
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0256489246110605,0.0067283569383518,0.012461345011891,0.03883650421023,0.000138543971968184
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX2,Peroxiredoxin-2,40333,0.0249802007721737,0.00655418683734464,0.0121339945709782,0.0378264069733692,0.0001389624903587
NMR metabolomics,X23408.Triglycerides in VLDL,CST7,Cystatin-F,42642,0.0373731129614647,0.00982140283393086,0.0181231634069602,0.0566230625159692,0.000142275886451048
NMR metabolomics,X23408.Triglycerides in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0155565364842542,0.00409620598592261,-0.0235851002166625,-0.00752797275184585,0.00014678191647097
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0147636866516837,0.00389083834971607,0.00713764348624023,0.0223897298171272,0.000148618561000641
NMR metabolomics,X23408.Triglycerides in VLDL,ALCAM,CD166 antigen,42794,0.0078140260962631,0.00205943303150663,0.0037775373545101,0.0118505148380161,0.000148725722210039
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI1,Neuroserpin,40267,0.0119904898422071,0.00316633200632735,0.00578447910980549,0.0181965005746087,0.000153362819053062
NMR metabolomics,X23408.Triglycerides in VLDL,CST1,Cystatin-SN,39042,0.0436553722905697,0.011547918248423,0.0210214525236607,0.0662892920574787,0.000157522066321678
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00853559905478418,0.00225814923473035,0.00410962655471269,0.0129615715548557,0.000157695746940203
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0193547061460833,0.0051330399245749,0.00929394789391651,0.0294154643982501,0.000163559406404038
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP3,Cysteine-rich secretory protein 3,40439,-0.0107408893329,0.00286142363262082,-0.0163492796528368,-0.00513249901296318,0.000175129616464461
NMR metabolomics,X23408.Triglycerides in VLDL,CLPS,Colipase,42590,0.028635329314641,0.00764163562025016,0.0136577234989506,0.0436129351303313,0.00017951476410607
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0114993112578921,0.0030751764956913,0.0054719653263371,0.017526657189447,0.000185227584938051
NMR metabolomics,X23408.Triglycerides in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0213358874688714,0.00570669390863802,0.0101507674079409,0.0325210075298019,0.000185853068235415
NMR metabolomics,X23408.Triglycerides in VLDL,MKI67,Proliferation marker protein Ki-67,40199,0.0151775996345745,0.00406352095966693,0.00721309855362734,0.0231421007155217,0.000188598712606227
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD9,COMM domain-containing protein 9,40451,0.0155388559743065,0.00416489907392242,0.00737565378941856,0.0237020581591944,0.000191728606610554
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11D,Transmembrane protease serine 11D,40470,0.015999875449561,0.00430055373201818,0.00757079013480538,0.0244289607643166,0.000199855748530504
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0130092791746222,0.00349841686749892,-0.0198661762349201,-0.00615238211432436,0.000201130708316366
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL1,Chordin-like protein 1,42654,0.0125939069192683,0.00338821808972718,0.00595299946340306,0.0192348143751336,0.000202442998081464
NMR metabolomics,X23408.Triglycerides in VLDL,YY1,Transcriptional repressor protein YY1,40199,0.0109937393906024,0.0029586226277286,0.00519483904025431,0.0167926397409504,0.000203540563517209
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5,Eukaryotic translation initiation factor 5,40116,0.0171722222005727,0.00462512198514259,0.0081069831096932,0.0262374612914522,0.000205986380263191
NMR metabolomics,X23408.Triglycerides in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0247036914093846,0.0066543963127045,0.0116610746364838,0.0377463081822854,0.000206297946909821
NMR metabolomics,X23408.Triglycerides in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0147612033153197,0.00397850496699924,0.00696333358000115,0.0225590730506382,0.000208060117103437
NMR metabolomics,X23408.Triglycerides in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0159473774813013,0.00430614319579753,0.00750733681753818,0.0243874181450645,0.000213737868466318
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN2,Calsyntenin-2,42754,-0.0153715556272204,0.00415688540809813,-0.0235190510270928,-0.00722406022734809,0.00021828763858044
NMR metabolomics,X23408.Triglycerides in VLDL,GSTP1,Glutathione S-transferase P,42237,-0.0271913381286951,0.00735626311629614,-0.0416096138366355,-0.0127730624207547,0.000219615427833445
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.0111330887507718,0.00302493387454051,0.00520421835667239,0.0170619591448712,0.000233918843910431
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO4,Roundabout homolog 4,40223,-0.00698439232180416,0.00191102300575612,-0.0107299974130861,-0.00323878723052217,0.000258585289979312
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0221910302883626,0.0060871384776472,0.010260238872174,0.0341218217045511,0.000267836776174476
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3,Granulocyte colony-stimulating factor,42370,0.0186806172170019,0.00512472554746281,0.00863615514397477,0.028725079290029,0.000268218489080911
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.0120792972723331,0.00332176218069767,-0.0185899511465005,-0.00556864339816563,0.000277482753085891
NMR metabolomics,X23408.Triglycerides in VLDL,DNPEP,Aspartyl aminopeptidase,40483,0.021724170083767,0.0059915150118904,0.00998080066046182,0.0334675395070722,0.000289311270927059
NMR metabolomics,X23408.Triglycerides in VLDL,DSC2,Desmocollin-2,42488,-0.0134590032325031,0.00371553763718236,-0.0207414570013805,-0.00617654946362564,0.000293018276528667
NMR metabolomics,X23408.Triglycerides in VLDL,FGF5,Fibroblast growth factor 5,42370,-0.0124735398570213,0.00346785409855055,-0.0192705338901804,-0.00567654582386225,0.00032320524156497
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0105033422849623,0.00292204150866123,-0.0162305436419383,-0.00477614092798626,0.000326369359214783
NMR metabolomics,X23408.Triglycerides in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0688943999154801,0.0191849194862767,0.0312919577223779,0.106496842108582,0.000330502433861646
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.0214487311288977,0.00597338152177949,-0.0331565589115855,-0.00974090334620988,0.0003309460741874
NMR metabolomics,X23408.Triglycerides in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0265023007000995,0.00739598798662938,-0.0409984371538931,-0.0120061642463059,0.000340668695254408
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.0169902305482657,0.00475143435284474,0.00767741921669002,0.0263030418798414,0.000350382206749919
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX2,Neuronal pentraxin-2,40527,-0.0123054194249795,0.00344694617252636,-0.0190614339231311,-0.0055494049268278,0.000358529070019547
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G1B,Phospholipase A2,42782,-0.0170558844512558,0.00477987861614788,-0.0264244465389057,-0.00768732236360598,0.000360587441557173
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0171176591137077,0.00479740398958042,-0.0265205709332854,-0.00771474729413009,0.000360807441293372
NMR metabolomics,X23408.Triglycerides in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0242305385687758,0.00679592166426853,0.0109105321068095,0.0375505450307421,0.00036476546895343
NMR metabolomics,X23408.Triglycerides in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.020210672131226,0.00567575041528122,0.00908620131727477,0.0313351429451771,0.000371133189654399
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0100628826867853,0.00283363746701898,-0.0156168121221425,-0.00450895325142814,0.000384754492477166
NMR metabolomics,X23408.Triglycerides in VLDL,VWF,von Willebrand factor,42794,-0.0267250001500301,0.00752982152594441,-0.0414834503408812,-0.0119665499591791,0.000387675905537725
NMR metabolomics,X23408.Triglycerides in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.0105052580868637,0.00296515847858724,0.0046935474688327,0.0163169687048947,0.000397104359659252
NMR metabolomics,X23408.Triglycerides in VLDL,TG,Thyroglobulin,40451,-0.0428237331077486,0.0120868448292154,-0.0665139489730108,-0.0191335172424863,0.000397199287331885
NMR metabolomics,X23408.Triglycerides in VLDL,CDK1,Cyclin-dependent kinase 1,40080,0.0136837388560166,0.0038710570077972,0.00609646712073404,0.0212710105912991,0.000409647244266284
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.0120456804752645,0.00340986388001966,-0.0187290136801031,-0.00536234727042598,0.000413192131731183
NMR metabolomics,X23408.Triglycerides in VLDL,EP300,Histone acetyltransferase p300,40199,0.0114754560180947,0.0032490071529317,0.00510740199834853,0.0178435100378408,0.000414135755931848
NMR metabolomics,X23408.Triglycerides in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0230106173558356,0.00652273292114006,0.0102260608304011,0.0357951738812701,0.000420524284091111
NMR metabolomics,X23408.Triglycerides in VLDL,APOA4,Apolipoprotein A-IV,40539,0.0133178105933423,0.00378199686796494,0.00590509673213107,0.0207305244545536,0.00043100878188187
NMR metabolomics,X23408.Triglycerides in VLDL,YAP1,Transcriptional coactivator YAP1,40483,0.0106112384062833,0.00301771389242486,0.00469651917713059,0.016525957635436,0.000439295825950592
NMR metabolomics,X23408.Triglycerides in VLDL,DPP4,Dipeptidyl peptidase 4,42441,0.0103571059341781,0.00295562906382431,0.00456407296908247,0.0161501388992738,0.000459498738021687
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN2,Neuroligin-2,40136,-0.017687144056123,0.00504836230392405,-0.0275819341718141,-0.00779235394043187,0.000460950195811108
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC6A,C-type lectin domain family 6 member A,42346,0.0174283136553958,0.00499028699607214,0.00764735114309437,0.0272092761676972,0.000480187964335372
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC2,PDZ domain-containing protein GIPC2,40483,0.0112921077459766,0.00324930647334282,0.00492346705822463,0.0176607484337285,0.000512320891564124
NMR metabolomics,X23408.Triglycerides in VLDL,GBP2,Guanylate-binding protein 2,42370,0.0221262607169538,0.00637037811925516,0.00964031960321368,0.0346122018306939,0.000515743320672841
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF8,SLAM family member 8,42346,0.0201389249673343,0.00580604088250791,0.00875908483761881,0.0315187650970498,0.000524821656514683
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R1,Interleukin-1 receptor type 1,42590,-0.00856387286833477,0.00247111630807537,-0.0134072608321625,-0.00372048490450705,0.000530729151764261
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.0251870963587862,0.00727548106741725,0.0109271534666484,0.039447039250924,0.000538019628977993
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA2,Paraneoplastic antigen Ma2,40136,0.0160800194925848,0.0046647144963776,0.00693717907968474,0.0252228599054849,0.00056864218592902
NMR metabolomics,X23408.Triglycerides in VLDL,CCN3,CCN family member 3,42779,0.0128155771366728,0.0037191813931108,0.00552598160617565,0.02010517266717,0.000571080681832873
NMR metabolomics,X23408.Triglycerides in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0108651332198473,0.00315541885924588,0.00468051225572541,0.0170497541839693,0.000576402544374549
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0141544131637478,0.00411111709908889,0.00609662364953359,0.022212202677962,0.000577142921978489
NMR metabolomics,X23408.Triglycerides in VLDL,C9orf40,Uncharacterized protein C9orf40,40449,0.0292876969453366,0.00852529793811751,0.0125781129866262,0.0459972809040469,0.000593844002082096
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS,RNA-binding protein with multiple splicing,40199,0.0229924322221104,0.00669878807754518,0.00986280759012182,0.0361220568540989,0.000600626875709712
NMR metabolomics,X23408.Triglycerides in VLDL,KLK4,Kallikrein-4,42721,-0.0227994361130154,0.00666572233991838,-0.0358642518992554,-0.0097346203267754,0.000627138511045954
NMR metabolomics,X23408.Triglycerides in VLDL,SPESP1,Sperm equatorial segment protein 1,40511,0.0114003006274112,0.00333311180395086,0.00486740149166752,0.0179331997631549,0.000627689567600579
NMR metabolomics,X23408.Triglycerides in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0314607040790733,0.00920982326857959,0.0134094504726573,0.0495119576854893,0.000637820942709301
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY2,Protein canopy homolog 2,42357,0.0220281490301497,0.00646628828453207,0.00935422399246684,0.0347020740678325,0.000659707408005761
NMR metabolomics,X23408.Triglycerides in VLDL,CENPJ,Centromere protein J,40302,0.0252906496491994,0.00743839520154664,0.010711395054168,0.0398699042442308,0.000676194506616365
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO3,R-spondin-3,42721,0.0105492573318769,0.0031165930417234,0.00444073497009907,0.0166577796936548,0.000714147315483301
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK13,Mitogen-activated protein kinase 13,40080,0.01485101149541,0.00438996153568054,0.00624668688547609,0.0234553361053438,0.000719649369325343
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0158735869761674,0.00469578910648927,0.00666984032744842,0.0250773336248864,0.00072637222217928
NMR metabolomics,X23408.Triglycerides in VLDL,GFRAL,GDNF family receptor alpha-like,40109,-0.022252522961453,0.00659990070495606,-0.0351883283431669,-0.00931671757973915,0.000749800398275235
NMR metabolomics,X23408.Triglycerides in VLDL,GUCA2A,Guanylin,42563,-0.0128452884446583,0.00382045494275113,-0.0203333801324505,-0.0053571967568661,0.000775295555137558
NMR metabolomics,X23408.Triglycerides in VLDL,CCL28,C-C motif chemokine 28,42538,0.0206025064152569,0.00615750426084071,0.00853379806400915,0.0326712147665047,0.000822368328186054
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0124618007479971,0.00372873614180796,0.00515347791005352,0.0197701235859407,0.000833749781789663
NMR metabolomics,X23408.Triglycerides in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0267647805398834,0.00800809145283999,0.011068921292317,0.0424606397874498,0.000833883887634443
NMR metabolomics,X23408.Triglycerides in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00815677197668203,0.00244100359415019,0.00337240493214765,0.0129411390212164,0.000835333606755141
NMR metabolomics,X23408.Triglycerides in VLDL,FCRLB,Fc receptor-like B,42346,0.0227035934869628,0.00681843054726464,0.00933946961432409,0.0360677173596015,0.000871664756240352
NMR metabolomics,X23408.Triglycerides in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.01498861421796,0.00451423882575182,0.0061407061194864,0.0238365223164335,0.000901615155137692
NMR metabolomics,X23408.Triglycerides in VLDL,FABP3,"Fatty acid-binding protein, heart",40511,0.0182674369574022,0.00550297420820424,0.00748160750932189,0.0290532664054825,0.000904452658485637
NMR metabolomics,X23408.Triglycerides in VLDL,OPTC,Opticin,42587,-0.0160684313670791,0.00485636693357377,-0.0255869105568837,-0.00654995217727448,0.000939656748340803
NMR metabolomics,X23408.Triglycerides in VLDL,GSAP,Gamma-secretase-activating protein,42346,0.0297037063387073,0.0089851784148847,0.0120927566455333,0.0473146560318813,0.000949402230078197
NMR metabolomics,X23408.Triglycerides in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00770518027347971,0.00233282328972602,0.00313284662561671,0.0122775139213427,0.000959264802113253
NMR metabolomics,X23408.Triglycerides in VLDL,TFF2,Trefoil factor 2,42654,0.0201386255267202,0.00610529038531717,0.00817225637149854,0.0321049946819418,0.000974365957838127
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.010736656452649,0.00325934223495834,0.00434834567213062,0.0171249672331673,0.000990430108596746
NMR metabolomics,X23408.Triglycerides in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00838845322314616,0.00255357501411118,0.00338344619548824,0.0133934602508041,0.00102306942033811
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA11,Serpin A11,42794,-0.0140465499386215,0.00428445553195929,-0.0224440827812617,-0.0056490170959813,0.001046256099246
NMR metabolomics,X23408.Triglycerides in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00678840197182649,0.0020728652737545,-0.0108512179083853,-0.00272558603526767,0.00106020680556236
NMR metabolomics,X23408.Triglycerides in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.0116180650655141,0.00355536788873273,0.00464954400359799,0.0185865861274303,0.00108728781193181
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA1,Ephrin-A1,42590,0.010383155747678,0.00317797732933818,0.00415432018217514,0.0166119913131808,0.0010888199690918
NMR metabolomics,X23408.Triglycerides in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0127076292321157,0.0039084023661708,-0.0203680978698104,-0.00504716059442088,0.00115199836625251
NMR metabolomics,X23408.Triglycerides in VLDL,SCG3,Secretogranin-3,42638,-0.0116013861444317,0.00358361661565506,-0.0186252747111156,-0.00457749757774777,0.00120941916211899
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN3,Perilipin-3,42636,0.0141727991318834,0.00440334916658202,0.0055422347653826,0.0228033634983841,0.00129105356348293
NMR metabolomics,X23408.Triglycerides in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0199490383695298,0.0062059120236667,0.00778545080314305,0.0321126259359165,0.00131043168549494
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG4,Proteasome assembly chaperone 4,40199,0.0191924722993567,0.0059748192885381,0.00748182649382201,0.0309031181048914,0.00132089525894492
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0170793638683468,0.0053179624751354,0.00665615741708142,0.0275025703196122,0.00132298644647342
NMR metabolomics,X23408.Triglycerides in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.011947877727539,0.00372032813028688,0.0046560345921767,0.0192397208629013,0.00132418168845787
NMR metabolomics,X23408.Triglycerides in VLDL,ACHE,Acetylcholinesterase,40283,0.0111616454903925,0.00348579782690811,0.00432948174965259,0.0179938092311324,0.00136845715796322
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA6C,Semaphorin-6C,40199,0.00881773936261782,0.00275486960229313,0.00341819494212328,0.0142172837831124,0.00137443992835039
NMR metabolomics,X23408.Triglycerides in VLDL,TNXB,Tenascin-X,42611,-0.00866486613574955,0.00270739058232012,-0.013971351677097,-0.00335838059440212,0.00137532977863616
NMR metabolomics,X23408.Triglycerides in VLDL,INSL3,Insulin-like 3,40483,0.0261146359572325,0.00820789833261382,0.0100271552253094,0.0422021166891556,0.00146836663565847
NMR metabolomics,X23408.Triglycerides in VLDL,EXTL1,Exostosin-like 1,40116,0.0158035690464166,0.00497111633887489,0.00606018102222186,0.0255469570706114,0.00148156361188718
NMR metabolomics,X23408.Triglycerides in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0229815733042678,0.00723168054249942,0.0088074794409689,0.0371556671675666,0.00148684204071887
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0277382125098811,0.00873872422080182,0.0106103130371095,0.0448661119826527,0.00150678482295451
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4C,Semaphorin-4C,42587,-0.00923666471780871,0.00291570014895014,-0.014951437009751,-0.00352189242586645,0.00153885883716813
NMR metabolomics,X23408.Triglycerides in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0495504899093552,0.015658549944942,0.0188597320172688,0.0802412478014415,0.00155738374447739
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171B,Protein FAM171B,40451,0.00875444239838778,0.00277238394105411,0.00332056987392172,0.0141883149228538,0.00159422203320155
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2,Apoptosis regulator Bcl-2,40449,0.0189413912015429,0.00600126427532066,0.00717891322191444,0.0307038691811714,0.00160242310700744
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0239798547530872,0.00760480553483517,0.00907443590481026,0.0388852736013642,0.00161886385858787
NMR metabolomics,X23408.Triglycerides in VLDL,NRCAM,Neuronal cell adhesion molecule,42636,0.00958150324997408,0.00304450288499521,0.00361427759538347,0.0155487289045647,0.00165231234850265
NMR metabolomics,X23408.Triglycerides in VLDL,JUN,Transcription factor AP-1,42370,0.0157997532468749,0.0050261927912145,0.00594841537609452,0.0256510911176554,0.00167320376004541
NMR metabolomics,X23408.Triglycerides in VLDL,CTSV,Cathepsin L2,42677,0.0137933322193429,0.00439007305629606,0.00518878902900265,0.0223978754096832,0.00168197512356948
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6,Seizure protein 6 homolog,40182,-0.0103606100822879,0.00329777501688754,-0.0168242491153875,-0.00389697104918833,0.00168417788981234
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00955064874532313,0.00304170734354763,-0.0155123951386765,-0.00358890235196979,0.00169450079481199
NMR metabolomics,X23408.Triglycerides in VLDL,SNX18,Sorting nexin-18,40449,0.0144360301036194,0.00459809252890283,0.00542376874696985,0.0234482914602689,0.00169633947120354
NMR metabolomics,X23408.Triglycerides in VLDL,OGN,Mimecan,42611,0.014540274956125,0.00464839052895535,0.00542942951937255,0.0236511203928775,0.00176362684914707
NMR metabolomics,X23408.Triglycerides in VLDL,NEO1,Neogenin,40482,0.00725578518446931,0.00233259592373633,0.0026838971739461,0.0118276731949925,0.00187169622241387
NMR metabolomics,X23408.Triglycerides in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0274720862329889,0.00883424104554729,0.0101569737837162,0.0447871986822616,0.00187738664802891
NMR metabolomics,X23408.Triglycerides in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.018702985352741,0.00601641042540408,0.00691082091894898,0.030495149786533,0.00188411567728055
NMR metabolomics,X23408.Triglycerides in VLDL,MBL2,Mannose-binding protein C,40379,-0.035447472478234,0.0114144714132415,-0.0578198364481874,-0.0130751085082807,0.00190442006458184
NMR metabolomics,X23408.Triglycerides in VLDL,BRK1,Protein BRICK1,42311,0.0146225083400478,0.00471146261852082,0.005388041607747,0.0238569750723486,0.00191586429890972
NMR metabolomics,X23408.Triglycerides in VLDL,VASN,Vasorin,42449,-0.00893789758184535,0.00288614521414059,-0.0145947422015609,-0.00328105296212979,0.00196011190297591
NMR metabolomics,X23408.Triglycerides in VLDL,CST6,Cystatin-M,42332,0.0164629119944668,0.00531979873165549,0.00603610648042205,0.0268897175085116,0.00197459647311722
NMR metabolomics,X23408.Triglycerides in VLDL,SLC12A2,Solute carrier family 12 member 2,40116,-0.00884348201860138,0.00286088447028749,-0.0144508155803649,-0.00323614845683789,0.00199870873159434
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0170115244763768,0.00550520254644301,0.00622132748534848,0.0278017214674051,0.00200604614911693
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB1,Lamin-B1,40434,0.0193245550691206,0.00626737074215745,0.00704050841449201,0.0316086017237492,0.00205173944437597
NMR metabolomics,X23408.Triglycerides in VLDL,CD160,CD160 antigen,42754,0.0158179953337535,0.00514208005629053,0.00573951842342406,0.025896472244083,0.00210084438095256
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO1,R-spondin-1,42495,0.0109380861496233,0.00355784886286925,0.00396470237839961,0.0179114699208471,0.00211386437330671
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3D,Protein FAM3D,40449,0.0276293355425557,0.00899797072590332,0.00999331291978522,0.0452653581653263,0.00214125052444564
NMR metabolomics,X23408.Triglycerides in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0183139096156422,0.00596449822372977,0.00662349309713185,0.0300043261341525,0.00214145560241851
NMR metabolomics,X23408.Triglycerides in VLDL,MYOC,Myocilin,42611,-0.0143935837166121,0.00468778395484064,-0.0235816402680998,-0.00520552716512448,0.00214167142952561
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0167981725703971,0.00547137650743085,0.00607427461583268,0.0275220705249616,0.00214431243888475
NMR metabolomics,X23408.Triglycerides in VLDL,KIF20B,Kinesin-like protein KIF20B,40136,0.0252272686797342,0.00821924458148005,0.00911754930003328,0.041336988059435,0.00215091382314661
NMR metabolomics,X23408.Triglycerides in VLDL,TXNL1,Thioredoxin-like protein 1,40124,0.0316278473681354,0.0103581798397485,0.0113258148822283,0.0519298798540425,0.00226794952821956
NMR metabolomics,X23408.Triglycerides in VLDL,IFNW1,Interferon omega-1,40116,-0.0117440147928345,0.00387174670367489,-0.0193326383320373,-0.00415539125363169,0.0024249516981773
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB4,Ephrin type-B receptor 4,42794,-0.00833321626371094,0.00276647061612981,-0.0137554986713254,-0.00291093385609651,0.00259821946780443
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1D,V-type proton ATPase subunit D,42587,0.00823236196020064,0.00274073625358332,0.00286051890317734,0.0136042050172239,0.00267207004523727
NMR metabolomics,X23408.Triglycerides in VLDL,CPA4,Carboxypeptidase A4,40060,0.0138900253188749,0.00463301430276578,0.00480931728545396,0.0229707333522958,0.00272324490119205
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0107391600992019,0.00358708594925885,0.00370847163865457,0.0177698485597493,0.00275994215414786
NMR metabolomics,X23408.Triglycerides in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0271353435651724,0.00906665333762352,0.00936470302343027,0.0449059841069145,0.00276972248553154
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0166088687476279,0.00555145528667721,0.00572801638574053,0.0274897211095152,0.00277849524847366
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS5,Transmembrane protease serine 5,42438,-0.0119157350555975,0.00399416834281652,-0.0197443050075179,-0.00408716510367715,0.00285693798361508
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA2,GDNF family receptor alpha-2,42587,0.00665732801689399,0.00223258904614768,0.00228145348644454,0.0110332025473434,0.00286993247054094
NMR metabolomics,X23408.Triglycerides in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00654927357557897,0.00220508414845737,-0.0108712385065554,-0.00222730864460252,0.00298364614970092
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM3,Intercellular adhesion molecule 3,42794,-0.00834967984541387,0.00281998328759044,-0.0138768470890911,-0.00282251260173662,0.00307274250721411
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.0149345659400614,0.00507053948011683,-0.0248728233210904,-0.00499630855903245,0.00323250670806857
NMR metabolomics,X23408.Triglycerides in VLDL,JCHAIN,Immunoglobulin J chain,42370,-0.0193591220689841,0.00657410903504697,-0.0322443757776761,-0.00647386836029199,0.00323778124867722
NMR metabolomics,X23408.Triglycerides in VLDL,SPON1,Spondin-1,42638,0.0104651209588571,0.00355510632258712,0.00349711256658638,0.0174331293511279,0.00324882251468003
NMR metabolomics,X23408.Triglycerides in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0178669392895715,0.00609984846640963,0.00591123629540864,0.0298226422837344,0.00340672964125355
NMR metabolomics,X23408.Triglycerides in VLDL,CEP112,Centrosomal protein of 112 kDa,40116,0.0137826729852324,0.0047121084284365,0.00454694046549687,0.023018405504968,0.00345222191558558
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC12A,C-type lectin domain family 12 member A,40199,0.00634485977736851,0.00217335968363439,0.00208507479744512,0.0106046447572919,0.00351440964464339
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.00952243121777109,0.00326645365727336,0.00312018204951532,0.0159246803860269,0.00356020256266128
NMR metabolomics,X23408.Triglycerides in VLDL,EDN1,Endothelin-1,40223,0.00925784057162047,0.00319423599406055,0.0029971380232618,0.0155185431199792,0.00375935834705087
NMR metabolomics,X23408.Triglycerides in VLDL,CEP164,Centrosomal protein of 164 kDa,42370,0.0200251460053088,0.00692826562959199,0.0064457453713085,0.0336045466393091,0.00385435492349051
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD5,Sushi domain-containing protein 5,40235,-0.0105303113745763,0.00364764651381585,-0.0176796985416553,-0.00338092420749724,0.00389839614836827
NMR metabolomics,X23408.Triglycerides in VLDL,COL3A1,Collagen alpha-1(III) chain,40527,0.00706909840251795,0.00245087512473081,0.00226538315804556,0.0118728136469903,0.00393003904093447
NMR metabolomics,X23408.Triglycerides in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0171033650036616,0.00594420282230804,0.00545272747193783,0.0287540025353853,0.00401715855401086
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.0137369516020779,0.00477467946881808,0.00437857984319442,0.0230953233609613,0.00402187197601441
NMR metabolomics,X23408.Triglycerides in VLDL,CYTL1,Cytokine-like protein 1,40527,0.00771849479389338,0.00268362910000824,0.00245858175787723,0.0129784078299095,0.00403320929346104
NMR metabolomics,X23408.Triglycerides in VLDL,PRG3,Proteoglycan 3,40527,-0.0150298187057377,0.00522878053683789,-0.02527822855794,-0.00478140885353544,0.00405497087160803
NMR metabolomics,X23408.Triglycerides in VLDL,AKAP12,A-kinase anchor protein 12,40283,-0.0066385338762785,0.0023104622705279,-0.0111670399265132,-0.00211002782604381,0.00407044938302838
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.0111620658258157,0.00389308517440335,0.0035316188839851,0.0187925127676463,0.00414969075570029
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0212339072590845,0.0074207755951192,0.00668918709265086,0.0357786274255181,0.00422531566125439
NMR metabolomics,X23408.Triglycerides in VLDL,DSG4,Desmoglein-4,42543,0.0149897229848794,0.00524880270833497,0.00470206967654288,0.025277376293216,0.00429898190585975
NMR metabolomics,X23408.Triglycerides in VLDL,MSLN,Mesothelin,42553,0.0178391673088978,0.00624794908568888,0.00559318710094755,0.030085147516848,0.00430754880399327
NMR metabolomics,X23408.Triglycerides in VLDL,RRP15,RRP15-like protein,40136,-0.0274985793664099,0.00964819069006793,-0.0464090331189431,-0.00858812561387675,0.00437832941203692
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0149404894556028,0.00524591513742355,0.0046584957862526,0.0252224831249529,0.00440713760085843
NMR metabolomics,X23408.Triglycerides in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.013915910654795,0.00490225259521758,0.00430749556816851,0.0235243257414214,0.00453821148888903
NMR metabolomics,X23408.Triglycerides in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0212135599057645,0.00747808878501795,0.00655650588712932,0.0358706139243997,0.00456413094059501
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549,UPF0606 protein KIAA1549,40302,0.0210328451995537,0.00743373749378325,0.0064627197117385,0.0356029706873688,0.0046722351563392
NMR metabolomics,X23408.Triglycerides in VLDL,LEG1,Protein LEG1 homolog,39926,-0.0207817744632204,0.0073479633802025,-0.0351837826884173,-0.0063797662380235,0.0046892017490793
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0109583066057193,0.00388037873274869,0.00335276428953191,0.0185638489219068,0.00475066862402782
NMR metabolomics,X23408.Triglycerides in VLDL,HEPACAM2,HEPACAM family member 2,40483,-0.0124761260404819,0.00442321746861716,-0.0211456322789716,-0.00380661980199231,0.00480175833903234
NMR metabolomics,X23408.Triglycerides in VLDL,CD5L,CD5 antigen-like,40479,0.0141041030595487,0.00500534885122913,0.00429361931113957,0.0239145868079577,0.00484370571351365
NMR metabolomics,X23408.Triglycerides in VLDL,SOX9,Transcription factor SOX-9,40182,0.00818748184043713,0.00291099109220338,0.00248193929971851,0.0138930243811558,0.00492284256201913
NMR metabolomics,X23408.Triglycerides in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.0171301046874152,0.00610055642146378,0.00517301410134618,0.0290871952734842,0.00499286246557383
NMR metabolomics,X23408.Triglycerides in VLDL,TLR1,Toll-like receptor 1,40199,0.00782701011984042,0.00281033794542646,0.00231874774680457,0.0133352724928763,0.00536063391438986
NMR metabolomics,X23408.Triglycerides in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0190563825267079,0.00684288103084242,0.00564433570625674,0.032468429347159,0.0053643509681892
NMR metabolomics,X23408.Triglycerides in VLDL,PRR5,Proline-rich protein 5,40199,0.0139703644207789,0.00501756521036849,0.0041359366084567,0.0238047922331012,0.00537363942563035
NMR metabolomics,X23408.Triglycerides in VLDL,CALCB,Calcitonin gene-related peptide 2,40483,0.0119796522794623,0.00430569381077142,0.00354049241035036,0.0204188121485743,0.00540678168127212
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.015352609036956,0.0055205299075538,0.0045323704181505,0.0261728476557614,0.00542825616848434
NMR metabolomics,X23408.Triglycerides in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0119158865462938,0.00428479004208361,-0.0203140750287776,-0.00351769806380988,0.00542890496973626
NMR metabolomics,X23408.Triglycerides in VLDL,NTF4,Neurotrophin-4,42346,0.0113814283428175,0.00409712436837194,0.00335106458080853,0.0194117921048266,0.00547878850695665
NMR metabolomics,X23408.Triglycerides in VLDL,CLNS1A,Methylosome subunit pICln,40182,0.00971688379232375,0.00350582677308931,0.00284546331706869,0.0165883042675788,0.00558688075351371
NMR metabolomics,X23408.Triglycerides in VLDL,ELAVL4,ELAV-like protein 4,40136,0.0246818472359958,0.00892270327907536,0.00719334880900812,0.0421703456629835,0.00568115068589698
NMR metabolomics,X23408.Triglycerides in VLDL,DDA1,DET1- and DDB1-associated protein 1,40116,0.0116887751047183,0.0042290956025091,0.00339974772380043,0.0199778024856361,0.00572116634878082
NMR metabolomics,X23408.Triglycerides in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.011220221302151,0.00405976939931963,0.0032630732794845,0.0191773693248174,0.0057218032141252
NMR metabolomics,X23408.Triglycerides in VLDL,IL6,Interleukin-6,42587,0.0222533324608541,0.00805946756443871,0.00645677603455424,0.038049888887154,0.00576780881964992
NMR metabolomics,X23408.Triglycerides in VLDL,TCN2,Transcobalamin-2,42771,-0.00891602359506139,0.00323403157837927,-0.0152547254886848,-0.00257732170143801,0.00584233951896499
NMR metabolomics,X23408.Triglycerides in VLDL,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0122832073064108,0.00446083089164817,-0.0210264358540412,-0.00353997875878042,0.00590470512957488
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0142600266791882,0.00518969105794281,0.00408823220562031,0.0244318211527561,0.00600991239589446
NMR metabolomics,X23408.Triglycerides in VLDL,NGF,Beta-nerve growth factor,42495,0.00345895470508077,0.0012592092630344,0.000990904549533338,0.00592700486062819,0.00602376492376586
NMR metabolomics,X23408.Triglycerides in VLDL,TPSAB1,Tryptase alpha/beta-1,42741,0.0150681141567257,0.0054946229644066,0.0042986531464888,0.0258375751669627,0.0061083620349946
NMR metabolomics,X23408.Triglycerides in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0177118873096096,0.00647293638506884,-0.0303988426243445,-0.00502493199487463,0.00622348369360076
NMR metabolomics,X23408.Triglycerides in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00597147807714292,0.0021823400967878,-0.010248864666847,-0.00169409148743883,0.00622398930767905
NMR metabolomics,X23408.Triglycerides in VLDL,TTN,Titin,40116,-0.018851609582636,0.00689408193452487,-0.0323640101743048,-0.00533920899096728,0.00625829213274981
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA2,Ephrin type-A receptor 2,42125,0.00965036309296711,0.00353264643532436,0.00272637607973136,0.0165743501062029,0.00630813617346436
NMR metabolomics,X23408.Triglycerides in VLDL,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00619094235525389,0.00226759114805375,0.00174646370506855,0.0106354210054392,0.00633818032181026
NMR metabolomics,X23408.Triglycerides in VLDL,CDH6,Cadherin-6,42636,-0.0110656749565596,0.00405519008272813,-0.0190138475187067,-0.00311750239441248,0.00636539669079215
NMR metabolomics,X23408.Triglycerides in VLDL,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0146114595102298,0.00536059243767615,-0.0251182206880751,-0.00410469833238457,0.0064261163860565
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00857895857574529,0.0031618365290019,0.00238175897890157,0.014776158172589,0.00667239280702915
NMR metabolomics,X23408.Triglycerides in VLDL,NRXN3,Neurexin-3,40182,0.0101294490583265,0.00373697314849676,0.00280498168727283,0.0174539164293801,0.0067265366824669
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.00984120630708134,0.00364394902974012,0.00269906620879072,0.016983346405372,0.00692819597797353
NMR metabolomics,X23408.Triglycerides in VLDL,RGMA,Repulsive guidance molecule A,42711,-0.00905591321046708,0.00335777077746384,-0.0156371439342962,-0.00247468248663796,0.00700536706657716
NMR metabolomics,X23408.Triglycerides in VLDL,S100G,Protein S100-G,40482,-0.0136245165616258,0.00506494233334342,-0.0235518035349789,-0.00369722958827273,0.00715646580468105
NMR metabolomics,X23408.Triglycerides in VLDL,GUK1,Guanylate kinase,40116,-0.0108501981068996,0.00403580889846167,-0.0187603835478844,-0.00294001266591469,0.00718866759117805
NMR metabolomics,X23408.Triglycerides in VLDL,BRD3,Bromodomain-containing protein 3,40116,0.0140294379329843,0.00522371111646639,0.00379096414471017,0.0242679117212584,0.00724825843819228
NMR metabolomics,X23408.Triglycerides in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0209900516580875,0.00781929179018558,0.00566423974932375,0.0363158635668512,0.00727508455363519
NMR metabolomics,X23408.Triglycerides in VLDL,CGA,Glycoprotein hormones alpha chain,42611,-0.0176874442482553,0.00660927257346787,-0.0306416184922523,-0.0047332700042583,0.00745624424069562
NMR metabolomics,X23408.Triglycerides in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00816925401085962,0.00305376079483646,0.00218388285298016,0.0141546251687391,0.00748073362514661
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR1,Folate receptor alpha,42600,0.00849119909289087,0.00318321417965489,0.00225209930076729,0.0147302988850145,0.00765114892880524
NMR metabolomics,X23408.Triglycerides in VLDL,TSC1,Hamartin,40199,0.0205404781238451,0.00770532558533613,0.00543803997658629,0.0356429162711039,0.00769287961576485
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.014556837996071,0.0054966060459485,0.00378349014601199,0.0253301858461301,0.0081004365009133
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.019826936473587,0.0075233769652296,-0.034572755325437,-0.00508111762173696,0.00841583934475525
NMR metabolomics,X23408.Triglycerides in VLDL,FABP9,Fatty acid-binding protein 9,42594,0.0156948360512239,0.00595595331961421,0.00402116754478004,0.0273685045576677,0.0084196668351218
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA4,Ephrin type-A receptor 4,40283,0.00805459849803302,0.00305658650794596,0.00206368894245894,0.0140455080536071,0.0084214278810174
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6A,Ras-related protein Rab-6A,42594,0.0126781938596281,0.00481174325536377,0.00324717707911515,0.0221092106401411,0.00842727501413554
NMR metabolomics,X23408.Triglycerides in VLDL,FCAR,Immunoglobulin alpha Fc receptor,42594,0.0134316702094727,0.00511638371813363,0.00340355812193074,0.0234597822970146,0.00866894702967979
NMR metabolomics,X23408.Triglycerides in VLDL,CEP152,Centrosomal protein of 152 kDa,40080,0.0114876649828303,0.00437905999987193,0.00290470738308133,0.0200706225825793,0.00871994776688727
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2B,Sodium channel subunit beta-2,40182,-0.00802006529818219,0.00306274889509348,-0.0140230531325654,-0.00201707746379897,0.00884167271823272
NMR metabolomics,X23408.Triglycerides in VLDL,LTA4H,Leukotriene A-4 hydrolase,42721,-0.0160436284171883,0.00613253018298477,-0.0280633875758384,-0.00402386925853812,0.00890258812386815
NMR metabolomics,X23408.Triglycerides in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.0153173663096626,0.00585930297500404,0.00383313247865473,0.0268016001406706,0.00895604713002449
NMR metabolomics,X23408.Triglycerides in VLDL,GM2A,Ganglioside GM2 activator,40269,0.0111842213097558,0.00429359111738294,0.00276878271968528,0.0195996598998264,0.00920335413420248
NMR metabolomics,X23408.Triglycerides in VLDL,LTO1,Protein LTO1 homolog,42370,0.011464555204181,0.00441948283594798,0.00280236884572291,0.020126741562639,0.00949454430806939
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM1,Myomesin-1,40136,0.0130849529664052,0.00505675132407389,0.00317372037122034,0.02299618556159,0.00967690795184433
NMR metabolomics,X23408.Triglycerides in VLDL,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.0130114831428474,0.00503436178830806,-0.0228788322479312,-0.00314413403776364,0.00976389752678527
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR1,Cadherin-related family member 1,42311,0.0115773681076019,0.00449004174402378,0.00277688628931528,0.0203778499258885,0.00993513741457398
NMR metabolomics,X23408.Triglycerides in VLDL,REG1A,Lithostathine-1-alpha,42575,-0.0141033408779045,0.00547375852700432,-0.0248319075908329,-0.00337477416497601,0.00999017179083789
NMR metabolomics,X23408.Triglycerides in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0231677875506201,0.00901222298698432,-0.0408317446051094,-0.00550383049613087,0.0101601484835034
NMR metabolomics,X23408.Triglycerides in VLDL,MB,Myoglobin,42794,-0.0143049143235441,0.00556494659032939,-0.0252122096405897,-0.00339761900649849,0.0101645690783926
NMR metabolomics,X23408.Triglycerides in VLDL,UNG,Uracil-DNA glycosylase,40451,0.00915689170612451,0.00358154708541834,0.00213705941870456,0.0161767239935445,0.010580454245089
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0143450486246274,0.0056357041502424,0.00329906849015234,0.0253910287591025,0.0109288866470272
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0100372981899678,0.00394544403026831,0.00230422789064191,0.0177703684892937,0.0109694986318439
NMR metabolomics,X23408.Triglycerides in VLDL,IL25,Interleukin-25,40036,0.00932675968306991,0.00367397772881454,0.00212576333459341,0.0165277560315464,0.0111435651154217
NMR metabolomics,X23408.Triglycerides in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.0105382993886053,0.00416039243756584,-0.0186926685662343,-0.00238393021097624,0.0113226397375857
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00681286471797229,0.00269238543416636,-0.0120899401689384,-0.00153578926700622,0.0114064137637777
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.0102959317117228,0.00408177942101308,-0.0182962193769084,-0.00229564404653718,0.0116693820488027
NMR metabolomics,X23408.Triglycerides in VLDL,PRR4,Proline-rich protein 4,40198,-0.0183640681851667,0.0072987438401102,-0.0326696061117827,-0.00405853025855069,0.0118816535937581
NMR metabolomics,X23408.Triglycerides in VLDL,RETN,Resistin,42598,0.0114461790081285,0.00455031349536939,0.00252756455720446,0.0203647934590525,0.0118989606288886
NMR metabolomics,X23408.Triglycerides in VLDL,SDC1,Syndecan-1,42636,0.0107076607010362,0.00425971303682591,0.00235862314885739,0.019056698253215,0.011958634047824
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM25,Transmembrane protein 25,40482,-0.0120295731724617,0.0047887755458432,-0.0214155732423144,-0.00264357310260907,0.0120175457370247
NMR metabolomics,X23408.Triglycerides in VLDL,FDX2,"Ferredoxin-2, mitochondrial",40116,0.0148621411921319,0.00592917888707198,0.00324095057347078,0.0264833318107929,0.0122039120188346
NMR metabolomics,X23408.Triglycerides in VLDL,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0142129425913678,0.00567558608389723,-0.0253370913158064,-0.00308879386692924,0.0122864427789985
NMR metabolomics,X23408.Triglycerides in VLDL,REN,Renin,42636,-0.0224256102827201,0.00896098968501046,-0.0399891500653406,-0.00486207050009963,0.0123408874047528
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.00556695906988617,0.0022283806948745,-0.00993458523184019,-0.00119933290793215,0.012496338694701
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0227197182180917,0.00910098550155238,0.00488178663504903,0.0405576498011344,0.0125579506060713
NMR metabolomics,X23408.Triglycerides in VLDL,RAD51,DNA repair protein RAD51 homolog 1,40302,0.0142244687962885,0.00570271117795908,0.00304715488748871,0.0254017827050883,0.0126337767614888
NMR metabolomics,X23408.Triglycerides in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0394197277848597,0.0158232673757212,0.0084061237284461,0.0704333318412733,0.0127414254586449
NMR metabolomics,X23408.Triglycerides in VLDL,IL19,Interleukin-19,42261,0.0188690752207789,0.00757518913054824,0.00402170452490432,0.0337164459166534,0.01275413946657
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5A,Cytochrome b5,40080,0.0191067170307748,0.007680380566746,0.00405317111995262,0.0341602629415969,0.0128709597167922
NMR metabolomics,X23408.Triglycerides in VLDL,ACRV1,Acrosomal protein SP-10,40199,0.0208263983955976,0.00841558858821596,0.00433184476269427,0.0373209520285008,0.0133482539032288
NMR metabolomics,X23408.Triglycerides in VLDL,CEP290,Centrosomal protein of 290 kDa,40302,0.0141683700831418,0.00572726303630747,0.00294293453197919,0.0253938056343045,0.0133815423731424
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42611,0.0117844382552064,0.00478811738289501,0.00239972818473222,0.0211691483256807,0.0138604246120912
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1,DNA topoisomerase 1,40449,0.0288456490336591,0.0117785128310391,0.00575976388482245,0.0519315341824957,0.0143402469272247
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B4,Protein ATP1B4,40080,-0.0108593048577143,0.00444270657722931,-0.0195670097490837,-0.00215159996634484,0.0145291325618697
NMR metabolomics,X23408.Triglycerides in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00831830717157954,0.00340643075261645,0.00164170289645129,0.0149949114467078,0.0146242064173406
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN5,Contactin-5,42640,-0.00974167562741799,0.0039937829842245,-0.017569490276498,-0.00191386097833797,0.0147322503939108
NMR metabolomics,X23408.Triglycerides in VLDL,OBP2B,Odorant-binding protein 2b,42462,-0.0156998403706646,0.00644160216719883,-0.0283253806183743,-0.00307430012295488,0.0148122017729137
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1B,Protein phosphatase 1B,40199,0.0155910928750373,0.00640470398120377,0.00303787307187791,0.0281443126781967,0.0149356296404914
NMR metabolomics,X23408.Triglycerides in VLDL,IL15,Interleukin-15,42594,0.00842809405979828,0.00348054119593662,0.0016062333157625,0.0152499548038341,0.0154702352661185
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0168934976167398,0.00700716068783626,0.0031594626685807,0.0306275325648988,0.0159274284642224
NMR metabolomics,X23408.Triglycerides in VLDL,DBH,Dopamine beta-hydroxylase,40515,0.0277112841365673,0.0114948881987311,0.0051813032670543,0.0502412650060803,0.0159356534157052
NMR metabolomics,X23408.Triglycerides in VLDL,FOLH1,Glutamate carboxypeptidase 2,40199,0.0256870582289949,0.0106657601692607,0.00478216829724393,0.0465919481607458,0.0160404254301824
NMR metabolomics,X23408.Triglycerides in VLDL,PXDNL,Peroxidasin-like protein,40451,-0.0140214945057005,0.0058514848641624,-0.0254904048394588,-0.00255258417194222,0.0165809806220386
NMR metabolomics,X23408.Triglycerides in VLDL,ACE,Angiotensin-converting enzyme,40532,-0.00674235410491552,0.00281465585290354,-0.0122590795766065,-0.00122562863322459,0.0166163096621763
NMR metabolomics,X23408.Triglycerides in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0232267470189994,0.00970899523963728,0.0041971163493103,0.0422563776886885,0.0167603919283779
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0099156759359233,0.00415111969933581,0.00177948132522512,0.0180518705466215,0.0169233035682386
NMR metabolomics,X23408.Triglycerides in VLDL,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00955696301640888,0.00400802372375249,0.00170123651785399,0.0174126895149638,0.0171184403685223
NMR metabolomics,X23408.Triglycerides in VLDL,TMOD4,Tropomodulin-4,40080,-0.0103245384063211,0.0043350677698501,-0.0188212712352273,-0.00182780557741488,0.0172531692083565
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1L,Allograft inflammatory factor 1-like,40223,0.013921689772556,0.00584601099465678,0.00246350822302871,0.0253798713220833,0.0172638442767119
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.00945012728315835,0.00398003527096996,0.00164925815205724,0.0172509964142595,0.017592292836466
NMR metabolomics,X23408.Triglycerides in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.00866175156909877,0.0036539284211792,0.00150005186358754,0.01582345127461,0.0177765642284264
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0191647044675147,0.0081067083453247,0.00327555611067832,0.0350538528243512,0.0180906154597386
NMR metabolomics,X23408.Triglycerides in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0215008194625357,0.00909670798063753,0.00367127182048615,0.0393303671045852,0.0181166647700144
NMR metabolomics,X23408.Triglycerides in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00843701074317636,0.00357455609754214,-0.015443140694359,-0.00143088079199375,0.0182778015945989
NMR metabolomics,X23408.Triglycerides in VLDL,CD55,Complement decay-accelerating factor,42201,0.00673860069329749,0.00285836905564595,0.00113619734423142,0.0123410040423636,0.0184132576186372
NMR metabolomics,X23408.Triglycerides in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00872239072871168,0.00370527066033923,0.00146006023444679,0.0159847212229766,0.0185876146953611
NMR metabolomics,X23408.Triglycerides in VLDL,CD2,T-cell surface antigen CD2,40116,0.00948644576207476,0.00404683343414654,0.00155465223114755,0.017418239293002,0.0190875496751426
NMR metabolomics,X23408.Triglycerides in VLDL,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00932439164525491,0.00398597205219029,-0.0171368968675479,-0.00151188642296193,0.0193377123803743
NMR metabolomics,X23408.Triglycerides in VLDL,IL36G,Interleukin-36 gamma,40154,0.016876728069033,0.00722677586351005,0.00271224737655333,0.0310412087615127,0.019545425689813
NMR metabolomics,X23408.Triglycerides in VLDL,TLR4,Toll-like receptor 4,40199,0.00718276665091013,0.00307647320463266,0.00115287916983013,0.0132126541319901,0.0195748674951655
NMR metabolomics,X23408.Triglycerides in VLDL,MMP8,Neutrophil collagenase,42681,0.0178389859672836,0.00765156076425463,0.00284192686934454,0.0328360450652227,0.019745985466914
NMR metabolomics,X23408.Triglycerides in VLDL,PRKCQ,Protein kinase C theta type,42370,0.0107029185170727,0.00459899886867544,0.00168888073446887,0.0197169562996766,0.0199682108350685
NMR metabolomics,X23408.Triglycerides in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00973733348143449,0.00420010292054427,0.00150513175716772,0.0179695352057013,0.0204481796104506
NMR metabolomics,X23408.Triglycerides in VLDL,KRT19,"Keratin, type I cytoskeletal 19",42562,0.0169781301923834,0.007398673277126,0.00247673056921642,0.0314795298155503,0.0217626849445633
NMR metabolomics,X23408.Triglycerides in VLDL,PI16,Peptidase inhibitor 16,40532,-0.00603006751760131,0.00263261880596431,-0.0111900003772913,-0.000870134657911273,0.0220094264778292
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.0103769909663373,0.00453755765205981,-0.0192706039643745,-0.00148337796830009,0.0222197670170116
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00626658508771721,0.00274382821883867,-0.011644488396641,-0.00088868177879342,0.0223968395514459
NMR metabolomics,X23408.Triglycerides in VLDL,IGLON5,IgLON family member 5,40080,-0.0227331797740023,0.00995863864645028,-0.0422521115210449,-0.00321424802695975,0.0224637149242197
NMR metabolomics,X23408.Triglycerides in VLDL,ENO1,Alpha-enolase,42588,0.0187583474329712,0.00823794724103277,0.00261197084054696,0.0349047240253954,0.0227979971565964
NMR metabolomics,X23408.Triglycerides in VLDL,RBP7,Retinoid-binding protein 7,40449,0.014326643066791,0.00629737131536861,0.00198379528866853,0.0266694908449135,0.0229234777048355
NMR metabolomics,X23408.Triglycerides in VLDL,TERF1,Telomeric repeat-binding factor 1,40199,-0.00704441367728017,0.00310461446802349,-0.0131294580346062,-0.000959369319954131,0.0232867490465521
NMR metabolomics,X23408.Triglycerides in VLDL,MTR,Methionine synthase,40116,0.0157793047091575,0.00697135779203718,0.00211544343676459,0.0294431659815503,0.0236276352259644
NMR metabolomics,X23408.Triglycerides in VLDL,DKKL1,Dickkopf-like protein 1,42587,-0.0208536553596624,0.00921813952501942,-0.0389212088287005,-0.00278610189062438,0.0236984569054649
NMR metabolomics,X23408.Triglycerides in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0120368785621171,0.00532957263997958,0.0015909161877571,0.022482840936477,0.023930407229421
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GL3,Endophilin-A3,40250,0.0202368712741623,0.0089644457742762,0.00266655755658093,0.0378071849917436,0.0239988179621525
NMR metabolomics,X23408.Triglycerides in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0145754368200854,0.00645816042557408,-0.0272334312542106,-0.00191744238596019,0.0240337115004208
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1,Methionine aminopeptidase 1,42311,0.00688115529381423,0.0030637979727727,0.000876111267179737,0.0128861993204487,0.0247234052380855
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.0077267544685895,0.00344441354533017,-0.0144778050174366,-0.000975703919742368,0.0248991304675548
NMR metabolomics,X23408.Triglycerides in VLDL,PTTG1,Securin,40302,0.00963274500294755,0.00430227743381617,0.00120028123266786,0.0180652087732272,0.0251764535656019
NMR metabolomics,X23408.Triglycerides in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0197343472108654,0.0088382740797313,0.00241133001459209,0.0370573644071388,0.0255803407655303
NMR metabolomics,X23408.Triglycerides in VLDL,KLK1,Kallikrein-1,42505,-0.0303304280292845,0.0135982975895898,-0.0569830913048805,-0.00367776475368862,0.025733671641147
NMR metabolomics,X23408.Triglycerides in VLDL,PALM3,Paralemmin-3,40116,0.0167636479016427,0.00751612427779839,0.00203204431715789,0.0314952514861276,0.0257439205584732
NMR metabolomics,X23408.Triglycerides in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.00770245215223379,0.00346508649808258,-0.0144940216884756,-0.000910882615991938,0.0262408371722943
NMR metabolomics,X23408.Triglycerides in VLDL,MUC2,Mucin-2,40527,0.021666434933682,0.00975932474507454,0.00253815843333586,0.0407947114340281,0.0264333708825719
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0689410160727978,0.0311094087370486,0.00796657494818258,0.129915457197413,0.0267025588297245
NMR metabolomics,X23408.Triglycerides in VLDL,FBLN2,Fibulin-2,40527,-0.00759171906069353,0.00342841169398733,-0.0143114059809087,-0.000872032140478375,0.026824221422483
NMR metabolomics,X23408.Triglycerides in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0283590657704508,0.012890872641389,0.00309295539332834,0.0536251761475733,0.0278289257135252
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00948008491129946,0.00431365345217907,0.00102532414502849,0.0179348456775704,0.0279917657729923
NMR metabolomics,X23408.Triglycerides in VLDL,TEF,Thyrotroph embryonic factor,40116,0.010008871440571,0.00456348652095736,0.00106443785949461,0.0189533050216475,0.0283103054623108
NMR metabolomics,X23408.Triglycerides in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0162810142425556,0.00742579657284438,0.00172645295978063,0.0308355755253306,0.0283645278582718
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.0118245100450295,0.00539714064781823,-0.0224029057147532,-0.00124611437530573,0.0284811919710094
NMR metabolomics,X23408.Triglycerides in VLDL,SLC13A1,Solute carrier family 13 member 1,40451,0.0143671229387997,0.00656889110327415,0.00149209637638241,0.0272421495012171,0.0287523815850643
NMR metabolomics,X23408.Triglycerides in VLDL,SULT1A1,Sulfotransferase 1A1,42711,-0.0291645533031089,0.0133566032175165,-0.0553434956094412,-0.00298561099677663,0.0290138850437695
NMR metabolomics,X23408.Triglycerides in VLDL,PKLR,Pyruvate kinase PKLR,42636,0.0148324382606234,0.00683778331615811,0.00143038296095353,0.0282344935602933,0.0300858745849783
NMR metabolomics,X23408.Triglycerides in VLDL,PADI2,Protein-arginine deiminase type-2,42370,0.0126434715542629,0.00584735788270003,0.00118265010417088,0.024104293004355,0.0306165605494016
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00777376477325265,0.00360005685465409,-0.0148298762083747,-0.000717653338130639,0.0308412565896076
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00641540039096589,0.00297171329747795,0.000590842327909117,0.0122399584540227,0.0308815577261085
NMR metabolomics,X23408.Triglycerides in VLDL,NME1,Nucleoside diphosphate kinase A,40199,-0.00498433433454359,0.0023110217884728,-0.00951393703995028,-0.000454731629136913,0.0310454519123561
NMR metabolomics,X23408.Triglycerides in VLDL,FDX1,"Adrenodoxin, mitochondrial",40116,0.0140146697020695,0.00650657224361235,0.00126178810458928,0.0267675512995497,0.0312678504908573
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0170040618523969,0.00792439116212356,0.0014722551746347,0.0325358685301591,0.0319111734729512
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0158045565000663,0.0073671019396863,0.0013650366982811,0.0302440763018514,0.0319474695410425
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.00755032390535092,0.0035204269815284,0.000650287021555257,0.0144503607891466,0.0319971642390335
NMR metabolomics,X23408.Triglycerides in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00855223794996651,0.00398957964944644,0.000732661837051493,0.0163718140628815,0.0320827335344664
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN7,Septin-7,40302,0.0122110378438599,0.00571489279137784,0.00100984797275937,0.0234122277149605,0.0326438079071712
NMR metabolomics,X23408.Triglycerides in VLDL,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0223384375904777,0.0104999073881493,-0.0429182560712502,-0.00175861910970508,0.0334018117270456
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,0.00670263827839761,0.00315255740845063,0.000523625757834375,0.0128816507989609,0.0335135109400178
NMR metabolomics,X23408.Triglycerides in VLDL,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00872693163616959,0.00411449225410103,-0.0167913364542076,-0.000662526818131578,0.0339423549882906
NMR metabolomics,X23408.Triglycerides in VLDL,MERTK,Tyrosine-protein kinase Mer,42754,-0.00567454687949963,0.00267788233086837,-0.0109231962480016,-0.000425897510997635,0.0341049891760275
NMR metabolomics,X23408.Triglycerides in VLDL,THY1,Thy-1 membrane glycoprotein,42711,0.00667762534180101,0.00315765858883742,0.000488614507679667,0.0128666361759224,0.034470408653813
NMR metabolomics,X23408.Triglycerides in VLDL,TJP3,Tight junction protein ZO-3,40136,-0.00934740703910996,0.00442099413689931,-0.0180125555474326,-0.00068225853078731,0.0345102950972997
NMR metabolomics,X23408.Triglycerides in VLDL,DRAXIN,Draxin,42495,0.00969881302117512,0.00460017145306881,0.000682476973160255,0.01871514906919,0.035018597239376
NMR metabolomics,X23408.Triglycerides in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0213296416335891,0.0101443518299237,0.00144671204693863,0.0412125712202396,0.0355217978104357
NMR metabolomics,X23408.Triglycerides in VLDL,SAT1,Diamine acetyltransferase 1,40116,-0.011337814925917,0.00539835403001872,-0.0219185888247537,-0.000757041027080291,0.0357310002457664
NMR metabolomics,X23408.Triglycerides in VLDL,TNR,Tenascin-R,42495,-0.00931253211368465,0.00444671367650008,-0.0180280909196248,-0.000596973307744483,0.0362565523879076
NMR metabolomics,X23408.Triglycerides in VLDL,APOH,Beta-2-glycoprotein 1,42611,-0.00798911086661891,0.00382072360931645,-0.0154777291408792,-0.000500492592358671,0.0365473492158455
NMR metabolomics,X23408.Triglycerides in VLDL,CEP350,Centrosome-associated protein 350,40080,0.00834883370251382,0.00399496037257661,0.000518711372263659,0.016178956032764,0.036655195827231
NMR metabolomics,X23408.Triglycerides in VLDL,NTF3,Neurotrophin-3,42594,0.00781030364185653,0.00376386730506268,0.000433123723933671,0.0151874835597794,0.0379987015090362
NMR metabolomics,X23408.Triglycerides in VLDL,NMI,N-myc-interactor,40421,0.0156622168718686,0.00754850999242204,0.00086713728672143,0.0304572964570158,0.0380208182972028
NMR metabolomics,X23408.Triglycerides in VLDL,C8B,Complement component C8 beta chain,40539,0.00660272013165265,0.00318438641300686,0.000361322762159205,0.0128441175011461,0.0381513528614241
NMR metabolomics,X23408.Triglycerides in VLDL,PLAU,Urokinase-type plasminogen activator,42611,-0.00640943881686377,0.00309156390214723,-0.0124689040650723,-0.000349973568655194,0.0381724540696244
NMR metabolomics,X23408.Triglycerides in VLDL,EGFR,Epidermal growth factor receptor,42794,0.00353575471617736,0.00170792285386614,0.000188225922599729,0.00688328350975499,0.0384517460932188
NMR metabolomics,X23408.Triglycerides in VLDL,C1QL2,Complement C1q-like protein 2,40199,0.00957470749659164,0.00462688764211602,0.000506007718044238,0.018643407275139,0.0385353742221871
NMR metabolomics,X23408.Triglycerides in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.0087163679782325,0.00421674152906558,0.000451554581263959,0.016981181375201,0.0387487810753599
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0106853701216781,0.00517176749717865,-0.0208220344161483,-0.00054870582720796,0.0388384565827631
NMR metabolomics,X23408.Triglycerides in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.0058842222955951,0.0028539433634068,0.000290493303317775,0.0114779512878724,0.039250893072256
NMR metabolomics,X23408.Triglycerides in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.0108096881219354,0.00524553433364799,-0.0210909354158855,-0.000528440827985364,0.0393512300652607
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.0059773559588375,0.00290681003701704,0.000280008286284103,0.0116747036313909,0.039770545308313
NMR metabolomics,X23408.Triglycerides in VLDL,EPN1,Epsin-1,40302,0.00960792556378646,0.00467535956692802,0.000444220812607542,0.0187716303149654,0.0399010645074517
NMR metabolomics,X23408.Triglycerides in VLDL,COL5A1,Collagen alpha-1(V) chain,40283,0.0088607011781288,0.00432941500313907,0.000375047771976233,0.0173463545842814,0.0407181673054089
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR1,Interferon gamma receptor 1,42676,0.00467503943294665,0.00229687288194594,0.000173168584332604,0.0091769102815607,0.0418308415442527
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00814034327501148,0.00400423164126677,0.000292049258128618,0.0159886372918943,0.0420828055755581
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0131964471606138,0.00649604231009939,0.000464204232818963,0.0259286900884086,0.0422325168200648
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0126015654466607,0.00621948567954971,0.000411373514743227,0.0247917573785781,0.0427744217521162
NMR metabolomics,X23408.Triglycerides in VLDL,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0116144414936683,0.00574827534446771,0.00034782181851155,0.022881061168825,0.0433561128248873
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN3,Neuronal-specific septin-3,40482,-0.0158396659189741,0.00786626084885469,-0.0312575371827292,-0.000421794655218865,0.0440730542721924
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00686546971045234,0.00341142560424551,0.000179075526131138,0.0135518638947735,0.0441917126480242
NMR metabolomics,X23408.Triglycerides in VLDL,ODAM,Odontogenic ameloblast-associated protein,42292,0.0118425362276714,0.00590381435265888,0.000271060096459967,0.0234140123588828,0.0448860878030432
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR4,Complement factor H-related protein 4,40509,0.0156189634514487,0.00781935646411377,0.000293024781785726,0.0309449021211117,0.0457975865810293
NMR metabolomics,X23408.Triglycerides in VLDL,CTNNA1,Catenin alpha-1,40136,-0.00737499728644654,0.00369575173399738,-0.0146186706850814,-0.000131323887811669,0.0460094472404363
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH3,Neurexophilin-3,40199,0.00641378062999933,0.00322646035383029,8.99183364919554e-05,0.0127376429235067,0.0468509138572364
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.00886499694271994,0.00446457295665423,0.000114433947677635,0.0176155599377622,0.0470943822177314
NMR metabolomics,X23408.Triglycerides in VLDL,LHB,Lutropin subunit beta,42346,0.0175507803273007,0.00884443358966048,0.000215690491566202,0.0348858701630353,0.0472334461269646
NMR metabolomics,X23408.Triglycerides in VLDL,TFF1,Trefoil factor 1,42556,0.0172432808720201,0.0087009920925948,0.000189336370534261,0.0342972253735059,0.0475265308636986
NMR metabolomics,X23408.Triglycerides in VLDL,RBM25,RNA-binding protein 25,40080,-0.00985702863155447,0.00498840412229743,-0.0196343007112574,-7.97565518515127e-05,0.0481813009321277
NMR metabolomics,X23408.Triglycerides in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0149475901831658,0.00757180786718202,0.000106846763489042,0.0297883336028425,0.0483934493520561
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00960148880459039,0.00487944567982569,-0.0191652023370487,-3.77752721320464e-05,0.049118175962895
NMR metabolomics,X23408.Triglycerides in VLDL,SPRING1,SREBP regulating gene protein,40080,0.0122023537301653,0.00621779071948407,1.54839199765066e-05,0.024389223540354,0.0497308656658342
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00775963363460481,0.00395543197503677,6.98696353274627e-06,0.0155122803056769,0.0498146629153642
NMR metabolomics,X23408.Triglycerides in VLDL,PCDHB15,Protocadherin beta-15,40451,-0.00829171647882914,0.0042295320196837,-0.0165815992374092,-1.83372024907882e-06,0.0499697640574916
NMR metabolomics,X23408.Triglycerides in VLDL,NELL2,Protein kinase C-binding protein NELL2,42676,0.0059406204955559,0.00303753002423336,-1.29383519414843e-05,0.0118941793430533,0.0505163546949698
NMR metabolomics,X23408.Triglycerides in VLDL,CDH23,Cadherin-23,40483,-0.00536099330715627,0.00274265672921293,-0.0107366004964136,1.4613882101059e-05,0.0506464873256367
NMR metabolomics,X23408.Triglycerides in VLDL,RALB,Ras-related protein Ral-B,40199,0.00613798603466323,0.00314714008382686,-3.04085296374077e-05,0.0123063805989639,0.0511612309249947
NMR metabolomics,X23408.Triglycerides in VLDL,CAPS,Calcyphosin,40483,0.0211946661909466,0.0108727237553106,-0.000115872369462058,0.0425052047513553,0.0512792254559326
NMR metabolomics,X23408.Triglycerides in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0131068919415373,0.00676148232466441,-0.000145613414804891,0.0263593972978796,0.0525921433692237
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB118,Beta-defensin 118,40136,0.0115341143482032,0.00599118772915625,-0.000208613600943089,0.0232768422973494,0.0542327425323159
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A1,Collagen alpha-1(IX) chain,42594,0.00981210065442901,0.00509859304403569,-0.000181141711880941,0.019805343020739,0.054316569643168
NMR metabolomics,X23408.Triglycerides in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00828540294706906,0.00431386444301151,-0.000169771361233492,0.0167405772553716,0.0547973403727169
NMR metabolomics,X23408.Triglycerides in VLDL,TBR1,T-box brain protein 1,40182,0.0097977047533209,0.00510157236076581,-0.000201377073780097,0.0197967865804219,0.0548172847745145
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAV,Integrin alpha-V,42721,-0.00328290171793162,0.00171783836478656,-0.00664986491291327,8.40614770500252e-05,0.0560172712182019
NMR metabolomics,X23408.Triglycerides in VLDL,GSTM4,Glutathione S-transferase Mu 4,40116,-0.014943251026089,0.0078258149023881,-0.0302818482347697,0.000395346182591627,0.0562261417935943
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.0101063336523609,0.00529746017105584,-0.000276688282908506,0.0204893555876304,0.0564428110454744
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00969655759182674,0.00509182140911422,-0.000283412370037131,0.0196765275536906,0.0568877379572399
NMR metabolomics,X23408.Triglycerides in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00720618757089087,0.00378980352496576,-0.000221827338042028,0.0146342024798238,0.0572626607036949
NMR metabolomics,X23408.Triglycerides in VLDL,POF1B,Protein POF1B,40199,0.00929603582896739,0.00489751098827662,-0.000303085708054774,0.0188951573659896,0.0577071615386308
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.00829232828454481,0.0043718199452746,-0.016861095377283,0.000276438808193395,0.0578801687520515
NMR metabolomics,X23408.Triglycerides in VLDL,ENOPH1,Enolase-phosphatase E1,40451,0.0109443631716984,0.00577294913349449,-0.000370617129950804,0.0222593434733476,0.0580119405296555
NMR metabolomics,X23408.Triglycerides in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00665232362129263,0.00351255023300577,-0.000232274835398671,0.0135369220779839,0.0582637898304732
NMR metabolomics,X23408.Triglycerides in VLDL,EFHD1,EF-hand domain-containing protein D1,40482,0.00717000672437937,0.0037895760688026,-0.000257562370473733,0.0145975758192325,0.0585120209028565
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL1,Interferon lambda-1,42311,0.00907144670857661,0.00480498641125703,-0.000346326657487159,0.0184892200746404,0.0590582742865192
NMR metabolomics,X23408.Triglycerides in VLDL,TP73,Tumor protein p73,40182,0.00685174444398163,0.00363503972573127,-0.000272933418451656,0.0139764223064149,0.0594675493223828
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0147039084180384,0.00781850347867382,-0.000620358400162262,0.0300281752362391,0.0600445083702743
NMR metabolomics,X23408.Triglycerides in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0125220695122738,0.00667380096930593,-0.0256027194121134,0.000558580387565809,0.0606400313189972
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00521834168144361,0.00278279470027278,-0.00023593593109104,0.0106726192939783,0.0607897866466236
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.00983362730935273,0.00524750212153038,-0.000451476848846817,0.0201187314675523,0.0609620872136853
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.00628356024021922,0.00337472159921672,-0.000330894094245547,0.012898014574684,0.0626361491365655
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RA,Interleukin-17 receptor A,42611,0.00858428386212769,0.0046149213516741,-0.000460961987153547,0.0176295297114089,0.0628911409848242
NMR metabolomics,X23408.Triglycerides in VLDL,ID4,DNA-binding protein inhibitor ID-4,40302,-0.0084572776954307,0.00456174982232048,-0.0173983073471788,0.000483751956317448,0.0637721260617726
NMR metabolomics,X23408.Triglycerides in VLDL,HCG22,Protein PBMUCL2,40116,-0.0110626224400451,0.00598874285207586,-0.0228005584301137,0.000675313550023635,0.0647399458944712
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.0093872310928004,0.00508503136394668,-0.0193538925661359,0.000579430380535081,0.0649117327324203
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC1,Sialoadhesin,42676,0.00835489853326718,0.00452983903580638,-0.000523585976913332,0.0172333830434477,0.065144752667273
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.00293299437168911,0.00159398049257343,-0.00605719613713303,0.000191207393754806,0.0657879575422514
NMR metabolomics,X23408.Triglycerides in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00558313870069523,0.00304429613792457,-0.0115499591310274,0.000383681729636924,0.0666812191422917
NMR metabolomics,X23408.Triglycerides in VLDL,CD58,Lymphocyte function-associated antigen 3,42600,-0.00340672670576623,0.00186120087030782,-0.00705468041156957,0.000241227000037101,0.0672135703805535
NMR metabolomics,X23408.Triglycerides in VLDL,BMP10,Bone morphogenetic protein 10,40283,-0.00551309670150508,0.00301435122479508,-0.0114212251021034,0.000395031699093266,0.0674339895097943
NMR metabolomics,X23408.Triglycerides in VLDL,IL22,Interleukin-22,40451,0.0134376097993211,0.00734948337350276,-0.000967377612744305,0.0278425972113865,0.0675197771962971
NMR metabolomics,X23408.Triglycerides in VLDL,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00657169935154212,0.00359722387646541,-0.00047885944633008,0.0136222581494143,0.0677440817797165
NMR metabolomics,X23408.Triglycerides in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.00626525966638785,0.00343687557847019,-0.000471016467413726,0.0130015358001894,0.0683332907154994
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF1,Signaling lymphocytic activation molecule,42370,0.0115493675636599,0.00635942340113247,-0.000915102302559753,0.0240138374298795,0.0693772979810695
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00602310028887968,0.00333352616981645,-0.0125568115817199,0.000510611003960563,0.0708168258640097
NMR metabolomics,X23408.Triglycerides in VLDL,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0228729476831643,0.012682850344416,-0.00198543899189109,0.0477313343582196,0.071344309714272
NMR metabolomics,X23408.Triglycerides in VLDL,GBP6,Guanylate-binding protein 6,40116,-0.00873721807594265,0.0048472145484172,-0.0182377585908404,0.000763322438955055,0.0714906393679235
NMR metabolomics,X23408.Triglycerides in VLDL,DENND2B,DENN domain-containing protein 2B,40116,-0.00945129611193071,0.00524791765827064,-0.0197372147221412,0.000834622498279742,0.0717365686853587
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF1,Formylglycine-generating enzyme,40199,0.0121279149875272,0.00673756843238134,-0.00107771913994019,0.0253335491149947,0.0718811755527161
NMR metabolomics,X23408.Triglycerides in VLDL,OTOA,Otoancorin,40136,-0.0103128721155838,0.00574190288172498,-0.0215670017637647,0.000941257532597163,0.0725106121715841
NMR metabolomics,X23408.Triglycerides in VLDL,SCP2,Non-specific lipid-transfer protein,42346,0.0139270985101981,0.00776378875544928,-0.00128992745048243,0.0291441244708787,0.0728595404169016
NMR metabolomics,X23408.Triglycerides in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.0075071620687655,0.0041931271168238,-0.000711367080209155,0.0157256912177402,0.0734245680179953
NMR metabolomics,X23408.Triglycerides in VLDL,PDCL2,Phosducin-like protein 2,40080,0.00997261134135592,0.00557541620001595,-0.000955204410675344,0.0209004270933872,0.0736948594207444
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00516268478580437,0.00288805036699857,-0.000497893933512828,0.0108232635051216,0.0738626814978334
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.00846029930536808,0.00475954745983422,-0.0177890123266431,0.000868413715906994,0.0755058932116152
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00807485076979031,0.0045500651694457,-0.0169929785019039,0.000843276962323275,0.0759807255872659
NMR metabolomics,X23408.Triglycerides in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.00959961544451289,0.00541263954120578,-0.00100915805625043,0.0202083889452762,0.0761646912550224
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3G,Semaphorin-3G,40283,0.00825686314191676,0.00469308429803695,-0.000941582082235673,0.0174553083660692,0.0785425675315719
NMR metabolomics,X23408.Triglycerides in VLDL,TEX101,Testis-expressed protein 101,40182,0.00978316473917685,0.00556374424021501,-0.00112177397164456,0.0206881034499983,0.0787110719808485
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_DRA,,42549,-0.00680179600174473,0.00387498289619738,-0.0143967624782916,0.000793170474802128,0.0792292321452491
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.0100740536785224,0.00576802360521573,-0.0213793799447452,0.00123127258770044,0.0807461329687803
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL5,Fc receptor-like protein 5,42611,-0.0107485195268754,0.00618550159100241,-0.0228721026452401,0.00137506359148934,0.0822873913707776
NMR metabolomics,X23408.Triglycerides in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00944718052987262,0.00546872624335662,-0.0201658839668516,0.00127152290710635,0.0841077530433706
NMR metabolomics,X23408.Triglycerides in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.010531741220029,0.00609838924705639,-0.00142110170420148,0.0224845841442596,0.0842010985870961
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00882241545949611,0.00510972601489583,-0.0188374784486919,0.00119264752969972,0.0842691209351134
NMR metabolomics,X23408.Triglycerides in VLDL,RBM19,Probable RNA-binding protein 19,40116,-0.00875069326319425,0.00507282515535941,-0.0186934305676987,0.00119204404131018,0.0845532796287686
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.00574511433862606,0.00334124729628675,-0.000803730362095981,0.0122939590393481,0.0855552060474791
NMR metabolomics,X23408.Triglycerides in VLDL,VNN2,Vascular non-inflammatory molecule 2,42587,0.00819067760753341,0.00477245200356464,-0.00116332831945328,0.0175446835345201,0.0861410739990411
NMR metabolomics,X23408.Triglycerides in VLDL,IDS,Iduronate 2-sulfatase,42754,0.00156828408408992,0.000915965656639647,-0.000227008602923792,0.00336357677110362,0.0868891808148206
NMR metabolomics,X23408.Triglycerides in VLDL,DUOX2,Dual oxidase 2,42357,0.0128175433560516,0.00749959944030479,-0.00188167154694582,0.027516758259049,0.087456544220577
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00519671780837401,0.00304957586117785,-0.0111738864962826,0.000780450879534588,0.0883947444482906
NMR metabolomics,X23408.Triglycerides in VLDL,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00737004059849774,0.00433436833877489,-0.00112532134550105,0.0158654025424965,0.0890839128873206
NMR metabolomics,X23408.Triglycerides in VLDL,TUBB3,Tubulin beta-3 chain,40136,-0.00501036294871057,0.00295585733023052,-0.0108038433159624,0.000783117418541257,0.0900920158226376
NMR metabolomics,X23408.Triglycerides in VLDL,SOX2,Transcription factor SOX-2,40461,0.00425701787363473,0.0025133026637025,-0.000669055347222167,0.00918309109449162,0.0903320065998524
NMR metabolomics,X23408.Triglycerides in VLDL,TYMP,Thymidine phosphorylase,42563,0.0114836789959941,0.006799727673387,-0.00184378724384441,0.0248111452358326,0.091272657505601
NMR metabolomics,X23408.Triglycerides in VLDL,NOP56,Nucleolar protein 56,40116,0.0198478451836802,0.0117567133765856,-0.00319531303442748,0.0428910034017879,0.0913987533657807
NMR metabolomics,X23408.Triglycerides in VLDL,MELTF,Melanotransferrin,40511,0.00534626134699307,0.00316835260706787,-0.000863709762859958,0.0115562324568461,0.0915550425631923
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.00474104997365314,0.00281319404973445,-0.0102549103111327,0.000772810363826375,0.0919601257390424
NMR metabolomics,X23408.Triglycerides in VLDL,DOC2B,Double C2-like domain-containing protein beta,40182,0.00640924276483012,0.00380653472323712,-0.00105156529271463,0.0138700508223749,0.0922589102282919
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.0033079084675598,0.00196463410789364,-0.000542774383911733,0.00715859131903134,0.0922618557557673
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.0108193175990103,0.00643682694672974,-0.0234354984146006,0.00179686321658001,0.0928165561279736
NMR metabolomics,X23408.Triglycerides in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00418065901634467,0.00249277515751873,-0.00906649832508138,0.000705180292392032,0.0935485928838164
NMR metabolomics,X23408.Triglycerides in VLDL,ARTN,Artemin,42370,0.00785591902382586,0.00469420757662686,-0.00134472782636278,0.0170565658740145,0.0942458286583281
NMR metabolomics,X23408.Triglycerides in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.011714035129529,0.0070165537842674,-0.00203841028763509,0.0254664805466931,0.0950450547831354
NMR metabolomics,X23408.Triglycerides in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0154305660846044,0.00924393324162725,-0.00268754306898505,0.0335486752381938,0.0950937068569368
NMR metabolomics,X23408.Triglycerides in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00571143476567176,0.00342205396107744,-0.000995790998040034,0.0124186605293835,0.0951444938016552
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00614306120395308,0.00368117745377951,-0.0133581690133609,0.00107204660545477,0.0951855296592165
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP2,Dipeptidase 2,42587,-0.0051558186120042,0.00309459876516502,-0.0112212321917276,0.000909594967719227,0.09572282963606
NMR metabolomics,X23408.Triglycerides in VLDL,ITM2A,Integral membrane protein 2A,42594,-0.0107740120046251,0.00647583900854595,-0.0234666564613751,0.001918632452125,0.0961908814256391
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS53,Serine protease 53,40483,0.00646480668864787,0.00391804014946765,-0.00121455200430872,0.0141441653816045,0.0989686448392353
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC4,MANSC domain-containing protein 4,40116,0.0123791053015281,0.00752188497365086,-0.00236378924682755,0.0271219998498838,0.0998450240834041
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0198729545828875,0.0121041571301517,-0.0038511933922099,0.0435971025579849,0.100653331609145
NMR metabolomics,X23408.Triglycerides in VLDL,LY6D,Lymphocyte antigen 6D,42548,0.00702021791980688,0.00428184421250876,-0.00137219673671029,0.015412632576324,0.101126197119921
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.0109953768197741,0.00672729802312563,-0.00219012730555214,0.0241808809451003,0.10219504068324
NMR metabolomics,X23408.Triglycerides in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00733945934655107,0.00450165910288469,-0.00148379249510291,0.0161627111882051,0.103047788201022
NMR metabolomics,X23408.Triglycerides in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.0132956041835418,0.00816726168540212,-0.00271222871984639,0.0293034370869299,0.103571943288556
NMR metabolomics,X23408.Triglycerides in VLDL,LIFR,Leukemia inhibitory factor receptor,42594,-0.00411973130034417,0.00253285634209789,-0.00908412973085603,0.000844667130167696,0.103863451584839
NMR metabolomics,X23408.Triglycerides in VLDL,CA9,Carbonic anhydrase 9,42721,-0.00825392592362576,0.005083242220998,-0.0182170806767818,0.00170922882953033,0.10445199802715
NMR metabolomics,X23408.Triglycerides in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00681672696804316,0.00419877311473502,-0.00141286833683749,0.0150463222729238,0.10451029130023
NMR metabolomics,X23408.Triglycerides in VLDL,BTLA,B- and T-lymphocyte attenuator,40080,0.01493835295172,0.00925539744701205,-0.00320222604442363,0.0330789319478636,0.106553094067172
NMR metabolomics,X23408.Triglycerides in VLDL,AMBN,Ameloblastin,42370,-0.00483917030294445,0.00300811362559106,-0.0107350730091029,0.00105673240321403,0.107704611058823
NMR metabolomics,X23408.Triglycerides in VLDL,STX1B,Syntaxin-1B,40182,0.00685596275202161,0.00426588553021975,-0.0015051728872091,0.0152170983912523,0.108047895493148
NMR metabolomics,X23408.Triglycerides in VLDL,DLL1,Delta-like protein 1,42679,-0.00529262019294007,0.00330034880729956,-0.0117613038552472,0.00117606346936706,0.108813584385349
NMR metabolomics,X23408.Triglycerides in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00453314255346878,0.00282679353572925,-0.00100737277656055,0.0100736578834981,0.108823736540912
NMR metabolomics,X23408.Triglycerides in VLDL,TNN,Tenascin-N,40527,0.00737909650113128,0.0046265204176777,-0.00168888351751701,0.0164470765197796,0.110749959714266
NMR metabolomics,X23408.Triglycerides in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00772528158624563,0.00484593902400108,-0.0172233220732877,0.00177275890079648,0.110925294106241
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0124412421942491,0.00781519327306227,-0.0277590210094512,0.00287653662095291,0.111429275302699
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00696809866310171,0.00439026639113181,-0.01557302078972,0.00163682346351663,0.112497764705642
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD7,FERM domain-containing protein 7,40182,0.0055837863402045,0.00351936677540781,-0.00131417253959481,0.0124817452200038,0.112634681261988
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00819655130608034,0.00517153656643931,-0.0183327629763014,0.00193966036414071,0.113004525042534
NMR metabolomics,X23408.Triglycerides in VLDL,CFD,Complement factor D,40539,0.00343449198429798,0.00219900105385674,-0.000875550081261237,0.00774453404985719,0.118353130633316
NMR metabolomics,X23408.Triglycerides in VLDL,PAPPA,Pappalysin-1,42370,0.00763811050137171,0.00490587419717946,-0.00197740292510003,0.0172536239278435,0.119510746350174
NMR metabolomics,X23408.Triglycerides in VLDL,IGFL4,Insulin growth factor-like family member 4,40199,0.0120275590881482,0.00772976534409441,-0.00312278098627686,0.0271778991625732,0.119735487717676
NMR metabolomics,X23408.Triglycerides in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00593065928382033,0.00381451538471249,-0.00154579087021614,0.0134071094378568,0.120031830059396
NMR metabolomics,X23408.Triglycerides in VLDL,CA11,Carbonic anhydrase-related protein 11,42346,0.00530179601418098,0.00341016243407735,-0.00138212235661063,0.0119857143849726,0.120040444699742
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00777752673850269,0.00500979692905606,-0.0175967287194526,0.00204167524244718,0.120580436083694
NMR metabolomics,X23408.Triglycerides in VLDL,TNNI3,"Troponin I, cardiac muscle",42357,0.0136863840129796,0.00884479397037714,-0.00364941216895956,0.0310221801949188,0.121792228883203
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT2,Angiopoietin-2,42721,0.00603345989965812,0.00396203993660882,-0.00173213837609516,0.0137990581754114,0.127827989502276
NMR metabolomics,X23408.Triglycerides in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00800269821519163,0.0052712994745986,-0.0183344451854049,0.00232904875502163,0.129001504231933
NMR metabolomics,X23408.Triglycerides in VLDL,PRC1,Protein regulator of cytokinesis 1,40451,0.00709449422390849,0.00467508850514839,-0.00206867924618236,0.0162576676939993,0.129166015796266
NMR metabolomics,X23408.Triglycerides in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0101276974166522,0.00669053604266885,-0.00298575322697871,0.0232411480602832,0.130121182561505
NMR metabolomics,X23408.Triglycerides in VLDL,CLMP,CXADR-like membrane protein,42721,0.0034851873141743,0.00230306983494505,-0.00102882956231799,0.00799920419066659,0.130232156356155
NMR metabolomics,X23408.Triglycerides in VLDL,FGF9,Fibroblast growth factor 9,40065,0.00654560009830888,0.00433015278206676,-0.00194149935454197,0.0150326995511597,0.130656421170051
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL1,Follistatin-related protein 1,40223,-0.00358472285810872,0.00237834680645958,-0.00824628259876951,0.00107683688255206,0.131779578536576
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0223991782704327,0.0149113457721071,-0.0516254159837627,0.00682705944289722,0.133084500453119
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00411973387434727,0.00274309409087095,-0.00125673054375979,0.00949619829245434,0.133157769888426
NMR metabolomics,X23408.Triglycerides in VLDL,NINJ1,Ninjurin-1,42346,0.00849797885716713,0.00566677690571133,-0.00260890387802708,0.0196048615923613,0.133738381764867
NMR metabolomics,X23408.Triglycerides in VLDL,NELL1,Protein kinase C-binding protein NELL1,42679,-0.0068734365040498,0.00458649539862959,-0.0158629674853638,0.00211609447726419,0.133994360440215
NMR metabolomics,X23408.Triglycerides in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0179215049901832,0.0119649593724388,-0.00552981537979688,0.0413728253601632,0.134200730045823
NMR metabolomics,X23408.Triglycerides in VLDL,ANPEP,Aminopeptidase N,42666,-0.00435196887131613,0.00290962426556533,-0.0100548324318242,0.00135089468919191,0.134751344650575
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00799865034103938,0.00534812620619165,-0.018480977705175,0.00248367702309625,0.134787167296003
NMR metabolomics,X23408.Triglycerides in VLDL,EDNRB,Endothelin receptor type B,40199,0.0069941638449733,0.0046817139513409,-0.00218199549965487,0.0161703231896015,0.135221976347245
NMR metabolomics,X23408.Triglycerides in VLDL,MYH7B,Myosin-7B,40080,-0.00703694247534753,0.00471414007678305,-0.0162766570258423,0.00220277207514724,0.135536625878471
NMR metabolomics,X23408.Triglycerides in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.0102396983737602,0.0068887360044346,-0.00326222419493164,0.023741620942452,0.137186594811117
NMR metabolomics,X23408.Triglycerides in VLDL,AGBL2,Cytosolic carboxypeptidase 2,40136,0.014083704860464,0.00954629358432383,-0.00462703056481071,0.0327944402857387,0.140159048390697
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA1,Laminin subunit alpha-1,40116,-0.00834102176246301,0.00566494161795357,-0.019444307333652,0.002762263808726,0.140943530954634
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB5,Serpin B5,42357,0.00751462472424755,0.00510504216576242,-0.0024912579206468,0.0175205073691419,0.141044644520292
NMR metabolomics,X23408.Triglycerides in VLDL,CD70,CD70 antigen,42594,-0.00667225980432874,0.00454221630461617,-0.0155750037613764,0.00223048415271896,0.141871548108845
NMR metabolomics,X23408.Triglycerides in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.0046504177721876,0.00317010072128322,-0.00156297964152751,0.0108638151859027,0.142409868880878
NMR metabolomics,X23408.Triglycerides in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00726386740715582,0.00495559179807212,-0.00244909251706554,0.0169768273313772,0.142733498683581
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2B,Alpha-amylase 2B,41779,-0.0076985587856515,0.00527458857824505,-0.0180367523990118,0.0026396348277088,0.144437027051995
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN7,Tetraspanin-7,40136,-0.0144521666178695,0.00990483717030443,-0.0338656474716662,0.00496131423592719,0.144565771851208
NMR metabolomics,X23408.Triglycerides in VLDL,GPNMB,Transmembrane glycoprotein NMB,42315,0.00445119963674787,0.00305119102257655,-0.00152913476750217,0.0104315340409979,0.14463307628421
NMR metabolomics,X23408.Triglycerides in VLDL,IL33,Interleukin-33,42370,0.00593303199691586,0.00406939412630913,-0.00204298049065004,0.0139090444844818,0.144874174246676
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00619513757296836,0.00425662384712769,-0.00214784516740191,0.0145381203133386,0.145583746106922
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00923466154508242,0.00636318322430389,-0.0032371775745532,0.021706500664718,0.146734906903387
NMR metabolomics,X23408.Triglycerides in VLDL,SHPK,Sedoheptulokinase,40302,-0.00622663788935014,0.00431449783302721,-0.0146830536420835,0.00222977786338319,0.148995300610182
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA6,Corticosteroid-binding globulin,40539,0.00236870374091717,0.00164648246054855,-0.000858401881757983,0.00559580936359232,0.150278718774842
NMR metabolomics,X23408.Triglycerides in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.00546196515673145,0.00379693776515463,-0.00198003286297163,0.0129039631764345,0.150310748716508
NMR metabolomics,X23408.Triglycerides in VLDL,PEPD,Xaa-Pro dipeptidase,40532,0.0039650225419785,0.0027714373366839,-0.00146699463792195,0.00939703972187894,0.152551309535025
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00863969035849695,0.00604704556353019,-0.0204918996630161,0.00321251894602222,0.153105881620944
NMR metabolomics,X23408.Triglycerides in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00800619183621766,0.00563368205881575,-0.00303582499906121,0.0190482086714965,0.155307446074935
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00670743959672675,0.00472084268321062,-0.00254541206236606,0.0159602912558196,0.155394490088222
NMR metabolomics,X23408.Triglycerides in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0089488995249016,0.00630020908213737,-0.0212973093258908,0.00339951027608764,0.155515995726972
NMR metabolomics,X23408.Triglycerides in VLDL,RBP1,Retinol-binding protein 1,40182,0.0101506588778783,0.00718581502902372,-0.00393353857900815,0.0242348563347648,0.157802650625452
NMR metabolomics,X23408.Triglycerides in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00508783563564727,0.00360910048806017,-0.00198600132095067,0.0121616725922452,0.158649679671037
NMR metabolomics,X23408.Triglycerides in VLDL,RYR1,Ryanodine receptor 1,40116,-0.00510872358345182,0.00362394759703985,-0.0122116608736499,0.00199421370674628,0.158653118269516
NMR metabolomics,X23408.Triglycerides in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00550140459149848,0.00390458238090308,-0.00215157687507156,0.0131543860580685,0.158874669777758
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL2,Podocalyxin-like protein 2,42679,-0.0041795916832645,0.00296731335661829,-0.00999552586223635,0.00163634249570736,0.158993077197864
NMR metabolomics,X23408.Triglycerides in VLDL,NOS2,"Nitric oxide synthase, inducible",40116,-0.00589106045304272,0.00418535403218523,-0.0140943543561258,0.00231223345004033,0.159295270785136
NMR metabolomics,X23408.Triglycerides in VLDL,GKN1,Gastrokine-1,42017,0.00414852113061842,0.00294816014784044,-0.00162987275914883,0.00992691502038568,0.159405383918725
NMR metabolomics,X23408.Triglycerides in VLDL,CA3,Carbonic anhydrase 3,42770,0.00877190282419485,0.00624624523074522,-0.00347073782806579,0.0210145434764555,0.160238084779787
NMR metabolomics,X23408.Triglycerides in VLDL,MSLNL,Mesothelin-like protein,40182,-0.00579613354375323,0.00413899032498134,-0.0139085545807167,0.0023162874932102,0.161429652394693
NMR metabolomics,X23408.Triglycerides in VLDL,SLK,STE20-like serine/threonine-protein kinase,40302,0.0117529446281769,0.00839337363182466,-0.00469806769019944,0.0282039569465532,0.161462004252682
NMR metabolomics,X23408.Triglycerides in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00714180005477543,0.00510901689559399,-0.0171554731701396,0.00287187306058879,0.162177051830276
NMR metabolomics,X23408.Triglycerides in VLDL,PCARE,Photoreceptor cilium actin regulator,40136,0.012330839713149,0.00883330891369595,-0.00498244575769505,0.0296441251839931,0.162758483252113
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.00616094131152947,0.00443447325372116,-0.00253062626576401,0.0148525088888229,0.1647557410521
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB7,Integrin beta-7,42721,0.00670710670642546,0.0048327988180605,-0.00276517897697312,0.016179392389824,0.165211453950219
NMR metabolomics,X23408.Triglycerides in VLDL,BCAN,Brevican core protein,42495,-0.00501569704807188,0.00363378114598118,-0.012137908094195,0.00210651399805123,0.167518429069469
NMR metabolomics,X23408.Triglycerides in VLDL,MRC1,Macrophage mannose receptor 1,40532,0.00422165253824268,0.00306244526277388,-0.00178074017679412,0.0102240452532795,0.168068938454236
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0111972771537668,0.00815396640015087,-0.00478449699052893,0.0271790512980625,0.169704022392586
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.00707581446973604,0.00515900551711094,-0.0171874652832735,0.0030358363438014,0.170227612264878
NMR metabolomics,X23408.Triglycerides in VLDL,S100A3,Protein S100-A3,40451,0.00625414559669999,0.00456944906183755,-0.00270197456450161,0.0152102657579016,0.171124442791105
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC2L,C-type lectin domain family 2 member L,40182,0.00706097096661606,0.00518029748951719,-0.00309241211283764,0.0172143540460698,0.172896722740011
NMR metabolomics,X23408.Triglycerides in VLDL,PMCH,Pro-MCH,40116,-0.0121118805300786,0.00890347948374912,-0.0295627003182268,0.00533893925806969,0.173746122571892
NMR metabolomics,X23408.Triglycerides in VLDL,FBN2,Fibrillin-2,40182,0.00870776921847908,0.00640278157716265,-0.00384168267275973,0.0212572211097179,0.173858504508016
NMR metabolomics,X23408.Triglycerides in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.00584780405252204,0.00431220206763002,-0.0142997201050769,0.0026041120000328,0.175088009347871
NMR metabolomics,X23408.Triglycerides in VLDL,MYO6,Unconventional myosin-VI,40482,0.00516609362955538,0.00381745504701059,-0.00231611826258538,0.0126483055216961,0.175992621018752
NMR metabolomics,X23408.Triglycerides in VLDL,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.00567333427242536,0.00420061952348853,-0.0139065485384629,0.00255987999361215,0.176853295925139
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00616566644880452,0.0045693626594103,-0.0151216172612487,0.00279028436363967,0.177252546049433
NMR metabolomics,X23408.Triglycerides in VLDL,CORO6,Coronin-6,40136,-0.00524782658151224,0.00391024548810577,-0.0129119077381996,0.00241625457517507,0.179600862929682
NMR metabolomics,X23408.Triglycerides in VLDL,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00513289802922387,0.00383259057156406,-0.0126447755494894,0.00237897949104169,0.180508416682775
NMR metabolomics,X23408.Triglycerides in VLDL,CTRC,Chymotrypsin-C,42626,0.00928780317397699,0.00694348597961467,-0.00432142934606777,0.0228970356940217,0.181040290187593
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB1,Scavenger receptor class B member 1,42311,0.00815495080745726,0.00610261333062154,-0.00380617132056094,0.0201160729354755,0.181472884757022
NMR metabolomics,X23408.Triglycerides in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.0051082130118891,0.00384546434521731,-0.00242889710473682,0.012645323128515,0.184077749709613
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00780517542080978,0.00588328293186221,-0.0193364099672597,0.00372605912564015,0.184645413727142
NMR metabolomics,X23408.Triglycerides in VLDL,IL5,Interleukin-5,42370,0.0194013817118688,0.0146378846004143,-0.00928887210494327,0.0480916355286809,0.185054036810785
NMR metabolomics,X23408.Triglycerides in VLDL,TLR2,Toll-like receptor 2,40302,0.00325890133950695,0.00245992411967273,-0.00156254993505159,0.00808035261406549,0.185265574643013
NMR metabolomics,X23408.Triglycerides in VLDL,RELB,Transcription factor RelB,40199,0.00684295205409144,0.00521753341970119,-0.0033834134485229,0.0170693175567058,0.189706096762446
NMR metabolomics,X23408.Triglycerides in VLDL,FGA,Fibrinogen alpha chain,40284,0.00422904942696503,0.00324569611041725,-0.00213251494945278,0.0105906138033828,0.192611555390394
NMR metabolomics,X23408.Triglycerides in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.00824008960683881,0.00633807146178673,-0.00418253045826318,0.0206627096719408,0.193596138495437
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR1,TGF-beta receptor type-1,40199,0.00294212257760962,0.00226942578827533,-0.00150595196741002,0.00739019712262925,0.194858980809095
NMR metabolomics,X23408.Triglycerides in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00509752620025628,0.00395602511979377,-0.00265628303453951,0.0128513354350521,0.197581744567299
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00912673562947683,0.00709679837492299,-0.00478298918537223,0.0230364604443259,0.198457722954917
NMR metabolomics,X23408.Triglycerides in VLDL,CHAD,Chondroadherin,40283,0.00694268756004392,0.00544643372585702,-0.00373232254263583,0.0176176976627237,0.202434452971878
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,0.00412329000127387,0.00324479863096731,-0.00223651531542206,0.0104830953179698,0.203848018370997
NMR metabolomics,X23408.Triglycerides in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.00845707166966623,0.00666709339577482,-0.0215245747253849,0.00461043138605241,0.204653620068062
NMR metabolomics,X23408.Triglycerides in VLDL,IL21R,Interleukin-21 receptor,40199,0.00743616638866407,0.00587603580032155,-0.00408086377996617,0.0189531965572943,0.205716313800199
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00502083113208595,0.0039912024285761,-0.0028019256279232,0.0128435878920951,0.208427699557132
NMR metabolomics,X23408.Triglycerides in VLDL,CCNE1,G1/S-specific cyclin-E1,40199,0.0117045864144096,0.0093060418160806,-0.00653525554510839,0.0299444283739275,0.208512279201219
NMR metabolomics,X23408.Triglycerides in VLDL,CNTF,Ciliary neurotrophic factor,40136,-0.00452720078584827,0.00361180014876284,-0.0116063290774234,0.00255192750572689,0.210069784481245
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL12,Stromal cell-derived factor 1,42370,0.00528805537163667,0.00421998087594244,-0.00298310714521052,0.0135592178884839,0.210191782589045
NMR metabolomics,X23408.Triglycerides in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00835247097019422,0.00668580400248431,-0.00475170487467503,0.0214566468150635,0.211587377648664
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.0110935896231248,0.00888919815230428,-0.0285164180016412,0.00632923875539164,0.212063241722097
NMR metabolomics,X23408.Triglycerides in VLDL,DDX1,ATP-dependent RNA helicase DDX1,40449,0.00650617424076709,0.00525223859587437,-0.00378821340714667,0.0168005618886808,0.215466491102031
NMR metabolomics,X23408.Triglycerides in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00774412080415731,0.00628075831517457,-0.00456616549358484,0.0200544071018995,0.217601002866148
NMR metabolomics,X23408.Triglycerides in VLDL,MAG,Myelin-associated glycoprotein,40182,0.0063254517681893,0.00515870811038127,-0.00378561612815799,0.0164365196645366,0.220161083605552
NMR metabolomics,X23408.Triglycerides in VLDL,CLINT1,Clathrin interactor 1,40080,0.00592201545824205,0.00485487188724883,-0.00359353344076566,0.0154375643572498,0.222563790049819
NMR metabolomics,X23408.Triglycerides in VLDL,SHH,Sonic hedgehog protein,40199,-0.00539716699786347,0.00443591532908478,-0.0140915610428696,0.0032972270471427,0.223745431429057
NMR metabolomics,X23408.Triglycerides in VLDL,CD86,T-lymphocyte activation antigen CD86,40449,0.00387376720077118,0.00318687867508471,-0.00237251500239484,0.0101200494039372,0.224187050188366
NMR metabolomics,X23408.Triglycerides in VLDL,GPR101,Probable G-protein coupled receptor 101,40136,-0.00766419292175013,0.00634717549393555,-0.0201046568898638,0.00477627104636354,0.227267047854831
NMR metabolomics,X23408.Triglycerides in VLDL,SAG,S-arrestin,40136,-0.00662204622795442,0.00550653579891721,-0.0174148563938322,0.00417076393792331,0.229165165609731
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.00777331584301454,0.00648002572426752,-0.00492753457654979,0.0204741662625789,0.230323470492528
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.0066831246337739,0.00563161026426652,-0.00435483148418848,0.0177210807517363,0.235365242161396
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC7A,C-type lectin domain family 7 member A,42754,0.00756579753171813,0.00637787764654557,-0.00493484265551117,0.0200664377189474,0.235541883273756
NMR metabolomics,X23408.Triglycerides in VLDL,IL4,Interleukin-4,42370,0.0116181978740483,0.00983545818597752,-0.00765930017046767,0.0308956959185642,0.237522205067654
NMR metabolomics,X23408.Triglycerides in VLDL,NCAN,Neurocan core protein,42711,-0.00469401658640275,0.00398344492106016,-0.0125015686316807,0.00311353545887516,0.23866541505898
NMR metabolomics,X23408.Triglycerides in VLDL,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00361604171058456,0.00307388907443757,-0.00240878087531309,0.0096408642964822,0.239467604275237
NMR metabolomics,X23408.Triglycerides in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00667380505449034,0.00567811465651585,-0.00445529967228073,0.0178029097812614,0.239877586933436
NMR metabolomics,X23408.Triglycerides in VLDL,H2AP,Huntingtin-interacting protein M,40080,-0.00649866038809655,0.00553572182299995,-0.0173486751611765,0.00435135438498335,0.240440753216989
NMR metabolomics,X23408.Triglycerides in VLDL,CDH22,Cadherin-22,40302,-0.00346587602096685,0.00295237483439844,-0.00925253069638778,0.00232077865445409,0.240448961638376
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS2,Podocin,40199,-0.0129468095596549,0.0110305187554021,-0.034566626320243,0.00867300720093321,0.240530087615517
NMR metabolomics,X23408.Triglycerides in VLDL,RTKN2,Rhotekin-2,40116,-0.00634824123828984,0.00542205395737134,-0.0169754669947377,0.00427898451815797,0.24169727214912
NMR metabolomics,X23408.Triglycerides in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00452723663694037,0.0038702074767405,-0.00305837001747102,0.0121128432913518,0.242120298176174
NMR metabolomics,X23408.Triglycerides in VLDL,ERCC1,DNA excision repair protein ERCC-1,40080,0.00419125337550731,0.00359116162068601,-0.00284742340103727,0.0112299301520519,0.243194579618714
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00667731552285139,0.00572243016623802,-0.0178932786486779,0.00453864760297513,0.243289138651084
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.0047857130084732,0.00410198260429411,-0.00325417289594326,0.0128255989128897,0.243363918890087
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00942757052258294,0.00818868688461249,-0.00662225577125754,0.0254773968164234,0.249637242258532
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1,Huntingtin-interacting protein 1,40116,0.00403556994127323,0.00351068723127166,-0.00284537703201923,0.0109165169145657,0.250370932408674
NMR metabolomics,X23408.Triglycerides in VLDL,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00380746852019321,0.00331522251495138,-0.0103053046494979,0.0026903676091115,0.250795480233559
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL2,Kin of IRRE-like protein 2,42311,0.00484156988558818,0.00424059925794293,-0.00347000465997996,0.0131531444311563,0.25359196248465
NMR metabolomics,X23408.Triglycerides in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42547,0.00335634675872073,0.00294751471308557,-0.00242078207892698,0.00913347559636845,0.254847067193402
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00410861189066533,0.0036250598758275,-0.00299650546595656,0.0112137292472872,0.257069879604647
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.0053191632157788,0.00470303925525016,-0.0145371201560691,0.00389879372451152,0.258072894645729
NMR metabolomics,X23408.Triglycerides in VLDL,FSHB,Follitropin subunit beta,40223,-0.00641819624922737,0.00568737586293046,-0.0175654529405711,0.00472906044211634,0.25913391360254
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.00714851308515888,0.00634644932633261,-0.00529052759445304,0.0195875537647708,0.260024925732143
NMR metabolomics,X23408.Triglycerides in VLDL,CDC123,Cell division cycle protein 123 homolog,40080,0.00745496383797651,0.00663579504523946,-0.00555119445069284,0.0204611221266459,0.261272485167089
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00484141942512134,0.00431000969195893,-0.0132890384213608,0.00360619957111816,0.261336070038643
NMR metabolomics,X23408.Triglycerides in VLDL,CD82,CD82 antigen,40302,-0.00483325459482545,0.0043033018325933,-0.0132677261867083,0.00360121699705741,0.261397954933612
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0148948940352748,0.0133227892147499,-0.0112177728256351,0.0410075608961847,0.263586911049999
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA10,Ephrin type-A receptor 10,42311,-0.00776395323530555,0.00702939056566066,-0.0215415587440004,0.00601365227338934,0.269397096607228
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00354084958298559,0.00322453344355478,-0.00277923596638178,0.00986093513235296,0.272182361968416
NMR metabolomics,X23408.Triglycerides in VLDL,HRAS,GTPase Hras,40286,0.0114866137846154,0.0104694676611635,-0.00903354283126497,0.0320067704004958,0.272598084904137
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2A,Pancreatic alpha-amylase,42114,-0.00562439281887986,0.00513960801236656,-0.0156980245231183,0.00444923888535861,0.273833609170862
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR4,Fibroblast growth factor receptor 4,40283,0.00607046700196289,0.00557032477775439,-0.00484736956243573,0.0169883035663615,0.275830704553565
NMR metabolomics,X23408.Triglycerides in VLDL,LYPLA2,Acyl-protein thioesterase 2,40136,0.0128074015438763,0.0117708929176413,-0.0102635485747006,0.0358783516624532,0.276593943402311
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.00894809130596501,0.00824449020993222,-0.0251072921174322,0.00721110950550215,0.277794131560053
NMR metabolomics,X23408.Triglycerides in VLDL,ASPN,Asporin,40511,0.00320173360262152,0.00295025309248863,-0.00258076245865619,0.00898422966389923,0.27783834855105
NMR metabolomics,X23408.Triglycerides in VLDL,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00878705893940046,0.00810206768225898,-0.00709299371782713,0.0246671115966281,0.278146914773578
NMR metabolomics,X23408.Triglycerides in VLDL,CBX2,Chromobox protein homolog 2,40116,-0.00457190157666809,0.00421751049483596,-0.0128382221465466,0.00369441899321039,0.278376091071896
NMR metabolomics,X23408.Triglycerides in VLDL,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.0083615396606065,0.00777955853631607,-0.023609474391786,0.00688639507057299,0.282483588293179
NMR metabolomics,X23408.Triglycerides in VLDL,GLI2,Zinc finger protein GLI2,40199,-0.00362022413722908,0.00337014068236382,-0.0102256998746622,0.00298525160020401,0.2827540759028
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00675885339002674,0.00629410325697356,-0.0190952957736949,0.00557758899364143,0.282918581666395
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00418208650454161,0.00390195053285316,-0.0118299095489338,0.00346573653985059,0.283836184872753
NMR metabolomics,X23408.Triglycerides in VLDL,NUP50,Nuclear pore complex protein Nup50,40116,-0.00389556930036907,0.00364750160237548,-0.011044672441025,0.00325353384028688,0.28553946798687
NMR metabolomics,X23408.Triglycerides in VLDL,TNPO1,Transportin-1,40302,0.00397513045161923,0.00372255585318505,-0.00332107902062346,0.0112713399238619,0.285611484918905
NMR metabolomics,X23408.Triglycerides in VLDL,MYL4,Myosin light chain 4,40223,0.00582349223634707,0.00548036792567885,-0.00491802889798347,0.0165650133706776,0.287982242473757
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A14,Zinc transporter ZIP14,42311,-0.00383726423860831,0.00362249126069755,-0.0109373471095755,0.00326281863235889,0.28948780242972
NMR metabolomics,X23408.Triglycerides in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00334172447099145,0.00317165940229982,-0.0095581768994991,0.00287472795751619,0.292080093999899
NMR metabolomics,X23408.Triglycerides in VLDL,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00396647078399752,0.0037700660165386,-0.00342285860841814,0.0113558001764132,0.292774550847708
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN4,Nectin-4,42679,-0.00380249607347034,0.0036217028051142,-0.0109010335714942,0.0032960414245535,0.293773981818895
NMR metabolomics,X23408.Triglycerides in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.00274620722266261,0.00261954652816474,-0.00238810397254027,0.0078805184178655,0.294495310627201
NMR metabolomics,X23408.Triglycerides in VLDL,TSLP,Thymic stromal lymphopoietin,42357,0.00671106350210329,0.00640170282385254,-0.00583627403264768,0.0192584010368543,0.294508258819376
NMR metabolomics,X23408.Triglycerides in VLDL,MYH4,Myosin-4,40116,-0.00496842142271821,0.00476466254634005,-0.0143071600135447,0.00437031716810828,0.297080411428298
NMR metabolomics,X23408.Triglycerides in VLDL,SLC44A4,Choline transporter-like protein 4,40182,-0.00780298701068479,0.00749898555054,-0.0225009986897432,0.0068950246683736,0.298112443903374
NMR metabolomics,X23408.Triglycerides in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00348054935486239,0.00334539012091675,-0.0100375139918592,0.00307641528213444,0.298172467087672
NMR metabolomics,X23408.Triglycerides in VLDL,ERVV_1,,40116,-0.00475733749772826,0.00458554391655663,-0.0137450035741792,0.00423032857872273,0.299542554875554
NMR metabolomics,X23408.Triglycerides in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00441409181878108,0.00428910965759845,-0.012820746747674,0.00399256311011187,0.303436216070794
NMR metabolomics,X23408.Triglycerides in VLDL,MN1,Transcriptional activator MN1,40182,-0.00637732219381534,0.00623484507161747,-0.0185976185341856,0.0058429741465549,0.306400463663417
NMR metabolomics,X23408.Triglycerides in VLDL,ZPR1,Zinc finger protein ZPR1,40136,0.0104636500614997,0.0102461070955757,-0.00961871984582871,0.0305460199688282,0.307167222564014
NMR metabolomics,X23408.Triglycerides in VLDL,CHGB,Secretogranin-1,42664,-0.00460253090926991,0.00450788242579906,-0.0134379804638361,0.00423291864529625,0.307274566842846
NMR metabolomics,X23408.Triglycerides in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00625955743194864,0.00617058908739176,-0.00583479717933921,0.0183539120432365,0.310405823032496
NMR metabolomics,X23408.Triglycerides in VLDL,FZD10,Frizzled-10,40182,0.00642049848847282,0.00638073007752397,-0.00608573246347416,0.0189267294404198,0.314325861024451
NMR metabolomics,X23408.Triglycerides in VLDL,GDF15,Growth/differentiation factor 15,42794,0.00487665017388852,0.00485052741257583,-0.0046303835547601,0.0143836839025371,0.314729121969784
NMR metabolomics,X23408.Triglycerides in VLDL,FH,"Fumarate hydratase, mitochondrial",40136,0.00903936295421026,0.00899562008689358,-0.00859205241610116,0.0266707783245217,0.314985195259408
NMR metabolomics,X23408.Triglycerides in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00299755658538733,0.00298595764188116,-0.00285492039269974,0.0088500335634744,0.315456362003709
NMR metabolomics,X23408.Triglycerides in VLDL,CHP1,Calcineurin B homologous protein 1,40136,0.00777144032818701,0.00778925273559822,-0.00749549503358551,0.0230383756899595,0.318440509879395
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.00327606480878416,0.00329667975801641,-0.00318542751692801,0.00973755713449632,0.320363854531408
NMR metabolomics,X23408.Triglycerides in VLDL,BMP4,Bone morphogenetic protein 4,42475,-0.00485474178748853,0.0048878592555368,-0.0144349459283407,0.00472546235336359,0.320618634267638
NMR metabolomics,X23408.Triglycerides in VLDL,CAPN3,Calpain-3,40451,-0.00398557177018359,0.00401455915544089,-0.0118541077148477,0.00388296417448057,0.320838792854964
NMR metabolomics,X23408.Triglycerides in VLDL,BRD2,Bromodomain-containing protein 2,40136,0.00370685410976018,0.00375810503376592,-0.00365903175642103,0.0110727399759414,0.323977039415955
NMR metabolomics,X23408.Triglycerides in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.00704324089021764,0.00714832480533863,-0.0210539575086814,0.00696747572824608,0.324494781708913
NMR metabolomics,X23408.Triglycerides in VLDL,SHD,SH2 domain-containing adapter protein D,40083,-0.00908747754103089,0.00923501796850804,-0.0271881127593067,0.00901315767724487,0.325125670704186
NMR metabolomics,X23408.Triglycerides in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.00739409877323344,0.0075180915695885,-0.00734136070316003,0.0221295582496269,0.325375421378961
NMR metabolomics,X23408.Triglycerides in VLDL,NEFL,Neurofilament light polypeptide,42262,0.00476774558337454,0.00485429106864543,-0.0047466649111705,0.0142821560779196,0.326033625352861
NMR metabolomics,X23408.Triglycerides in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.0057697599181065,0.0059052903013061,-0.00580460907245345,0.0173441289086665,0.328566332618499
NMR metabolomics,X23408.Triglycerides in VLDL,MATN3,Matrilin-3,42475,-0.00334384352668579,0.00343579456589976,-0.0100780008758493,0.00339031382247774,0.330453087140499
NMR metabolomics,X23408.Triglycerides in VLDL,KLK15,Kallikrein-15,40429,0.00544753453146388,0.00560444356432492,-0.00553717485461297,0.0164322439175407,0.331070108372699
NMR metabolomics,X23408.Triglycerides in VLDL,IL1A,Interleukin-1 alpha,42370,0.00593921142407368,0.00612173800998639,-0.00605939507549963,0.017937817923647,0.331972662138198
NMR metabolomics,X23408.Triglycerides in VLDL,IL17F,Interleukin-17F,42370,0.00768765736471214,0.00793620284488176,-0.00786730021125611,0.0232426149406804,0.332721623832308
NMR metabolomics,X23408.Triglycerides in VLDL,GFAP,Glial fibrillary acidic protein,42326,0.00496815649905078,0.00513615223200335,-0.0050987018756758,0.0150350148737774,0.333416135334593
NMR metabolomics,X23408.Triglycerides in VLDL,EVI2B,Protein EVI2B,40080,-0.00415733808411349,0.00430323186897943,-0.0125916725473132,0.00427699637908619,0.334017259874517
NMR metabolomics,X23408.Triglycerides in VLDL,IL13,Interleukin-13,42370,-0.00480743412405934,0.00498596971053532,-0.0145799347567086,0.00496506650858989,0.334967167086813
NMR metabolomics,X23408.Triglycerides in VLDL,IL20,Interleukin-20,42370,-0.00497804407451329,0.00516332045488325,-0.0150981521660845,0.00514206401705787,0.335005056979227
NMR metabolomics,X23408.Triglycerides in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.0048672183563666,0.0050667714928255,-0.0147980904823046,0.00506365376957138,0.336766884233693
NMR metabolomics,X23408.Triglycerides in VLDL,IL17A,Interleukin-17A,42347,-0.00435297642292757,0.00453189411123924,-0.0132354888809565,0.00452953603510133,0.336811061041324
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.00325680745979039,0.00341228036058876,-0.00994487696654437,0.00343126204696358,0.339883166712234
NMR metabolomics,X23408.Triglycerides in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00659512960601605,0.00691302909451641,-0.00695440741923611,0.0201446666312682,0.340097090884463
NMR metabolomics,X23408.Triglycerides in VLDL,CCND2,G1/S-specific cyclin-D2,40302,0.00368622718590157,0.00387707586072435,-0.00391284150111815,0.0112852958729213,0.341739241779522
NMR metabolomics,X23408.Triglycerides in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.00618946339782032,0.00652205080926088,-0.00659375618833101,0.0189726829839717,0.342638551762744
NMR metabolomics,X23408.Triglycerides in VLDL,KLK12,Kallikrein-12,42346,0.0138889104474805,0.0146609497460695,-0.0148465510548158,0.0426243719497768,0.343482740118892
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB5,Integrin beta-5,42679,-0.00368859124418658,0.00390079703304986,-0.0113341534289643,0.00395697094059115,0.344369904768222
NMR metabolomics,X23408.Triglycerides in VLDL,IL31,Interleukin-31,40199,0.00559579383836285,0.00591806936265941,-0.00600362211244958,0.0171952097891753,0.344402076069409
NMR metabolomics,X23408.Triglycerides in VLDL,GAGE2A,G antigen 2A,40080,0.00661725581509532,0.00700649200815626,-0.00711546852089095,0.0203499801510816,0.344962565283093
NMR metabolomics,X23408.Triglycerides in VLDL,PSCA,Prostate stem cell antigen,40449,0.0263784647637906,0.0279476887636875,-0.0283990052130369,0.0811559347406182,0.345265857611478
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD2,Leiomodin-2,40136,0.00614236429436028,0.00655554054235361,-0.0067064951686528,0.0189912237573734,0.348793141336976
NMR metabolomics,X23408.Triglycerides in VLDL,ACTA2,"Actin, aortic smooth muscle",42357,-0.0043060764808122,0.00460996053864466,-0.0133415991365557,0.00472944617493134,0.35027925387285
NMR metabolomics,X23408.Triglycerides in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00266634376090556,0.00285645800848469,-0.00293231393572444,0.00826500145753556,0.350610618116572
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD4,Sushi domain-containing protein 4,40451,-0.00408530113765449,0.00440738876557286,-0.0127237831181773,0.00455318084286831,0.353987432689449
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00489600888809374,0.00528611887032702,-0.00546478409774722,0.0152568018739347,0.354361930316453
NMR metabolomics,X23408.Triglycerides in VLDL,CD177,CD177 antigen,42595,-0.0127888901153944,0.0138287390725332,-0.0398932186975595,0.0143154384667707,0.355083885787408
NMR metabolomics,X23408.Triglycerides in VLDL,CGN,Cingulin,40182,0.0040062299078348,0.0043335845574779,-0.00448759582482189,0.0125000556404915,0.355266649463217
NMR metabolomics,X23408.Triglycerides in VLDL,MUCL3,Mucin-like protein 3,40080,-0.00413099098580554,0.00447430716978287,-0.01290063303858,0.00463865106696889,0.355887282845682
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL2,Interferon lambda-2,40136,0.00598488004960901,0.00650608056440316,-0.00676703785662118,0.0187367979558392,0.35765039529676
NMR metabolomics,X23408.Triglycerides in VLDL,TAGLN3,Transgelin-3,40080,0.00592130671260959,0.00644257211178259,-0.00670613462648429,0.0185487480517035,0.358068610823029
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP4,Contactin-associated protein-like 4,40182,0.00987415264886431,0.0108185714984794,-0.0113302474881554,0.031078552785884,0.361418304567472
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN4,Alpha-actinin-4,42370,0.00313513892718983,0.00343792176726255,-0.00360318773664476,0.00987346559102443,0.361823028262279
NMR metabolomics,X23408.Triglycerides in VLDL,CDH4,Cadherin-4,40136,0.00474249746161575,0.00522784957693859,-0.00550408770918387,0.0149890826324154,0.364342024375052
NMR metabolomics,X23408.Triglycerides in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00678187234498993,0.00749494819722915,-0.00790822612157921,0.0214719708115591,0.365559857353413
NMR metabolomics,X23408.Triglycerides in VLDL,SKIV2L,Helicase SKI2W,40116,-0.00376221498210009,0.00418343259377828,-0.0119617428659055,0.00443731290170534,0.368505833624353
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00320665951445509,0.00356616572491371,-0.010196344335286,0.00378302530637579,0.368571445077777
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA2,Protein disulfide-isomerase A2,40080,-0.00398051189309009,0.00442932059542631,-0.0126619802601257,0.00470095647394549,0.368846610874761
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAX,Integrin alpha-X,40302,0.00513223553980879,0.00571781171556829,-0.00607467542270505,0.0163391465023226,0.369425032303349
NMR metabolomics,X23408.Triglycerides in VLDL,SLC1A4,Neutral amino acid transporter A,40182,0.00488163137143351,0.00547986465801818,-0.00585890335828213,0.0156221661011491,0.373039536708721
NMR metabolomics,X23408.Triglycerides in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.00559561281595206,0.00628359392597566,-0.00672023127896023,0.0179114569108644,0.373207457191055
NMR metabolomics,X23408.Triglycerides in VLDL,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00366328830211136,0.00414215939730792,-0.00445534411661217,0.0117819207208349,0.376504672078964
NMR metabolomics,X23408.Triglycerides in VLDL,IL9,Interleukin-9,40302,0.00521885722255731,0.00590901396010928,-0.00636281013925687,0.0168005245843715,0.37714586397048
NMR metabolomics,X23408.Triglycerides in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00386504458187575,0.00440544434817611,-0.0124997155043009,0.00476962634054942,0.380324700572246
NMR metabolomics,X23408.Triglycerides in VLDL,HYAL1,Hyaluronidase-1,42544,0.00210952361436573,0.002432136582384,-0.00265746408710691,0.00687651131583837,0.385763617561814
NMR metabolomics,X23408.Triglycerides in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.00525221371724464,0.00606206502184602,-0.00662943372557356,0.0171338611600628,0.386282771747505
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00358410386881294,0.00414410964626962,-0.0117065587755014,0.0045383510378755,0.387130098382877
NMR metabolomics,X23408.Triglycerides in VLDL,EFNB2,Ephrin-B2,40182,0.00495267188953348,0.00573751440416895,-0.00629285634263765,0.0161982001217046,0.388041615825744
NMR metabolomics,X23408.Triglycerides in VLDL,IL17C,Interleukin-17C,42370,-0.00674146327072283,0.00784241078906575,-0.0221125884172917,0.00862966187584603,0.390016287735409
NMR metabolomics,X23408.Triglycerides in VLDL,HBQ1,Hemoglobin subunit theta-1,42721,-0.00542614295680932,0.00632006649475665,-0.0178134732865324,0.00696118737291371,0.390599691567685
NMR metabolomics,X23408.Triglycerides in VLDL,TCN1,Transcobalamin-1,40337,0.00306268429046971,0.00358445262561232,-0.00396284285573044,0.0100882114366698,0.392881990806522
NMR metabolomics,X23408.Triglycerides in VLDL,GPA33,Cell surface A33 antigen,42587,0.0124281310172826,0.0145637788304966,-0.0161168754904907,0.0409731375250559,0.39347553963981
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RG,Cytokine receptor common subunit gamma,40451,0.00325980269152013,0.00384447724916192,-0.00427537271683723,0.0107949780998775,0.396501488976539
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6B,Ras-related protein Rab-6B,42311,0.00436128558651891,0.00517181162772951,-0.00577546520383093,0.0144980363768688,0.399087212657982
NMR metabolomics,X23408.Triglycerides in VLDL,NOS1,"Nitric oxide synthase, brain",42311,-0.00476890288557426,0.00569305508783958,-0.0159272908577398,0.00638948508659132,0.402231188016352
NMR metabolomics,X23408.Triglycerides in VLDL,OSTN,Osteocrin,40182,-0.00366541203496545,0.00439917316778894,-0.0122877914438318,0.00495696737390088,0.404747367384667
NMR metabolomics,X23408.Triglycerides in VLDL,HSP90B1,Endoplasmin,42247,-0.00581265668113594,0.00700278468139173,-0.0195381146566637,0.00791280129439185,0.40652607808946
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC2,MAM domain-containing protein 2,40511,-0.00318070120982375,0.00383314219166408,-0.0106936599054853,0.00433225748583784,0.406675301241926
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L,Seizure 6-like protein,42679,-0.00243755582461971,0.00294442125859567,-0.00820862149146722,0.00333350984222781,0.407766894785355
NMR metabolomics,X23408.Triglycerides in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00381273149830853,0.00461247043165324,-0.00522771054773182,0.0128531735443489,0.40847354237191
NMR metabolomics,X23408.Triglycerides in VLDL,ENPEP,Glutamyl aminopeptidase,40116,-0.00411672717605812,0.00501217474330366,-0.0139405896729333,0.00570713532081705,0.411467424402902
NMR metabolomics,X23408.Triglycerides in VLDL,UBQLN3,Ubiquilin-3,40116,0.00464612906799296,0.00570030249807104,-0.00652646382822628,0.0158187219642122,0.415051670740194
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.00292874136526679,0.00361481562972857,-0.0100137799995348,0.00415629726900121,0.417836786630887
NMR metabolomics,X23408.Triglycerides in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00214246321730715,0.00265033719852734,-0.00733712412642074,0.00305219769180644,0.418893080638629
NMR metabolomics,X23408.Triglycerides in VLDL,CPLX2,Complexin-2,40080,-0.00269518360921615,0.00333747688309528,-0.0092366383000829,0.00384627108165061,0.419366608094603
NMR metabolomics,X23408.Triglycerides in VLDL,BSND,Barttin,40080,0.00288703857134444,0.00358826568679643,-0.00414596217477656,0.00992003931746544,0.421080982603474
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC8,Histone deacetylase 8,40199,0.00494121401870587,0.006206901754603,-0.00722431342031602,0.0171067414577277,0.426000493195408
NMR metabolomics,X23408.Triglycerides in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00335297843606808,0.0042138888247852,-0.00490624366051092,0.0116122005326471,0.426225368876721
NMR metabolomics,X23408.Triglycerides in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00398189051216942,0.00504654668413628,-0.00590934098873769,0.0138731220130765,0.430110003450326
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1,Integrin beta-1,42638,-0.0017649869851278,0.00224117768171615,-0.00615769524129146,0.00262772127103586,0.430987561219324
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_A,,40482,-0.0027404477950827,0.00348437092962131,-0.00956981481714047,0.00408891922697507,0.431592800498291
NMR metabolomics,X23408.Triglycerides in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00298300852100178,0.0038095293800075,-0.0104496861058165,0.00448366906381291,0.433621427974759
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.00388150131256194,0.00497376823939892,-0.00586708443665994,0.0136300870617838,0.435175340947267
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00232632083857859,0.00298499904249632,-0.00817691896187139,0.0035242772847142,0.435794742429194
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00223961476180113,0.00287444864338535,-0.00339430457923416,0.00787353410283642,0.435907354734058
NMR metabolomics,X23408.Triglycerides in VLDL,GJA8,Gap junction alpha-8 protein,40080,0.00529087619397089,0.00685867873730346,-0.0081521341311439,0.0187338865190857,0.44047872109836
NMR metabolomics,X23408.Triglycerides in VLDL,DCLRE1C,Protein artemis,40080,0.00252696949140447,0.00328453131500178,-0.00391071188599903,0.00896465086880796,0.441699485726257
NMR metabolomics,X23408.Triglycerides in VLDL,INSL4,Early placenta insulin-like peptide,40451,-0.00393104918419672,0.00511329326588554,-0.0139531039853324,0.00609100561693895,0.442034062095735
NMR metabolomics,X23408.Triglycerides in VLDL,IL10,Interleukin-10,42370,0.00685196590460794,0.00891884846305596,-0.0106289770829818,0.0243329088921976,0.44234840798779
NMR metabolomics,X23408.Triglycerides in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00315022655411448,0.00411645639287894,-0.0112184810841572,0.00491802797592825,0.444123563998626
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00540642227822251,0.0071023203110976,-0.0193269700879738,0.00851412553152878,0.446542612561704
NMR metabolomics,X23408.Triglycerides in VLDL,RAP1A,Ras-related protein Rap-1A,40199,0.00565725158170871,0.00745606713448219,-0.00895664000187639,0.0202711431652938,0.448021528366742
NMR metabolomics,X23408.Triglycerides in VLDL,GAD2,Glutamate decarboxylase 2,40199,-0.00365435956691182,0.00484237024278322,-0.0131454052427669,0.00583668610894329,0.450467123828897
NMR metabolomics,X23408.Triglycerides in VLDL,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00638219113069855,0.00846483044373716,-0.0229732588004234,0.0102088765390263,0.450885847911478
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA10,Annexin A10,42311,0.00681776443373967,0.00905403279393133,-0.0109281398423657,0.0245636687098451,0.451458268504425
NMR metabolomics,X23408.Triglycerides in VLDL,TPSG1,Tryptase gamma,40199,0.002097947780446,0.00279211081704065,-0.00337458942095367,0.00757048498184567,0.452437573200822
NMR metabolomics,X23408.Triglycerides in VLDL,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0212402089896597,0.0284651389225023,-0.0345514632984449,0.0770318812777642,0.455572647756978
NMR metabolomics,X23408.Triglycerides in VLDL,GPR158,Probable G-protein coupled receptor 158,40482,0.00281508167178822,0.00378263216755269,-0.00459887737661505,0.0102290407201915,0.456763493679452
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC1,Plexin domain-containing protein 1,42346,0.00245028171068924,0.00331102657220846,-0.00403933037083934,0.00893989379221782,0.459290837793128
NMR metabolomics,X23408.Triglycerides in VLDL,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00540686094418019,0.00730856568073995,-0.0197316496784305,0.00891792779007012,0.459438583719862
NMR metabolomics,X23408.Triglycerides in VLDL,ALMS1,Alstrom syndrome protein 1,40302,-0.00346503669597589,0.0046851716739823,-0.0126479731769812,0.00571789978502942,0.459573433854585
NMR metabolomics,X23408.Triglycerides in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.00228868714163831,0.00311866347520491,-0.00382389326976331,0.00840126755303993,0.46304451464828
NMR metabolomics,X23408.Triglycerides in VLDL,SLC4A1,Band 3 anion transport protein,40527,0.00359924199109768,0.00492427876759988,-0.00605234439339808,0.0132508283755935,0.464844599039482
NMR metabolomics,X23408.Triglycerides in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.00402915969400712,0.0055451720140786,-0.0148976968416012,0.00683937745358693,0.467479491201699
NMR metabolomics,X23408.Triglycerides in VLDL,SELENOP,Selenoprotein P,40539,-0.00174209004740595,0.00241423473869082,-0.00647399013523996,0.00298981004042806,0.470560847930207
NMR metabolomics,X23408.Triglycerides in VLDL,FABP1,"Fatty acid-binding protein, liver",42618,0.0071277955518976,0.00988698765126404,-0.0122507002445799,0.0265062913483751,0.470967033566519
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00205671910354265,0.00288635537768209,-0.00771397564379955,0.00360053743671425,0.476126496472968
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00335905809926176,0.00471446460505246,-0.0125994087251646,0.00588129252664106,0.476169707202154
NMR metabolomics,X23408.Triglycerides in VLDL,DCTPP1,dCTP pyrophosphatase 1,42636,0.00235856150590077,0.00331834585586968,-0.0041453963716038,0.00886251938340535,0.477242687650045
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00278649968131545,0.0039722469618195,-0.00499910436385077,0.0105721037264817,0.483010937845612
NMR metabolomics,X23408.Triglycerides in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00353234400790994,0.00507700869746258,-0.0134832810549366,0.00641859303911672,0.48659585712067
NMR metabolomics,X23408.Triglycerides in VLDL,MORC3,MORC family CW-type zinc finger protein 3,40483,0.00206078864750361,0.00297141917586825,-0.00376319293719817,0.00788477023220539,0.487986987636207
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.0027027470924261,0.0038984859539642,-0.0103437795621959,0.00493828537734373,0.488147351324532
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN6,Prefoldin subunit 6,40182,0.0047186103669201,0.00681252259413335,-0.00863393391758127,0.0180711546514215,0.488551547156208
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00585503827268176,0.00852274563985218,-0.022559619726792,0.0108495431814285,0.492103575354088
NMR metabolomics,X23408.Triglycerides in VLDL,TET2,Methylcytosine dioxygenase TET2,40286,0.00738149127746316,0.0107518733004325,-0.0136921803913845,0.0284551629463108,0.492392852722561
NMR metabolomics,X23408.Triglycerides in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00182107958302991,0.00265431106798503,-0.00338137011022075,0.00702352927628058,0.492674358381884
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAC1,Cartilage acidic protein 1,42794,-0.00214578478900828,0.00313250067430449,-0.00828548611064507,0.00399391653262852,0.493351198238562
NMR metabolomics,X23408.Triglycerides in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.01233683176571,0.0180753437320134,-0.0477645054804563,0.0230908419490362,0.494920465390404
NMR metabolomics,X23408.Triglycerides in VLDL,MMP15,Matrix metalloproteinase-15,40511,0.00349547134395879,0.00512848893926307,-0.00655636697699683,0.0135473096649144,0.495519023644541
NMR metabolomics,X23408.Triglycerides in VLDL,PLB1,"Phospholipase B1, membrane-associated",40483,-0.00429598183132772,0.00631191804661493,-0.016667341202693,0.00807537754003754,0.496129519856127
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42611,0.00262127027801985,0.00385424445183241,-0.00493304884757167,0.0101755894036114,0.496453104490789
NMR metabolomics,X23408.Triglycerides in VLDL,IL11,Interleukin-11,42370,0.00447307138016491,0.00658044258397785,-0.00842459608443168,0.0173707388447615,0.496673217719193
NMR metabolomics,X23408.Triglycerides in VLDL,PITHD1,PITH domain-containing protein 1,40065,-0.0057508551697143,0.00848476798415718,-0.0223810004186624,0.0108792900792338,0.497921947106923
NMR metabolomics,X23408.Triglycerides in VLDL,CASP4,Caspase-4,40302,0.0120847999578176,0.0181468523192171,-0.023483030587848,0.0476526305034831,0.505460282381003
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.0025800588935426,0.00387628869706519,-0.00501746695270517,0.0101775847397904,0.50568059030508
NMR metabolomics,X23408.Triglycerides in VLDL,FGF3,Fibroblast growth factor 3,40199,0.00202947730602646,0.00305555576679667,-0.00395941199689502,0.00801836660894794,0.506581011092241
NMR metabolomics,X23408.Triglycerides in VLDL,DCN,Decorin,42357,-0.0016731779178083,0.00252107188202068,-0.00661447880656883,0.00326812297095224,0.506908560992695
NMR metabolomics,X23408.Triglycerides in VLDL,TFF3,Trefoil factor 3,42613,0.00299539126341518,0.00451743303485938,-0.0058587774849092,0.0118495600117396,0.507294711081337
NMR metabolomics,X23408.Triglycerides in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00485479275443074,0.0073742899636756,-0.00959881557437342,0.0193084010832349,0.510333296327833
NMR metabolomics,X23408.Triglycerides in VLDL,EPB41L5,Band 4.1-like protein 5,40182,0.00421777876685245,0.00644399518417776,-0.00841245179413596,0.0168480093278409,0.512785044954691
NMR metabolomics,X23408.Triglycerides in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00312540698746059,0.00478620946486992,-0.00625556356368446,0.0125063775386056,0.513766079020168
NMR metabolomics,X23408.Triglycerides in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.001942632623309,0.00298358112624401,-0.00390518638412927,0.00779045163074726,0.514990565698242
NMR metabolomics,X23408.Triglycerides in VLDL,STEAP4,Metalloreductase STEAP4,40136,0.00497607415624147,0.00765327603039904,-0.0100243468633406,0.0199764951758236,0.515583942166512
NMR metabolomics,X23408.Triglycerides in VLDL,NENF,Neudesin,40451,0.00748818739315996,0.0115567727834935,-0.0151630872624872,0.0301394620488071,0.517031821875641
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.00350330519810585,0.00545779937328673,-0.0142005919697478,0.00719398157353613,0.52095586462154
NMR metabolomics,X23408.Triglycerides in VLDL,OMP,Olfactory marker protein,40136,-0.00338030621142284,0.00528874925937944,-0.0137462547598066,0.00698564233696086,0.522738473758997
NMR metabolomics,X23408.Triglycerides in VLDL,GH2,Growth hormone variant,42346,0.0111072009298512,0.0175187281836639,-0.02322950631013,0.0454439081698325,0.52607965741744
NMR metabolomics,X23408.Triglycerides in VLDL,PALLD,Palladin,40199,-0.002582780831159,0.0040928637377477,-0.0106047937571445,0.0054392320948265,0.528024265227466
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,40483,-0.00207195377625306,0.00329391785171346,-0.00852803276561144,0.00438412521310532,0.529345993536658
NMR metabolomics,X23408.Triglycerides in VLDL,KLHL41,Kelch-like protein 41,40482,-0.00316021012219829,0.00503301082465092,-0.0130249113385141,0.0067044910941175,0.530084414685039
NMR metabolomics,X23408.Triglycerides in VLDL,REG1B,Lithostathine-1-beta,42794,0.00385127823135052,0.00614128931849846,-0.00818564883290647,0.0158882052956075,0.530596135082463
NMR metabolomics,X23408.Triglycerides in VLDL,DHODH,Dihydroorotate dehydrogenase,40116,0.00319642307283986,0.00511035464843599,-0.00681987203809468,0.0132127181837744,0.531669338749002
NMR metabolomics,X23408.Triglycerides in VLDL,PSMA1,Proteasome subunit alpha type-1,42346,0.00302838210863247,0.00485469273606901,-0.0064868156540628,0.0125435798713277,0.532766405797782
NMR metabolomics,X23408.Triglycerides in VLDL,MMP9,Matrix metalloproteinase-9,42594,0.00391394699266247,0.00630211598991035,-0.00843820034756182,0.0162660943328868,0.534575425092722
NMR metabolomics,X23408.Triglycerides in VLDL,CD33,Myeloid cell surface antigen CD33,42679,0.0052197746363938,0.00840785566148248,-0.0112596224601119,0.0216991717328994,0.534727797041525
NMR metabolomics,X23408.Triglycerides in VLDL,RASA1,Ras GTPase-activating protein 1,42311,0.00210516217543438,0.00339960235656432,-0.00455805844343169,0.00876838279430045,0.535770489216336
NMR metabolomics,X23408.Triglycerides in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00403855917092799,0.00665604553970244,-0.00900729008688878,0.0170844084287448,0.544029135033423
NMR metabolomics,X23408.Triglycerides in VLDL,ISM2,Isthmin-2,40527,0.00275734916845825,0.0045507972836325,-0.00616221350746144,0.0116769118443779,0.544590215705063
NMR metabolomics,X23408.Triglycerides in VLDL,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00180859855947242,0.00298988847701476,-0.00766877997442135,0.0040515828554765,0.545254210826935
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00452378910705226,0.00748290927685575,-0.0191902912896895,0.010142713075585,0.545490900926923
NMR metabolomics,X23408.Triglycerides in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00190054784029226,0.00315584348402952,-0.00428490538840559,0.00808600106899011,0.547032207511497
NMR metabolomics,X23408.Triglycerides in VLDL,CDSN,Corneodesmosin,42710,-0.00280544224730846,0.00467262396586681,-0.0119637852204074,0.00635290072579049,0.5482499229064
NMR metabolomics,X23408.Triglycerides in VLDL,PGR,Progesterone receptor,40199,0.00613673568942145,0.0102716634159591,-0.0139957246058584,0.0262691959847012,0.55022379605035
NMR metabolomics,X23408.Triglycerides in VLDL,GAL,Galanin peptides,42676,0.00401499650014881,0.0067376453134179,-0.00919078831415027,0.0172207813144479,0.551248699507307
NMR metabolomics,X23408.Triglycerides in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.00892922579653268,0.0150617636765349,-0.0205918310094757,0.0384502826025411,0.553300113879136
NMR metabolomics,X23408.Triglycerides in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00295779635327922,0.00499262400389373,-0.0127433394009109,0.00682774669435249,0.553570431297257
NMR metabolomics,X23408.Triglycerides in VLDL,IKZF2,Zinc finger protein Helios,42346,0.00546390515343266,0.00923786929213858,-0.012642318659159,0.0235701289660243,0.554216977264472
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00331885819157929,0.00562197133080253,-0.0143379219999523,0.00770020561679366,0.554976707064447
NMR metabolomics,X23408.Triglycerides in VLDL,EPGN,Epigen,40451,0.00281700909724502,0.00477858613195881,-0.00654901972139425,0.0121830379158843,0.555533171685959
NMR metabolomics,X23408.Triglycerides in VLDL,REST,RE1-silencing transcription factor,40080,-0.00212238732617287,0.00360553404603141,-0.00918923405639442,0.00494445940404869,0.556110213389802
NMR metabolomics,X23408.Triglycerides in VLDL,INHBB,Inhibin beta B chain,40283,0.00334829404083522,0.00571939212134581,-0.00786171451700257,0.014558302598673,0.558271673452611
NMR metabolomics,X23408.Triglycerides in VLDL,PYDC1,Pyrin domain-containing protein 1,40223,-0.00262733704425661,0.0044961496770523,-0.0114397904112791,0.0061851163227659,0.558995018708145
NMR metabolomics,X23408.Triglycerides in VLDL,RGS8,Regulator of G-protein signaling 8,42370,0.00393857829587115,0.00677100600486506,-0.00933259347366436,0.0172097500654067,0.560790254210399
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00459851479122674,0.00794646435204345,-0.0109765553387784,0.0201735849212319,0.562812370284281
NMR metabolomics,X23408.Triglycerides in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00355024792729718,0.00614517629013338,-0.0155947934559586,0.00849429760136425,0.563458833712704
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO1,Amphoterin-induced protein 1,40182,0.00306016216712644,0.00531725367344862,-0.00736165503283285,0.0134819793670857,0.564954463003028
NMR metabolomics,X23408.Triglycerides in VLDL,RLN1,Prorelaxin H1,40482,0.00292540799208685,0.00508561327180577,-0.00704239402065247,0.0128932100048262,0.565145802702603
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP29,Dual specificity phosphatase 29,40182,-0.00404490975498028,0.00708180818800118,-0.0179252538034626,0.00983543429350202,0.567896727778773
NMR metabolomics,X23408.Triglycerides in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,0.00286333884506512,0.00502459491171794,-0.00698486718190203,0.0127115448720323,0.568778966947872
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN1,Calsyntenin-1,42311,-0.00316550541674111,0.0055776221139219,-0.014097644760028,0.00776663392654581,0.57035929224668
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00256339455215457,0.00454445918384649,-0.0114705345524937,0.00634374544818454,0.572717836121569
NMR metabolomics,X23408.Triglycerides in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.00433919791805129,0.00770816355898061,-0.0194471984936533,0.0107688026575507,0.573490426815338
NMR metabolomics,X23408.Triglycerides in VLDL,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00162120756734125,0.0029042055373164,-0.00731345042048141,0.0040710352857989,0.576698265377375
NMR metabolomics,X23408.Triglycerides in VLDL,TPBGL,Trophoblast glycoprotein-like,40182,-0.00244003450947424,0.00441739624769111,-0.0110981311549488,0.00621806213600033,0.58070652718676
NMR metabolomics,X23408.Triglycerides in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00416304998486705,0.00754066030887458,-0.0106166442205271,0.0189427441902612,0.580904568540523
NMR metabolomics,X23408.Triglycerides in VLDL,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00282791766373077,0.0051423433668973,-0.00725107533538793,0.0129069106628495,0.582380043933079
NMR metabolomics,X23408.Triglycerides in VLDL,NRN1,Neuritin,40482,0.00209663774624406,0.00382097054328041,-0.00539246451858555,0.00958574001107367,0.583209407231529
NMR metabolomics,X23408.Triglycerides in VLDL,LCN15,Lipocalin-15,40482,-0.0035789123346078,0.00657457716710916,-0.0164650835821417,0.00930725891292616,0.586207081286277
NMR metabolomics,X23408.Triglycerides in VLDL,MYL6B,Myosin light chain 6B,40182,0.00520401010991602,0.00956510910003225,-0.0135436037261472,0.0239516239459792,0.586410011644716
NMR metabolomics,X23408.Triglycerides in VLDL,CASQ2,Calsequestrin-2,40116,-0.00279588287543893,0.00515999268530708,-0.0129094685386408,0.00731770278776295,0.587940795786664
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK1C,Divergent protein kinase domain 1C,40182,0.00238813103142575,0.00441934995737922,-0.00627379488503751,0.011050056947889,0.588945528628764
NMR metabolomics,X23408.Triglycerides in VLDL,KHDC3L,KH domain-containing protein 3,40080,-0.00390994137638879,0.00725458824864788,-0.0181289343437386,0.0103090515909611,0.589924668685894
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,0.00216042007557932,0.00401883176008394,-0.0057164901741852,0.0100373303253438,0.590879994774024
NMR metabolomics,X23408.Triglycerides in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00351568951491279,0.00657900890707275,-0.0164105469727754,0.00937916794294981,0.593089643359884
NMR metabolomics,X23408.Triglycerides in VLDL,NEB,Nebulin,40116,-0.002104681663304,0.00403492178309853,-0.0100131283581771,0.00580376503156912,0.601947969382639
NMR metabolomics,X23408.Triglycerides in VLDL,RUVBL1,RuvB-like 1,42346,0.00573078514818405,0.0110983889514731,-0.0160220571967032,0.0274836274930712,0.605610355779808
NMR metabolomics,X23408.Triglycerides in VLDL,HBZ,Hemoglobin subunit zeta,40511,0.00573070041789841,0.0111664301576798,-0.016155502691154,0.0276169035269508,0.607815902929711
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA5,Annexin A5,42261,0.00164956757116736,0.00321977964014562,-0.00466120052351805,0.00796033566585276,0.608433541538355
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00307700351935455,0.0060302236391966,-0.00874223481347078,0.0148962418521799,0.609875165982096
NMR metabolomics,X23408.Triglycerides in VLDL,SELL,L-selectin,40539,0.00126652801124527,0.00250268097686457,-0.00363872670340927,0.00617178272589982,0.612818395114446
NMR metabolomics,X23408.Triglycerides in VLDL,FGF20,Fibroblast growth factor 20,40199,-0.00238279920642122,0.00473927821046927,-0.011671784498941,0.00690618608609855,0.615131256825758
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4C,C-type lectin domain family 4 member C,42594,0.00252492245986449,0.00503211450859858,-0.00733802197698872,0.0123878668967177,0.615843382865476
NMR metabolomics,X23408.Triglycerides in VLDL,DAND5,DAN domain family member 5,40199,0.00290484327020867,0.00582091951942812,-0.00850415898787044,0.0143138455282878,0.617764617916422
NMR metabolomics,X23408.Triglycerides in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.00335735879092051,0.00676332711678596,-0.016613479939821,0.00989876235797998,0.619617690100229
NMR metabolomics,X23408.Triglycerides in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.00153647955565337,0.0031057053896241,-0.00455070300800987,0.00762366211931661,0.620801706084977
NMR metabolomics,X23408.Triglycerides in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00275802665885589,0.00560883230527668,-0.00823528465948641,0.0137513379771982,0.622920670351089
NMR metabolomics,X23408.Triglycerides in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.00464517996722076,0.00951135778738407,-0.0232874412304935,0.013997081296052,0.625288720109424
NMR metabolomics,X23408.Triglycerides in VLDL,FGF7,Fibroblast growth factor 7,40080,-0.00406518969819327,0.008333445434414,-0.0203987427496447,0.0122683633532582,0.625689858643651
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK2B,Divergent protein kinase domain 2B,40283,0.00142434640928986,0.00292507749626983,-0.00430880548339902,0.00715749830197873,0.626308253401307
NMR metabolomics,X23408.Triglycerides in VLDL,LPO,Lactoperoxidase,42134,0.00305789176932472,0.00638455947512028,-0.00945584480191103,0.0155716283405605,0.631981511434383
NMR metabolomics,X23408.Triglycerides in VLDL,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00127107102865633,0.00265752853991446,-0.00647982696688866,0.003937684909576,0.632452589246653
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR1B,Cornifin-B,40302,-0.00416675996156784,0.00872593336399559,-0.0212695893549992,0.0129360694318635,0.633005172773852
NMR metabolomics,X23408.Triglycerides in VLDL,TXK,Tyrosine-protein kinase TXK,40302,0.0037487882950078,0.00788266517046192,-0.0117012354390976,0.0191988120291132,0.634387462780983
NMR metabolomics,X23408.Triglycerides in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.0020067490834717,0.00426968007928249,-0.00636182387192197,0.0103753220388654,0.638364476948008
NMR metabolomics,X23408.Triglycerides in VLDL,TPSD1,Tryptase delta,40482,-0.00188503396301305,0.0040336160918563,-0.00979092150305139,0.00602085357702529,0.640272079941675
NMR metabolomics,X23408.Triglycerides in VLDL,PRRT3,Proline-rich transmembrane protein 3,40223,-0.00196267473778046,0.00420200055689557,-0.0101985958292958,0.00627324635373485,0.640451134617541
NMR metabolomics,X23408.Triglycerides in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00149376192456948,0.00322089319102417,-0.0048191887298379,0.00780671257897685,0.642818363861062
NMR metabolomics,X23408.Triglycerides in VLDL,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00461733901539805,0.0100506494491082,-0.0150819339048541,0.0243166119356502,0.645951044017832
NMR metabolomics,X23408.Triglycerides in VLDL,IL6ST,Interleukin-6 receptor subunit beta,42636,0.000835783518247723,0.00183358623421764,-0.00275804550081884,0.00442961253731429,0.64852747414304
NMR metabolomics,X23408.Triglycerides in VLDL,CA8,Carbonic anhydrase-related protein,40199,0.00136606553258965,0.00300753110966466,-0.00452869544235307,0.00726082650753238,0.649683096008113
NMR metabolomics,X23408.Triglycerides in VLDL,TPT1,Translationally-controlled tumor protein,42370,-0.00311595315803841,0.00686324230757557,-0.0165679080808865,0.0103360017648097,0.649831989339428
NMR metabolomics,X23408.Triglycerides in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00341212859069226,0.00753077477854798,-0.0113481899752618,0.0181724471566463,0.650491994983112
NMR metabolomics,X23408.Triglycerides in VLDL,MORN4,MORN repeat-containing protein 4,40080,-0.0036383777242989,0.00808151369874895,-0.0194781445738468,0.012201389125249,0.652568041408516
NMR metabolomics,X23408.Triglycerides in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00333435289085624,0.00740709557654796,-0.0111835544391778,0.0178522602208902,0.652606319165229
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00140068427799454,0.00312464879184108,-0.00472362735401398,0.00752499591000305,0.653966189987722
NMR metabolomics,X23408.Triglycerides in VLDL,GAD1,Glutamate decarboxylase 1,40080,-0.00121844725409468,0.00275085482072939,-0.00661012270272429,0.00417322819453492,0.657822242310492
NMR metabolomics,X23408.Triglycerides in VLDL,CRNN,Cornulin,42209,0.00318024026023419,0.007256418078387,-0.0110423391734043,0.0174028196938727,0.661200849933902
NMR metabolomics,X23408.Triglycerides in VLDL,COMP,Cartilage oligomeric matrix protein,42511,-0.00153271549255924,0.00352863024755344,-0.00844883077776399,0.00538339979264551,0.664030032379562
NMR metabolomics,X23408.Triglycerides in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00231530705911809,0.00535701488127591,-0.0081844421081827,0.0128150562264189,0.665603831367807
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,0.00240357890125315,0.00556265118978997,-0.00849921743073519,0.0133063752332415,0.665682586782963
NMR metabolomics,X23408.Triglycerides in VLDL,HMMR,Hyaluronan mediated motility receptor,40059,0.00223893363272835,0.00522261130673307,-0.00799738452846847,0.0124752517939252,0.668150036467696
NMR metabolomics,X23408.Triglycerides in VLDL,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.0025199398522625,0.00590194953344822,-0.014087760937821,0.009047881233296,0.669410104280493
NMR metabolomics,X23408.Triglycerides in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00226663064586369,0.00542130267569863,-0.012892383890233,0.00835912259850562,0.675884367780867
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN1,Neuroligin-1,40182,-0.00307219602986685,0.00734840573778591,-0.0174750712759272,0.0113306792161935,0.675899328268565
NMR metabolomics,X23408.Triglycerides in VLDL,FGF6,Fibroblast growth factor 6,40199,-0.00182072191311202,0.00435542294851663,-0.0103573508922046,0.00671590706598057,0.67592923394504
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.0015156225834941,0.00365754499781918,-0.0086844107792197,0.0056531656122315,0.678600607977066
NMR metabolomics,X23408.Triglycerides in VLDL,ABO,Histo-blood group ABO system transferase,40532,-0.00628480516449414,0.0152372554360477,-0.0361498258191475,0.0235802154901593,0.680007841670031
NMR metabolomics,X23408.Triglycerides in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.00104341758388361,0.00254434349747745,-0.00394349567117219,0.00603033083893942,0.681744208282459
NMR metabolomics,X23408.Triglycerides in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00168651889460641,0.0041434671194977,-0.00643467665960909,0.0098077144488219,0.683993092920828
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.00342733944137147,0.00845199278128256,-0.0199932452926853,0.0131385664099424,0.685111713270081
NMR metabolomics,X23408.Triglycerides in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.0015999707740563,0.0039477058819959,-0.00933747430276826,0.00613753275465566,0.685270125813385
NMR metabolomics,X23408.Triglycerides in VLDL,COPE,Coatomer subunit epsilon,42311,0.00201696282314547,0.00497926898673305,-0.00774240439085131,0.0117763300371423,0.685431137730198
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00176316033157122,0.00437866565509116,-0.0103453450155499,0.00681902435240745,0.687198318238399
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC2,Plexin domain-containing protein 2,40483,-0.00114453456252905,0.00286693900456002,-0.00676373501146669,0.00447466588640859,0.68973989993861
NMR metabolomics,X23408.Triglycerides in VLDL,WNT9A,Protein Wnt-9a,42370,-0.00123398847932588,0.00311691327483566,-0.00734313849800377,0.00487516153935202,0.692184616358332
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2BP,LRP2-binding protein,40182,0.00357393454007135,0.00907477564146411,-0.0142126257171983,0.021360494797341,0.693712922640022
NMR metabolomics,X23408.Triglycerides in VLDL,ARG2,"Arginase-2, mitochondrial",40451,0.00176406366042414,0.00448649853610171,-0.00702947347033522,0.0105576007911835,0.694183753006232
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00128802393280038,0.00332647201211734,-0.00780790907655036,0.00523186121094961,0.698612572018905
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00127560004797474,0.00331809929181173,-0.00522787456397625,0.00777907465992573,0.700660811813907
NMR metabolomics,X23408.Triglycerides in VLDL,TFAP2A,Transcription factor AP-2-alpha,40136,0.00246392642516821,0.00641084553319609,-0.0101013308198961,0.0150291836702325,0.700736008057774
NMR metabolomics,X23408.Triglycerides in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00317346632117626,0.00826285369213741,-0.0130217269154131,0.0193686595577656,0.700938293790288
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00358851318022065,0.00951280489035846,-0.0222336107653232,0.0150565844048819,0.706009971213874
NMR metabolomics,X23408.Triglycerides in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00430432000029052,0.0115829761448934,-0.0183983132437006,0.0270069532442817,0.710192364650611
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA3,GDNF family receptor alpha-3,42474,-0.00111702442894047,0.00301977947027082,-0.00703579219067128,0.00480174333279034,0.711460925331072
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR3,Folate receptor gamma,42629,-0.00717386987619816,0.0194623947769583,-0.0453201636390364,0.03097242388664,0.71243050987806
NMR metabolomics,X23408.Triglycerides in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00255592814278291,0.00693660521886179,-0.016151674371752,0.0110398180861862,0.712530274567887
NMR metabolomics,X23408.Triglycerides in VLDL,LY96,Lymphocyte antigen 96,42495,0.00136554634119072,0.00374679055309733,-0.00597816314288005,0.00870925582526149,0.715522114092307
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB116,Beta-defensin 116,40136,-0.00294111761735141,0.00809262472920441,-0.0188026620865921,0.0129204268518892,0.716289330303562
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.00129353743710413,0.00363805319042169,-0.00842412169033064,0.00583704681612239,0.722177443966992
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP2,Cysteine-rich secretory protein 2,42721,0.00217578824179664,0.00622865555371715,-0.010032376643489,0.0143839531270823,0.726855211644729
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00179215315113,0.00514584493151229,-0.0118780092168941,0.00829370291463409,0.727642735353736
NMR metabolomics,X23408.Triglycerides in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.00137710719619406,0.0039650605634615,-0.00914862590057859,0.00639441150819047,0.728364749787263
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM132A,Transmembrane protein 132A,40223,0.00228448287846591,0.00658351749950272,-0.0106192114205594,0.0151881771774912,0.728597676229436
NMR metabolomics,X23408.Triglycerides in VLDL,CADPS,Calcium-dependent secretion activator 1,40182,0.00154302764187439,0.00450418732905516,-0.00728517952307371,0.0103712348068225,0.731923818268578
NMR metabolomics,X23408.Triglycerides in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.00229541535582853,0.00670331056792656,-0.0154339040689646,0.0108430733573075,0.732033811473564
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3A,Uroplakin-3a,40136,0.00181829884984498,0.00537190238092598,-0.00871062981676994,0.0123472275164599,0.735005559791115
NMR metabolomics,X23408.Triglycerides in VLDL,TCP11,T-complex protein 11 homolog,40302,0.0021031365469427,0.00621921822910219,-0.0100865311820976,0.014292804275983,0.735243469870075
NMR metabolomics,X23408.Triglycerides in VLDL,DNLZ,DNL-type zinc finger protein,40136,0.00321800211859891,0.00956752412731433,-0.0155343451709372,0.021970349408135,0.736616127649936
NMR metabolomics,X23408.Triglycerides in VLDL,IL24,Interleukin-24,42370,0.00178261354071302,0.00530740117152198,-0.00861989275547006,0.0121851198368961,0.736971874527472
NMR metabolomics,X23408.Triglycerides in VLDL,SCIN,Adseverin,40136,0.0025485292133397,0.00766363217972993,-0.012472189858931,0.0175692482856104,0.739481511147762
NMR metabolomics,X23408.Triglycerides in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,0.00120289126757954,0.00367544540809368,-0.00600098173228407,0.00840676426744315,0.74346294819152
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB2,Integrin beta-2,42569,0.00097357458597703,0.00300218124480166,-0.00491070065383422,0.00685784982578828,0.745724259385237
NMR metabolomics,X23408.Triglycerides in VLDL,PGM2,Phosphoglucomutase-2,40182,0.0020338550162065,0.00628760073526247,-0.0102898424249079,0.0143575524573209,0.746344900898329
NMR metabolomics,X23408.Triglycerides in VLDL,LAYN,Layilin,42476,-0.00128429768299206,0.0039722258812397,-0.00906986041022186,0.00650126504423774,0.746458454401078
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00215199205643347,0.00665822780275383,-0.015202118549831,0.010898134436964,0.746543856153026
NMR metabolomics,X23408.Triglycerides in VLDL,UNC5D,Netrin receptor UNC5D,40199,-0.000887435025683412,0.00274745024466154,-0.00627243750522003,0.00449756745385321,0.746699009118498
NMR metabolomics,X23408.Triglycerides in VLDL,IL2,Interleukin-2,42370,-0.00108246740015918,0.00336907091648588,-0.00768584639647151,0.00552091159615315,0.747991545490014
NMR metabolomics,X23408.Triglycerides in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00205134594989549,0.00644023214459955,-0.0146742009533106,0.0105715090535196,0.750096238930967
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00580762071501176,0.018393158224486,-0.0302429694049809,0.0418582108350044,0.752198910581334
NMR metabolomics,X23408.Triglycerides in VLDL,IL3,Interleukin-3,40080,0.0020495178743874,0.00649493662071656,-0.010680557902217,0.0147795936509918,0.752345394970563
NMR metabolomics,X23408.Triglycerides in VLDL,FZD8,Frizzled-8,40136,0.00151620095206389,0.00480871102919638,-0.00790887266516102,0.0109412745692888,0.752537629991222
NMR metabolomics,X23408.Triglycerides in VLDL,S100A16,Protein S100-A16,42292,0.00199891127733446,0.00637407924516319,-0.0104942840431854,0.0144921065978543,0.753829850222761
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.000956512989825272,0.00307803456767719,-0.00507643476282202,0.00698946074247256,0.755993172730149
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX1,Neuronal pentraxin-1,42611,-0.00130187060920001,0.00420463311367497,-0.00954295151200295,0.00693921029360294,0.756848946678719
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC12,WAP four-disulfide core domain protein 12,42698,0.00211958337231123,0.00686655074574499,-0.0113388560893489,0.0155780228339714,0.757567893978101
NMR metabolomics,X23408.Triglycerides in VLDL,NPTN,Neuroplastin,42346,-0.00252180341841587,0.00825932340550883,-0.0187100772932132,0.0136664704563814,0.760121117884738
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3B,Sodium channel subunit beta-3,40136,0.00154439579251104,0.00506020621842193,-0.00837360839559593,0.011462399980618,0.760216498968604
NMR metabolomics,X23408.Triglycerides in VLDL,SHC1,SHC-transforming protein 1,40080,-0.0037696843252535,0.0124170210172385,-0.028107045519041,0.0205676768685339,0.761446016825555
NMR metabolomics,X23408.Triglycerides in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00119566337464874,0.00395764320048202,-0.0089526440475935,0.00656131729829603,0.762569081041948
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D2,DCN1-like protein 2,40080,0.00252995727596121,0.00842332961966715,-0.0139797687785864,0.0190396833305088,0.763915007685902
NMR metabolomics,X23408.Triglycerides in VLDL,MLLT1,Protein ENL,40080,0.0020828758886853,0.00697757394136226,-0.0115931690363847,0.0157589208137553,0.765319610602259
NMR metabolomics,X23408.Triglycerides in VLDL,EVPL,Envoplakin,40302,-0.00109701125725751,0.00369779647585563,-0.00834469234993455,0.00615066983541953,0.766726905143717
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,-0.00216313914964965,0.00733798754698932,-0.0165455947417487,0.0122193164424494,0.768162542533473
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L2,Mortality factor 4-like protein 2,40080,0.00113187635958362,0.0038634832681049,-0.00644055084590199,0.00870430356506923,0.769552315399217
NMR metabolomics,X23408.Triglycerides in VLDL,KDM3A,Lysine-specific demethylase 3A,40199,-0.00267486149723529,0.00920285335380462,-0.0207124540706923,0.0153627310762218,0.771320156490336
NMR metabolomics,X23408.Triglycerides in VLDL,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.00159925827635793,0.00553309595535519,-0.0124441263488541,0.00924560979613824,0.772559931958682
NMR metabolomics,X23408.Triglycerides in VLDL,TEX33,Testis-expressed protein 33,40302,-0.00115403010729244,0.00400823094933395,-0.00901016276798699,0.0067021025534021,0.773417119904645
NMR metabolomics,X23408.Triglycerides in VLDL,GPHA2,Glycoprotein hormone alpha-2,40449,-0.00140586594850938,0.00489016202421513,-0.010990583515971,0.00817885161895227,0.773743504538845
NMR metabolomics,X23408.Triglycerides in VLDL,SYT1,Synaptotagmin-1,40483,0.00127925532390344,0.00445042608151228,-0.00744357979586063,0.0100020904436675,0.773776438256483
NMR metabolomics,X23408.Triglycerides in VLDL,IL36A,Interleukin-36 alpha,40199,-0.00173618584527032,0.00604571143169665,-0.0135857802513958,0.0101134085608551,0.773982637035618
NMR metabolomics,X23408.Triglycerides in VLDL,TP53BP1,TP53-binding protein 1,40199,0.00261710619385384,0.00911623151370055,-0.0152507075729992,0.0204849199607069,0.77405492082969
NMR metabolomics,X23408.Triglycerides in VLDL,MAPT,Microtubule-associated protein tau,42311,-0.00159219408182184,0.00558735983436114,-0.0125434193571697,0.00935903119352599,0.77567654056313
NMR metabolomics,X23408.Triglycerides in VLDL,CLSPN,Claspin,42292,0.00104801152487952,0.00368071195734481,-0.00616618391151629,0.00826220696127534,0.77585500484531
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC11A,C-type lectin domain family 11 member A,42592,-0.00146410246405965,0.00514807361967101,-0.0115543267586148,0.00862612183049552,0.776109694013369
NMR metabolomics,X23408.Triglycerides in VLDL,NCLN,Nicalin,42370,0.00154707024353896,0.00544431457801815,-0.00912378632937662,0.0122179268164545,0.776290288838545
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.000951484190600202,0.00340595130529253,-0.00762714874897355,0.00572418036777315,0.779973403312372
NMR metabolomics,X23408.Triglycerides in VLDL,SCGN,Secretagogin,42370,-0.00132200766410821,0.00474820115240656,-0.0106284819228251,0.00798446659460865,0.780692155347383
NMR metabolomics,X23408.Triglycerides in VLDL,PSMC3,26S proteasome regulatory subunit 6A,40080,-0.000886419775406637,0.00321899278921491,-0.00719564564226785,0.00542280609145458,0.783035848695054
NMR metabolomics,X23408.Triglycerides in VLDL,PCNA,Proliferating cell nuclear antigen,40080,0.00178593043600937,0.0065738635264692,-0.0110988420758703,0.014670702947889,0.785879877411536
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF75D,Zinc finger protein 75D,40302,0.00171513020739494,0.00644554013701139,-0.0109181284611474,0.0143483888759373,0.790170481967667
NMR metabolomics,X23408.Triglycerides in VLDL,ADA2,Adenosine deaminase 2,42572,0.00123807995434402,0.00465391801787828,-0.00788359936069741,0.0103597592693854,0.790220511348671
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00152335501910125,0.00575703744202988,-0.0128071484054798,0.00976043836727732,0.791316832781274
NMR metabolomics,X23408.Triglycerides in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.000717629921504328,0.00271787887819879,-0.00604467252277396,0.00460941267976531,0.791753742959142
NMR metabolomics,X23408.Triglycerides in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.0013186466953218,0.00501325654310917,-0.0111446295198158,0.00850733612917218,0.79253092342937
NMR metabolomics,X23408.Triglycerides in VLDL,ESPL1,Separin,40080,0.00156919807522145,0.00604592476800143,-0.0102808144700613,0.0134192106205043,0.79521858563801
NMR metabolomics,X23408.Triglycerides in VLDL,ENG,Endoglin,42794,-0.000471806438247063,0.0018233842277801,-0.00404563952469606,0.00310202664820193,0.79582961290239
NMR metabolomics,X23408.Triglycerides in VLDL,SLC51B,Organic solute transporter subunit beta,40116,-0.00208609342484311,0.00809610765367185,-0.0179544644260399,0.0137822775763537,0.796669375798371
NMR metabolomics,X23408.Triglycerides in VLDL,CDH17,Cadherin-17,42636,0.00186471569196112,0.00728612747747401,-0.012416094163888,0.0161455255478102,0.798011233696155
NMR metabolomics,X23408.Triglycerides in VLDL,PAEP,Glycodelin,42495,0.00240680607786654,0.00945312260992472,-0.0161213142375859,0.020934926393319,0.799032639986828
NMR metabolomics,X23408.Triglycerides in VLDL,CDC25A,M-phase inducer phosphatase 1,40080,-0.0010398806417742,0.00409747399896601,-0.00907092967974758,0.00699116839619918,0.799665851350473
NMR metabolomics,X23408.Triglycerides in VLDL,L1CAM,Neural cell adhesion molecule L1,42679,-0.000779213297577924,0.00307069712453792,-0.00679777966167224,0.0052393530665164,0.799686558251842
NMR metabolomics,X23408.Triglycerides in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00152962326063592,0.00606156567871922,-0.0103510454696537,0.0134102919909256,0.800776945046022
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D1,DCN1-like protein 1,40136,-0.00197691622736985,0.00787576928667183,-0.0174134240292466,0.0134595915745069,0.801809188752059
NMR metabolomics,X23408.Triglycerides in VLDL,BTNL10,Butyrophilin-like protein 10,40080,-0.00111949993957422,0.00448260163957997,-0.00990539915315096,0.00766639927400253,0.802790545876258
NMR metabolomics,X23408.Triglycerides in VLDL,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00143461606159889,0.00583946719166195,-0.0100107396340585,0.0128799717572563,0.805937800227165
NMR metabolomics,X23408.Triglycerides in VLDL,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.000973198116281098,0.00397913171214664,-0.00877229627208851,0.00682590003952631,0.806788883241197
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT3,Kunitz-type protease inhibitor 3,40449,-0.00370311134666475,0.0156039652739252,-0.0342868832835581,0.0268806605902286,0.812413945312233
NMR metabolomics,X23408.Triglycerides in VLDL,RANGAP1,Ran GTPase-activating protein 1,42346,0.00119424747460121,0.00507202526952636,-0.00874692205367045,0.0111354170028729,0.813857161722799
NMR metabolomics,X23408.Triglycerides in VLDL,CYTH3,Cytohesin-3,40080,-0.00183276530169185,0.00785077802071896,-0.017220290222301,0.0135547596189173,0.815416264627369
NMR metabolomics,X23408.Triglycerides in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.0010948611208462,0.00475335837029657,-0.00822172128493507,0.0104114435266275,0.817836395116555
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN1,Cerebellin-1,40136,0.00224653867558198,0.00997344507401296,-0.0173014136694834,0.0217944910206474,0.82178742746412
NMR metabolomics,X23408.Triglycerides in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00121896661676613,0.00544748686148817,-0.0118960408652829,0.00945810763175069,0.82294293704718
NMR metabolomics,X23408.Triglycerides in VLDL,EXOSC10,Exosome component 10,40116,-0.00141977376865026,0.00634643332554094,-0.0138587830867105,0.01101923554941,0.82298553362093
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN2,Contactin-2,42721,0.00104210711937581,0.00467708160638045,-0.00812497282912988,0.0102091870678815,0.82368565613585
NMR metabolomics,X23408.Triglycerides in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.000626742852145023,0.00297511610915434,-0.00520448472179749,0.00645797042608753,0.833154499305327
NMR metabolomics,X23408.Triglycerides in VLDL,KLK3,Prostate-specific antigen,40527,0.00213077751785338,0.0103116190215239,-0.0180799957643335,0.0223415508000402,0.836295900323049
NMR metabolomics,X23408.Triglycerides in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00125669717677598,0.00608635288321823,-0.0106725544743317,0.0131859488278837,0.836421511297475
NMR metabolomics,X23408.Triglycerides in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.00127510053145378,0.00622312932284238,-0.0134724340042248,0.0109222329413173,0.837656409990408
NMR metabolomics,X23408.Triglycerides in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00108134135254685,0.00531351338584072,-0.00933314488370095,0.0114958275887947,0.838741963368316
NMR metabolomics,X23408.Triglycerides in VLDL,ANK2,Ankyrin-2,40116,-0.00150119030040163,0.00773666107201139,-0.0166650460015439,0.0136626654007407,0.84615134945899
NMR metabolomics,X23408.Triglycerides in VLDL,HMCN2,Hemicentin-2,40269,-0.00118807219550517,0.00613328134744262,-0.0132093036364927,0.0108331592454824,0.846407245882986
NMR metabolomics,X23408.Triglycerides in VLDL,ESR1,Estrogen receptor,40199,-0.00111375791845815,0.00580839699830128,-0.0124982160351287,0.0102707001982124,0.847941873462948
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RB,Interleukin-2 receptor subunit beta,42370,0.000782108431596577,0.00412250970078835,-0.00729801058194859,0.00886222744514174,0.849534152069042
NMR metabolomics,X23408.Triglycerides in VLDL,CHIT1,Chitotriosidase-1,42699,-0.00306753732729442,0.0161834271583134,-0.0347870545575888,0.0286519799029999,0.849666134788557
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,0.00234728307882766,0.0124513217346924,-0.0220573075211694,0.0267518736788247,0.850474414027177
NMR metabolomics,X23408.Triglycerides in VLDL,SSB,Lupus La protein,42311,0.00113942119090712,0.00611308896176623,-0.0108422331741547,0.0131210755559689,0.852141490530175
NMR metabolomics,X23408.Triglycerides in VLDL,CRX,Cone-rod homeobox protein,42357,-0.00203964833025086,0.0111490363157621,-0.0238917595091446,0.0198124628486428,0.854844844198348
NMR metabolomics,X23408.Triglycerides in VLDL,NPTXR,Neuronal pentraxin receptor,42636,0.000650079248837562,0.00356107579468404,-0.00632962930874316,0.00762978780641828,0.855152800637866
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN4,Prefoldin subunit 4,40080,-0.00100629854798764,0.00551931945586642,-0.0118241646814858,0.00981156758551055,0.8553326920999
NMR metabolomics,X23408.Triglycerides in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,40302,0.00127542061749333,0.00704231601365023,-0.0125275187692611,0.0150783600042478,0.856286014966446
NMR metabolomics,X23408.Triglycerides in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,42240,0.000742314659641304,0.00423407671025931,-0.00755647569246695,0.00904110501174956,0.860831599143755
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.000605347903202543,0.00349584152822902,-0.00745719729853143,0.00624650149212634,0.862527071784093
NMR metabolomics,X23408.Triglycerides in VLDL,GAMT,Guanidinoacetate N-methyltransferase,40116,0.00067124836740813,0.00398153775692279,-0.00713256563616054,0.0084750623709768,0.866122087448564
NMR metabolomics,X23408.Triglycerides in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.000837380892375371,0.00499971523792029,-0.0089620609739484,0.0106368227586991,0.866990985628812
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,0.000767193699353968,0.00459310142435423,-0.00823528509238032,0.00976967249108825,0.867347599785328
NMR metabolomics,X23408.Triglycerides in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.000766845735380422,0.00461118891446104,-0.00980477600772407,0.00827108453696322,0.867923036290358
NMR metabolomics,X23408.Triglycerides in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.000970280879797302,0.0058362971655254,-0.0104688615646325,0.0124094233242271,0.867963775226035
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM2,Intercellular adhesion molecule 2,42794,0.000554991728468202,0.00340032785631247,-0.00610965086990424,0.00721963432684065,0.870349910266266
NMR metabolomics,X23408.Triglycerides in VLDL,CD27,CD27 antigen,42679,0.000705133971101653,0.00464429928415639,-0.00839769262584487,0.00980796056804817,0.879324987591946
NMR metabolomics,X23408.Triglycerides in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.000468937719982489,0.00309438463404441,-0.00653393160270953,0.00559605616274455,0.879548727765968
NMR metabolomics,X23408.Triglycerides in VLDL,DLGAP5,Disks large-associated protein 5,40482,0.000806076262257393,0.00533685136486409,-0.00965415241287623,0.011266304937391,0.879947122636853
NMR metabolomics,X23408.Triglycerides in VLDL,MSMB,Beta-microseminoprotein,42559,0.00110747188477002,0.00759798288016077,-0.0137845745603451,0.0159995183298851,0.884114101510688
NMR metabolomics,X23408.Triglycerides in VLDL,CDAN1,Codanin-1,40483,0.000345552612103676,0.00237599561585334,-0.00431139879496887,0.00500250401917623,0.884370131997666
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.000982500381999344,0.00682362721781803,-0.0143568097289227,0.012391808964924,0.885514421119744
NMR metabolomics,X23408.Triglycerides in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.000798188427456929,0.00598588685825238,-0.0109341498147177,0.0125305266696316,0.893922947149114
NMR metabolomics,X23408.Triglycerides in VLDL,KCNIP4,Kv channel-interacting protein 4,42311,-0.000638006592307982,0.00517674731964537,-0.0107844313388129,0.00950841815419694,0.901915230059487
NMR metabolomics,X23408.Triglycerides in VLDL,PRND,Prion-like protein doppel,40483,-0.000677622750501737,0.00549824594806336,-0.0114541848087059,0.0100989393077024,0.901916520728708
NMR metabolomics,X23408.Triglycerides in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.000847108599405038,0.00694017882453939,-0.0127556418966922,0.0144498590955022,0.902854430265237
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN15,Tetraspanin-15,40116,0.000667950735068577,0.00547592914476763,-0.010064870388676,0.0114007718588131,0.902917550404741
NMR metabolomics,X23408.Triglycerides in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.000567788565031504,0.00470312988556652,-0.00865034601067887,0.00978592314074188,0.903910464836837
NMR metabolomics,X23408.Triglycerides in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.000785950190273031,0.0066113684757345,-0.0121723320221666,0.0137442324027127,0.905373690477791
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.000499899234640889,0.00429457975033232,-0.00791747707601045,0.00891727554529223,0.907335444049478
NMR metabolomics,X23408.Triglycerides in VLDL,FOS,Proto-oncogene c-Fos,40065,0.000435468353139032,0.00375541149745816,-0.00692513818187896,0.00779607488815702,0.907688319062153
NMR metabolomics,X23408.Triglycerides in VLDL,ACAN,Aggrecan core protein,42488,-0.000321648811315862,0.00291124197440108,-0.00602768308114197,0.00538438545851025,0.912026347238076
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171A2,Protein FAM171A2,40482,0.00179120316001173,0.0167979922010199,-0.0311328615539873,0.0347152678740108,0.915082842147689
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L1,Mortality factor 4-like protein 1,40302,0.00043775128075137,0.00419530985878401,-0.00778505604246529,0.00866055860396803,0.916899026756375
NMR metabolomics,X23408.Triglycerides in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.000548480277258229,0.00539964631313279,-0.0111317870509985,0.010034826496482,0.91909428904024
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.000896028031191987,0.00890859544467292,-0.0183568751027509,0.0165648190403669,0.919885568290438
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.000757821083089123,0.0080464172772389,-0.0150131567802991,0.0165287989464774,0.924966909796539
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF830,Zinc finger protein 830,40451,-0.000740663283996516,0.00814255727245805,-0.0167000755380143,0.0152187489700213,0.92752440491267
NMR metabolomics,X23408.Triglycerides in VLDL,BEX3,Protein BEX3,40080,0.000447602219674461,0.00502498271262928,-0.00940136389707892,0.0102965683364278,0.929023646063618
NMR metabolomics,X23408.Triglycerides in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.000428588201412851,0.00514106421518038,-0.0096478976603407,0.0105050740631664,0.933562310579902
NMR metabolomics,X23408.Triglycerides in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.000274210962555092,0.00348839108111492,-0.00656303555643014,0.00711145748154033,0.937346641344116
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC9,Histone deacetylase 9,40136,-0.000508735569761186,0.00689696015376474,-0.0140267774711401,0.0130093063316177,0.941200882376279
NMR metabolomics,X23408.Triglycerides in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.000396831197503498,0.00565949797363776,-0.0114894472258335,0.0106957848308265,0.944101229726493
NMR metabolomics,X23408.Triglycerides in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.000164463606380859,0.00238586490131933,-0.00451183160020502,0.00484075881296674,0.945044370846652
NMR metabolomics,X23408.Triglycerides in VLDL,NXPE4,NXPE family member 4,40116,-0.000223101809828927,0.00354226282766071,-0.00716593695204392,0.00671973333238606,0.949781313118592
NMR metabolomics,X23408.Triglycerides in VLDL,HEBP1,Heme-binding protein 1,42357,0.000343910405185502,0.00553175154073234,-0.0104983226146499,0.0111861434250209,0.950428193467026
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,-0.000593773345692357,0.0101193364669273,-0.0204276728208699,0.0192401261294852,0.953210374273082
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF174,Zinc finger protein 174,40199,0.000223313483921588,0.00393154957937416,-0.00748252369165177,0.00792915065949495,0.954705247716209
NMR metabolomics,X23408.Triglycerides in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.000263660001734777,0.00468737469054747,-0.00945091439520782,0.00892359439173826,0.955144496908243
NMR metabolomics,X23408.Triglycerides in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00017197444806742,0.00308689962254154,-0.00622229770824883,0.00587834881211399,0.955572971175738
NMR metabolomics,X23408.Triglycerides in VLDL,FGF12,Fibroblast growth factor 12,40199,0.000250006589918444,0.00491738457451692,-0.00938806717613471,0.0098880803559716,0.959452844239731
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB2,Beta-crystallin B2,40483,0.00037809705830126,0.00857723296991881,-0.0164332795627396,0.0171894736793421,0.964840240967566
NMR metabolomics,X23408.Triglycerides in VLDL,TAP1,Antigen peptide transporter 1,40302,-0.00027959685327781,0.00647286862085332,-0.0129664193501503,0.0124072256435947,0.965546707922253
NMR metabolomics,X23408.Triglycerides in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,0.000278372660402767,0.00734582365600004,-0.0141194417053573,0.0146761870261628,0.969771802068644
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,-0.000202288321828313,0.00546120195519683,-0.0109062441540141,0.0105016675103575,0.970453000558531
NMR metabolomics,X23408.Triglycerides in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.000305769955841432,0.00828862248464316,-0.0159399301140592,0.016551470025742,0.970573126227651
NMR metabolomics,X23408.Triglycerides in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.000216670904686538,0.00602156183278881,-0.0115855902875795,0.0120189320969526,0.971296963048905
NMR metabolomics,X23408.Triglycerides in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000123506214290543,0.00363565046783964,-0.00724938113125624,0.00700236870267516,0.972901001411747
NMR metabolomics,X23408.Triglycerides in VLDL,NME3,Nucleoside diphosphate kinase 3,42638,4.58373075405503e-05,0.00251335830185035,-0.00488034496408613,0.00497201957916723,0.985449678035892
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,6.03837157927573e-05,0.00353648154390956,-0.00687112011026998,0.00699188754185549,0.986377479965201
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRA2,Ankyrin repeat family A protein 2,40080,-8.16498177635069e-05,0.0060339352848237,-0.011908162976018,0.0117448633404909,0.989203787983228
NMR metabolomics,X23408.Triglycerides in VLDL,MAGEA3,Melanoma-associated antigen 3,40302,9.13738949906548e-05,0.00912117927220527,-0.0177861374785317,0.017968885268513,0.992007287918358
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE10,Inactive ribonuclease-like protein 10,40223,4.90002016009874e-05,0.00519628038205476,-0.0101357093472263,0.0102337097504283,0.992476341576661
NMR metabolomics,X23408.Triglycerides in VLDL,PRTN3,Myeloblastin,42276,-3.31202047010327e-05,0.00511941700374542,-0.0100671775320421,0.01000093712264,0.994838199231319
NMR metabolomics,X23408.Triglycerides in VLDL,HK2,Hexokinase-2,42357,1.38774447163234e-05,0.00289456760766123,-0.00565947506629969,0.00568722995573234,0.996174784055065
NMR metabolomics,X23408.Triglycerides in VLDL,TFRC,Transferrin receptor protein 1,42673,1.38682047449857e-05,0.00396806307921491,-0.00776353543051625,0.00779127184000622,0.997211486189963
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,1.54079852229594e-05,0.00445885561500909,-0.00872394902019485,0.00875476499064077,0.997242904717915
NMR metabolomics,X23408.Triglycerides in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,1.12403538160603e-05,0.00520605472582524,-0.0101926269088014,0.0102151076164335,0.99827733418325
